data_1stu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1stu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 N-CA-C 109.674 -0.933 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 18' ' ' PHE . 5.7 mm -76.63 -51.17 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 t -52.05 -37.5 53.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.635 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 30.6 mt-30 -63.17 -53.65 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.67 ' HA ' HD23 ' A' ' 62' ' ' LEU . 24.2 t -54.9 -67.92 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.581 ' CE1' HG13 ' A' ' 16' ' ' VAL . 92.4 m-70 -36.87 -38.89 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.331 -0.855 . . . . 0.0 109.448 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 2.7 mt-10 -60.08 -62.26 2.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.717 -0.615 . . . . 0.0 110.171 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.607 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -74.1 -51.46 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.607 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -44.3 -52.38 7.22 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -78.0 -37.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.08 -1.247 . . . . 0.0 110.17 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.537 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 8.6 mmtm -60.65 -16.84 43.12 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.468 -0.77 . . . . 0.0 111.171 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.585 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.7 tpt180 -116.32 -44.1 2.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.79 -1.194 . . . . 0.0 109.578 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.585 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER 155.46 -15.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.017 -0.427 . . . . 0.0 109.928 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.567 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -71.91 111.8 7.47 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.834 -1.166 . . . . 0.0 110.054 -179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.532 ' CG2' ' NE2' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -64.93 121.85 15.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.029 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.59 ' CG1' HG13 ' A' ' 5' ' ' VAL . 60.7 t -98.19 110.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.653 ' CD2' ' CG2' ' A' ' 37' ' ' ILE . 4.2 m-70 -136.49 95.5 3.17 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.588 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.651 ' CE2' ' HB3' ' A' ' 36' ' ' CYS . 60.2 m-85 -78.71 135.14 37.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 110.997 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 4.7 mtmt -150.36 110.49 4.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 95.2 t -78.62 118.39 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 108.818 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.544 HD22 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -118.76 10.26 12.34 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -178.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.125 . . . . 0.0 110.267 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 4.6 m-85 -99.87 127.09 46.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.029 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.6 mp -88.81 97.31 6.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.549 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 5.1 m -86.16 118.04 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -82.01 114.49 20.61 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.873 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.651 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -110.22 113.19 25.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.653 ' CG2' ' CD2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -78.77 138.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.196 -0.94 . . . . 0.0 109.336 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.552 ' N ' ' CD1' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -131.4 146.42 33.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 42.38 -112.88 0.5 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 2.77 11.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -1.204 . . . . 0.0 109.94 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 37' ' ' ILE . 1.8 mp -120.76 154.15 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 108.477 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.92 160.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.855 -1.153 . . . . 0.0 110.229 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.536 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 23.3 m -150.34 90.6 1.67 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.549 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 3.8 mt-10 -81.12 -172.84 3.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.865 -1.147 . . . . 0.0 110.686 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.31 119.57 0.83 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.535 ' CG ' HG13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -80.37 92.01 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.072 -1.252 . . . . 0.0 111.107 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.516 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -35.57 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.701 -0.624 . . . . 0.0 110.935 -179.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 52' ' ' VAL . 13.4 mttp -76.29 -49.68 16.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.593 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.73 -35.72 81.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.145 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 2.1 tpp180 -76.87 -40.32 48.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 109.885 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.549 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -61.81 -51.67 67.33 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 108.356 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -63.0 -56.38 17.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 110.051 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.503 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mt-10 -46.78 -43.6 18.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.731 -1.231 . . . . 0.0 108.112 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.97 -43.2 95.25 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.562 ' CE ' ' O ' ' A' ' 36' ' ' CYS . 5.9 ttm -65.15 -70.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 110.484 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.67 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -47.71 -62.58 1.38 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 78.8 t -44.32 -38.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.37 -0.831 . . . . 0.0 108.991 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -58.03 -57.34 13.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.588 -0.695 . . . . 0.0 111.059 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.54 ' HG ' ' CE ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -110.04 24.04 13.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.846 -1.159 . . . . 0.0 111.608 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 21.1 mm-40 -112.16 -20.41 11.92 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.6 -33.41 10.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.578 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.305 -1.352 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.681 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.525 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 3.0 Cg_exo . . . . . 0 N--CA 1.496 1.668 0 N-CA-C 109.597 -0.963 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.569 HD11 ' CE2' ' A' ' 18' ' ' PHE . 2.7 mm -80.32 -62.29 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.236 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -42.02 69.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.6 mm100 -57.1 -52.0 67.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.107 -0.995 . . . . 0.0 108.936 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.649 ' HA ' HD22 ' A' ' 62' ' ' LEU . 74.7 t -55.61 -68.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.499 ' C ' ' O ' ' A' ' 5' ' ' VAL . 82.6 m-70 -35.15 -34.58 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.656 0.741 . . . . 0.0 109.578 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.2 mt-10 -68.61 -52.56 30.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.73 -0.606 . . . . 0.0 110.585 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -73.23 -45.89 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.676 -179.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.634 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -50.73 -52.97 27.66 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.4 -47.4 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.057 -1.26 . . . . 0.0 109.451 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -63.99 -10.05 19.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -125.22 8.06 7.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.833 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 80.19 -10.78 1.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.686 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.522 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -72.94 89.53 1.42 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.067 -1.021 . . . . 0.0 109.081 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -43.48 149.36 0.27 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 109.509 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.548 ' CG1' HG11 ' A' ' 5' ' ' VAL . 39.9 t -125.93 102.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.167 -0.958 . . . . 0.0 109.033 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.577 ' CB ' HG23 ' A' ' 37' ' ' ILE . 39.0 m-70 -121.77 95.09 4.53 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.524 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 3.1 m-85 -81.21 129.82 34.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.955 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.66 111.41 4.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 70.7 t -78.06 103.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 0.0 109.035 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.583 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -89.68 -21.85 22.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.072 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.494 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.647 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 2.8 m120 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.392 0.615 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 20.6 m-85 -103.98 119.3 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 2.1 mm -89.48 92.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.021 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.594 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 19.5 m -89.59 113.46 24.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.493 -0.754 . . . . 0.0 109.131 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.583 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -80.01 116.61 20.24 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.44 -0.788 . . . . 0.0 110.236 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.63 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -113.27 115.24 27.87 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.577 HG23 ' CB ' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -76.69 134.78 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.961 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.546 ' CG2' ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -130.17 135.11 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 49.23 -127.29 21.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -104.51 5.05 33.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -1.13 . . . . 0.0 109.774 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -122.15 151.61 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 108.894 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG11 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.85 160.96 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.968 -1.083 . . . . 0.0 109.746 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 21.2 m -150.45 92.01 1.81 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.565 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -81.42 -173.74 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.878 -1.138 . . . . 0.0 110.446 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.37 110.95 0.46 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 pt-20 -79.25 75.61 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 110.681 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 53' ' ' SER . 1.2 p . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 3.4 p 84.38 -57.93 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.915 -0.49 . . . . 0.0 109.693 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' N ' ' OG ' ' A' ' 53' ' ' SER . 4.6 pttp -80.06 -48.83 12.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 108.966 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 98.4 mttt -68.62 -30.03 68.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.536 ' HG3' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -79.49 -38.82 33.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.478 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.594 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.022 -1.049 . . . . 0.0 108.394 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -65.1 -54.69 26.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.474 -0.766 . . . . 0.0 110.214 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.529 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.4 mt-10 -48.51 -42.71 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.61 -1.306 . . . . 0.0 107.76 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.7 tptp -62.76 -39.46 94.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.546 ' SD ' ' CG2' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -65.78 -71.46 0.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.613 . . . . 0.0 110.072 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 5' ' ' VAL . 1.3 mt -51.76 -56.98 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.127 -0.983 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 79.0 t -47.19 -39.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 108.506 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -61.15 -68.39 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.748 . . . . 0.0 110.386 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.35 -27.96 1.84 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.185 . . . . 0.0 109.964 -178.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 24.2 mm-40 -54.03 -49.49 68.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.931 -1.106 . . . . 0.0 109.536 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -51.22 36.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.985 . . . . 0.0 109.338 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.48 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.496 1.651 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.514 HD11 ' N ' ' A' ' 2' ' ' ILE . 3.4 mm -68.24 -54.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.152 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -53.09 -30.67 37.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 109.216 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.6 mm100 -65.04 -55.81 16.71 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.621 ' CG1' HD22 ' A' ' 62' ' ' LEU . 21.8 t -53.64 -67.67 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.531 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 90.7 m-70 -36.46 -39.12 0.18 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 7.5 mt-10 -63.56 -59.02 5.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.845 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.636 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.8 pp -70.92 -50.4 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.897 -1.127 . . . . 0.0 110.31 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.636 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -47.53 -49.65 20.4 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.54 -45.6 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.664 -1.492 . . . . 0.0 109.823 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -64.0 -11.74 31.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.68 15.32 8.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.98 -1.075 . . . . 0.0 109.717 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 1.2 m-20 72.68 -4.82 2.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.545 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 3.0 mtp -79.75 91.2 5.28 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.809 -1.182 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -44.59 158.46 0.05 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.083 -1.011 . . . . 0.0 109.869 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.583 ' CG1' HG13 ' A' ' 5' ' ' VAL . 54.9 t -128.04 91.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.583 ' CG ' HG23 ' A' ' 37' ' ' ILE . 27.7 m-70 -109.42 92.88 4.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.581 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 39.7 m-85 -81.47 115.1 20.63 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -149.71 117.71 6.32 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.07 -1.018 . . . . 0.0 109.481 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 53.0 t -79.13 116.86 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.542 HD22 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.52 5.06 13.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.503 -0.748 . . . . 0.0 110.957 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 O-C-N 120.761 -1.212 . . . . 0.0 110.398 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.476 ' HB3' HG11 ' A' ' 20' ' ' VAL . 5.2 m-85 -106.08 151.41 24.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.067 -1.021 . . . . 0.0 108.647 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 5.8 mm -87.55 102.05 12.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.582 ' HB ' ' CB ' ' A' ' 57' ' ' ALA . 91.6 m -88.78 111.1 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.807 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.542 ' CB ' HD22 ' A' ' 21' ' ' LEU . . . -80.27 117.06 20.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 110.3 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -111.69 112.7 24.58 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.583 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.62 137.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.047 -1.033 . . . . 0.0 110.159 -177.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.537 ' CG2' ' SD ' ' A' ' 61' ' ' MET . 0.6 OUTLIER -131.29 126.19 58.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.487 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 56.05 -121.83 25.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.35 4.72 19.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.15 . . . . 0.0 109.418 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.49 161.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 0.0 108.923 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG11 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -102.86 142.05 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.868 -1.145 . . . . 0.0 110.425 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.551 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 20.3 m -132.49 92.1 3.03 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.1 mp0 -85.36 -168.71 2.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.012 -1.055 . . . . 0.0 111.171 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -155.75 -179.25 30.69 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.5 -2.64 . . . . 0.0 106.5 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 2.5 mt-10 -133.92 71.33 1.46 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 119.453 1.626 . . . . 0.0 110.874 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . . . . . . 0 N--CA 1.494 2.549 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.867 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.52 HG11 ' N ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.52 ' N ' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -33.81 -63.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.268 0.556 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HA ' ' CE ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -47.02 -51.04 18.25 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.111 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 56' ' ' ARG . 1.4 mttt -57.39 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.458 -0.776 . . . . 0.0 109.035 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -29.26 -66.48 0.09 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.889 -0.507 . . . . 0.0 111.226 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.582 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -46.36 -55.03 7.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 110.704 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.574 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -61.2 -53.96 50.3 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.19 -0.944 . . . . 0.0 111.529 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.562 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.8 mm-40 -49.47 -38.02 28.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.382 -1.449 . . . . 0.0 107.545 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 18.5 tptt -63.52 -41.16 98.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.551 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 3.3 ttm -68.48 -73.1 0.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.756 -0.59 . . . . 0.0 110.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.621 HD22 ' CG1' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -48.5 -47.58 38.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.326 -0.859 . . . . 0.0 109.857 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 72.2 t -60.71 -37.92 77.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 108.254 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -58.13 -58.01 10.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.634 -0.666 . . . . 0.0 110.341 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.853 -1.155 . . . . 0.0 110.13 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -50.75 -26.4 5.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -58.5 -53.42 58.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.487 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.579 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.652 0 N-CA-C 109.646 -0.944 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.656 ' CG2' ' CD2' ' A' ' 6' ' ' HIS . 2.5 mp 81.43 -55.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 2' ' ' ILE . 92.9 p -46.38 -50.26 16.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.723 -1.235 . . . . 0.0 108.451 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -58.04 -51.78 68.25 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.569 ' CG2' HD22 ' A' ' 62' ' ' LEU . 47.0 t -49.51 -77.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.656 ' CD2' ' CG2' ' A' ' 2' ' ' ILE . 93.4 m-70 -28.92 -41.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.419 0.628 . . . . 0.0 110.126 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 5' ' ' VAL . 4.0 mm-40 -60.34 -64.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.605 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -70.32 -49.43 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -0.957 . . . . 0.0 110.651 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.605 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -46.96 -56.32 7.74 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -32.56 51.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.259 . . . . 0.0 109.321 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.3 mmtp -76.7 -4.55 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 110.422 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -133.91 16.07 3.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.381 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 80.22 -10.98 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.656 -0.652 . . . . 0.0 109.98 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.572 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 5.2 mtt -75.74 100.37 4.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.81 -1.182 . . . . 0.0 109.674 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -50.5 174.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.827 -1.17 . . . . 0.0 109.55 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 6' ' ' HIS . 95.8 t -149.09 88.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.569 ' CG ' HG23 ' A' ' 37' ' ' ILE . 45.7 m-70 -112.18 95.76 5.64 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.708 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 33.0 m-85 -80.21 118.65 22.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.507 -0.745 . . . . 0.0 111.441 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.528 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.45 123.3 8.69 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 53.4 t -79.78 130.07 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.943 -1.098 . . . . 0.0 108.925 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.546 HD22 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -89.0 -22.37 23.03 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.773 -0.579 . . . . 0.0 109.721 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.528 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 33.8 m-80 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.706 0.765 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 7.2 m-85 -117.86 117.96 30.7 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.507 HD11 ' N ' ' A' ' 33' ' ' ILE . 1.6 mm -86.55 91.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.051 -1.031 . . . . 0.0 108.581 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.576 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 34.7 m -88.8 111.16 21.69 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.546 ' CB ' HD22 ' A' ' 21' ' ' LEU . . . -79.84 113.88 18.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.438 -0.789 . . . . 0.0 110.485 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.646 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -110.93 119.43 39.04 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.569 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -78.75 134.01 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.727 -1.233 . . . . 0.0 111.104 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.595 ' CG1' ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -129.97 140.5 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.456 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 50.61 -91.67 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.9 m -143.51 2.39 1.25 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -1.175 . . . . 0.0 110.35 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 mm -117.05 160.8 16.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.991 -1.068 . . . . 0.0 108.603 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.69 125.38 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.862 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.523 ' CG2' ' HB3' ' A' ' 61' ' ' MET . 73.4 m -115.29 88.67 2.93 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -80.88 -172.82 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.985 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -160.89 115.96 0.69 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.059 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.47 78.59 4.93 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.131 -1.217 . . . . 0.0 109.816 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.496 2.674 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.987 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.482 ' CG1' ' C ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.849 0.357 . . . . 0.0 110.322 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.526 ' OG ' ' CG ' ' A' ' 32' ' ' PHE . 3.9 m -33.49 -74.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.705 -0.622 . . . . 0.0 111.739 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' SER . 33.1 pttt -43.1 -51.73 5.74 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.145 -0.972 . . . . 0.0 111.1 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -54.51 -39.27 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.94 -1.1 . . . . 0.0 110.464 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.589 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -72.66 -35.85 67.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.576 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -63.82 -53.0 57.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.91 -1.119 . . . . 0.0 108.405 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -62.3 -64.05 1.05 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.429 -0.794 . . . . 0.0 109.403 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 30.9 mt-10 -50.91 -25.5 4.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.754 -1.216 . . . . 0.0 108.502 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -65.89 -53.15 43.36 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.604 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 3.6 ptp -73.62 -51.46 16.7 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.865 -1.534 . . . . 0.0 110.448 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.584 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -48.66 -55.95 9.87 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 62.5 t -54.52 -37.77 39.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -53.88 -72.81 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -44.87 -37.44 3.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 21.5 mm-40 -58.33 -45.94 87.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.02 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -36.37 83.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.024 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.574 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 55' ' ' LYS . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.628 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 54' ' ' LYS . 10.0 mm -95.12 -56.76 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.145 -0.972 . . . . 0.0 108.863 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -57.56 -33.84 68.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.534 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 3.2 pt20 -62.66 -48.88 77.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 108.479 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.645 ' HA ' HD23 ' A' ' 62' ' ' LEU . 99.1 t -59.98 -68.16 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.527 ' C ' ' O ' ' A' ' 5' ' ' VAL . 81.5 m-70 -34.7 -34.28 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.579 0.704 . . . . 0.0 109.514 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' VAL . 6.3 mt-10 -67.76 -69.37 0.32 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.171 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.612 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -57.89 -52.94 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.16 -0.962 . . . . 0.0 109.492 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.612 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -46.82 -49.65 16.56 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -80.16 -65.34 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.338 . . . . 0.0 109.955 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -39.68 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.473 -0.767 . . . . 0.0 111.428 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -104.67 -49.67 3.47 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.78 -1.2 . . . . 0.0 109.272 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.6 m-20 150.34 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.585 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 4.5 mmt -56.19 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.154 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -46.41 158.37 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.725 -1.234 . . . . 0.0 109.361 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.554 ' CG1' HG13 ' A' ' 5' ' ' VAL . 96.9 t -130.35 82.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.585 ' CD2' HG22 ' A' ' 37' ' ' ILE . 23.9 m-70 -110.22 89.2 2.96 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.003 -1.479 . . . . 0.0 111.117 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' A' ' 36' ' ' CYS . 52.9 m-85 -75.87 120.78 21.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' O ' HD21 ' A' ' 21' ' ' LEU . 31.4 tttp -145.65 116.78 7.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 47.2 t -78.31 113.38 17.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.967 -1.083 . . . . 0.0 109.062 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.585 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -111.05 16.71 21.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.84 -178.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.543 ' CD ' HG13 ' A' ' 33' ' ' ILE . 2.0 mtt180 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 120.779 -1.201 . . . . 0.0 110.407 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.455 ' HB3' HG12 ' A' ' 20' ' ' VAL . 17.3 m-85 -121.36 139.35 53.54 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.657 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 5.1 mm -89.39 96.57 6.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.596 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 4.3 m -88.33 119.88 29.17 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.548 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.585 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -95.14 114.16 25.92 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.523 -0.735 . . . . 0.0 111.085 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.631 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 5.5 t -101.91 126.05 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.585 HG22 ' CD2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -75.11 133.37 31.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.616 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.56 ' CB ' ' HE3' ' A' ' 61' ' ' MET . 0.4 OUTLIER -125.11 130.88 73.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.127 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.516 ' N ' ' SD ' ' A' ' 14' ' ' MET . . . 42.34 -107.53 0.11 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 t -116.53 -7.51 11.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.604 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 38' ' ' VAL . 11.2 mt -112.87 148.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 108.661 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -91.31 128.01 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.913 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.504 ' OG1' ' HE1' ' A' ' 61' ' ' MET . 20.5 p -103.89 93.05 4.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.529 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 2.5 pt-20 -94.93 179.47 5.22 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.753 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -164.13 166.97 37.9 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.557 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -114.76 92.81 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.885 -1.362 . . . . 0.0 110.079 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.526 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.303 0.573 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.49 ' O ' ' HB1' ' A' ' 57' ' ' ALA . 26.6 p -38.06 -33.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.453 ' HB3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -72.9 -47.19 47.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.032 -1.042 . . . . 0.0 109.448 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -59.73 -51.79 68.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -60.29 -63.67 1.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.947 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.596 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -42.06 -48.61 4.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.397 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.23 -55.14 34.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.805 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.538 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.0 mm-40 -48.51 -33.54 9.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -66.1 -44.47 84.3 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.572 ' SD ' ' CG1' ' A' ' 5' ' ' VAL . 22.7 ttm -64.73 -60.73 2.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.389 -0.819 . . . . 0.0 110.081 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -56.45 -61.24 2.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 53.8 t -49.71 -34.56 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.913 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 61' ' ' MET . 2.4 mm-40 -59.93 -63.75 1.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -59.57 -22.28 61.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.1 -1.0 . . . . 0.0 109.993 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 1.8 mp0 -82.22 -23.35 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 0.0 109.954 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -79.93 -35.1 38.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.011 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.59 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.533 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 3.3 Cg_exo . . . . . 0 N--CA 1.496 1.664 0 N-CA-C 109.634 -0.949 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.572 HD11 ' CE2' ' A' ' 18' ' ' PHE . 4.5 mm -72.5 -54.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.266 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.8 p -54.08 -37.31 64.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.432 -0.792 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.7 -60.87 3.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.918 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.566 ' CG1' HD22 ' A' ' 62' ' ' LEU . 39.4 t -51.32 -66.91 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.585 ' CE1' HG13 ' A' ' 16' ' ' VAL . 75.5 m-70 -35.38 -35.96 0.06 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.578 -0.701 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -69.47 -50.63 43.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.472 -0.768 . . . . 0.0 110.261 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.617 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -74.57 -48.51 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.999 -1.063 . . . . 0.0 109.337 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -50.44 -50.79 34.36 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.11 -46.46 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.816 -1.402 . . . . 0.0 109.784 -179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.87 -10.97 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.997 . . . . 0.0 110.089 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -121.03 8.19 10.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 110.001 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER 80.35 -11.53 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.444 -0.785 . . . . 0.0 109.579 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.58 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 4.2 mtt -73.57 106.92 5.56 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.015 -1.053 . . . . 0.0 109.071 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.531 HG23 ' NE2' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -61.32 136.36 58.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.431 -0.793 . . . . 0.0 109.931 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.585 HG13 ' CE1' ' A' ' 6' ' ' HIS . 69.0 t -110.73 112.13 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.496 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.648 ' CD2' ' CG2' ' A' ' 37' ' ' ILE . 15.0 m-70 -131.15 103.76 6.68 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.644 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 58' ' ' ALA . 2.9 m-85 -90.67 136.27 33.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.606 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.52 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -150.33 110.07 4.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.9 t -77.51 123.13 33.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.963 -1.086 . . . . 0.0 108.389 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -107.19 -14.58 14.87 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.348 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.537 ' CB ' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.0 -1.063 . . . . 0.0 110.715 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.578 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 2.3 m120 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.533 0.683 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 58.6 m-85 -152.69 121.88 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.547 -0.721 . . . . 0.0 109.317 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' A' ' 22' ' ' ARG . 3.1 mm -89.4 92.15 3.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.55 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 31.1 m -87.76 109.83 20.01 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.969 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -77.55 122.07 24.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.556 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -126.18 111.67 14.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.464 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.648 ' CG2' ' CD2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -78.49 136.63 23.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.223 -0.923 . . . . 0.0 110.844 -178.137 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.596 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.2 t -127.45 127.73 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 52.61 -118.05 7.3 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -111.1 0.47 16.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -1.161 . . . . 0.0 109.864 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mt -116.11 134.02 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 108.971 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -97.55 142.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.893 -1.129 . . . . 0.0 110.714 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.54 HG22 ' CE ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -135.97 112.91 10.31 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -84.23 -170.24 3.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.841 -1.162 . . . . 0.0 109.098 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -160.81 108.61 0.36 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.45 -1.357 . . . . 0.0 109.785 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' CB ' HD12 ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.04 79.1 4.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.258 -1.142 . . . . 0.0 109.871 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' CA ' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.502 ' N ' HG11 ' A' ' 52' ' ' VAL . 65.3 m -57.68 -80.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.206 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -51.29 -53.39 36.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.259 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 24.3 ttpp -53.22 -29.55 33.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 109.628 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -74.35 -45.16 48.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.468 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.55 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -60.71 -57.36 13.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.246 -0.909 . . . . 0.0 108.553 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -54.55 -48.44 72.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.368 -0.833 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.535 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.7 mm-40 -53.56 -39.29 64.66 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.32 -37.66 84.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.596 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 64.0 mmm -70.18 -71.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.0 110.95 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.611 HD21 ' N ' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -49.5 -48.79 47.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.066 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 75.1 t -60.04 -37.81 74.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -55.48 -61.09 2.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.595 -0.69 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -60.79 -34.28 74.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 110.521 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 21.2 mm-40 -65.56 -28.57 69.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.709 -1.244 . . . . 0.0 109.666 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -70.83 -30.16 66.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 C--N 1.304 -1.386 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.461 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.494 ' HD2' ' CA ' ' A' ' 55' ' ' LYS . 5.4 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 N-CA-C 109.745 -0.906 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.583 HD11 ' CE2' ' A' ' 18' ' ' PHE . 5.1 mm -69.85 -58.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 p -55.6 -37.89 68.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.6 mm100 -60.96 -55.71 29.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 0.0 108.644 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.565 ' CG1' HD22 ' A' ' 62' ' ' LEU . 23.5 t -51.77 -70.11 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.579 ' CE1' HG13 ' A' ' 16' ' ' VAL . 86.3 m-70 -34.68 -38.68 0.08 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.619 -0.675 . . . . 0.0 109.779 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.8 mt-10 -62.51 -63.8 1.12 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.433 -0.792 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.621 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.11 -49.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.191 -0.943 . . . . 0.0 110.58 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.621 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -47.59 -56.22 8.62 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -30.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.118 -1.225 . . . . 0.0 109.504 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 6.5 mttm -79.84 -3.76 49.24 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 110.267 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.73 14.32 4.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 109.384 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 80.69 -10.33 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.635 -0.666 . . . . 0.0 109.764 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.546 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 1.8 mtt -76.48 99.56 4.96 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.935 -1.103 . . . . 0.0 109.342 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -53.78 142.18 24.57 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 6' ' ' HIS . 98.5 t -114.45 94.33 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.588 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 96.6 m-70 -119.26 102.74 8.91 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.161 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CD1' ' HB3' ' A' ' 36' ' ' CYS . 3.2 m-85 -86.84 125.3 33.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -138.99 114.67 9.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.532 ' CG2' ' OG1' ' A' ' 34' ' ' THR . 61.3 t -78.55 128.77 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.046 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -111.26 -11.16 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.706 -0.621 . . . . 0.0 110.097 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.524 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 12.3 mmt180 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.031 -1.043 . . . . 0.0 109.993 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.676 0.75 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.492 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 3.2 m-85 -108.62 126.44 52.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.524 ' CG1' ' HB2' ' A' ' 22' ' ' ARG . 1.3 mm -96.01 123.88 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 6.1 m -119.85 116.47 25.91 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.56 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -79.54 112.7 17.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.541 -0.725 . . . . 0.0 109.179 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.586 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -109.82 111.82 23.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.587 -1.321 . . . . 0.0 107.6 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -79.36 138.09 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 111.133 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -125.29 136.0 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 42.24 -88.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' VAL . 12.8 t -136.82 -7.13 1.88 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.087 -1.243 . . . . 0.0 110.609 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.469 ' O ' HG22 ' A' ' 38' ' ' VAL . 2.9 mt -108.05 136.85 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.908 -1.12 . . . . 0.0 108.414 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -92.03 129.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.851 -1.156 . . . . 0.0 110.729 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.52 HG22 ' CG2' ' A' ' 38' ' ' VAL . 68.2 p -115.76 98.37 6.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.56 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -82.94 -174.15 5.11 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.599 -1.313 . . . . 0.0 109.639 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -149.73 172.95 29.61 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -139.76 76.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.285 -1.127 . . . . 0.0 108.693 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.488 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.563 ' CG2' ' CD ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.388 0.614 . . . . 0.0 109.414 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.492 ' HB3' ' CB ' ' A' ' 32' ' ' PHE . 35.2 p -48.93 -54.93 13.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.888 -1.132 . . . . 0.0 109.559 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -55.94 -70.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 109.926 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' CA ' ' HD2' ' A' ' 1' ' ' PRO . 48.5 mttp -41.35 -68.9 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.742 . . . . 0.0 109.559 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.563 ' CD ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -36.67 -63.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.895 -0.503 . . . . 0.0 110.494 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -44.17 -49.31 9.14 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.925 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.67 -57.91 10.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.344 -0.847 . . . . 0.0 110.637 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.497 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 20.8 mt-10 -46.28 -45.24 17.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.762 -1.211 . . . . 0.0 108.136 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -56.23 -43.55 78.71 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.569 ' CE ' ' O ' ' A' ' 36' ' ' CYS . 4.8 ttm -66.41 -72.34 0.16 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.375 0.607 . . . . 0.0 110.602 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.579 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -46.89 -60.63 2.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.931 -1.106 . . . . 0.0 108.589 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 70.2 t -47.11 -39.13 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.749 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -58.07 -66.61 0.45 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' CD1' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -53.4 -28.2 28.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.979 -1.075 . . . . 0.0 110.547 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 31.5 mm-40 -65.11 -37.17 86.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.832 -1.168 . . . . 0.0 109.605 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -34.36 70.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.639 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.515 ' HG2' ' CG ' ' A' ' 55' ' ' LYS . 4.5 Cg_exo . . . . . 0 N--CA 1.496 1.625 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.516 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.0 mm -71.04 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -51.32 -37.64 48.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.349 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.5 mm-40 -62.45 -51.49 67.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.623 ' CG1' HD22 ' A' ' 62' ' ' LEU . 38.8 t -54.98 -66.83 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.37 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.573 ' CE1' HG13 ' A' ' 16' ' ' VAL . 93.6 m-70 -38.38 -38.61 0.38 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.494 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -61.03 -63.18 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.733 -0.604 . . . . 0.0 110.69 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.626 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.14 -49.06 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.029 -1.044 . . . . 0.0 110.791 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.626 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -49.36 -54.25 16.8 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.49 -39.24 82.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.885 -1.362 . . . . 0.0 109.476 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 11.3 mttm -69.64 -9.36 53.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 109.892 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.67 10.09 7.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.237 -0.915 . . . . 0.0 109.09 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 79.32 -10.28 1.35 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.75 . . . . 0.0 109.42 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.545 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -75.54 101.76 5.01 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.943 -1.098 . . . . 0.0 109.302 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -53.06 163.58 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.575 ' CG1' HG13 ' A' ' 5' ' ' VAL . 48.9 t -133.45 92.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.579 ' CG ' HG23 ' A' ' 37' ' ' ILE . 31.8 m-70 -113.68 95.64 5.44 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.621 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.636 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 54.7 m-85 -81.65 119.32 23.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.623 -0.673 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' O ' HD21 ' A' ' 21' ' ' LEU . 8.3 ttmm -151.01 115.96 5.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 93.4 t -79.01 119.29 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 0.0 108.668 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.594 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.21 1.39 13.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 110.984 -178.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 120.676 -1.265 . . . . 0.0 110.819 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 1.7 m-20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 35.2 m-85 -144.55 141.55 29.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.6 mm -89.47 99.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.591 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 35.8 m -89.22 113.31 24.51 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.459 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.594 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -80.85 119.51 23.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -0.909 . . . . 0.0 110.036 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.636 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -114.37 116.01 28.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.579 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.32 134.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.816 -1.177 . . . . 0.0 109.983 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' C ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER -129.19 131.22 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -10.0 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.504 3.226 0 CA-C-O 121.142 0.301 . . . . 0.0 112.579 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.48 ' HB3' HD13 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -36.29 -59.19 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.691 -0.888 . . . . 0.0 111.328 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.513 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -162.07 -168.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.935 -1.103 . . . . 0.0 108.854 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.481 HG11 HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -89.1 133.47 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.095 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.513 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 2.4 m -121.63 103.57 9.0 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 15.2 pt-20 -84.46 -169.8 2.79 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 110.441 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -156.96 178.99 33.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -127.94 82.73 2.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.892 -1.358 . . . . 0.0 110.533 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 53' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.551 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 0.1 OUTLIER 83.18 -55.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 109.571 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -44.15 44.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.022 . . . . 0.0 108.89 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.515 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -66.01 -44.81 83.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.275 -0.89 . . . . 0.0 108.636 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.454 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -61.78 -64.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.591 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -41.35 -46.25 3.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.504 -0.747 . . . . 0.0 109.244 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -57.91 -61.57 2.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.42 -0.8 . . . . 0.0 110.31 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -45.53 -50.26 13.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.795 -1.19 . . . . 0.0 108.59 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 12.9 tptt -51.22 -45.53 61.96 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.537 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 2.2 ttm -63.3 -70.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.59 -0.694 . . . . 0.0 110.353 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.623 HD22 ' CG1' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -46.25 -64.16 0.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 10.6 t -51.51 -29.48 9.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.448 -0.783 . . . . 0.0 109.561 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 3.8 mm-40 -67.89 -55.81 11.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.085 -1.01 . . . . 0.0 111.391 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.544 HD11 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -95.32 8.38 43.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.432 -1.418 . . . . 0.0 110.404 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 88.5 mt-30 -101.12 -13.33 18.22 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.381 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 -36.95 5.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 109.274 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.563 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.519 ' CG ' ' HB3' ' A' ' 55' ' ' LYS . 2.0 Cg_endo . . . . . 0 N--CA 1.495 1.608 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.406 ' HA ' HD11 ' A' ' 2' ' ' ILE . 5.1 mm -71.73 -64.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.5 p -51.36 -42.11 61.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.42 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.1 mt-30 -57.66 -54.0 51.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 108.837 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.591 ' HA ' HD23 ' A' ' 62' ' ' LEU . 56.5 t -53.15 -68.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.54 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 88.0 m-70 -34.97 -38.87 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.683 -0.636 . . . . 0.0 109.701 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.7 mt-10 -63.98 -56.53 14.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 110.06 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.645 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -72.41 -53.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.192 -0.943 . . . . 0.0 109.723 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.645 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -45.36 -48.34 11.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -73.84 -44.82 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.587 -1.537 . . . . 0.0 110.358 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.9 mtmt -64.61 -11.06 31.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.074 -1.016 . . . . 0.0 110.321 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -120.36 8.1 10.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.938 . . . . 0.0 109.856 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.0 t-20 78.86 -6.44 1.9 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.552 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 32.6 mtp -79.45 89.93 5.04 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -42.0 161.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.467 -0.771 . . . . 0.0 109.844 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.547 ' CG1' ' CE2' ' A' ' 18' ' ' PHE . 60.7 t -132.65 93.38 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.558 ' CB ' HG23 ' A' ' 37' ' ' ILE . 40.8 m-70 -110.31 97.7 7.11 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 118.306 -1.358 . . . . 0.0 110.439 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 39.0 m-85 -84.69 119.39 25.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 110.972 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' O ' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.52 116.58 5.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 86.4 t -78.66 126.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 109.327 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 ' CD2' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -126.78 9.49 6.99 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.624 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.527 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.192 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.455 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 3.0 m-85 -88.02 129.72 35.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.603 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.3 mp -89.45 96.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 26.4 m -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.888 0.852 . . . . 0.0 108.91 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -90.09 120.2 31.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.938 -0.476 . . . . 0.0 109.912 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.628 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -117.94 117.74 30.07 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.558 HG23 ' CB ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -77.26 132.56 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.952 -1.092 . . . . 0.0 110.536 -177.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.545 ' CG1' ' HE1' ' A' ' 14' ' ' MET . 0.8 OUTLIER -125.0 108.24 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 14' ' ' MET . . . 18.6 -105.82 0.01 OUTLIER Glycine 0 N--CA 1.504 3.216 0 CA-C-O 121.44 0.467 . . . . 0.0 112.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.1 m -24.18 -56.14 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.452 HG13 ' C ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -156.4 -161.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.09 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.59 163.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.47 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 53.8 m -150.5 90.51 1.65 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.545 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 6.7 pt-20 -86.64 -169.97 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.918 -1.114 . . . . 0.0 109.903 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -172.87 156.01 24.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 1.2 pt-20 -110.79 98.23 7.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.833 -1.392 . . . . 0.0 110.623 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' HA3' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.493 2.478 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.867 0.365 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 54' ' ' LYS . 49.6 m -60.91 -93.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.89 -1.131 . . . . 0.0 110.217 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -32.15 -61.41 0.25 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.522 -0.736 . . . . 0.0 111.424 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.519 ' HB3' ' CG ' ' A' ' 1' ' ' PRO . 1.1 mttt -49.35 -50.75 38.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.054 . . . . 0.0 109.808 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.558 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 7.6 tpt180 -55.53 -57.52 11.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 109.787 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -44.59 -47.14 10.31 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.047 0.927 . . . . 0.0 108.658 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -54.31 -64.72 0.74 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 74.2 mt-10 -49.02 -23.97 1.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.201 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -64.36 -53.95 40.54 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.236 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 36' ' ' CYS . 3.4 ptp -77.72 -51.36 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.419 -1.312 . . . . 0.0 110.196 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -46.74 -47.73 20.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.393 -1.442 . . . . 0.0 107.732 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 79.3 t -65.21 -38.66 83.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' MET . 1.8 mm-40 -51.33 -68.79 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.541 ' CD2' ' HE2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -48.51 -44.32 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.602 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 5.1 mm-40 -45.51 -65.01 0.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.962 -1.086 . . . . 0.0 109.489 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -46.02 -52.46 11.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.629 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 68' ' ' LEU . 5.0 mt . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.566 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.529 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 N-CA-C 109.556 -0.978 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.51 HG23 ' NE2' ' A' ' 6' ' ' HIS . 7.9 mm -78.66 -47.88 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -46.81 -51.12 17.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -50.73 -57.65 7.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.931 -1.106 . . . . 0.0 110.271 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.622 ' HA ' HD23 ' A' ' 62' ' ' LEU . 24.9 t -54.08 -58.17 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.803 -1.186 . . . . 0.0 108.969 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.536 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 79.0 m-70 -42.56 -34.69 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.837 -1.164 . . . . 0.0 108.839 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 9.7 mt-10 -71.23 -71.73 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.485 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.619 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -54.48 -48.47 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 120.669 -1.269 . . . . 0.0 109.745 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -52.98 -59.2 9.71 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.9 -52.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.699 -1.471 . . . . 0.0 110.212 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -55.4 -19.47 9.24 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.046 -179.051 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -121.75 23.07 10.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.6 -1.313 . . . . 0.0 111.168 -179.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 77.53 -11.82 1.15 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.084 -1.01 . . . . 0.0 111.141 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.576 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 4.6 mtt -78.3 93.93 4.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.124 . . . . 0.0 109.603 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -42.63 166.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.893 -1.129 . . . . 0.0 110.194 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.526 ' CG1' HG13 ' A' ' 5' ' ' VAL . 24.2 t -139.67 77.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.563 ' CG ' HG23 ' A' ' 37' ' ' ILE . 36.8 m-70 -102.15 91.57 4.37 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.348 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.641 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 29.1 m-85 -80.1 110.14 15.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.548 0.689 . . . . 0.0 110.767 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -131.53 119.0 20.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 67.6 t -79.89 136.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.033 -1.042 . . . . 0.0 110.175 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 3.4 mt -96.04 -15.08 22.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.562 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.691 0.758 . . . . 0.0 110.665 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 1.1 m120 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.669 0.747 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 3.0 m-85 -90.33 128.54 36.47 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 2.9 mm -88.51 95.94 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.097 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.581 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 53.5 m -90.03 114.6 26.51 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -82.44 129.53 34.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.095 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.641 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -123.26 116.39 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.5 -1.375 . . . . 0.0 107.612 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -80.41 136.34 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.01 -1.056 . . . . 0.0 111.961 -177.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.586 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 0.9 OUTLIER -135.35 136.35 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.66 -124.44 19.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.34 5.54 23.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.16 148.27 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 108.898 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.514 ' CG2' HG12 ' A' ' 37' ' ' ILE . 1.5 t -108.07 143.2 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.946 -1.097 . . . . 0.0 110.293 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.552 ' OG1' ' CE ' ' A' ' 61' ' ' MET . 50.9 p -132.1 113.96 13.96 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -87.69 -168.02 2.08 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 110.008 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 60' ' ' LYS . . . -161.11 114.47 0.61 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -77.99 83.65 4.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.959 -1.318 . . . . 0.0 109.88 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.536 ' C ' ' CG1' ' A' ' 52' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' C ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.933 0.397 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.503 ' C ' ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -24.35 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -69.16 -59.65 2.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.937 -1.102 . . . . 0.0 109.648 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 3.6 ttpm? -50.06 -42.89 50.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.847 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.525 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -69.99 -34.4 73.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.396 -0.815 . . . . 0.0 110.471 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.581 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -64.66 -51.13 64.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.891 -1.131 . . . . 0.0 108.645 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -60.97 -51.71 68.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.532 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 4.8 mt-10 -51.18 -44.33 61.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.453 ' HG2' ' HA2' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -61.58 -36.23 80.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.586 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 34.8 tpp -70.25 -71.37 0.24 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.49 -0.756 . . . . 0.0 110.617 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.622 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -49.34 -52.69 26.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 108.33 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 78.1 t -52.02 -39.7 26.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 108.653 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 61' ' ' MET . 1.8 mm-40 -59.36 -64.26 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -53.58 -28.41 31.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.978 -1.076 . . . . 0.0 110.257 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 18.1 mm-40 -54.04 -62.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.842 -1.161 . . . . 0.0 109.615 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -54.92 -39.98 69.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.521 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.447 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 55' ' ' LYS . 4.6 Cg_exo . . . . . 0 N--CA 1.493 1.497 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.53 HG21 ' CE2' ' A' ' 18' ' ' PHE . 8.1 mm -97.58 -50.91 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 109.111 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.49 -45.76 18.62 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 0.0 109.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -55.6 -60.18 3.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.975 . . . . 0.0 108.979 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.628 ' HA ' HD22 ' A' ' 62' ' ' LEU . 48.5 t -46.59 -68.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 108.355 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.56 ' CE1' HG13 ' A' ' 16' ' ' VAL . 92.9 m-70 -36.8 -38.93 0.19 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.457 -0.777 . . . . 0.0 110.242 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.551 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -67.0 -48.12 69.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.653 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -75.82 -52.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.176 -0.953 . . . . 0.0 109.449 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.653 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -48.5 -53.44 16.47 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.69 -41.46 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.669 -1.489 . . . . 0.0 109.06 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -63.27 -13.37 37.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.411 -0.806 . . . . 0.0 110.178 -179.008 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.31 10.5 8.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 12.5 t30 79.66 -9.21 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.571 ' HA ' ' CA ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -75.98 91.22 3.04 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.119 -0.988 . . . . 0.0 109.642 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -42.86 160.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.568 ' CG1' HG13 ' A' ' 5' ' ' VAL . 41.4 t -128.2 96.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.589 ' CG ' HG23 ' A' ' 37' ' ' ILE . 37.4 m-70 -114.12 94.57 4.88 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.126 -1.43 . . . . 0.0 110.957 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.62 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 52.5 m-85 -80.5 118.68 22.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.633 -0.667 . . . . 0.0 109.659 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' O ' HD21 ' A' ' 21' ' ' LEU . 27.7 tttt -149.39 116.02 5.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.105 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 55.2 t -78.51 118.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.566 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -114.0 9.44 17.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.692 -0.63 . . . . 0.0 110.5 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' NH1' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 120.85 -1.156 . . . . 0.0 110.171 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 43.7 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.276 0.56 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 52.5 m-85 -150.42 125.65 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 109.195 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 3.2 mm -89.29 92.12 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.593 ' HB ' ' CB ' ' A' ' 57' ' ' ALA . 99.7 m -88.89 115.08 26.18 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.94 0.876 . . . . 0.0 109.606 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.566 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -80.67 118.17 22.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.762 -0.586 . . . . 0.0 109.665 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -111.95 115.75 29.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.589 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -78.19 134.79 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.712 -1.243 . . . . 0.0 110.735 -177.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.55 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -136.55 120.67 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 8.75 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.506 3.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.916 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.523 ' CB ' HD13 ' A' ' 41' ' ' ILE . 18.4 m -29.3 -60.66 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.088 -0.654 . . . . 0.0 111.265 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.562 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -160.56 -167.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.552 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' CG2' HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -99.13 138.86 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.224 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.6 m -126.09 108.38 11.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -82.18 -168.86 2.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.997 -1.064 . . . . 0.0 109.891 -178.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 112.65 0.52 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 3.2 pt-20 -78.02 80.59 4.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.16 -1.2 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.532 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 53' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.533 ' CB ' ' OG1' ' A' ' 34' ' ' THR . 0.1 OUTLIER -36.36 -47.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.985 -0.447 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' CG ' HD13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -65.33 -47.45 76.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.531 ' CB ' ' HD2' ' A' ' 1' ' ' PRO . 3.5 mttp -58.65 -65.17 0.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.967 . . . . 0.0 109.269 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.532 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -45.77 -60.96 1.93 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.579 -0.701 . . . . 0.0 109.552 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.593 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -43.28 -46.01 6.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.988 . . . . 0.0 109.797 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -62.9 -65.15 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 58' ' ' ALA . 4.9 mt-10 -44.14 -59.63 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.946 -1.097 . . . . 0.0 108.504 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -43.67 -47.04 7.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.59 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 39.0 tpp -60.09 -72.31 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.595 -0.69 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD22 ' HA ' ' A' ' 5' ' ' VAL . 1.2 mt -45.38 -67.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 62' ' ' LEU . 6.4 t -41.98 -33.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -67.8 -63.83 0.98 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.247 -0.908 . . . . 0.0 111.004 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.611 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -86.29 10.61 14.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.985 -178.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.3 mm-40 -96.77 -15.65 21.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.461 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.23 -32.6 22.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 67' ' ' LYS . 16.0 mt . . . . . 0 C--N 1.304 -1.392 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.461 ' O ' HG22 ' A' ' 5' ' ' VAL . 4.6 Cg_exo . . . . . 0 N--CA 1.496 1.666 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' A' ' 54' ' ' LYS . 8.0 mm -69.62 -65.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -55.59 -30.73 61.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.64 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 26.3 mt-30 -63.84 -55.24 24.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.198 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.663 ' HA ' HD23 ' A' ' 62' ' ' LEU . 36.1 t -57.94 -55.76 19.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 82.3 m-70 -44.53 -38.83 4.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.694 -1.254 . . . . 0.0 108.684 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -62.46 -67.83 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.691 -0.631 . . . . 0.0 110.868 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.11 -50.48 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 0.0 110.274 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.592 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -44.37 -57.05 5.2 Favored Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.8 -29.65 41.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -1.18 . . . . 0.0 109.451 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -80.25 -3.29 48.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.414 -0.804 . . . . 0.0 110.58 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -134.84 16.19 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 109.842 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.4 t-20 78.53 -6.88 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.548 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 5.8 mmm -81.82 90.69 6.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.049 . . . . 0.0 108.79 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.579 ' CG2' ' NE2' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -41.79 157.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.115 -0.991 . . . . 0.0 110.391 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 6' ' ' HIS . 24.3 t -131.72 80.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 108.657 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.579 ' NE2' ' CG2' ' A' ' 15' ' ' THR . 84.5 m-70 -117.7 96.86 5.56 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.695 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 58' ' ' ALA . 3.2 m-30 -79.7 137.7 37.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 110.372 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 6.9 ptpt -150.71 118.48 6.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 66.3 t -78.97 129.25 37.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 108.984 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -88.61 -25.55 22.38 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.554 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 33.3 m-20 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.328 0.585 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 35.8 m-85 -131.86 125.83 32.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.342 -0.848 . . . . 0.0 109.429 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.532 HG23 ' CG ' ' A' ' 44' ' ' GLU . 2.0 mm -88.94 94.1 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.397 -0.814 . . . . 0.0 108.896 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.588 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 23.6 m -89.54 111.73 22.72 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 109.575 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -78.06 116.54 18.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.46 -0.775 . . . . 0.0 109.724 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.604 ' O ' ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -109.63 118.42 36.51 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.545 ' CG2' ' HB2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -87.41 134.17 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.776 -1.202 . . . . 0.0 112.808 -176.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 15' ' ' THR . 1.5 m -144.11 142.97 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.017 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 54.52 19.11 11.91 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 1.0 OUTLIER 87.43 -23.25 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.926 -0.749 . . . . 0.0 109.576 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 39' ' ' GLY . 1.3 mp -89.43 130.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -90.67 133.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 120.877 -1.139 . . . . 0.0 110.897 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.565 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.0 OUTLIER -128.71 105.7 8.44 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.575 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -81.42 -172.92 4.07 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.112 -0.993 . . . . 0.0 111.455 -177.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -155.83 112.33 0.52 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -78.0 78.24 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.064 -1.256 . . . . 0.0 111.02 -178.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' HA2' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.495 2.587 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 53' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.547 ' N ' HG11 ' A' ' 52' ' ' VAL . 22.7 p -42.11 -46.27 4.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.285 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HB3' HD13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -62.04 -44.66 96.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HD2' ' HG3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -62.2 -73.63 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.827 . . . . 0.0 109.181 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.515 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -39.0 -38.24 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -0.759 . . . . 0.0 110.072 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.588 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -62.6 -51.33 67.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.95 -1.094 . . . . 0.0 108.539 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -65.2 -57.94 7.25 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.293 -0.879 . . . . 0.0 110.842 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.526 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 17.5 mt-10 -46.79 -43.85 18.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.568 -1.333 . . . . 0.0 107.762 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.5 tttp -60.0 -43.54 95.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.604 ' CE ' ' O ' ' A' ' 36' ' ' CYS . 2.3 mmt -57.0 -72.09 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.019 0.914 . . . . 0.0 111.368 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -54.18 -56.98 13.04 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 49.1 t -47.91 -32.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.146 -0.971 . . . . 0.0 108.693 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.539 ' CA ' ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -67.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.813 . . . . 0.0 110.027 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -53.36 -24.4 12.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.114 -0.992 . . . . 0.0 110.073 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 32.1 mm-40 -80.31 -33.09 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.881 -1.137 . . . . 0.0 109.011 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -68.29 -41.24 81.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.89 . . . . 0.0 109.379 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--N 1.305 -1.363 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.554 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.501 ' HG2' ' CG ' ' A' ' 55' ' ' LYS . 2.4 Cg_endo . . . . . 0 N--CA 1.497 1.695 0 N-CA-C 109.792 -0.888 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.479 HG21 ' CD2' ' A' ' 18' ' ' PHE . 4.8 mm -68.5 -59.21 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -53.15 -33.48 52.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.9 mt-30 -64.32 -49.88 69.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.702 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.595 ' CG1' HD22 ' A' ' 62' ' ' LEU . 19.6 t -57.73 -64.9 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.414 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.523 ' CE1' HG13 ' A' ' 16' ' ' VAL . 93.7 m-70 -40.17 -39.0 0.84 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.624 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.0 mm-40 -62.2 -63.93 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.689 . . . . 0.0 110.676 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.603 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -67.75 -49.91 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.032 -1.043 . . . . 0.0 110.514 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.603 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -47.13 -54.3 9.94 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.83 -35.14 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.048 -1.266 . . . . 0.0 109.625 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.8 mmtm -76.16 -5.19 45.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -130.79 12.63 5.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.607 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 79.44 -8.7 1.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.559 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 4.3 mtt -76.21 96.18 3.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.995 -1.066 . . . . 0.0 109.376 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -49.75 153.75 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.017 -1.052 . . . . 0.0 109.438 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.55 ' CG1' HG13 ' A' ' 5' ' ' VAL . 98.1 t -127.41 95.63 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.563 ' CD2' HG22 ' A' ' 37' ' ' ILE . 26.1 m-70 -116.47 92.69 3.95 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.425 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.618 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 43.6 m-85 -79.63 123.81 27.97 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.54 0.686 . . . . 0.0 110.43 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' HD22 ' A' ' 21' ' ' LEU . 8.9 tttm -150.19 117.18 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 88.1 t -78.13 130.93 35.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 108.903 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -88.68 -26.38 21.87 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.956 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.889 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.478 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 2.6 m120 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 23.0 m-85 -144.54 137.72 27.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 109.653 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.0 mm -91.62 96.95 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.586 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 9.4 m -89.53 118.79 29.42 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 110.374 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.571 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.0 122.61 26.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.776 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.618 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -120.35 115.92 24.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.383 -1.448 . . . . 0.0 107.292 178.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG22 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -77.54 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.102 -0.998 . . . . 0.0 111.214 -177.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.563 HG21 ' CE ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -121.56 141.31 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -52.77 83.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER 160.37 -45.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.453 -1.027 . . . . 0.0 108.55 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -168.44 -175.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.458 HG11 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -93.31 129.22 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.93 -1.106 . . . . 0.0 109.03 179.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.515 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 31.8 m -119.52 90.34 3.31 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.571 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 5.6 pm0 -80.76 -171.17 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.925 -1.109 . . . . 0.0 109.604 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -162.77 165.63 36.41 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.435 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -122.35 93.04 3.85 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.965 -1.315 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.52 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 53' ' ' SER . 2.6 p . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -36.53 -41.45 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.835 -0.54 . . . . 0.0 110.464 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HA ' HG23 ' A' ' 34' ' ' THR . 0.1 OUTLIER -63.91 -61.97 1.94 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.981 -1.075 . . . . 0.0 109.416 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.501 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 7.7 mtpt -48.75 -62.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -44.52 -68.48 0.19 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.311 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.586 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -34.0 -47.63 0.28 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.352 0.596 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -58.33 -53.74 54.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 0.0 109.221 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -49.69 -40.91 41.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.023 -1.048 . . . . 0.0 108.388 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.5 -40.41 94.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.563 ' CE ' HG21 ' A' ' 38' ' ' VAL . 5.6 ttm -69.73 -70.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 110.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.601 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -48.49 -56.19 8.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 108.757 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 99.0 t -50.66 -41.89 21.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.549 -0.72 . . . . 0.0 110.142 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.506 HD11 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -48.83 -31.39 7.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.027 -1.046 . . . . 0.0 110.088 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.506 ' NE2' HD11 ' A' ' 65' ' ' LEU . 22.1 mm-40 -66.27 -41.65 89.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 0.0 109.738 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -66.46 -35.14 79.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.474 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.545 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.501 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 2.5 Cg_endo . . . . . 0 N--CA 1.496 1.626 0 N-CA-C 109.785 -0.891 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.535 HD11 ' CE2' ' A' ' 18' ' ' PHE . 5.6 mm -71.74 -46.51 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.79 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 p -59.61 -32.86 70.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 110.079 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 39.7 mt-30 -64.89 -55.59 18.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.012 . . . . 0.0 109.183 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.598 ' HA ' HD22 ' A' ' 62' ' ' LEU . 7.0 t -57.34 -63.61 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.576 ' CE1' HG13 ' A' ' 16' ' ' VAL . 81.7 m-70 -39.41 -37.59 0.47 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.083 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 1.5 mt-10 -62.0 -67.59 0.4 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.521 -0.737 . . . . 0.0 110.427 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.62 -49.78 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.058 -1.026 . . . . 0.0 110.556 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.593 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -46.17 -55.28 7.73 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.34 -46.38 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.264 . . . . 0.0 109.919 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -62.83 -11.7 19.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.79 10.12 7.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.007 . . . . 0.0 109.781 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 39.3 t30 79.38 -10.58 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.946 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.528 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -72.51 86.09 1.16 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.956 -1.09 . . . . 0.0 108.8 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -39.72 163.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.613 0.72 . . . . 0.0 110.731 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.586 HG11 ' CE1' ' A' ' 18' ' ' PHE . 61.1 t -137.38 88.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.597 ' CG ' HG23 ' A' ' 37' ' ' ILE . 51.6 m-70 -105.87 93.51 4.68 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.13 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CE1' HG11 ' A' ' 16' ' ' VAL . 3.2 m-85 -86.76 131.14 34.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.519 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.89 114.09 4.82 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 56.0 t -78.19 111.69 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.87 -1.144 . . . . 0.0 108.909 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 HD21 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -91.32 -25.36 19.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.812 -0.555 . . . . 0.0 109.791 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.631 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 m120 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.941 0.877 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.526 ' HB3' ' CB ' ' A' ' 53' ' ' SER . 9.6 m-85 -140.26 117.26 11.12 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 3.3 mm -90.74 122.24 41.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 120.943 -1.098 . . . . 0.0 108.764 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.589 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 10.0 m -123.59 109.71 14.11 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -76.31 118.77 19.36 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.602 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.57 ' HB2' ' HG3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -123.05 114.41 20.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.059 -1.026 . . . . 0.0 108.335 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.597 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -78.95 135.07 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -0.839 . . . . 0.0 111.548 -177.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.562 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 0.9 OUTLIER -133.12 148.65 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 45.14 -124.11 6.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t -111.96 8.11 20.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.574 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.461 ' O ' HD11 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -125.69 149.65 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 108.794 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -103.87 141.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.483 ' OG1' ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -132.96 114.16 13.68 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.7 mt-10 -82.72 -167.51 1.66 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.859 -1.15 . . . . 0.0 109.773 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -152.14 110.79 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.641 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -84.25 64.66 8.41 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.33 -1.1 . . . . 0.0 110.041 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.496 2.689 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 53' ' ' SER . 1.7 p . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.552 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 3.0 p 84.3 -58.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.79 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' CG ' ' N ' ' A' ' 55' ' ' LYS . 7.9 ptmt -77.84 -47.26 19.25 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.228 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.501 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 18.4 tttm -66.21 -39.57 89.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.385 -0.822 . . . . 0.0 108.997 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.554 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -68.14 -46.14 71.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.371 -0.831 . . . . 0.0 109.425 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -56.56 -57.84 10.62 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.113 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.477 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -53.34 -48.67 68.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.164 -0.96 . . . . 0.0 110.294 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.548 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 3.3 mt-10 -54.83 -35.77 64.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 11.8 tptp -64.52 -36.3 83.77 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.57 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 54.1 mmm -73.32 -71.12 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.649 -0.657 . . . . 0.0 110.704 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -49.57 -41.03 40.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 0.0 109.004 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 70.5 t -65.6 -39.72 85.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.64 -59.83 3.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.681 -0.637 . . . . 0.0 109.455 179.105 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -59.95 -40.87 90.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.272 -0.892 . . . . 0.0 110.292 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 8.8 mm-40 -46.41 -25.77 0.72 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.778 -1.201 . . . . 0.0 109.1 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.7 -66.04 0.64 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 109.283 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 67' ' ' LYS . 5.3 mt . . . . . 0 C--N 1.3 -1.562 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 5' ' ' VAL . 5.4 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.727 -0.913 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 2' ' ' ILE . 2.9 mm -72.74 -64.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.392 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 p -53.16 -28.06 24.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.268 -0.895 . . . . 0.0 109.233 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.4 mt-30 -67.08 -51.83 49.5 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 108.589 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.574 ' CG2' HD22 ' A' ' 62' ' ' LEU . 19.1 t -58.37 -60.38 2.36 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.509 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 92.6 m-70 -43.56 -39.98 3.74 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.953 -1.092 . . . . 0.0 109.093 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.1 mm-40 -60.53 -64.12 1.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 110.971 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.617 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.16 -49.95 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.891 -1.131 . . . . 0.0 110.727 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -48.0 -51.04 20.12 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.48 -46.35 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.662 -1.493 . . . . 0.0 109.889 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.92 -9.61 22.57 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.97 15.39 8.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 109.687 -179.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 72.64 -7.38 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.434 -0.791 . . . . 0.0 110.125 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 5.4 mtt -79.65 92.64 5.39 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.604 -1.31 . . . . 0.0 108.881 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -42.41 168.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.484 ' CG1' HG13 ' A' ' 5' ' ' VAL . 84.6 t -137.73 83.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 108.4 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.585 ' CG ' HG23 ' A' ' 37' ' ' ILE . 37.3 m-70 -106.42 92.53 4.16 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.563 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.634 ' CE1' ' HB2' ' A' ' 36' ' ' CYS . 37.4 m-85 -78.36 122.04 25.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.651 -0.656 . . . . 0.0 110.394 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.34 122.02 8.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.137 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.534 ' CG2' ' OG1' ' A' ' 34' ' ' THR . 53.2 t -77.42 130.01 36.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 108.526 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -88.67 -22.46 23.4 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.414 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -116.51 143.01 46.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.379 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 5.1 mm -90.62 111.8 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.604 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 7.4 m -103.86 118.63 37.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.144 -0.972 . . . . 0.0 110.737 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.582 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -84.68 122.96 29.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 0.0 111.141 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.634 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 4.1 t -114.63 121.07 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.585 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.86 130.57 36.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.662 -1.274 . . . . 0.0 109.929 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.585 ' CG1' ' CE ' ' A' ' 14' ' ' MET . 1.0 OUTLIER -135.5 119.35 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.387 0.613 . . . . 0.0 109.479 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . 15.5 -101.44 0.01 OUTLIER Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.478 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -27.62 -60.79 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.223 -0.575 . . . . 0.0 111.247 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -164.79 -167.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.048 -1.032 . . . . 0.0 108.603 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -89.67 134.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.996 -1.065 . . . . 0.0 110.168 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.573 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.8 m -123.25 107.96 12.26 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.582 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -90.05 -173.65 3.94 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.21 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -154.92 175.97 32.78 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -128.88 93.69 3.66 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.287 . . . . 0.0 109.683 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 53' ' ' SER . 2.9 p . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.535 0.684 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.49 ' O ' ' HB1' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -39.59 -45.92 1.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.624 -0.672 . . . . 0.0 110.545 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 34' ' ' THR . 1.9 tttt -62.31 -56.73 15.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.197 -0.939 . . . . 0.0 110.088 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -55.58 -65.64 0.56 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.651 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.466 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -43.8 -42.15 5.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.855 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.604 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -59.06 -46.07 89.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.075 -1.015 . . . . 0.0 108.779 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -61.18 -58.05 9.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 110.243 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -48.67 -40.61 28.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.909 -1.119 . . . . 0.0 107.996 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.62 -43.48 93.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.573 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 54.9 tpp -67.51 -70.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.612 -0.68 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.588 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -45.93 -60.17 2.41 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 84.9 t -48.77 -39.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 108.622 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -57.96 -69.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.929 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -45.72 -34.38 3.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.887 -1.133 . . . . 0.0 109.741 -179.061 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 28.9 mm-40 -63.82 -45.11 91.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.82 -1.175 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.06 -48.12 83.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--N 1.301 -1.525 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.542 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.453 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 4.7 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.468 HD13 ' HB3' ' A' ' 54' ' ' LYS . 2.5 mm -68.3 -66.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.2 -30.57 7.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 21.1 mm100 -63.94 -61.62 2.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.565 ' HA ' HD22 ' A' ' 62' ' ' LEU . 26.2 t -51.52 -57.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.935 . . . . 0.0 108.61 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.501 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 89.2 m-70 -44.41 -41.1 5.94 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.793 -1.192 . . . . 0.0 109.351 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.6 mm-40 -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.772 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.646 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -64.65 -54.08 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.184 -0.948 . . . . 0.0 110.355 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.646 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -48.97 -52.72 20.86 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.06 -45.53 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.352 . . . . 0.0 109.92 -178.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -65.12 -13.42 58.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -118.21 9.34 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 0.0 109.893 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 18.0 t-20 80.4 -12.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.589 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 5.6 mtt -76.52 98.89 4.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.998 -1.064 . . . . 0.0 108.662 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.53 HG23 ' NE2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -46.6 172.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.695 -1.253 . . . . 0.0 109.85 -179.378 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 5' ' ' VAL . 59.6 t -143.57 83.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.526 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 90.0 m-70 -116.81 97.35 5.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.399 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 36' ' ' CYS . 58.7 m-85 -78.09 130.65 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.573 -0.704 . . . . 0.0 110.917 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' O ' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -151.05 115.08 5.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.539 ' CG2' ' OG1' ' A' ' 34' ' ' THR . 78.9 t -78.37 118.95 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.965 -1.084 . . . . 0.0 108.461 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.605 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -114.03 -11.97 12.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.669 -0.645 . . . . 0.0 111.154 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.546 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 120.813 -1.179 . . . . 0.0 110.631 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 17.0 m-80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.606 0.717 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 45.6 m-85 -150.44 127.11 10.91 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 3.1 mm -89.6 96.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.573 ' HB ' ' CB ' ' A' ' 57' ' ' ALA . 19.9 m -88.73 114.06 24.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.44 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.605 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -87.76 115.28 25.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.551 -0.718 . . . . 0.0 111.098 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.634 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 12.4 t -105.59 114.5 28.71 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.565 ' CG2' ' HB2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -77.59 130.47 36.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.739 -1.225 . . . . 0.0 109.906 -178.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.589 ' CG1' ' CE ' ' A' ' 14' ' ' MET . 1.1 t -132.71 135.84 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 14' ' ' MET . . . 59.23 -116.16 8.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.413 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -120.56 12.43 11.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -1.091 . . . . 0.0 109.377 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.413 HG13 ' C ' ' A' ' 40' ' ' SER . 2.0 mp -135.0 151.21 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 108.984 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -95.9 135.46 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.015 -1.053 . . . . 0.0 110.424 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.2 m -121.93 101.8 7.78 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 5.2 mt-10 -88.16 -173.9 4.43 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 110.664 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -161.32 116.07 0.69 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.547 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.96 89.38 4.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.196 -1.179 . . . . 0.0 110.644 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.297 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.52 HG11 ' N ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.52 ' N ' HG11 ' A' ' 52' ' ' VAL . 1.7 p -39.31 -46.75 1.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 110.098 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HB3' HD13 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -62.27 -75.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HG3' ' HB3' ' A' ' 1' ' ' PRO . 3.4 tttt -41.7 -66.53 0.33 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' NH1' ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -38.75 -56.6 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.744 . . . . 0.0 110.286 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.573 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -50.72 -50.42 55.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.171 -0.956 . . . . 0.0 110.036 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -58.08 -57.09 14.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.428 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 39.0 mt-10 -48.21 -38.6 18.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.745 -1.222 . . . . 0.0 107.999 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.9 -43.46 98.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.591 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 41.0 tpp -67.83 -69.42 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.688 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.608 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -47.24 -60.14 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 94.1 t -46.93 -41.01 5.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.085 -1.009 . . . . 0.0 108.395 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -54.51 -66.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.526 -0.734 . . . . 0.0 110.022 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -56.53 -21.42 26.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 110.164 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 20.2 mm-40 -67.06 -46.56 73.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.915 -1.116 . . . . 0.0 109.329 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -61.52 -53.51 55.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.312 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.2 mt . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.599 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.479 ' HG2' ' HG2' ' A' ' 55' ' ' LYS . 2.3 Cg_endo . . . . . 0 N--CA 1.497 1.701 0 N-CA-C 109.739 -0.908 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 54' ' ' LYS . 4.8 mm -71.15 -59.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.392 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p -56.24 -33.3 65.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.28 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -64.09 -52.14 60.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 108.56 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.636 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 16.4 t -55.41 -66.23 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.52 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 91.4 m-70 -39.68 -38.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.471 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -60.72 -62.67 1.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 110.46 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -69.6 -50.11 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.067 -1.021 . . . . 0.0 110.809 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.602 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -47.64 -52.23 15.55 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.9 -45.47 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.356 . . . . 0.0 109.62 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.44 -10.3 24.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 -179.111 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.45 10.03 7.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.637 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.7 OUTLIER 79.7 -11.46 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.147 179.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.541 ' HA ' ' CA ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -74.72 95.16 2.82 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -47.34 158.83 0.15 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.372 -0.83 . . . . 0.0 109.486 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.545 ' CG1' ' CE2' ' A' ' 18' ' ' PHE . 42.3 t -133.03 94.63 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.578 ' CG ' HG23 ' A' ' 37' ' ' ILE . 35.8 m-70 -111.92 96.2 5.92 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.454 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.62 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 45.7 m-85 -83.51 120.03 25.42 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.475 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 10.7 mttm -151.15 113.81 4.67 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.338 -0.851 . . . . 0.0 108.86 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 72.3 t -78.57 118.87 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 108.672 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.577 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -117.24 -8.57 11.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 110.955 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.52 ' NH1' ' HG3' ' A' ' 22' ' ' ARG . 1.2 ttm-85 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 0.0 110.538 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 18.5 m-20 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.724 0.773 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 43.4 m-85 -150.86 132.56 14.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.585 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.4 mp -89.99 99.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.554 ' HB ' ' CB ' ' A' ' 57' ' ' ALA . 26.8 m -87.01 117.65 25.88 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.607 0.718 . . . . 0.0 109.229 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.577 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -81.01 117.07 21.3 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.499 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -117.41 114.36 23.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.578 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.93 132.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.067 -1.021 . . . . 0.0 110.77 -177.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.574 ' CG2' ' CE ' ' A' ' 61' ' ' MET . 0.8 OUTLIER -124.31 133.41 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -9.18 -84.1 0.01 OUTLIER Glycine 0 N--CA 1.507 3.383 0 CA-C-O 121.332 0.406 . . . . 0.0 112.781 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.482 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -35.11 -59.82 0.49 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.681 -0.894 . . . . 0.0 111.773 -178.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -161.31 -159.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.871 -1.143 . . . . 0.0 108.428 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -88.39 157.95 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.752 -1.218 . . . . 0.0 109.356 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.56 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 5.6 m -150.97 93.96 2.0 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.562 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -79.56 -169.83 2.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 110.213 -179.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.533 ' HA2' ' CD ' ' A' ' 60' ' ' LYS . . . -170.78 118.86 0.77 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 4.3 pm0 -77.79 91.0 4.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -1.206 . . . . 0.0 110.585 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.485 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.496 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 52' ' ' VAL . 9.2 p -33.51 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.24 0.543 . . . . 0.0 110.542 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HB3' HD13 ' A' ' 2' ' ' ILE . 3.9 mttt -62.46 -50.1 72.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.326 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HG2' ' HG2' ' A' ' 1' ' ' PRO . 50.7 mtpt -57.41 -69.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -39.3 -61.83 0.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.999 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -43.06 -53.4 4.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -54.71 -53.56 53.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.317 -0.865 . . . . 0.0 110.923 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -49.43 -43.52 44.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.537 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -55.02 -43.82 74.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.574 ' CE ' ' CG2' ' A' ' 38' ' ' VAL . 67.2 mmm -64.5 -67.67 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.872 0.844 . . . . 0.0 111.363 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.636 ' CD2' ' HA ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -50.88 -57.19 9.1 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.028 -1.045 . . . . 0.0 108.959 -177.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 2.5 t -59.06 -25.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.202 -0.937 . . . . 0.0 109.007 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -64.5 -54.18 36.35 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.222 -0.924 . . . . 0.0 111.001 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.604 ' CD1' ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -110.57 12.29 22.8 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.731 -1.231 . . . . 0.0 111.595 -178.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 76.3 mm-40 -94.94 -16.97 22.4 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.959 -1.088 . . . . 0.0 109.412 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -98.85 -49.07 4.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 2.2 mt . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 4.8 Cg_exo . . . . . 0 N--CA 1.496 1.653 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 54' ' ' LYS . 3.5 mm -79.59 -69.61 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.14 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -52.67 -23.86 7.43 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.7 mt-30 -66.85 -54.09 25.88 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.739 ' HA ' HD23 ' A' ' 62' ' ' LEU . 61.5 t -60.0 -55.93 20.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.49 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 89.7 m-70 -46.2 -37.16 6.75 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.875 -1.14 . . . . 0.0 108.599 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.5 mt-10 -62.18 -65.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 110.832 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.609 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.89 -49.7 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.58 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.609 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -47.22 -52.16 13.52 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.71 -45.73 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.809 -1.407 . . . . 0.0 109.852 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -66.2 -8.16 22.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 110.333 -179.122 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.52 10.01 8.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.625 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.9 t-20 79.86 -11.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.829 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.553 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -76.66 96.68 4.24 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.86 -1.15 . . . . 0.0 109.573 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -46.65 154.95 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.69 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.531 ' CG1' HG13 ' A' ' 5' ' ' VAL . 46.8 t -129.92 90.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 37' ' ' ILE . 24.5 m-70 -114.34 91.85 3.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.56 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.622 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 57.3 m-85 -79.82 123.01 27.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.691 -0.631 . . . . 0.0 110.137 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.461 ' O ' HD21 ' A' ' 21' ' ' LEU . 13.8 mttt -150.92 112.25 4.39 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.2 t -78.48 121.32 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.063 -1.023 . . . . 0.0 109.124 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.592 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -115.59 8.92 15.21 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.808 -178.313 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 3.6 mpp_? . . . . . 0 N--CA 1.493 1.714 0 O-C-N 120.88 -1.138 . . . . 0.0 110.058 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.389 0.614 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 52.1 m-85 -150.88 125.74 9.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.445 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 2.4 mm -89.8 93.42 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 18.0 m -88.05 112.71 22.93 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.823 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.592 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -79.57 115.45 19.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.622 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -113.67 113.99 25.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.573 HG22 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.58 132.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.152 -0.968 . . . . 0.0 110.515 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.5 OUTLIER -119.74 147.25 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -47.99 88.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 155.51 -50.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.812 -0.817 . . . . 0.0 109.118 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.457 HG13 ' HB3' ' A' ' 40' ' ' SER . 0.2 OUTLIER -170.68 -166.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.312 -0.868 . . . . 0.0 108.718 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.54 133.79 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.382 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.549 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.8 m -127.01 93.67 3.82 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.576 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 2.7 pm0 -80.49 -173.52 4.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.737 -1.227 . . . . 0.0 110.604 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.89 113.42 0.56 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -78.2 81.95 4.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.208 -1.172 . . . . 0.0 110.232 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.52 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.516 ' O ' ' C ' ' A' ' 53' ' ' SER . 1.2 p . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.516 ' C ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -29.84 -68.02 0.08 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 23.9 mmtt -45.83 -50.61 14.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HA ' ' HD2' ' A' ' 1' ' ' PRO . 6.7 tttt -58.66 -73.14 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -37.62 -67.23 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.201 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -40.56 -55.14 2.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -51.55 -57.46 9.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.813 . . . . 0.0 110.633 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.5 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 25.5 mt-10 -47.94 -44.87 30.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 108.253 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.2 -44.03 71.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 108.976 179.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.614 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 70.7 mmm -65.95 -66.27 0.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.806 0.812 . . . . 0.0 111.311 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -50.82 -60.4 3.11 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 8.7 t -56.28 -26.95 23.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.184 -0.947 . . . . 0.0 109.13 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.0 mm-40 -62.89 -55.56 24.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -112.57 16.05 19.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.744 -1.223 . . . . 0.0 111.49 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.536 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 9.5 mm-40 -98.86 -33.8 10.73 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.064 -1.022 . . . . 0.0 109.261 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -66.86 -26.06 66.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.509 179.811 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.52 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 4.5 Cg_exo . . . . . 0 N--CA 1.497 1.709 0 N-CA-C 109.613 -0.957 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 54' ' ' LYS . 3.6 mm -72.23 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.937 . . . . 0.0 109.276 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -54.55 -31.6 56.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.0 mm100 -63.41 -53.5 51.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.251 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.728 ' HA ' HD23 ' A' ' 62' ' ' LEU . 61.1 t -58.53 -54.82 27.92 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 108.534 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.495 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 87.4 m-70 -47.16 -37.59 10.32 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 120.618 -1.301 . . . . 0.0 108.755 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 13.0 mt-10 -63.24 -66.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.974 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -65.4 -49.33 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.012 . . . . 0.0 110.276 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.591 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -46.49 -56.6 7.12 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.2 OUTLIER -69.37 -30.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.076 -1.25 . . . . 0.0 109.73 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.1 mtmp? -79.92 -4.3 51.77 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.22 13.22 4.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.65 -179.556 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.8 t30 78.84 -7.6 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.777 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.539 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 3.5 mmt -78.84 95.2 5.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.958 -1.089 . . . . 0.0 109.01 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -47.38 155.35 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.786 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.53 HG12 ' CG1' ' A' ' 5' ' ' VAL . 45.8 t -131.72 93.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 108.724 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.577 ' CD2' HG22 ' A' ' 37' ' ' ILE . 29.1 m-70 -118.85 91.3 3.52 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.664 -1.215 . . . . 0.0 110.316 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 57.1 m-85 -78.49 129.42 34.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 110.441 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.522 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 28.3 mttt -151.47 110.78 3.94 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 72.0 t -78.6 118.84 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 109.033 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.544 HD22 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -119.22 10.69 12.1 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.703 . . . . 0.0 110.677 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.527 ' CB ' HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.96 -1.087 . . . . 0.0 110.32 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.417 0.627 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.506 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 15.6 m-85 -136.67 133.95 36.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG12 ' CB ' ' A' ' 22' ' ' ARG . 4.9 mm -89.21 97.5 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.133 -0.979 . . . . 0.0 108.472 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 57' ' ' ALA . 18.8 m -88.47 113.21 23.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.55 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -78.81 117.7 20.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.589 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.614 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -116.04 116.11 27.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.577 HG22 ' CD2' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -79.14 130.41 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 111.248 -177.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.601 ' CG1' ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -112.78 146.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.039 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -53.18 84.94 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 159.91 -46.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.585 -0.95 . . . . 0.0 108.451 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.596 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -169.79 -176.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.8 153.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.86 -1.15 . . . . 0.0 108.884 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.576 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 17.1 m -149.04 94.71 2.28 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.55 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -79.68 -172.74 3.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.894 -1.128 . . . . 0.0 110.237 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.04 117.78 0.79 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -77.86 88.83 4.06 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.999 -1.295 . . . . 0.0 110.105 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.502 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.506 ' HB3' ' CB ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -32.07 -38.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.263 0.554 . . . . 0.0 110.478 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -69.45 -53.25 20.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.146 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HG3' ' CG ' ' A' ' 1' ' ' PRO . 0.4 OUTLIER -56.35 -59.21 5.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.525 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -52.53 -43.03 64.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.118 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.523 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -55.3 -51.99 64.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.907 -1.12 . . . . 0.0 108.513 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.13 -50.02 70.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.571 -0.705 . . . . 0.0 110.168 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 8.3 mt-10 -54.37 -36.83 64.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.91 -36.44 83.96 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.601 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 80.0 mmm -71.49 -69.33 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.569 0.699 . . . . 0.0 111.141 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -51.8 -38.14 54.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 72.8 t -69.64 -36.37 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -58.07 -55.51 33.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.479 HD22 ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -62.82 -38.35 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.026 -1.047 . . . . 0.0 109.527 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.422 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -66.01 -14.72 62.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 109.71 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -54.98 3.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.302 -1.496 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.57 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . 0.587 ' CG ' ' CG ' ' A' ' 55' ' ' LYS . 5.0 Cg_exo . . . . . 0 N--CA 1.495 1.603 0 N-CA-C 109.557 -0.978 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.563 HD11 ' CE2' ' A' ' 18' ' ' PHE . 4.3 mm -66.42 -60.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 108.975 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -27.69 43.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.395 -0.815 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 11.4 mt-30 -64.76 -57.35 9.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.584 ' CG1' HD22 ' A' ' 62' ' ' LEU . 13.8 t -53.42 -63.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.587 ' CE1' HG13 ' A' ' 16' ' ' VAL . 90.5 m-70 -39.86 -39.04 0.75 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.19 -0.944 . . . . 0.0 109.685 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.3 mt-10 -61.7 -62.06 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.612 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -70.02 -51.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.005 -1.059 . . . . 0.0 110.698 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.612 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -46.89 -49.29 17.59 Favored Glycine 0 N--CA 1.48 1.613 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.86 -46.29 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.529 -1.571 . . . . 0.0 109.851 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.73 -10.14 25.28 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 110.162 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -122.74 8.34 9.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.828 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 8.3 t-20 78.3 -8.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.416 -0.803 . . . . 0.0 109.627 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.55 ' CE ' HG13 ' A' ' 38' ' ' VAL . 8.6 mtp -78.66 87.67 4.58 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.899 -1.126 . . . . 0.0 109.404 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -40.28 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.579 -0.701 . . . . 0.0 109.896 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.587 HG13 ' CE1' ' A' ' 6' ' ' HIS . 42.0 t -137.43 78.85 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.608 ' CD2' ' CG2' ' A' ' 37' ' ' ILE . 37.3 m-70 -100.73 95.59 6.76 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.951 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.567 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 3.2 m-85 -76.28 127.77 33.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 109.672 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -147.97 110.97 4.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 53.0 t -76.39 117.23 20.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.981 -1.074 . . . . 0.0 108.873 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.544 HD21 ' N ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -93.0 -23.1 18.79 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.933 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 110.277 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 78.2 m-20 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.519 ' CB ' ' CB ' ' A' ' 53' ' ' SER . 4.4 m-85 -118.63 121.13 39.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.029 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 1.8 mm -89.08 91.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.593 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 15.4 m -88.95 108.64 19.67 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.874 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.604 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -79.85 115.73 19.61 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 18' ' ' PHE . 5.0 t -108.21 121.23 44.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 176.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.608 ' CG2' ' CD2' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -76.28 128.78 37.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.925 -1.109 . . . . 0.0 110.428 -177.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' C ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -116.69 102.94 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . 6.65 -73.4 0.0 OUTLIER Glycine 0 N--CA 1.504 3.169 0 C-N-CA 122.979 0.323 . . . . 0.0 112.547 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 38' ' ' VAL . 30.6 m -41.93 -65.8 0.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -1.053 . . . . 0.0 109.908 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.538 HD13 ' N ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -147.64 -139.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -113.37 161.89 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.19 . . . . 0.0 109.502 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.512 ' HB ' ' HE1' ' A' ' 61' ' ' MET . 19.8 m -150.37 91.92 1.81 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.604 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.5 pt-20 -86.17 -176.5 5.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.156 -0.965 . . . . 0.0 110.686 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -154.9 109.08 0.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.7 pm0 -79.24 80.44 5.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.297 -1.119 . . . . 0.0 109.563 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 53' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.557 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 28.6 p -14.75 -56.15 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.303 0.573 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 52' ' ' VAL . 14.5 mmtp -63.55 -59.64 4.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.364 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.587 ' CG ' ' CG ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -56.29 -62.61 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.526 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -42.05 -44.88 3.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 110.029 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -59.48 -58.94 6.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.938 -1.102 . . . . 0.0 108.631 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -48.43 -66.55 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.948 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.516 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.2 mm-40 -44.43 -40.1 5.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.333 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -56.07 -49.4 73.9 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 108.999 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.546 ' HE1' ' CG2' ' A' ' 38' ' ' VAL . 18.5 ttm -68.65 -62.57 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.723 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.616 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -47.75 -64.3 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.825 -1.172 . . . . 0.0 108.274 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 48.6 t -50.61 -34.92 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -52.2 -66.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 109.05 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.548 HD12 ' CE ' ' A' ' 14' ' ' MET . 1.3 mm? -53.83 -44.18 70.06 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.9 -1.125 . . . . 0.0 110.15 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.453 ' OE1' ' HA ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -53.55 -31.69 47.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.352 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.37 -41.7 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.617 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 64' ' ' GLU . 13.3 mt . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 N-CA-C 109.674 -0.933 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 18' ' ' PHE . 5.7 mm -76.63 -51.17 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 t -52.05 -37.5 53.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.635 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 30.6 mt-30 -63.17 -53.65 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.67 ' HA ' HD23 ' A' ' 62' ' ' LEU . 24.2 t -54.9 -67.92 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.581 ' CE1' HG13 ' A' ' 16' ' ' VAL . 92.4 m-70 -36.87 -38.89 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.331 -0.855 . . . . 0.0 109.448 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 2.7 mt-10 -60.08 -62.26 2.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.717 -0.615 . . . . 0.0 110.171 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.607 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -74.1 -51.46 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.607 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -44.3 -52.38 7.22 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -78.0 -37.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.08 -1.247 . . . . 0.0 110.17 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.537 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 8.6 mmtm -60.65 -16.84 43.12 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.468 -0.77 . . . . 0.0 111.171 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.585 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.7 tpt180 -116.32 -44.1 2.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.79 -1.194 . . . . 0.0 109.578 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.585 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER 155.46 -15.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.017 -0.427 . . . . 0.0 109.928 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.567 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -71.91 111.8 7.47 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.834 -1.166 . . . . 0.0 110.054 -179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.532 ' CG2' ' NE2' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -64.93 121.85 15.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.029 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.59 ' CG1' HG13 ' A' ' 5' ' ' VAL . 60.7 t -98.19 110.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.653 ' CD2' ' CG2' ' A' ' 37' ' ' ILE . 4.2 m-70 -136.49 95.5 3.17 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.588 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.651 ' CE2' ' HB3' ' A' ' 36' ' ' CYS . 60.2 m-85 -78.71 135.14 37.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 110.997 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 4.7 mtmt -150.36 110.49 4.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 95.2 t -78.62 118.39 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 108.818 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.544 HD22 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -118.76 10.26 12.34 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -178.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -139.16 166.88 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.125 . . . . 0.0 110.267 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 7.9 mt-10 -156.93 42.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.766 . . . . 0.0 109.429 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 31' ' ' ASN . 7.6 pt-20 -176.3 -169.12 0.29 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.989 -1.069 . . . . 0.0 110.032 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.48 -148.66 5.35 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.75 -62.1 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.189 1.926 . . . . 0.0 110.12 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' CB ' ' A' ' 28' ' ' HIS . . . -174.73 40.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 109.303 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.606 ' N ' ' CD2' ' A' ' 28' ' ' HIS . 0.2 OUTLIER 164.4 73.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.347 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 28' ' ' HIS . 3.6 mtt 163.26 106.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.3 84.41 0.26 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.391 -0.818 . . . . 0.0 109.601 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 24' ' ' GLU . 6.5 m-20 -120.09 128.15 53.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.135 -0.978 . . . . 0.0 109.413 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 4.6 m-85 -99.87 127.09 46.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.029 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.6 mp -88.81 97.31 6.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.549 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 5.1 m -86.16 118.04 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -82.01 114.49 20.61 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.873 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.651 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -110.22 113.19 25.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.653 ' CG2' ' CD2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -78.77 138.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.196 -0.94 . . . . 0.0 109.336 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.552 ' N ' ' CD1' ' A' ' 37' ' ' ILE . 0.5 OUTLIER -131.4 146.42 33.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 42.38 -112.88 0.5 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 2.77 11.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -1.204 . . . . 0.0 109.94 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 37' ' ' ILE . 1.8 mp -120.76 154.15 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 108.477 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.92 160.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.855 -1.153 . . . . 0.0 110.229 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.536 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 23.3 m -150.34 90.6 1.67 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.549 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 3.8 mt-10 -81.12 -172.84 3.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.865 -1.147 . . . . 0.0 110.686 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.31 119.57 0.83 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.535 ' CG ' HG13 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -80.37 92.01 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.072 -1.252 . . . . 0.0 111.107 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . -81.19 120.29 5.09 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.485 ' O ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -61.4 101.44 0.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.152 -1.204 . . . . 0.0 110.207 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 133.69 177.11 14.72 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.501 ' HG3' ' N ' ' A' ' 51' ' ' LYS . 3.4 pttm -94.34 -46.49 7.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -1.126 . . . . 0.0 109.56 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' N ' ' HG3' ' A' ' 50' ' ' LYS . 12.4 tttt -84.14 -9.69 58.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -84.81 -39.34 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.516 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -35.57 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.701 -0.624 . . . . 0.0 110.935 -179.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 52' ' ' VAL . 13.4 mttp -76.29 -49.68 16.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.593 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.73 -35.72 81.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.145 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 2.1 tpp180 -76.87 -40.32 48.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 109.885 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.549 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -61.81 -51.67 67.33 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 108.356 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -63.0 -56.38 17.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 110.051 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.503 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mt-10 -46.78 -43.6 18.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.731 -1.231 . . . . 0.0 108.112 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.97 -43.2 95.25 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.562 ' CE ' ' O ' ' A' ' 36' ' ' CYS . 5.9 ttm -65.15 -70.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 110.484 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.67 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -47.71 -62.58 1.38 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 78.8 t -44.32 -38.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.37 -0.831 . . . . 0.0 108.991 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -58.03 -57.34 13.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.588 -0.695 . . . . 0.0 111.059 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.54 ' HG ' ' CE ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -110.04 24.04 13.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.846 -1.159 . . . . 0.0 111.608 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 21.1 mm-40 -112.16 -20.41 11.92 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.6 -33.41 10.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.578 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.305 -1.352 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.681 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.525 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 3.0 Cg_exo . . . . . 0 N--CA 1.496 1.668 0 N-CA-C 109.597 -0.963 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.569 HD11 ' CE2' ' A' ' 18' ' ' PHE . 2.7 mm -80.32 -62.29 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.236 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -42.02 69.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.6 mm100 -57.1 -52.0 67.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.107 -0.995 . . . . 0.0 108.936 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.649 ' HA ' HD22 ' A' ' 62' ' ' LEU . 74.7 t -55.61 -68.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.499 ' C ' ' O ' ' A' ' 5' ' ' VAL . 82.6 m-70 -35.15 -34.58 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.656 0.741 . . . . 0.0 109.578 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.2 mt-10 -68.61 -52.56 30.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.73 -0.606 . . . . 0.0 110.585 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -73.23 -45.89 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.676 -179.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.634 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -50.73 -52.97 27.66 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.4 -47.4 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.057 -1.26 . . . . 0.0 109.451 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -63.99 -10.05 19.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -125.22 8.06 7.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.833 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 80.19 -10.78 1.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.686 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.522 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -72.94 89.53 1.42 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.067 -1.021 . . . . 0.0 109.081 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -43.48 149.36 0.27 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 109.509 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.548 ' CG1' HG11 ' A' ' 5' ' ' VAL . 39.9 t -125.93 102.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.167 -0.958 . . . . 0.0 109.033 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.577 ' CB ' HG23 ' A' ' 37' ' ' ILE . 39.0 m-70 -121.77 95.09 4.53 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.524 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 3.1 m-85 -81.21 129.82 34.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.955 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.66 111.41 4.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 70.7 t -78.06 103.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 0.0 109.035 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.583 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -89.68 -21.85 22.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.072 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.494 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -131.81 144.21 50.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.647 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 39.2 mt-10 -133.04 113.61 12.99 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 109.643 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.573 ' HG3' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 34.91 63.2 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.716 -0.615 . . . . 0.0 110.482 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 24' ' ' GLU . . . 42.9 -141.61 1.96 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.81 -67.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.989 1.793 . . . . 0.0 110.119 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -167.57 81.17 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.342 -0.849 . . . . 0.0 109.565 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.526 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 45.8 m-70 -156.53 34.98 0.32 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 109.737 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 8.7 ptt? 39.85 30.49 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.461 -0.775 . . . . 0.0 110.268 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' N ' ' HB3' ' A' ' 24' ' ' GLU . 13.2 mttm -68.03 -98.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.109 -0.994 . . . . 0.0 109.768 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 2.8 m120 -131.23 147.08 52.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.898 -1.126 . . . . 0.0 110.66 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 20.6 m-85 -103.98 119.3 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 2.1 mm -89.48 92.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.021 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.594 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 19.5 m -89.59 113.46 24.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.493 -0.754 . . . . 0.0 109.131 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.583 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -80.01 116.61 20.24 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.44 -0.788 . . . . 0.0 110.236 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.63 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -113.27 115.24 27.87 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.577 HG23 ' CB ' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -76.69 134.78 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.961 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.546 ' CG2' ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -130.17 135.11 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 49.23 -127.29 21.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -104.51 5.05 33.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -1.13 . . . . 0.0 109.774 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -122.15 151.61 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 108.894 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG11 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.85 160.96 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.968 -1.083 . . . . 0.0 109.746 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 21.2 m -150.45 92.01 1.81 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.565 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -81.42 -173.74 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.878 -1.138 . . . . 0.0 110.446 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.37 110.95 0.46 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 pt-20 -79.25 75.61 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 110.681 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -49.6 169.94 0.16 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 49' ' ' GLY . 0.8 OUTLIER -113.45 98.24 6.96 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.962 -1.317 . . . . 0.0 110.959 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.499 ' O ' ' HG2' ' A' ' 50' ' ' LYS . . . 33.99 -156.21 0.01 OUTLIER Glycine 0 N--CA 1.496 2.698 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 2.2 ptmt 45.9 -174.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.916 . . . . 0.0 109.465 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 89.02 0.05 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 53' ' ' SER . 1.2 p -146.64 -158.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 3.4 p 84.38 -57.93 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.915 -0.49 . . . . 0.0 109.693 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' N ' ' OG ' ' A' ' 53' ' ' SER . 4.6 pttp -80.06 -48.83 12.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 108.966 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 98.4 mttt -68.62 -30.03 68.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.536 ' HG3' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -79.49 -38.82 33.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.478 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.594 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.022 -1.049 . . . . 0.0 108.394 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -65.1 -54.69 26.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.474 -0.766 . . . . 0.0 110.214 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.529 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.4 mt-10 -48.51 -42.71 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.61 -1.306 . . . . 0.0 107.76 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.7 tptp -62.76 -39.46 94.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.546 ' SD ' ' CG2' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -65.78 -71.46 0.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.613 . . . . 0.0 110.072 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 5' ' ' VAL . 1.3 mt -51.76 -56.98 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.127 -0.983 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 79.0 t -47.19 -39.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 108.506 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -61.15 -68.39 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.748 . . . . 0.0 110.386 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.35 -27.96 1.84 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.185 . . . . 0.0 109.964 -178.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 24.2 mm-40 -54.03 -49.49 68.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.931 -1.106 . . . . 0.0 109.536 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -51.22 36.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.985 . . . . 0.0 109.338 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.48 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.496 1.651 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.514 HD11 ' N ' ' A' ' 2' ' ' ILE . 3.4 mm -68.24 -54.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.152 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -53.09 -30.67 37.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 109.216 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.6 mm100 -65.04 -55.81 16.71 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.621 ' CG1' HD22 ' A' ' 62' ' ' LEU . 21.8 t -53.64 -67.67 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.531 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 90.7 m-70 -36.46 -39.12 0.18 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 7.5 mt-10 -63.56 -59.02 5.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.845 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.636 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.8 pp -70.92 -50.4 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.897 -1.127 . . . . 0.0 110.31 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.636 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -47.53 -49.65 20.4 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.54 -45.6 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.664 -1.492 . . . . 0.0 109.823 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -64.0 -11.74 31.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.68 15.32 8.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.98 -1.075 . . . . 0.0 109.717 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 1.2 m-20 72.68 -4.82 2.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.545 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 3.0 mtp -79.75 91.2 5.28 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.809 -1.182 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -44.59 158.46 0.05 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.083 -1.011 . . . . 0.0 109.869 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.583 ' CG1' HG13 ' A' ' 5' ' ' VAL . 54.9 t -128.04 91.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.583 ' CG ' HG23 ' A' ' 37' ' ' ILE . 27.7 m-70 -109.42 92.88 4.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.581 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 39.7 m-85 -81.47 115.1 20.63 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -149.71 117.71 6.32 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.07 -1.018 . . . . 0.0 109.481 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 53.0 t -79.13 116.86 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.542 HD22 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.52 5.06 13.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.503 -0.748 . . . . 0.0 110.957 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -138.14 150.3 46.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.761 -1.212 . . . . 0.0 110.398 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 1.2 mp0 -131.24 121.88 25.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.527 -0.733 . . . . 0.0 109.208 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.49 166.96 21.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.42 103.89 1.65 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -59.52 -73.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.049 1.833 . . . . 0.0 110.327 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.407 ' H ' ' CD2' ' A' ' 28' ' ' HIS . . . -165.78 36.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.545 ' N ' ' CD2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -163.24 22.68 0.08 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.043 -1.035 . . . . 0.0 109.668 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 170.82 85.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.261 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.554 ' O ' ' CA ' ' A' ' 49' ' ' GLY . 4.1 mttt -76.98 122.23 24.6 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 109.696 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -137.67 123.49 20.02 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.089 -1.007 . . . . 0.0 108.448 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.639 ' CE1' ' ND2' ' A' ' 48' ' ' ASN . 5.2 m-85 -106.08 151.41 24.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.067 -1.021 . . . . 0.0 108.647 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 5.8 mm -87.55 102.05 12.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.582 ' HB ' ' CB ' ' A' ' 57' ' ' ALA . 91.6 m -88.78 111.1 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.807 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.542 ' CB ' HD22 ' A' ' 21' ' ' LEU . . . -80.27 117.06 20.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 110.3 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.619 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -111.69 112.7 24.58 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.583 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.62 137.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.047 -1.033 . . . . 0.0 110.159 -177.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.537 ' CG2' ' SD ' ' A' ' 61' ' ' MET . 0.6 OUTLIER -131.29 126.19 58.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.487 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 56.05 -121.83 25.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.35 4.72 19.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.15 . . . . 0.0 109.418 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.49 161.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 0.0 108.923 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG11 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -102.86 142.05 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.868 -1.145 . . . . 0.0 110.425 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.551 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 20.3 m -132.49 92.1 3.03 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.1 mp0 -85.36 -168.71 2.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.012 -1.055 . . . . 0.0 111.171 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -155.75 -179.25 30.69 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.5 -2.64 . . . . 0.0 106.5 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 2.5 mt-10 -133.92 71.33 1.46 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 119.453 1.626 . . . . 0.0 110.874 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.612 ' O ' ' CB ' ' A' ' 48' ' ' ASN . . . -134.96 170.46 22.84 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.867 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.639 ' ND2' ' CE1' ' A' ' 32' ' ' PHE . 0.6 OUTLIER 148.0 -17.71 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 122.075 -0.662 . . . . 0.0 109.871 179.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.554 ' CA ' ' O ' ' A' ' 30' ' ' LYS . . . -43.28 -48.39 6.77 Favored Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.11 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.15 72.06 1.45 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.1 -1.235 . . . . 0.0 109.978 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 50.13 49.0 21.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.31 -0.869 . . . . 0.0 109.783 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.52 HG11 ' N ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -117.19 -27.35 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.173 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.52 ' N ' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -33.81 -63.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.268 0.556 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HA ' ' CE ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -47.02 -51.04 18.25 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.111 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 56' ' ' ARG . 1.4 mttt -57.39 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.458 -0.776 . . . . 0.0 109.035 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -29.26 -66.48 0.09 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.889 -0.507 . . . . 0.0 111.226 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.582 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -46.36 -55.03 7.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 110.704 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.574 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -61.2 -53.96 50.3 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.19 -0.944 . . . . 0.0 111.529 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.562 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.8 mm-40 -49.47 -38.02 28.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.382 -1.449 . . . . 0.0 107.545 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 18.5 tptt -63.52 -41.16 98.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.551 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 3.3 ttm -68.48 -73.1 0.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.756 -0.59 . . . . 0.0 110.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.621 HD22 ' CG1' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -48.5 -47.58 38.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.326 -0.859 . . . . 0.0 109.857 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 72.2 t -60.71 -37.92 77.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 108.254 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -58.13 -58.01 10.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.634 -0.666 . . . . 0.0 110.341 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.853 -1.155 . . . . 0.0 110.13 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -50.75 -26.4 5.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -58.5 -53.42 58.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.487 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.579 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.652 0 N-CA-C 109.646 -0.944 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.656 ' CG2' ' CD2' ' A' ' 6' ' ' HIS . 2.5 mp 81.43 -55.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 2' ' ' ILE . 92.9 p -46.38 -50.26 16.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.723 -1.235 . . . . 0.0 108.451 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -58.04 -51.78 68.25 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.569 ' CG2' HD22 ' A' ' 62' ' ' LEU . 47.0 t -49.51 -77.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.656 ' CD2' ' CG2' ' A' ' 2' ' ' ILE . 93.4 m-70 -28.92 -41.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.419 0.628 . . . . 0.0 110.126 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 5' ' ' VAL . 4.0 mm-40 -60.34 -64.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.605 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -70.32 -49.43 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -0.957 . . . . 0.0 110.651 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.605 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -46.96 -56.32 7.74 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -32.56 51.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.259 . . . . 0.0 109.321 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.3 mmtp -76.7 -4.55 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 110.422 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -133.91 16.07 3.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.381 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 80.22 -10.98 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.656 -0.652 . . . . 0.0 109.98 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.572 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 5.2 mtt -75.74 100.37 4.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.81 -1.182 . . . . 0.0 109.674 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -50.5 174.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.827 -1.17 . . . . 0.0 109.55 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 6' ' ' HIS . 95.8 t -149.09 88.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.569 ' CG ' HG23 ' A' ' 37' ' ' ILE . 45.7 m-70 -112.18 95.76 5.64 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.708 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 33.0 m-85 -80.21 118.65 22.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.507 -0.745 . . . . 0.0 111.441 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.528 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.45 123.3 8.69 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 53.4 t -79.78 130.07 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.943 -1.098 . . . . 0.0 108.925 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.546 HD22 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -89.0 -22.37 23.03 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.773 -0.579 . . . . 0.0 109.721 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 162.82 154.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.528 -179.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -103.19 87.59 2.93 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 3.3 mm-40 -41.0 143.22 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 110.104 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' HA3' ' HG3' ' A' ' 30' ' ' LYS . . . 100.7 148.82 22.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.92 -81.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.252 1.968 . . . . 0.0 110.431 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.474 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -156.5 77.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 0.0 109.289 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.534 ' O ' ' CG ' ' A' ' 29' ' ' MET . 28.2 m-70 -153.98 58.86 0.73 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.89 . . . . 0.0 109.5 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.534 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 5.0 ptp 41.39 31.45 0.17 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.414 -0.804 . . . . 0.0 109.672 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' HG3' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -58.35 -161.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 110.131 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 33.8 m-80 -89.13 152.25 21.74 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.07 -1.019 . . . . 0.0 110.284 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.614 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 7.2 m-85 -117.86 117.96 30.7 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.507 HD11 ' N ' ' A' ' 33' ' ' ILE . 1.6 mm -86.55 91.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.051 -1.031 . . . . 0.0 108.581 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.576 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 34.7 m -88.8 111.16 21.69 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.546 ' CB ' HD22 ' A' ' 21' ' ' LEU . . . -79.84 113.88 18.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.438 -0.789 . . . . 0.0 110.485 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.646 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -110.93 119.43 39.04 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.569 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -78.75 134.01 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.727 -1.233 . . . . 0.0 111.104 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.595 ' CG1' ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -129.97 140.5 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 50.61 -91.67 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.9 m -143.51 2.39 1.25 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -1.175 . . . . 0.0 110.35 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 mm -117.05 160.8 16.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.991 -1.068 . . . . 0.0 108.603 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.69 125.38 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.862 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.523 ' CG2' ' HB3' ' A' ' 61' ' ' MET . 73.4 m -115.29 88.67 2.93 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -80.88 -172.82 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.985 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -160.89 115.96 0.69 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.059 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.47 78.59 4.93 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.131 -1.217 . . . . 0.0 109.816 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . -74.33 129.1 11.1 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.987 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.582 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -48.97 88.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.389 -1.065 . . . . 0.0 109.961 179.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.615 ' O ' ' CB ' ' A' ' 50' ' ' LYS . . . -29.6 157.93 0.0 OUTLIER Glycine 0 N--CA 1.498 2.817 0 CA-C-O 121.597 0.554 . . . . 0.0 112.131 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.615 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER 97.94 57.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 50' ' ' LYS . 4.0 tttp 72.57 59.91 0.12 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -164.64 -41.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.916 . . . . 0.0 110.322 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.526 ' OG ' ' CG ' ' A' ' 32' ' ' PHE . 3.9 m -33.49 -74.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.705 -0.622 . . . . 0.0 111.739 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' SER . 33.1 pttt -43.1 -51.73 5.74 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.145 -0.972 . . . . 0.0 111.1 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -54.51 -39.27 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.94 -1.1 . . . . 0.0 110.464 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.589 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -72.66 -35.85 67.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.576 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -63.82 -53.0 57.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.91 -1.119 . . . . 0.0 108.405 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -62.3 -64.05 1.05 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.429 -0.794 . . . . 0.0 109.403 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 30.9 mt-10 -50.91 -25.5 4.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.754 -1.216 . . . . 0.0 108.502 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -65.89 -53.15 43.36 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.604 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 3.6 ptp -73.62 -51.46 16.7 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.865 -1.534 . . . . 0.0 110.448 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.584 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -48.66 -55.95 9.87 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 62.5 t -54.52 -37.77 39.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -53.88 -72.81 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -44.87 -37.44 3.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 21.5 mm-40 -58.33 -45.94 87.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.02 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -36.37 83.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.024 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.574 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 55' ' ' LYS . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.628 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 54' ' ' LYS . 10.0 mm -95.12 -56.76 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.145 -0.972 . . . . 0.0 108.863 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -57.56 -33.84 68.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.534 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 3.2 pt20 -62.66 -48.88 77.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 108.479 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.645 ' HA ' HD23 ' A' ' 62' ' ' LEU . 99.1 t -59.98 -68.16 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.527 ' C ' ' O ' ' A' ' 5' ' ' VAL . 81.5 m-70 -34.7 -34.28 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.579 0.704 . . . . 0.0 109.514 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' VAL . 6.3 mt-10 -67.76 -69.37 0.32 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.171 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.612 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -57.89 -52.94 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.16 -0.962 . . . . 0.0 109.492 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.612 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -46.82 -49.65 16.56 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -80.16 -65.34 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.338 . . . . 0.0 109.955 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -39.68 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.473 -0.767 . . . . 0.0 111.428 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -104.67 -49.67 3.47 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.78 -1.2 . . . . 0.0 109.272 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.6 m-20 150.34 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.585 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 4.5 mmt -56.19 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.154 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -46.41 158.37 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.725 -1.234 . . . . 0.0 109.361 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.554 ' CG1' HG13 ' A' ' 5' ' ' VAL . 96.9 t -130.35 82.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.585 ' CD2' HG22 ' A' ' 37' ' ' ILE . 23.9 m-70 -110.22 89.2 2.96 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.003 -1.479 . . . . 0.0 111.117 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' A' ' 36' ' ' CYS . 52.9 m-85 -75.87 120.78 21.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' O ' HD21 ' A' ' 21' ' ' LEU . 31.4 tttp -145.65 116.78 7.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 47.2 t -78.31 113.38 17.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.967 -1.083 . . . . 0.0 109.062 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.585 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -111.05 16.71 21.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.84 -178.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.543 ' CD ' HG13 ' A' ' 33' ' ' ILE . 2.0 mtt180 -147.45 155.81 42.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.779 -1.201 . . . . 0.0 110.407 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 10.2 mt-10 -156.18 119.07 4.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 6.9 pt-20 -140.06 172.13 13.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.085 -1.009 . . . . 0.0 110.084 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . 122.34 145.37 6.99 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HG2' ' NE2' ' A' ' 28' ' ' HIS . 2.2 Cg_endo -62.05 -69.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.149 1.9 . . . . 0.0 110.178 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -170.38 33.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 109.759 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -159.43 -70.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 51.6 mtm -86.35 58.27 4.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.21 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.506 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 48.7 mttt -74.77 115.49 14.41 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.314 -0.866 . . . . 0.0 110.04 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.483 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 36.2 m-20 -94.99 144.27 25.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.197 -0.94 . . . . 0.0 108.509 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' A' ' 49' ' ' GLY . 17.3 m-85 -121.36 139.35 53.54 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.657 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 5.1 mm -89.39 96.57 6.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.596 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 4.3 m -88.33 119.88 29.17 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.548 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.585 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -95.14 114.16 25.92 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.523 -0.735 . . . . 0.0 111.085 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.631 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 5.5 t -101.91 126.05 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.585 HG22 ' CD2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -75.11 133.37 31.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.616 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.56 ' CB ' ' HE3' ' A' ' 61' ' ' MET . 0.4 OUTLIER -125.11 130.88 73.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.127 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' N ' ' SD ' ' A' ' 14' ' ' MET . . . 42.34 -107.53 0.11 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 t -116.53 -7.51 11.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.604 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 38' ' ' VAL . 11.2 mt -112.87 148.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 108.661 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -91.31 128.01 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.913 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.504 ' OG1' ' HE1' ' A' ' 61' ' ' MET . 20.5 p -103.89 93.05 4.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.529 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 2.5 pt-20 -94.93 179.47 5.22 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.753 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -164.13 166.97 37.9 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.557 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -114.76 92.81 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.885 -1.362 . . . . 0.0 110.079 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . -73.86 167.82 54.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.445 ' C ' HG12 ' A' ' 52' ' ' VAL . 10.5 p-10 -110.69 92.51 4.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -1.172 . . . . 0.0 109.621 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 32' ' ' PHE . . . 140.2 -154.98 24.3 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 tttm -112.81 -45.95 3.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -1.217 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -88.73 -14.75 36.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.382 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.526 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -76.27 -39.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 0.0 109.463 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.49 ' O ' ' HB1' ' A' ' 57' ' ' ALA . 26.6 p -38.06 -33.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.453 ' HB3' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -72.9 -47.19 47.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.032 -1.042 . . . . 0.0 109.448 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -59.73 -51.79 68.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -60.29 -63.67 1.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.947 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.596 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -42.06 -48.61 4.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.397 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.23 -55.14 34.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.805 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.538 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.0 mm-40 -48.51 -33.54 9.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -66.1 -44.47 84.3 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.572 ' SD ' ' CG1' ' A' ' 5' ' ' VAL . 22.7 ttm -64.73 -60.73 2.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.389 -0.819 . . . . 0.0 110.081 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -56.45 -61.24 2.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 53.8 t -49.71 -34.56 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.913 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 61' ' ' MET . 2.4 mm-40 -59.93 -63.75 1.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -59.57 -22.28 61.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.1 -1.0 . . . . 0.0 109.993 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 1.8 mp0 -82.22 -23.35 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 0.0 109.954 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -79.93 -35.1 38.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.011 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.59 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.533 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 3.3 Cg_exo . . . . . 0 N--CA 1.496 1.664 0 N-CA-C 109.634 -0.949 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.572 HD11 ' CE2' ' A' ' 18' ' ' PHE . 4.5 mm -72.5 -54.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.266 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.8 p -54.08 -37.31 64.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.432 -0.792 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.7 -60.87 3.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.918 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.566 ' CG1' HD22 ' A' ' 62' ' ' LEU . 39.4 t -51.32 -66.91 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.585 ' CE1' HG13 ' A' ' 16' ' ' VAL . 75.5 m-70 -35.38 -35.96 0.06 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.578 -0.701 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -69.47 -50.63 43.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.472 -0.768 . . . . 0.0 110.261 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.617 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -74.57 -48.51 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.999 -1.063 . . . . 0.0 109.337 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -50.44 -50.79 34.36 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.11 -46.46 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.816 -1.402 . . . . 0.0 109.784 -179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.87 -10.97 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.997 . . . . 0.0 110.089 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -121.03 8.19 10.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 110.001 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER 80.35 -11.53 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.444 -0.785 . . . . 0.0 109.579 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.58 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 4.2 mtt -73.57 106.92 5.56 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.015 -1.053 . . . . 0.0 109.071 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.531 HG23 ' NE2' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -61.32 136.36 58.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.431 -0.793 . . . . 0.0 109.931 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.585 HG13 ' CE1' ' A' ' 6' ' ' HIS . 69.0 t -110.73 112.13 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.496 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.648 ' CD2' ' CG2' ' A' ' 37' ' ' ILE . 15.0 m-70 -131.15 103.76 6.68 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.644 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 58' ' ' ALA . 2.9 m-85 -90.67 136.27 33.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.606 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -150.33 110.07 4.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 68.9 t -77.51 123.13 33.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.963 -1.086 . . . . 0.0 108.389 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -107.19 -14.58 14.87 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.348 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.537 ' CB ' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -122.27 149.57 43.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.0 -1.063 . . . . 0.0 110.715 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' CG ' ' C ' ' A' ' 22' ' ' ARG . 9.8 mt-10 -157.99 92.07 1.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -54.96 -166.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 109.725 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.97 -147.08 15.69 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 3.2 Cg_exo -59.97 -79.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.294 1.996 . . . . 0.0 110.571 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.549 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -118.62 79.41 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.549 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 2.4 m-70 -157.79 88.1 0.96 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 108.926 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.53 ' O ' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER 51.5 35.07 13.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.138 -0.976 . . . . 0.0 108.586 -179.301 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -41.83 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.658 -0.651 . . . . 0.0 110.094 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.578 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 2.3 m120 -139.9 -178.89 5.65 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.503 -0.748 . . . . 0.0 109.278 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 58.6 m-85 -152.69 121.88 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.547 -0.721 . . . . 0.0 109.317 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' A' ' 22' ' ' ARG . 3.1 mm -89.4 92.15 3.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.55 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 31.1 m -87.76 109.83 20.01 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.969 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -77.55 122.07 24.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.556 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -126.18 111.67 14.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.464 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.648 ' CG2' ' CD2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -78.49 136.63 23.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.223 -0.923 . . . . 0.0 110.844 -178.137 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.596 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.2 t -127.45 127.73 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 52.61 -118.05 7.3 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -111.1 0.47 16.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -1.161 . . . . 0.0 109.864 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mt -116.11 134.02 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 108.971 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -97.55 142.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.893 -1.129 . . . . 0.0 110.714 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.54 HG22 ' CE ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -135.97 112.91 10.31 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -84.23 -170.24 3.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.841 -1.162 . . . . 0.0 109.098 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -160.81 108.61 0.36 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.45 -1.357 . . . . 0.0 109.785 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' CB ' HD12 ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.04 79.1 4.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.258 -1.142 . . . . 0.0 109.871 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 48' ' ' ASN . . . -85.25 136.75 14.72 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.605 ' N ' HG12 ' A' ' 52' ' ' VAL . 16.1 m-20 -51.63 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -1.159 . . . . 0.0 111.164 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -46.36 178.52 0.01 OUTLIER Glycine 0 N--CA 1.497 2.721 0 O-C-N 121.332 -0.855 . . . . 0.0 111.204 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -46.67 175.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.552 -0.97 . . . . 0.0 109.528 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? 59.82 33.22 21.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -179.66 -31.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.62 -0.675 . . . . 0.0 109.347 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.502 ' N ' HG11 ' A' ' 52' ' ' VAL . 65.3 m -57.68 -80.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.206 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -51.29 -53.39 36.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.259 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 24.3 ttpp -53.22 -29.55 33.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 109.628 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -74.35 -45.16 48.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.468 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.55 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -60.71 -57.36 13.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.246 -0.909 . . . . 0.0 108.553 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -54.55 -48.44 72.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.368 -0.833 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.535 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.7 mm-40 -53.56 -39.29 64.66 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.32 -37.66 84.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.596 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 64.0 mmm -70.18 -71.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.0 110.95 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.611 HD21 ' N ' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -49.5 -48.79 47.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.066 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 75.1 t -60.04 -37.81 74.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -55.48 -61.09 2.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.595 -0.69 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -60.79 -34.28 74.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 110.521 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 21.2 mm-40 -65.56 -28.57 69.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.709 -1.244 . . . . 0.0 109.666 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -70.83 -30.16 66.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 C--N 1.304 -1.386 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.461 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.494 ' HD2' ' CA ' ' A' ' 55' ' ' LYS . 5.4 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 N-CA-C 109.745 -0.906 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.583 HD11 ' CE2' ' A' ' 18' ' ' PHE . 5.1 mm -69.85 -58.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 p -55.6 -37.89 68.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.6 mm100 -60.96 -55.71 29.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 0.0 108.644 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.565 ' CG1' HD22 ' A' ' 62' ' ' LEU . 23.5 t -51.77 -70.11 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.579 ' CE1' HG13 ' A' ' 16' ' ' VAL . 86.3 m-70 -34.68 -38.68 0.08 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.619 -0.675 . . . . 0.0 109.779 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.8 mt-10 -62.51 -63.8 1.12 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.433 -0.792 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.621 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.11 -49.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.191 -0.943 . . . . 0.0 110.58 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.621 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -47.59 -56.22 8.62 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -30.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.118 -1.225 . . . . 0.0 109.504 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 6.5 mttm -79.84 -3.76 49.24 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 110.267 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.73 14.32 4.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 109.384 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 80.69 -10.33 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.635 -0.666 . . . . 0.0 109.764 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.546 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 1.8 mtt -76.48 99.56 4.96 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.935 -1.103 . . . . 0.0 109.342 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -53.78 142.18 24.57 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 6' ' ' HIS . 98.5 t -114.45 94.33 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.588 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 96.6 m-70 -119.26 102.74 8.91 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.161 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CD1' ' HB3' ' A' ' 36' ' ' CYS . 3.2 m-85 -86.84 125.3 33.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -138.99 114.67 9.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.532 ' CG2' ' OG1' ' A' ' 34' ' ' THR . 61.3 t -78.55 128.77 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.046 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -111.26 -11.16 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.706 -0.621 . . . . 0.0 110.097 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.524 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 12.3 mmt180 -140.23 170.33 16.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.031 -1.043 . . . . 0.0 109.993 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 32' ' ' PHE . 24.1 mp0 -144.08 20.38 1.76 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 49.3 tt0 161.75 141.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.881 . . . . 0.0 109.749 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.43 -138.02 1.97 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HG2' ' NE2' ' A' ' 28' ' ' HIS . 5.8 Cg_exo -59.42 -42.59 47.22 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.732 1.621 . . . . 0.0 109.578 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . . . 173.81 -77.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.456 -0.778 . . . . 0.0 109.589 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.52 ' NE2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -37.03 123.6 0.88 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.702 -0.624 . . . . 0.0 110.412 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.29 97.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.428 -0.795 . . . . 0.0 110.134 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -67.58 105.64 1.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 108.682 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 26.9 m-20 -108.6 141.43 40.54 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.676 0.75 . . . . 0.0 110.986 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 3.2 m-85 -108.62 126.44 52.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.524 ' CG1' ' HB2' ' A' ' 22' ' ' ARG . 1.3 mm -96.01 123.88 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 6.1 m -119.85 116.47 25.91 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.56 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -79.54 112.7 17.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.541 -0.725 . . . . 0.0 109.179 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.586 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -109.82 111.82 23.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.587 -1.321 . . . . 0.0 107.6 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -79.36 138.09 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 111.133 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -125.29 136.0 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 42.24 -88.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' VAL . 12.8 t -136.82 -7.13 1.88 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.087 -1.243 . . . . 0.0 110.609 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.469 ' O ' HG22 ' A' ' 38' ' ' VAL . 2.9 mt -108.05 136.85 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.908 -1.12 . . . . 0.0 108.414 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -92.03 129.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.851 -1.156 . . . . 0.0 110.729 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.52 HG22 ' CG2' ' A' ' 38' ' ' VAL . 68.2 p -115.76 98.37 6.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.56 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -82.94 -174.15 5.11 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.599 -1.313 . . . . 0.0 109.639 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -149.73 172.95 29.61 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -139.76 76.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.285 -1.127 . . . . 0.0 108.693 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.488 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -85.01 -160.8 33.1 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 61.5 m-20 -89.73 -160.04 0.65 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.274 -1.133 . . . . 0.0 108.251 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.571 ' HA2' ' CD1' ' A' ' 32' ' ' PHE . . . -107.36 139.14 14.86 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 80.6 127.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.556 -0.967 . . . . 0.0 110.292 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 30.31 69.52 0.09 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.261 0.553 . . . . 0.0 110.859 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.563 ' CG2' ' CD ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -178.26 -42.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 0.0 109.414 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.492 ' HB3' ' CB ' ' A' ' 32' ' ' PHE . 35.2 p -48.93 -54.93 13.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.888 -1.132 . . . . 0.0 109.559 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -55.94 -70.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 109.926 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' CA ' ' HD2' ' A' ' 1' ' ' PRO . 48.5 mttp -41.35 -68.9 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.742 . . . . 0.0 109.559 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.563 ' CD ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -36.67 -63.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.895 -0.503 . . . . 0.0 110.494 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -44.17 -49.31 9.14 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.925 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.67 -57.91 10.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.344 -0.847 . . . . 0.0 110.637 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.497 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 20.8 mt-10 -46.28 -45.24 17.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.762 -1.211 . . . . 0.0 108.136 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -56.23 -43.55 78.71 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.569 ' CE ' ' O ' ' A' ' 36' ' ' CYS . 4.8 ttm -66.41 -72.34 0.16 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.375 0.607 . . . . 0.0 110.602 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.579 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -46.89 -60.63 2.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.931 -1.106 . . . . 0.0 108.589 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 70.2 t -47.11 -39.13 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.749 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -58.07 -66.61 0.45 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' CD1' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -53.4 -28.2 28.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.979 -1.075 . . . . 0.0 110.547 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 31.5 mm-40 -65.11 -37.17 86.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.832 -1.168 . . . . 0.0 109.605 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -34.36 70.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.639 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.515 ' HG2' ' CG ' ' A' ' 55' ' ' LYS . 4.5 Cg_exo . . . . . 0 N--CA 1.496 1.625 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.516 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.0 mm -71.04 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -51.32 -37.64 48.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.349 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.5 mm-40 -62.45 -51.49 67.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.623 ' CG1' HD22 ' A' ' 62' ' ' LEU . 38.8 t -54.98 -66.83 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.37 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.573 ' CE1' HG13 ' A' ' 16' ' ' VAL . 93.6 m-70 -38.38 -38.61 0.38 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.494 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -61.03 -63.18 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.733 -0.604 . . . . 0.0 110.69 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.626 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.14 -49.06 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.029 -1.044 . . . . 0.0 110.791 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.626 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -49.36 -54.25 16.8 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.49 -39.24 82.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.885 -1.362 . . . . 0.0 109.476 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 11.3 mttm -69.64 -9.36 53.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 109.892 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.67 10.09 7.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.237 -0.915 . . . . 0.0 109.09 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 79.32 -10.28 1.35 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.75 . . . . 0.0 109.42 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.545 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -75.54 101.76 5.01 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.943 -1.098 . . . . 0.0 109.302 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -53.06 163.58 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.575 ' CG1' HG13 ' A' ' 5' ' ' VAL . 48.9 t -133.45 92.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.579 ' CG ' HG23 ' A' ' 37' ' ' ILE . 31.8 m-70 -113.68 95.64 5.44 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.621 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.636 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 54.7 m-85 -81.65 119.32 23.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.623 -0.673 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' O ' HD21 ' A' ' 21' ' ' LEU . 8.3 ttmm -151.01 115.96 5.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 93.4 t -79.01 119.29 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 0.0 108.668 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.594 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.21 1.39 13.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 110.984 -178.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -152.95 163.08 40.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.676 -1.265 . . . . 0.0 110.819 -179.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -122.08 -162.62 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -143.09 104.03 4.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.002 -1.061 . . . . 0.0 109.687 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . 57.9 160.56 0.03 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.514 ' HD2' ' NE2' ' A' ' 28' ' ' HIS . 4.1 Cg_exo -60.67 -69.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.406 2.07 . . . . 0.0 110.347 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 30' ' ' LYS . . . -120.16 -63.77 1.33 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.402 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.514 ' NE2' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -38.89 106.01 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.651 -0.655 . . . . 0.0 109.625 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 69.01 81.77 0.18 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.258 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -84.96 64.8 8.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.7 m-20 -89.71 171.91 9.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.874 -1.141 . . . . 0.0 109.236 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 35.2 m-85 -144.55 141.55 29.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.6 mm -89.47 99.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.591 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 35.8 m -89.22 113.31 24.51 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.459 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.594 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -80.85 119.51 23.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -0.909 . . . . 0.0 110.036 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.636 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -114.37 116.01 28.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.579 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.32 134.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.816 -1.177 . . . . 0.0 109.983 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' C ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER -129.19 131.22 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -10.0 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.504 3.226 0 CA-C-O 121.142 0.301 . . . . 0.0 112.579 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.48 ' HB3' HD13 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -36.29 -59.19 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.691 -0.888 . . . . 0.0 111.328 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.513 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -162.07 -168.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.935 -1.103 . . . . 0.0 108.854 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.481 HG11 HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -89.1 133.47 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.095 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.513 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 2.4 m -121.63 103.57 9.0 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 15.2 pt-20 -84.46 -169.8 2.79 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 110.441 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -156.96 178.99 33.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -127.94 82.73 2.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.892 -1.358 . . . . 0.0 110.533 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . -52.83 167.62 1.04 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -130.67 81.5 2.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.257 . . . . 0.0 110.726 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.525 ' O ' ' CG1' ' A' ' 52' ' ' VAL . . . 108.11 -172.07 16.73 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.31 -177.31 5.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.384 -1.068 . . . . 0.0 109.167 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt 48.96 23.78 0.76 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 108.831 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 53' ' ' SER . 0.8 OUTLIER -144.93 -156.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.452 -0.78 . . . . 0.0 109.124 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.551 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 0.1 OUTLIER 83.18 -55.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 109.571 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -44.15 44.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.022 . . . . 0.0 108.89 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.515 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -66.01 -44.81 83.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.275 -0.89 . . . . 0.0 108.636 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.454 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -61.78 -64.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.591 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -41.35 -46.25 3.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.504 -0.747 . . . . 0.0 109.244 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -57.91 -61.57 2.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.42 -0.8 . . . . 0.0 110.31 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -45.53 -50.26 13.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.795 -1.19 . . . . 0.0 108.59 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 12.9 tptt -51.22 -45.53 61.96 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.537 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 2.2 ttm -63.3 -70.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.59 -0.694 . . . . 0.0 110.353 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.623 HD22 ' CG1' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -46.25 -64.16 0.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 10.6 t -51.51 -29.48 9.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.448 -0.783 . . . . 0.0 109.561 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 3.8 mm-40 -67.89 -55.81 11.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.085 -1.01 . . . . 0.0 111.391 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.544 HD11 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -95.32 8.38 43.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.432 -1.418 . . . . 0.0 110.404 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 88.5 mt-30 -101.12 -13.33 18.22 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.381 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 -36.95 5.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 109.274 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.563 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.519 ' CG ' ' HB3' ' A' ' 55' ' ' LYS . 2.0 Cg_endo . . . . . 0 N--CA 1.495 1.608 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' HA ' HD11 ' A' ' 2' ' ' ILE . 5.1 mm -71.73 -64.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.5 p -51.36 -42.11 61.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.42 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.1 mt-30 -57.66 -54.0 51.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 108.837 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.591 ' HA ' HD23 ' A' ' 62' ' ' LEU . 56.5 t -53.15 -68.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.54 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 88.0 m-70 -34.97 -38.87 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.683 -0.636 . . . . 0.0 109.701 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.7 mt-10 -63.98 -56.53 14.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 110.06 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.645 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -72.41 -53.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.192 -0.943 . . . . 0.0 109.723 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.645 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -45.36 -48.34 11.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -73.84 -44.82 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.587 -1.537 . . . . 0.0 110.358 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.9 mtmt -64.61 -11.06 31.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.074 -1.016 . . . . 0.0 110.321 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -120.36 8.1 10.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.938 . . . . 0.0 109.856 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.0 t-20 78.86 -6.44 1.9 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.552 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 32.6 mtp -79.45 89.93 5.04 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -42.0 161.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.467 -0.771 . . . . 0.0 109.844 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.547 ' CG1' ' CE2' ' A' ' 18' ' ' PHE . 60.7 t -132.65 93.38 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.558 ' CB ' HG23 ' A' ' 37' ' ' ILE . 40.8 m-70 -110.31 97.7 7.11 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 118.306 -1.358 . . . . 0.0 110.439 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 39.0 m-85 -84.69 119.39 25.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 110.972 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' O ' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.52 116.58 5.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 86.4 t -78.66 126.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 109.327 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' CD2' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -126.78 9.49 6.99 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.624 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.527 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -145.05 156.43 43.92 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.192 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 32' ' ' PHE . 5.3 mt-10 -157.32 141.21 16.03 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' A' ' 25' ' ' GLY . 37.9 tp10 -46.08 160.02 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -0.97 . . . . 0.0 109.763 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' N ' ' HG3' ' A' ' 24' ' ' GLU . . . -64.31 -126.75 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.405 ' HG2' ' NE2' ' A' ' 28' ' ' HIS . 1.6 Cg_endo -62.71 -81.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.017 1.812 . . . . 0.0 110.541 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.535 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -143.79 92.47 2.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 109.805 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.535 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 34.8 m-70 -157.69 91.34 1.14 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.281 -0.887 . . . . 0.0 108.915 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.471 ' O ' ' N ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER 50.92 78.72 0.1 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.073 -1.017 . . . . 0.0 108.4 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -55.4 86.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.557 -0.715 . . . . 0.0 110.45 -179.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 6.6 m120 -104.5 108.31 19.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.939 -1.101 . . . . 0.0 108.286 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 3.0 m-85 -88.02 129.72 35.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.603 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.3 mp -89.45 96.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 26.4 m -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.888 0.852 . . . . 0.0 108.91 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.545 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -90.09 120.2 31.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.938 -0.476 . . . . 0.0 109.912 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.628 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -117.94 117.74 30.07 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.558 HG23 ' CB ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -77.26 132.56 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.952 -1.092 . . . . 0.0 110.536 -177.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.545 ' CG1' ' HE1' ' A' ' 14' ' ' MET . 0.8 OUTLIER -125.0 108.24 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 14' ' ' MET . . . 18.6 -105.82 0.01 OUTLIER Glycine 0 N--CA 1.504 3.216 0 CA-C-O 121.44 0.467 . . . . 0.0 112.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.1 m -24.18 -56.14 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.452 HG13 ' C ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -156.4 -161.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.09 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.59 163.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.47 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 53.8 m -150.5 90.51 1.65 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.545 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 6.7 pt-20 -86.64 -169.97 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.918 -1.114 . . . . 0.0 109.903 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -172.87 156.01 24.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 1.2 pt-20 -110.79 98.23 7.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.833 -1.392 . . . . 0.0 110.623 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' HA3' ' CB ' ' A' ' 56' ' ' ARG . . . -101.47 131.83 10.73 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.579 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -49.47 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.331 -1.099 . . . . 0.0 110.031 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 50' ' ' LYS . . . -30.46 155.66 0.0 OUTLIER Glycine 0 N--CA 1.497 2.748 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.652 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.6 OUTLIER 104.87 60.03 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 78.81 20.24 0.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.579 ' CG1' ' N ' ' A' ' 48' ' ' ASN . 0.8 OUTLIER -134.11 -17.52 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 54' ' ' LYS . 49.6 m -60.91 -93.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.89 -1.131 . . . . 0.0 110.217 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -32.15 -61.41 0.25 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.522 -0.736 . . . . 0.0 111.424 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.519 ' HB3' ' CG ' ' A' ' 1' ' ' PRO . 1.1 mttt -49.35 -50.75 38.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.054 . . . . 0.0 109.808 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.558 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 7.6 tpt180 -55.53 -57.52 11.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 109.787 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -44.59 -47.14 10.31 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.047 0.927 . . . . 0.0 108.658 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -54.31 -64.72 0.74 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 74.2 mt-10 -49.02 -23.97 1.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.201 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -64.36 -53.95 40.54 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.236 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.536 ' CE ' ' O ' ' A' ' 36' ' ' CYS . 3.4 ptp -77.72 -51.36 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.419 -1.312 . . . . 0.0 110.196 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -46.74 -47.73 20.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.393 -1.442 . . . . 0.0 107.732 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 79.3 t -65.21 -38.66 83.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' MET . 1.8 mm-40 -51.33 -68.79 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.541 ' CD2' ' HE2' ' A' ' 14' ' ' MET . 0.0 OUTLIER -48.51 -44.32 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.602 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 5.1 mm-40 -45.51 -65.01 0.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.962 -1.086 . . . . 0.0 109.489 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -46.02 -52.46 11.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.629 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 68' ' ' LEU . 5.0 mt . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.566 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.529 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 N-CA-C 109.556 -0.978 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.51 HG23 ' NE2' ' A' ' 6' ' ' HIS . 7.9 mm -78.66 -47.88 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -46.81 -51.12 17.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -50.73 -57.65 7.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.931 -1.106 . . . . 0.0 110.271 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.622 ' HA ' HD23 ' A' ' 62' ' ' LEU . 24.9 t -54.08 -58.17 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.803 -1.186 . . . . 0.0 108.969 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.536 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 79.0 m-70 -42.56 -34.69 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.837 -1.164 . . . . 0.0 108.839 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 9.7 mt-10 -71.23 -71.73 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.485 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.619 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -54.48 -48.47 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 120.669 -1.269 . . . . 0.0 109.745 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.619 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -52.98 -59.2 9.71 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.9 -52.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.699 -1.471 . . . . 0.0 110.212 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -55.4 -19.47 9.24 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.046 -179.051 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -121.75 23.07 10.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.6 -1.313 . . . . 0.0 111.168 -179.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 77.53 -11.82 1.15 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.084 -1.01 . . . . 0.0 111.141 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.576 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 4.6 mtt -78.3 93.93 4.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.124 . . . . 0.0 109.603 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -42.63 166.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.893 -1.129 . . . . 0.0 110.194 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.526 ' CG1' HG13 ' A' ' 5' ' ' VAL . 24.2 t -139.67 77.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.563 ' CG ' HG23 ' A' ' 37' ' ' ILE . 36.8 m-70 -102.15 91.57 4.37 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.348 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.641 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 29.1 m-85 -80.1 110.14 15.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.548 0.689 . . . . 0.0 110.767 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -131.53 119.0 20.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 67.6 t -79.89 136.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.033 -1.042 . . . . 0.0 110.175 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 3.4 mt -96.04 -15.08 22.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.562 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 91.08 171.09 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.691 0.758 . . . . 0.0 110.665 179.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.596 ' HG2' ' CD1' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -44.47 175.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.72 0.772 . . . . 0.0 111.128 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.46 96.81 10.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.692 -0.63 . . . . 0.0 110.451 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.68 -122.27 27.44 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.667 ' HA ' ' NE2' ' A' ' 28' ' ' HIS . 9.7 Cg_endo -64.96 -140.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.66 1.573 . . . . 0.0 108.716 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' O ' ' ND1' ' A' ' 28' ' ' HIS . . . 57.81 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.473 -0.767 . . . . 0.0 111.388 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.667 ' NE2' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER 57.0 32.21 21.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.237 -0.914 . . . . 0.0 109.79 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 3.2 mmt -162.78 22.51 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.503 -0.748 . . . . 0.0 109.142 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -129.09 -111.88 0.27 Allowed 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.114 -0.991 . . . . 0.0 110.762 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' N ' ' OE2' ' A' ' 23' ' ' GLU . 1.1 m120 -91.38 118.5 30.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.75 -1.219 . . . . 0.0 111.041 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.596 ' CD1' ' HG2' ' A' ' 23' ' ' GLU . 3.0 m-85 -90.33 128.54 36.47 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 2.9 mm -88.51 95.94 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.097 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.581 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 53.5 m -90.03 114.6 26.51 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -82.44 129.53 34.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.095 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.641 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -123.26 116.39 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.5 -1.375 . . . . 0.0 107.612 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -80.41 136.34 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.01 -1.056 . . . . 0.0 111.961 -177.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.586 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 0.9 OUTLIER -135.35 136.35 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.66 -124.44 19.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.34 5.54 23.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.16 148.27 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 108.898 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.514 ' CG2' HG12 ' A' ' 37' ' ' ILE . 1.5 t -108.07 143.2 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.946 -1.097 . . . . 0.0 110.293 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.552 ' OG1' ' CE ' ' A' ' 61' ' ' MET . 50.9 p -132.1 113.96 13.96 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -87.69 -168.02 2.08 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 110.008 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 60' ' ' LYS . . . -161.11 114.47 0.61 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -77.99 83.65 4.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.959 -1.318 . . . . 0.0 109.88 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.536 ' C ' ' CG1' ' A' ' 52' ' ' VAL . . . -86.68 122.28 6.06 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.54 ' O ' ' O ' ' A' ' 49' ' ' GLY . 3.8 m120 -47.49 93.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -1.181 . . . . 0.0 109.508 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' ASN . . . -13.06 -114.58 0.0 OUTLIER Glycine 0 N--CA 1.506 3.361 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.772 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER 36.33 38.18 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.659 -0.906 . . . . 0.0 109.56 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 50' ' ' LYS . 2.1 ttmt 71.26 62.81 0.16 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' C ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -149.37 -44.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 110.252 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.503 ' C ' ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -24.35 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -69.16 -59.65 2.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.937 -1.102 . . . . 0.0 109.648 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 3.6 ttpm? -50.06 -42.89 50.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.847 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.525 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -69.99 -34.4 73.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.396 -0.815 . . . . 0.0 110.471 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.581 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -64.66 -51.13 64.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.891 -1.131 . . . . 0.0 108.645 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -60.97 -51.71 68.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.532 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 4.8 mt-10 -51.18 -44.33 61.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.453 ' HG2' ' HA2' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -61.58 -36.23 80.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.586 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 34.8 tpp -70.25 -71.37 0.24 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.49 -0.756 . . . . 0.0 110.617 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.622 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -49.34 -52.69 26.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 108.33 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 78.1 t -52.02 -39.7 26.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 108.653 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 61' ' ' MET . 1.8 mm-40 -59.36 -64.26 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -53.58 -28.41 31.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.978 -1.076 . . . . 0.0 110.257 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 18.1 mm-40 -54.04 -62.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.842 -1.161 . . . . 0.0 109.615 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -54.92 -39.98 69.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.521 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.447 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 55' ' ' LYS . 4.6 Cg_exo . . . . . 0 N--CA 1.493 1.497 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.53 HG21 ' CE2' ' A' ' 18' ' ' PHE . 8.1 mm -97.58 -50.91 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 109.111 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.49 -45.76 18.62 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 0.0 109.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -55.6 -60.18 3.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.975 . . . . 0.0 108.979 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.628 ' HA ' HD22 ' A' ' 62' ' ' LEU . 48.5 t -46.59 -68.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 108.355 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.56 ' CE1' HG13 ' A' ' 16' ' ' VAL . 92.9 m-70 -36.8 -38.93 0.19 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.457 -0.777 . . . . 0.0 110.242 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.551 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -67.0 -48.12 69.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.653 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -75.82 -52.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.176 -0.953 . . . . 0.0 109.449 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.653 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -48.5 -53.44 16.47 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.69 -41.46 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.669 -1.489 . . . . 0.0 109.06 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -63.27 -13.37 37.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.411 -0.806 . . . . 0.0 110.178 -179.008 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.31 10.5 8.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 12.5 t30 79.66 -9.21 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.571 ' HA ' ' CA ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -75.98 91.22 3.04 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.119 -0.988 . . . . 0.0 109.642 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -42.86 160.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.568 ' CG1' HG13 ' A' ' 5' ' ' VAL . 41.4 t -128.2 96.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.589 ' CG ' HG23 ' A' ' 37' ' ' ILE . 37.4 m-70 -114.12 94.57 4.88 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.126 -1.43 . . . . 0.0 110.957 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.62 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 52.5 m-85 -80.5 118.68 22.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.633 -0.667 . . . . 0.0 109.659 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' O ' HD21 ' A' ' 21' ' ' LEU . 27.7 tttt -149.39 116.02 5.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.105 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 55.2 t -78.51 118.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.566 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -114.0 9.44 17.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.692 -0.63 . . . . 0.0 110.5 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' NH1' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -156.95 157.61 35.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.85 -1.156 . . . . 0.0 110.171 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -148.13 46.67 1.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.446 -0.784 . . . . 0.0 108.9 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -46.06 117.94 1.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.65 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' CD ' ' A' ' 30' ' ' LYS . . . 153.03 71.94 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.82 -74.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.129 1.886 . . . . 0.0 109.88 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.75 20.81 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.452 -0.78 . . . . 0.0 109.058 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.1 146.3 7.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.234 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 53.51 74.86 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.33 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 25' ' ' GLY . 1.1 mmmm -84.3 89.55 7.38 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.221 -0.924 . . . . 0.0 109.814 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 43.7 m-20 -107.31 -178.77 3.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.576 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 52.5 m-85 -150.42 125.65 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 109.195 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 3.2 mm -89.29 92.12 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.593 ' HB ' ' CB ' ' A' ' 57' ' ' ALA . 99.7 m -88.89 115.08 26.18 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.94 0.876 . . . . 0.0 109.606 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.566 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -80.67 118.17 22.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.762 -0.586 . . . . 0.0 109.665 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -111.95 115.75 29.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.589 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -78.19 134.79 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.712 -1.243 . . . . 0.0 110.735 -177.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.55 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -136.55 120.67 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 8.75 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.506 3.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.916 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.523 ' CB ' HD13 ' A' ' 41' ' ' ILE . 18.4 m -29.3 -60.66 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.088 -0.654 . . . . 0.0 111.265 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.562 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -160.56 -167.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.552 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' CG2' HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -99.13 138.86 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.224 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.6 m -126.09 108.38 11.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -82.18 -168.86 2.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.997 -1.064 . . . . 0.0 109.891 -178.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 112.65 0.52 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 3.2 pt-20 -78.02 80.59 4.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.16 -1.2 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.532 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . -61.4 178.67 3.93 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -129.96 101.45 5.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -1.139 . . . . 0.0 109.834 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.47 ' O ' HG11 ' A' ' 52' ' ' VAL . . . 119.89 162.94 12.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.78 164.79 22.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -1.125 . . . . 0.0 109.333 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' O ' ' HD2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER 56.22 18.44 3.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.221 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.486 HG11 ' N ' ' A' ' 53' ' ' SER . 0.4 OUTLIER -123.47 -37.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.377 -0.827 . . . . 0.0 109.12 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.533 ' CB ' ' OG1' ' A' ' 34' ' ' THR . 0.1 OUTLIER -36.36 -47.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.985 -0.447 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' CG ' HD13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -65.33 -47.45 76.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.531 ' CB ' ' HD2' ' A' ' 1' ' ' PRO . 3.5 mttp -58.65 -65.17 0.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.967 . . . . 0.0 109.269 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.532 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -45.77 -60.96 1.93 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.579 -0.701 . . . . 0.0 109.552 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.593 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -43.28 -46.01 6.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.988 . . . . 0.0 109.797 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -62.9 -65.15 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 58' ' ' ALA . 4.9 mt-10 -44.14 -59.63 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.946 -1.097 . . . . 0.0 108.504 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -43.67 -47.04 7.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.59 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 39.0 tpp -60.09 -72.31 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.595 -0.69 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD22 ' HA ' ' A' ' 5' ' ' VAL . 1.2 mt -45.38 -67.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 62' ' ' LEU . 6.4 t -41.98 -33.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -67.8 -63.83 0.98 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.247 -0.908 . . . . 0.0 111.004 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.611 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -86.29 10.61 14.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.985 -178.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.3 mm-40 -96.77 -15.65 21.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.461 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.23 -32.6 22.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 67' ' ' LYS . 16.0 mt . . . . . 0 C--N 1.304 -1.392 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.461 ' O ' HG22 ' A' ' 5' ' ' VAL . 4.6 Cg_exo . . . . . 0 N--CA 1.496 1.666 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' A' ' 54' ' ' LYS . 8.0 mm -69.62 -65.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -55.59 -30.73 61.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.64 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 26.3 mt-30 -63.84 -55.24 24.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.198 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.663 ' HA ' HD23 ' A' ' 62' ' ' LEU . 36.1 t -57.94 -55.76 19.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 82.3 m-70 -44.53 -38.83 4.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.694 -1.254 . . . . 0.0 108.684 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -62.46 -67.83 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.691 -0.631 . . . . 0.0 110.868 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.11 -50.48 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 0.0 110.274 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.592 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -44.37 -57.05 5.2 Favored Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.8 -29.65 41.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -1.18 . . . . 0.0 109.451 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -80.25 -3.29 48.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.414 -0.804 . . . . 0.0 110.58 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -134.84 16.19 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 109.842 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.4 t-20 78.53 -6.88 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.548 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 5.8 mmm -81.82 90.69 6.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.049 . . . . 0.0 108.79 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.579 ' CG2' ' NE2' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -41.79 157.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.115 -0.991 . . . . 0.0 110.391 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 6' ' ' HIS . 24.3 t -131.72 80.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 108.657 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.579 ' NE2' ' CG2' ' A' ' 15' ' ' THR . 84.5 m-70 -117.7 96.86 5.56 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.695 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 58' ' ' ALA . 3.2 m-30 -79.7 137.7 37.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 110.372 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 6.9 ptpt -150.71 118.48 6.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 66.3 t -78.97 129.25 37.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 108.984 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -88.61 -25.55 22.38 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.554 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER 161.96 -163.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.234 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.605 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -121.58 82.65 1.97 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.525 -0.735 . . . . 0.0 109.161 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER 73.68 -161.59 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 109.522 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.51 -99.28 2.12 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.59 -77.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.074 1.849 . . . . 0.0 110.008 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 28' ' ' HIS . . . -118.04 -146.3 0.39 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.48 -0.763 . . . . 0.0 109.063 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 44.52 36.83 1.83 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.089 -1.007 . . . . 0.0 109.109 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -67.42 -8.05 30.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.12 -34.6 22.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.838 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 33.3 m-20 -89.47 161.53 16.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.065 -1.022 . . . . 0.0 109.693 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.605 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 35.8 m-85 -131.86 125.83 32.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.342 -0.848 . . . . 0.0 109.429 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.532 HG23 ' CG ' ' A' ' 44' ' ' GLU . 2.0 mm -88.94 94.1 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.397 -0.814 . . . . 0.0 108.896 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.588 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 23.6 m -89.54 111.73 22.72 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 109.575 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -78.06 116.54 18.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.46 -0.775 . . . . 0.0 109.724 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.604 ' O ' ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -109.63 118.42 36.51 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.545 ' CG2' ' HB2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -87.41 134.17 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.776 -1.202 . . . . 0.0 112.808 -176.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 15' ' ' THR . 1.5 m -144.11 142.97 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.017 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 54.52 19.11 11.91 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 1.0 OUTLIER 87.43 -23.25 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.926 -0.749 . . . . 0.0 109.576 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 39' ' ' GLY . 1.3 mp -89.43 130.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -90.67 133.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 120.877 -1.139 . . . . 0.0 110.897 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.565 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.0 OUTLIER -128.71 105.7 8.44 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.575 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -81.42 -172.92 4.07 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.112 -0.993 . . . . 0.0 111.455 -177.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -155.83 112.33 0.52 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -78.0 78.24 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.064 -1.256 . . . . 0.0 111.02 -178.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' HA2' ' CB ' ' A' ' 56' ' ' ARG . . . -53.85 177.61 0.23 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 97.0 m-20 -128.82 86.72 2.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.959 -1.318 . . . . 0.0 110.703 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . 146.12 158.8 7.9 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 49' ' ' GLY . 2.4 mttm -42.97 -63.57 0.78 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.306 -1.114 . . . . 0.0 108.093 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' VAL . 29.2 mttt -83.86 -162.09 0.6 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER 81.82 -37.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.271 -0.893 . . . . 0.0 110.037 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.547 ' N ' HG11 ' A' ' 52' ' ' VAL . 22.7 p -42.11 -46.27 4.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.285 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HB3' HD13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -62.04 -44.66 96.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HD2' ' HG3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -62.2 -73.63 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.827 . . . . 0.0 109.181 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.515 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -39.0 -38.24 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -0.759 . . . . 0.0 110.072 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.588 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -62.6 -51.33 67.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.95 -1.094 . . . . 0.0 108.539 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -65.2 -57.94 7.25 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.293 -0.879 . . . . 0.0 110.842 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.526 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 17.5 mt-10 -46.79 -43.85 18.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.568 -1.333 . . . . 0.0 107.762 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.5 tttp -60.0 -43.54 95.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.604 ' CE ' ' O ' ' A' ' 36' ' ' CYS . 2.3 mmt -57.0 -72.09 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.019 0.914 . . . . 0.0 111.368 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -54.18 -56.98 13.04 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 49.1 t -47.91 -32.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.146 -0.971 . . . . 0.0 108.693 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.539 ' CA ' ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -67.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.813 . . . . 0.0 110.027 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -53.36 -24.4 12.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.114 -0.992 . . . . 0.0 110.073 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 32.1 mm-40 -80.31 -33.09 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.881 -1.137 . . . . 0.0 109.011 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -68.29 -41.24 81.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.89 . . . . 0.0 109.379 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--N 1.305 -1.363 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.554 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.501 ' HG2' ' CG ' ' A' ' 55' ' ' LYS . 2.4 Cg_endo . . . . . 0 N--CA 1.497 1.695 0 N-CA-C 109.792 -0.888 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.479 HG21 ' CD2' ' A' ' 18' ' ' PHE . 4.8 mm -68.5 -59.21 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -53.15 -33.48 52.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.9 mt-30 -64.32 -49.88 69.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.702 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.595 ' CG1' HD22 ' A' ' 62' ' ' LEU . 19.6 t -57.73 -64.9 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.414 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.523 ' CE1' HG13 ' A' ' 16' ' ' VAL . 93.7 m-70 -40.17 -39.0 0.84 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.624 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.0 mm-40 -62.2 -63.93 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.689 . . . . 0.0 110.676 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.603 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -67.75 -49.91 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.032 -1.043 . . . . 0.0 110.514 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.603 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -47.13 -54.3 9.94 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.83 -35.14 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.048 -1.266 . . . . 0.0 109.625 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.8 mmtm -76.16 -5.19 45.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -130.79 12.63 5.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.607 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 79.44 -8.7 1.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.559 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 4.3 mtt -76.21 96.18 3.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.995 -1.066 . . . . 0.0 109.376 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -49.75 153.75 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.017 -1.052 . . . . 0.0 109.438 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.55 ' CG1' HG13 ' A' ' 5' ' ' VAL . 98.1 t -127.41 95.63 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.563 ' CD2' HG22 ' A' ' 37' ' ' ILE . 26.1 m-70 -116.47 92.69 3.95 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.425 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.618 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 43.6 m-85 -79.63 123.81 27.97 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.54 0.686 . . . . 0.0 110.43 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' HD22 ' A' ' 21' ' ' LEU . 8.9 tttm -150.19 117.18 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 88.1 t -78.13 130.93 35.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 108.903 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -88.68 -26.38 21.87 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 160.46 -165.08 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.889 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -104.91 -158.34 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 13.8 tt0 178.3 133.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.646 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 139.55 141.38 4.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.514 ' HG2' ' NE2' ' A' ' 28' ' ' HIS . 1.7 Cg_endo -63.04 -80.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.122 1.881 . . . . 0.0 110.3 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.11 14.02 1.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.514 ' NE2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -150.18 39.15 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.95 . . . . 0.0 109.406 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 30.7 mtt -152.85 79.02 1.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.187 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -76.23 92.72 3.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.478 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 2.6 m120 -135.94 167.83 20.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.549 -0.72 . . . . 0.0 109.161 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 23' ' ' GLU . 23.0 m-85 -144.54 137.72 27.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 109.653 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.0 mm -91.62 96.95 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.586 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 9.4 m -89.53 118.79 29.42 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 110.374 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.571 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -80.0 122.61 26.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.776 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.618 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -120.35 115.92 24.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.383 -1.448 . . . . 0.0 107.292 178.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG22 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -77.54 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.102 -0.998 . . . . 0.0 111.214 -177.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.563 HG21 ' CE ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -121.56 141.31 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -52.77 83.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER 160.37 -45.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.453 -1.027 . . . . 0.0 108.55 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -168.44 -175.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.458 HG11 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -93.31 129.22 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.93 -1.106 . . . . 0.0 109.03 179.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.515 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 31.8 m -119.52 90.34 3.31 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.571 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 5.6 pm0 -80.76 -171.17 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.925 -1.109 . . . . 0.0 109.604 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -162.77 165.63 36.41 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.435 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -122.35 93.04 3.85 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.965 -1.315 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.52 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . -88.56 -163.98 39.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.518 ' CA ' HG13 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -90.5 -161.44 0.8 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.266 -1.138 . . . . 0.0 108.638 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.565 ' HA2' ' CD1' ' A' ' 32' ' ' PHE . . . -89.18 -176.93 46.2 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 1.1 tttt 74.16 -156.5 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -1.161 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -86.39 54.1 3.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.159 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.518 HG13 ' CA ' ' A' ' 48' ' ' ASN . 2.6 p -115.4 -43.56 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.523 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -36.53 -41.45 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.835 -0.54 . . . . 0.0 110.464 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HA ' HG23 ' A' ' 34' ' ' THR . 0.1 OUTLIER -63.91 -61.97 1.94 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.981 -1.075 . . . . 0.0 109.416 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.501 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 7.7 mtpt -48.75 -62.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -44.52 -68.48 0.19 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.311 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.586 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -34.0 -47.63 0.28 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.352 0.596 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -58.33 -53.74 54.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 0.0 109.221 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -49.69 -40.91 41.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.023 -1.048 . . . . 0.0 108.388 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.5 -40.41 94.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.563 ' CE ' HG21 ' A' ' 38' ' ' VAL . 5.6 ttm -69.73 -70.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 110.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.601 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -48.49 -56.19 8.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 108.757 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 99.0 t -50.66 -41.89 21.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.549 -0.72 . . . . 0.0 110.142 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.506 HD11 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -48.83 -31.39 7.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.027 -1.046 . . . . 0.0 110.088 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.506 ' NE2' HD11 ' A' ' 65' ' ' LEU . 22.1 mm-40 -66.27 -41.65 89.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 0.0 109.738 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -66.46 -35.14 79.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.474 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.545 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.501 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 2.5 Cg_endo . . . . . 0 N--CA 1.496 1.626 0 N-CA-C 109.785 -0.891 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.535 HD11 ' CE2' ' A' ' 18' ' ' PHE . 5.6 mm -71.74 -46.51 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.79 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 p -59.61 -32.86 70.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 110.079 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 39.7 mt-30 -64.89 -55.59 18.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.012 . . . . 0.0 109.183 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.598 ' HA ' HD22 ' A' ' 62' ' ' LEU . 7.0 t -57.34 -63.61 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.576 ' CE1' HG13 ' A' ' 16' ' ' VAL . 81.7 m-70 -39.41 -37.59 0.47 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.083 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 1.5 mt-10 -62.0 -67.59 0.4 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.521 -0.737 . . . . 0.0 110.427 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.62 -49.78 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.058 -1.026 . . . . 0.0 110.556 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.593 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -46.17 -55.28 7.73 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.34 -46.38 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.264 . . . . 0.0 109.919 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -62.83 -11.7 19.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.79 10.12 7.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.007 . . . . 0.0 109.781 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 39.3 t30 79.38 -10.58 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.946 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.528 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -72.51 86.09 1.16 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.956 -1.09 . . . . 0.0 108.8 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -39.72 163.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.613 0.72 . . . . 0.0 110.731 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.586 HG11 ' CE1' ' A' ' 18' ' ' PHE . 61.1 t -137.38 88.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.597 ' CG ' HG23 ' A' ' 37' ' ' ILE . 51.6 m-70 -105.87 93.51 4.68 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.13 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CE1' HG11 ' A' ' 16' ' ' VAL . 3.2 m-85 -86.76 131.14 34.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.89 114.09 4.82 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 56.0 t -78.19 111.69 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.87 -1.144 . . . . 0.0 108.909 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 HD21 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -91.32 -25.36 19.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.812 -0.555 . . . . 0.0 109.791 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -129.98 158.73 38.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.631 -179.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.575 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 55.2 mt-10 -153.53 68.69 0.79 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.348 -0.845 . . . . 0.0 109.389 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.581 ' HG3' ' CE1' ' A' ' 28' ' ' HIS . 0.1 OUTLIER 57.73 156.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.413 -0.805 . . . . 0.0 109.669 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . -61.76 -136.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.558 ' HD2' ' NE2' ' A' ' 28' ' ' HIS . 2.9 Cg_exo -55.66 -74.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.088 1.858 . . . . 0.0 110.913 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.691 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -153.37 124.72 7.55 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 109.629 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.691 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 168.08 -165.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.074 -1.016 . . . . 0.0 108.913 -178.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 mtm -107.7 50.02 0.79 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.098 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 2.3 mmmt -78.13 -144.35 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.306 -0.871 . . . . 0.0 110.215 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -109.2 178.37 4.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.96 -1.088 . . . . 0.0 111.243 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 9.6 m-85 -140.26 117.26 11.12 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 3.3 mm -90.74 122.24 41.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 120.943 -1.098 . . . . 0.0 108.764 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.589 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 10.0 m -123.59 109.71 14.11 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -76.31 118.77 19.36 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.602 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.57 ' HB2' ' HG3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -123.05 114.41 20.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.059 -1.026 . . . . 0.0 108.335 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.597 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -78.95 135.07 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -0.839 . . . . 0.0 111.548 -177.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.562 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 0.9 OUTLIER -133.12 148.65 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 45.14 -124.11 6.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t -111.96 8.11 20.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.574 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.461 ' O ' HD11 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -125.69 149.65 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 108.794 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -103.87 141.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.483 ' OG1' ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -132.96 114.16 13.68 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.7 mt-10 -82.72 -167.51 1.66 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.859 -1.15 . . . . 0.0 109.773 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -152.14 110.79 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.641 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -84.25 64.66 8.41 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.33 -1.1 . . . . 0.0 110.041 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -47.86 -179.54 0.01 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.51 ' O ' ' C ' ' A' ' 49' ' ' GLY . 11.6 p-10 -121.51 92.56 3.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.079 -1.248 . . . . 0.0 110.101 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 48' ' ' ASN . . . 24.22 -143.87 0.01 OUTLIER Glycine 0 N--CA 1.501 2.992 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 35.16 75.69 0.05 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.893 -0.769 . . . . 0.0 110.713 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER 41.61 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 53' ' ' SER . 1.7 p -162.32 -150.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.073 -1.017 . . . . 0.0 109.306 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.552 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 3.0 p 84.3 -58.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.79 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' CG ' ' N ' ' A' ' 55' ' ' LYS . 7.9 ptmt -77.84 -47.26 19.25 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.228 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.501 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 18.4 tttm -66.21 -39.57 89.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.385 -0.822 . . . . 0.0 108.997 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -68.14 -46.14 71.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.371 -0.831 . . . . 0.0 109.425 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -56.56 -57.84 10.62 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.113 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.477 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -53.34 -48.67 68.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.164 -0.96 . . . . 0.0 110.294 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.548 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 3.3 mt-10 -54.83 -35.77 64.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 11.8 tptp -64.52 -36.3 83.77 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.57 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 54.1 mmm -73.32 -71.12 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.649 -0.657 . . . . 0.0 110.704 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -49.57 -41.03 40.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 0.0 109.004 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 70.5 t -65.6 -39.72 85.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.64 -59.83 3.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.681 -0.637 . . . . 0.0 109.455 179.105 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -59.95 -40.87 90.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.272 -0.892 . . . . 0.0 110.292 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 8.8 mm-40 -46.41 -25.77 0.72 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.778 -1.201 . . . . 0.0 109.1 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.7 -66.04 0.64 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 109.283 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 67' ' ' LYS . 5.3 mt . . . . . 0 C--N 1.3 -1.562 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.452 ' O ' HG22 ' A' ' 5' ' ' VAL . 5.4 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.727 -0.913 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 2' ' ' ILE . 2.9 mm -72.74 -64.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.392 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 p -53.16 -28.06 24.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.268 -0.895 . . . . 0.0 109.233 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.4 mt-30 -67.08 -51.83 49.5 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 108.589 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.574 ' CG2' HD22 ' A' ' 62' ' ' LEU . 19.1 t -58.37 -60.38 2.36 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.509 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 92.6 m-70 -43.56 -39.98 3.74 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.953 -1.092 . . . . 0.0 109.093 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.1 mm-40 -60.53 -64.12 1.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 110.971 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.617 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.16 -49.95 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.891 -1.131 . . . . 0.0 110.727 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.617 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -48.0 -51.04 20.12 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.48 -46.35 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.662 -1.493 . . . . 0.0 109.889 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.92 -9.61 22.57 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.97 15.39 8.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 109.687 -179.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 72.64 -7.38 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.434 -0.791 . . . . 0.0 110.125 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 5.4 mtt -79.65 92.64 5.39 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.604 -1.31 . . . . 0.0 108.881 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -42.41 168.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.484 ' CG1' HG13 ' A' ' 5' ' ' VAL . 84.6 t -137.73 83.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 108.4 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.585 ' CG ' HG23 ' A' ' 37' ' ' ILE . 37.3 m-70 -106.42 92.53 4.16 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.563 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.634 ' CE1' ' HB2' ' A' ' 36' ' ' CYS . 37.4 m-85 -78.36 122.04 25.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.651 -0.656 . . . . 0.0 110.394 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.34 122.02 8.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.137 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.534 ' CG2' ' OG1' ' A' ' 34' ' ' THR . 53.2 t -77.42 130.01 36.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 108.526 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -88.67 -22.46 23.4 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 160.15 -165.35 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.414 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.585 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -112.07 -172.0 1.96 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HG3' HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -142.92 134.24 26.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.975 . . . . 0.0 109.438 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.1 149.72 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.31 -62.27 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.092 1.862 . . . . 0.0 110.215 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -156.12 -146.44 0.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.443 -0.786 . . . . 0.0 109.215 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.539 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 1.7 m-70 64.05 12.2 6.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.967 . . . . 0.0 109.165 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 164.07 72.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.141 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' C ' ' OD1' ' A' ' 31' ' ' ASN . 13.0 mtmt -57.28 109.4 0.67 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.176 -0.953 . . . . 0.0 109.79 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 3.9 m120 -143.35 133.18 23.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.469 -0.769 . . . . 0.0 109.363 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CE1' ' HB3' ' A' ' 23' ' ' GLU . 6.2 m-85 -116.51 143.01 46.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.379 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 5.1 mm -90.62 111.8 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.604 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 7.4 m -103.86 118.63 37.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.144 -0.972 . . . . 0.0 110.737 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.582 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -84.68 122.96 29.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 0.0 111.141 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.634 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 4.1 t -114.63 121.07 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.585 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.86 130.57 36.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.662 -1.274 . . . . 0.0 109.929 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.585 ' CG1' ' CE ' ' A' ' 14' ' ' MET . 1.0 OUTLIER -135.5 119.35 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.387 0.613 . . . . 0.0 109.479 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . 15.5 -101.44 0.01 OUTLIER Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.478 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -27.62 -60.79 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.223 -0.575 . . . . 0.0 111.247 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -164.79 -167.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.048 -1.032 . . . . 0.0 108.603 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -89.67 134.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.996 -1.065 . . . . 0.0 110.168 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.573 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.8 m -123.25 107.96 12.26 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.582 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -90.05 -173.65 3.94 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.21 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -154.92 175.97 32.78 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -128.88 93.69 3.66 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.287 . . . . 0.0 109.683 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . -92.23 -170.89 41.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.571 ' CB ' HG13 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -80.33 -160.0 0.26 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.175 -1.191 . . . . 0.0 108.73 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 50' ' ' LYS . . . -121.24 80.62 0.34 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 0.3 OUTLIER 169.52 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.504 -0.998 . . . . 0.0 108.915 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 5.5 tttt 45.36 46.7 10.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 108.504 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.571 HG13 ' CB ' ' A' ' 48' ' ' ASN . 2.9 p -137.45 -41.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.399 -0.813 . . . . 0.0 109.751 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.49 ' O ' ' HB1' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -39.59 -45.92 1.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.624 -0.672 . . . . 0.0 110.545 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 34' ' ' THR . 1.9 tttt -62.31 -56.73 15.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.197 -0.939 . . . . 0.0 110.088 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -55.58 -65.64 0.56 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.651 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -43.8 -42.15 5.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.855 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.604 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -59.06 -46.07 89.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.075 -1.015 . . . . 0.0 108.779 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -61.18 -58.05 9.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 110.243 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.51 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -48.67 -40.61 28.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.909 -1.119 . . . . 0.0 107.996 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.62 -43.48 93.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.573 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 54.9 tpp -67.51 -70.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.612 -0.68 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.588 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -45.93 -60.17 2.41 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 84.9 t -48.77 -39.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 108.622 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -57.96 -69.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.929 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -45.72 -34.38 3.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.887 -1.133 . . . . 0.0 109.741 -179.061 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 28.9 mm-40 -63.82 -45.11 91.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.82 -1.175 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.06 -48.12 83.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--N 1.301 -1.525 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.542 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.453 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 4.7 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.468 HD13 ' HB3' ' A' ' 54' ' ' LYS . 2.5 mm -68.3 -66.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.2 -30.57 7.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 21.1 mm100 -63.94 -61.62 2.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.565 ' HA ' HD22 ' A' ' 62' ' ' LEU . 26.2 t -51.52 -57.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.935 . . . . 0.0 108.61 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.501 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 89.2 m-70 -44.41 -41.1 5.94 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.793 -1.192 . . . . 0.0 109.351 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.6 mm-40 -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.772 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.646 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -64.65 -54.08 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.184 -0.948 . . . . 0.0 110.355 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.646 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -48.97 -52.72 20.86 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.06 -45.53 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.352 . . . . 0.0 109.92 -178.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -65.12 -13.42 58.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -118.21 9.34 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 0.0 109.893 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 18.0 t-20 80.4 -12.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.589 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 5.6 mtt -76.52 98.89 4.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.998 -1.064 . . . . 0.0 108.662 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.53 HG23 ' NE2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -46.6 172.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.695 -1.253 . . . . 0.0 109.85 -179.378 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 5' ' ' VAL . 59.6 t -143.57 83.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.526 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 90.0 m-70 -116.81 97.35 5.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.399 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.634 ' CE2' ' HB2' ' A' ' 36' ' ' CYS . 58.7 m-85 -78.09 130.65 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.573 -0.704 . . . . 0.0 110.917 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' O ' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -151.05 115.08 5.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.539 ' CG2' ' OG1' ' A' ' 34' ' ' THR . 78.9 t -78.37 118.95 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.965 -1.084 . . . . 0.0 108.461 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.605 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -114.03 -11.97 12.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.669 -0.645 . . . . 0.0 111.154 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.546 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -126.19 136.18 52.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.813 -1.179 . . . . 0.0 110.631 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 10.9 mt-10 -158.39 124.52 4.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 25' ' ' GLY . 5.5 mm-40 -39.23 137.26 0.76 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.44 -0.787 . . . . 0.0 109.926 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . -42.23 -90.74 0.01 OUTLIER Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.626 ' HA ' ' NE2' ' A' ' 28' ' ' HIS . 10.8 Cg_endo -68.94 -138.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 N-CA-C 107.216 -1.878 . . . . 0.0 107.216 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.611 ' O ' ' ND1' ' A' ' 28' ' ' HIS . . . 57.54 -77.24 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.18 -0.95 . . . . 0.0 111.477 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.626 ' NE2' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER 57.33 21.04 6.36 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.19 -0.944 . . . . 0.0 108.788 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.7 18.81 0.53 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.75 -86.09 0.42 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.287 -0.883 . . . . 0.0 109.821 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 17.0 m-80 -132.58 171.81 13.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.97 . . . . 0.0 110.031 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 45.6 m-85 -150.44 127.11 10.91 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 3.1 mm -89.6 96.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.573 ' HB ' ' CB ' ' A' ' 57' ' ' ALA . 19.9 m -88.73 114.06 24.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.44 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.605 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -87.76 115.28 25.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.551 -0.718 . . . . 0.0 111.098 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.634 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 12.4 t -105.59 114.5 28.71 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.565 ' CG2' ' HB2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -77.59 130.47 36.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.739 -1.225 . . . . 0.0 109.906 -178.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.589 ' CG1' ' CE ' ' A' ' 14' ' ' MET . 1.1 t -132.71 135.84 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 14' ' ' MET . . . 59.23 -116.16 8.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.413 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -120.56 12.43 11.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -1.091 . . . . 0.0 109.377 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG13 ' C ' ' A' ' 40' ' ' SER . 2.0 mp -135.0 151.21 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 108.984 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -95.9 135.46 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.015 -1.053 . . . . 0.0 110.424 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.2 m -121.93 101.8 7.78 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 5.2 mt-10 -88.16 -173.9 4.43 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 110.664 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -161.32 116.07 0.69 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.547 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.96 89.38 4.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.196 -1.179 . . . . 0.0 110.644 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.49 176.07 39.21 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.442 ' C ' HG13 ' A' ' 52' ' ' VAL . 3.4 m-20 -125.0 102.62 7.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -1.198 . . . . 0.0 110.277 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.536 ' O ' ' CG1' ' A' ' 52' ' ' VAL . . . 106.85 149.03 15.74 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.03 171.34 1.77 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.124 -1.221 . . . . 0.0 109.146 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.2 16.28 4.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.163 -0.96 . . . . 0.0 109.244 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 49' ' ' GLY . 0.3 OUTLIER -131.46 -37.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.52 ' N ' HG11 ' A' ' 52' ' ' VAL . 1.7 p -39.31 -46.75 1.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 110.098 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HB3' HD13 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -62.27 -75.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HG3' ' HB3' ' A' ' 1' ' ' PRO . 3.4 tttt -41.7 -66.53 0.33 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' NH1' ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -38.75 -56.6 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.744 . . . . 0.0 110.286 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.573 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -50.72 -50.42 55.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.171 -0.956 . . . . 0.0 110.036 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -58.08 -57.09 14.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.428 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 39.0 mt-10 -48.21 -38.6 18.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.745 -1.222 . . . . 0.0 107.999 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.9 -43.46 98.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.591 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 41.0 tpp -67.83 -69.42 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.688 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.608 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -47.24 -60.14 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 94.1 t -46.93 -41.01 5.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.085 -1.009 . . . . 0.0 108.395 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -54.51 -66.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.526 -0.734 . . . . 0.0 110.022 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -56.53 -21.42 26.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 110.164 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 20.2 mm-40 -67.06 -46.56 73.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.915 -1.116 . . . . 0.0 109.329 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -61.52 -53.51 55.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.312 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.2 mt . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.599 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.479 ' HG2' ' HG2' ' A' ' 55' ' ' LYS . 2.3 Cg_endo . . . . . 0 N--CA 1.497 1.701 0 N-CA-C 109.739 -0.908 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.436 HD13 ' HB3' ' A' ' 54' ' ' LYS . 4.8 mm -71.15 -59.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.392 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p -56.24 -33.3 65.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.28 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -64.09 -52.14 60.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 108.56 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.636 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 16.4 t -55.41 -66.23 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.52 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 91.4 m-70 -39.68 -38.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.471 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -60.72 -62.67 1.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 110.46 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -69.6 -50.11 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.067 -1.021 . . . . 0.0 110.809 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.602 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -47.64 -52.23 15.55 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.9 -45.47 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.356 . . . . 0.0 109.62 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.44 -10.3 24.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 -179.111 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.45 10.03 7.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.637 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.7 OUTLIER 79.7 -11.46 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.147 179.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.541 ' HA ' ' CA ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -74.72 95.16 2.82 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -47.34 158.83 0.15 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.372 -0.83 . . . . 0.0 109.486 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.545 ' CG1' ' CE2' ' A' ' 18' ' ' PHE . 42.3 t -133.03 94.63 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.578 ' CG ' HG23 ' A' ' 37' ' ' ILE . 35.8 m-70 -111.92 96.2 5.92 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.454 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.62 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 45.7 m-85 -83.51 120.03 25.42 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.475 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 10.7 mttm -151.15 113.81 4.67 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.338 -0.851 . . . . 0.0 108.86 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 72.3 t -78.57 118.87 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 108.672 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.577 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -117.24 -8.57 11.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 110.955 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.52 ' NH1' ' HG3' ' A' ' 22' ' ' ARG . 1.2 ttm-85 -124.84 158.72 32.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 0.0 110.538 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 3.0 mt-10 -154.75 156.59 36.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.598 -0.689 . . . . 0.0 109.23 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -59.4 -146.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.464 -0.773 . . . . 0.0 109.58 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . -55.24 -136.45 0.0 OUTLIER Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HD2' ' NE2' ' A' ' 28' ' ' HIS . 9.9 Cg_exo -46.19 -76.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.895 1.73 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.582 ' O ' ' ND1' ' A' ' 28' ' ' HIS . . . -147.57 -71.32 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.0 -1.063 . . . . 0.0 109.761 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.582 ' ND1' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 37.92 -162.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.571 0.701 . . . . 0.0 110.346 178.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.5 mtt -126.78 33.89 4.88 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 76.5 mttt -64.37 -111.78 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.576 -0.702 . . . . 0.0 110.342 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 18.5 m-20 -118.57 171.25 8.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.646 -1.284 . . . . 0.0 110.462 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 43.4 m-85 -150.86 132.56 14.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.585 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.4 mp -89.99 99.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.554 ' HB ' ' CB ' ' A' ' 57' ' ' ALA . 26.8 m -87.01 117.65 25.88 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.607 0.718 . . . . 0.0 109.229 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.577 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -81.01 117.07 21.3 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.499 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -117.41 114.36 23.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.578 HG23 ' CG ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.93 132.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.067 -1.021 . . . . 0.0 110.77 -177.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.574 ' CG2' ' CE ' ' A' ' 61' ' ' MET . 0.8 OUTLIER -124.31 133.41 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -9.18 -84.1 0.01 OUTLIER Glycine 0 N--CA 1.507 3.383 0 CA-C-O 121.332 0.406 . . . . 0.0 112.781 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.482 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -35.11 -59.82 0.49 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.681 -0.894 . . . . 0.0 111.773 -178.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -161.31 -159.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.871 -1.143 . . . . 0.0 108.428 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -88.39 157.95 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.752 -1.218 . . . . 0.0 109.356 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.56 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 5.6 m -150.97 93.96 2.0 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.562 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -79.56 -169.83 2.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 110.213 -179.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.533 ' HA2' ' CD ' ' A' ' 60' ' ' LYS . . . -170.78 118.86 0.77 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 4.3 pm0 -77.79 91.0 4.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -1.206 . . . . 0.0 110.585 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.485 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -82.23 154.9 33.83 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.486 ' O ' HG12 ' A' ' 52' ' ' VAL . 49.6 t30 -93.77 101.74 13.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.893 -1.357 . . . . 0.0 109.886 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.6 170.21 11.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -81.74 -52.12 7.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.4 -1.059 . . . . 0.0 109.606 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.8 -36.74 28.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.689 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.496 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -51.73 -37.86 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.941 . . . . 0.0 109.418 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 52' ' ' VAL . 9.2 p -33.51 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.24 0.543 . . . . 0.0 110.542 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HB3' HD13 ' A' ' 2' ' ' ILE . 3.9 mttt -62.46 -50.1 72.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.326 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HG2' ' HG2' ' A' ' 1' ' ' PRO . 50.7 mtpt -57.41 -69.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -39.3 -61.83 0.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.999 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -43.06 -53.4 4.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -54.71 -53.56 53.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.317 -0.865 . . . . 0.0 110.923 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -49.43 -43.52 44.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.537 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -55.02 -43.82 74.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.574 ' CE ' ' CG2' ' A' ' 38' ' ' VAL . 67.2 mmm -64.5 -67.67 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.872 0.844 . . . . 0.0 111.363 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.636 ' CD2' ' HA ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -50.88 -57.19 9.1 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.028 -1.045 . . . . 0.0 108.959 -177.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 2.5 t -59.06 -25.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.202 -0.937 . . . . 0.0 109.007 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -64.5 -54.18 36.35 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.222 -0.924 . . . . 0.0 111.001 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.604 ' CD1' ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -110.57 12.29 22.8 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.731 -1.231 . . . . 0.0 111.595 -178.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 76.3 mm-40 -94.94 -16.97 22.4 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.959 -1.088 . . . . 0.0 109.412 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -98.85 -49.07 4.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 2.2 mt . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 4.8 Cg_exo . . . . . 0 N--CA 1.496 1.653 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 54' ' ' LYS . 3.5 mm -79.59 -69.61 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.14 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -52.67 -23.86 7.43 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.7 mt-30 -66.85 -54.09 25.88 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.739 ' HA ' HD23 ' A' ' 62' ' ' LEU . 61.5 t -60.0 -55.93 20.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.49 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 89.7 m-70 -46.2 -37.16 6.75 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.875 -1.14 . . . . 0.0 108.599 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.5 mt-10 -62.18 -65.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 110.832 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.609 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.89 -49.7 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.58 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.609 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -47.22 -52.16 13.52 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.71 -45.73 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.809 -1.407 . . . . 0.0 109.852 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -66.2 -8.16 22.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 110.333 -179.122 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.52 10.01 8.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.625 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.9 t-20 79.86 -11.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.829 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.553 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -76.66 96.68 4.24 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.86 -1.15 . . . . 0.0 109.573 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -46.65 154.95 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.69 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.531 ' CG1' HG13 ' A' ' 5' ' ' VAL . 46.8 t -129.92 90.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.573 ' CD2' HG22 ' A' ' 37' ' ' ILE . 24.5 m-70 -114.34 91.85 3.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.56 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.622 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 57.3 m-85 -79.82 123.01 27.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.691 -0.631 . . . . 0.0 110.137 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' O ' HD21 ' A' ' 21' ' ' LEU . 13.8 mttt -150.92 112.25 4.39 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 69.2 t -78.48 121.32 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.063 -1.023 . . . . 0.0 109.124 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.592 ' CD2' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -115.59 8.92 15.21 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.808 -178.313 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 3.6 mpp_? -151.86 81.07 1.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.88 -1.138 . . . . 0.0 110.058 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HA ' ' CD2' ' A' ' 32' ' ' PHE . 4.9 mp0 -75.2 93.42 2.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.123 -0.985 . . . . 0.0 109.735 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 3.4 tt0 77.47 -156.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.012 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 26' ' ' PRO . . . 177.29 -150.25 10.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HD2' ' NE2' ' A' ' 28' ' ' HIS . 2.8 Cg_exo -53.91 -69.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.13 1.887 . . . . 0.0 110.838 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.671 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -165.69 122.29 1.4 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.266 -0.896 . . . . 0.0 109.379 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.671 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 176.69 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.891 -1.131 . . . . 0.0 109.488 -178.015 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' ASN . 4.0 tpt 76.53 110.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.131 -0.981 . . . . 0.0 108.56 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 29' ' ' MET . 0.1 OUTLIER -30.56 92.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.423 0.63 . . . . 0.0 110.697 -179.328 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -114.0 -176.37 2.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.639 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.576 ' CD2' ' HA ' ' A' ' 23' ' ' GLU . 52.1 m-85 -150.88 125.74 9.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.445 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 2.4 mm -89.8 93.42 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.587 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 18.0 m -88.05 112.71 22.93 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.823 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.592 ' CB ' ' CD2' ' A' ' 21' ' ' LEU . . . -79.57 115.45 19.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.622 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -113.67 113.99 25.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.573 HG22 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.58 132.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.152 -0.968 . . . . 0.0 110.515 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 40' ' ' SER . 0.5 OUTLIER -119.74 147.25 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -47.99 88.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 155.51 -50.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.812 -0.817 . . . . 0.0 109.118 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.457 HG13 ' HB3' ' A' ' 40' ' ' SER . 0.2 OUTLIER -170.68 -166.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.312 -0.868 . . . . 0.0 108.718 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.54 133.79 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.382 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.549 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.8 m -127.01 93.67 3.82 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.576 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 2.7 pm0 -80.49 -173.52 4.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.737 -1.227 . . . . 0.0 110.604 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.89 113.42 0.56 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -78.2 81.95 4.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.208 -1.172 . . . . 0.0 110.232 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.52 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . -66.35 -178.92 9.4 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 6.6 t30 -129.16 106.1 8.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -1.211 . . . . 0.0 109.664 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' HG11 ' A' ' 52' ' ' VAL . . . 130.3 155.42 8.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.461 ' HA ' ' CE1' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -65.97 -65.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.152 . . . . 0.0 109.219 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.78 74.71 7.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 109.095 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.516 ' O ' ' C ' ' A' ' 53' ' ' SER . 1.2 p -161.75 -40.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.232 -0.917 . . . . 0.0 109.23 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.516 ' C ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -29.84 -68.02 0.08 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 23.9 mmtt -45.83 -50.61 14.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HA ' ' HD2' ' A' ' 1' ' ' PRO . 6.7 tttt -58.66 -73.14 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -37.62 -67.23 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.201 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -40.56 -55.14 2.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -51.55 -57.46 9.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.813 . . . . 0.0 110.633 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.5 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 25.5 mt-10 -47.94 -44.87 30.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 108.253 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.2 -44.03 71.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 108.976 179.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.614 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 70.7 mmm -65.95 -66.27 0.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.806 0.812 . . . . 0.0 111.311 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -50.82 -60.4 3.11 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 8.7 t -56.28 -26.95 23.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.184 -0.947 . . . . 0.0 109.13 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.0 mm-40 -62.89 -55.56 24.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -112.57 16.05 19.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.744 -1.223 . . . . 0.0 111.49 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.536 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 9.5 mm-40 -98.86 -33.8 10.73 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.064 -1.022 . . . . 0.0 109.261 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -66.86 -26.06 66.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.509 179.811 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.52 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 4.5 Cg_exo . . . . . 0 N--CA 1.497 1.709 0 N-CA-C 109.613 -0.957 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 54' ' ' LYS . 3.6 mm -72.23 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.937 . . . . 0.0 109.276 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -54.55 -31.6 56.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.0 mm100 -63.41 -53.5 51.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.251 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.728 ' HA ' HD23 ' A' ' 62' ' ' LEU . 61.1 t -58.53 -54.82 27.92 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 108.534 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.495 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 87.4 m-70 -47.16 -37.59 10.32 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 120.618 -1.301 . . . . 0.0 108.755 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 13.0 mt-10 -63.24 -66.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.974 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -65.4 -49.33 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.012 . . . . 0.0 110.276 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.591 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -46.49 -56.6 7.12 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.2 OUTLIER -69.37 -30.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.076 -1.25 . . . . 0.0 109.73 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.1 mtmp? -79.92 -4.3 51.77 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.22 13.22 4.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.65 -179.556 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.8 t30 78.84 -7.6 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.777 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.539 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 3.5 mmt -78.84 95.2 5.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.958 -1.089 . . . . 0.0 109.01 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -47.38 155.35 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.786 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG12 ' CG1' ' A' ' 5' ' ' VAL . 45.8 t -131.72 93.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 108.724 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.577 ' CD2' HG22 ' A' ' 37' ' ' ILE . 29.1 m-70 -118.85 91.3 3.52 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.664 -1.215 . . . . 0.0 110.316 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.614 ' CE1' ' HB3' ' A' ' 36' ' ' CYS . 57.1 m-85 -78.49 129.42 34.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 110.441 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.522 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 28.3 mttt -151.47 110.78 3.94 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 72.0 t -78.6 118.84 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 109.033 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.544 HD22 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -119.22 10.69 12.1 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.703 . . . . 0.0 110.677 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.527 ' CB ' HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -136.47 155.5 49.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.96 -1.087 . . . . 0.0 110.32 -179.601 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HA ' ' CD2' ' A' ' 32' ' ' PHE . 12.3 mt-10 -144.94 52.09 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 109.025 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -45.12 116.53 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.883 . . . . 0.0 109.659 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.54 132.52 1.8 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 -61.98 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.934 1.756 . . . . 0.0 110.058 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.58 39.02 0.79 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.381 -0.824 . . . . 0.0 109.24 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -144.67 -149.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.33 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.6 ptp -125.34 71.79 1.22 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.459 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 5.5 mmtt -75.23 -97.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -0.912 . . . . 0.0 109.497 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -120.88 158.05 28.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.921 -1.112 . . . . 0.0 109.576 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.576 ' CD2' ' HA ' ' A' ' 23' ' ' GLU . 15.6 m-85 -136.67 133.95 36.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG12 ' CB ' ' A' ' 22' ' ' ARG . 4.9 mm -89.21 97.5 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.133 -0.979 . . . . 0.0 108.472 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 57' ' ' ALA . 18.8 m -88.47 113.21 23.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.55 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -78.81 117.7 20.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.589 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.614 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -116.04 116.11 27.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.577 HG22 ' CD2' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -79.14 130.41 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 111.248 -177.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.601 ' CG1' ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -112.78 146.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.039 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -53.18 84.94 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 159.91 -46.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.585 -0.95 . . . . 0.0 108.451 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.596 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -169.79 -176.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.8 153.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.86 -1.15 . . . . 0.0 108.884 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.576 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 17.1 m -149.04 94.71 2.28 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.55 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -79.68 -172.74 3.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.894 -1.128 . . . . 0.0 110.237 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.04 117.78 0.79 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -77.86 88.83 4.06 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.999 -1.295 . . . . 0.0 110.105 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -74.84 178.19 46.46 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.473 ' O ' HG12 ' A' ' 52' ' ' VAL . 15.2 p-10 -115.24 98.54 6.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -1.144 . . . . 0.0 109.728 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.27 159.25 10.18 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -78.53 -33.76 47.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -1.119 . . . . 0.0 109.59 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.0 31.2 2.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.552 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.502 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -136.22 -39.04 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.309 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.506 ' HB3' ' CB ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -32.07 -38.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.263 0.554 . . . . 0.0 110.478 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -69.45 -53.25 20.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.146 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HG3' ' CG ' ' A' ' 1' ' ' PRO . 0.4 OUTLIER -56.35 -59.21 5.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.525 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -52.53 -43.03 64.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.118 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.523 ' CB ' ' HB ' ' A' ' 34' ' ' THR . . . -55.3 -51.99 64.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.907 -1.12 . . . . 0.0 108.513 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.13 -50.02 70.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.571 -0.705 . . . . 0.0 110.168 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 8.3 mt-10 -54.37 -36.83 64.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.91 -36.44 83.96 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.601 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 80.0 mmm -71.49 -69.33 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.569 0.699 . . . . 0.0 111.141 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -51.8 -38.14 54.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 72.8 t -69.64 -36.37 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -58.07 -55.51 33.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.479 HD22 ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -62.82 -38.35 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.026 -1.047 . . . . 0.0 109.527 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.422 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -66.01 -14.72 62.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 109.71 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -54.98 3.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.302 -1.496 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.57 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.587 ' CG ' ' CG ' ' A' ' 55' ' ' LYS . 5.0 Cg_exo . . . . . 0 N--CA 1.495 1.603 0 N-CA-C 109.557 -0.978 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.563 HD11 ' CE2' ' A' ' 18' ' ' PHE . 4.3 mm -66.42 -60.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 108.975 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -27.69 43.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.395 -0.815 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 11.4 mt-30 -64.76 -57.35 9.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.584 ' CG1' HD22 ' A' ' 62' ' ' LEU . 13.8 t -53.42 -63.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.587 ' CE1' HG13 ' A' ' 16' ' ' VAL . 90.5 m-70 -39.86 -39.04 0.75 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.19 -0.944 . . . . 0.0 109.685 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.3 mt-10 -61.7 -62.06 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.612 ' CD1' ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -70.02 -51.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.005 -1.059 . . . . 0.0 110.698 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.612 ' N ' ' CD1' ' A' ' 8' ' ' ILE . . . -46.89 -49.29 17.59 Favored Glycine 0 N--CA 1.48 1.613 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.86 -46.29 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.529 -1.571 . . . . 0.0 109.851 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.73 -10.14 25.28 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 110.162 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -122.74 8.34 9.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.828 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 8.3 t-20 78.3 -8.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.416 -0.803 . . . . 0.0 109.627 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.55 ' CE ' HG13 ' A' ' 38' ' ' VAL . 8.6 mtp -78.66 87.67 4.58 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.899 -1.126 . . . . 0.0 109.404 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -40.28 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.579 -0.701 . . . . 0.0 109.896 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.587 HG13 ' CE1' ' A' ' 6' ' ' HIS . 42.0 t -137.43 78.85 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.608 ' CD2' ' CG2' ' A' ' 37' ' ' ILE . 37.3 m-70 -100.73 95.59 6.76 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.951 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.567 ' CE1' ' SG ' ' A' ' 36' ' ' CYS . 3.2 m-85 -76.28 127.77 33.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 109.672 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -147.97 110.97 4.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 53.0 t -76.39 117.23 20.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.981 -1.074 . . . . 0.0 108.873 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.544 HD21 ' N ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -93.0 -23.1 18.79 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.933 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -138.39 151.2 47.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 110.277 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 24.0 mp0 -144.92 93.0 2.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.483 -0.761 . . . . 0.0 109.195 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 3.0 tm-20 62.78 138.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -0.941 . . . . 0.0 109.425 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.466 ' O ' ' OE2' ' A' ' 24' ' ' GLU . . . -74.35 -139.1 0.52 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.472 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 3.8 Cg_exo -59.88 -76.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.094 1.863 . . . . 0.0 110.324 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.01 7.84 4.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.467 ' N ' ' CD2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -141.97 -172.98 3.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.919 . . . . 0.0 109.512 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.464 ' HG2' ' ND2' ' A' ' 31' ' ' ASN . 5.4 ttm 49.15 78.03 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -0.947 . . . . 0.0 109.297 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.485 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 8.2 mttt -84.37 46.82 1.26 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.464 ' ND2' ' HG2' ' A' ' 29' ' ' MET . 78.2 m-20 -89.7 145.29 25.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.829 -1.169 . . . . 0.0 109.352 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 4.4 m-85 -118.63 121.13 39.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.029 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 1.8 mm -89.08 91.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.593 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 15.4 m -88.95 108.64 19.67 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.874 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.604 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -79.85 115.73 19.61 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 18' ' ' PHE . 5.0 t -108.21 121.23 44.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 176.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.608 ' CG2' ' CD2' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -76.28 128.78 37.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.925 -1.109 . . . . 0.0 110.428 -177.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.555 ' O ' ' C ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -116.69 102.94 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . 6.65 -73.4 0.0 OUTLIER Glycine 0 N--CA 1.504 3.169 0 C-N-CA 122.979 0.323 . . . . 0.0 112.547 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 38' ' ' VAL . 30.6 m -41.93 -65.8 0.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -1.053 . . . . 0.0 109.908 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.538 HD13 ' N ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -147.64 -139.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -113.37 161.89 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.19 . . . . 0.0 109.502 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.512 ' HB ' ' HE1' ' A' ' 61' ' ' MET . 19.8 m -150.37 91.92 1.81 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.604 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.5 pt-20 -86.17 -176.5 5.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.156 -0.965 . . . . 0.0 110.686 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -154.9 109.08 0.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.7 pm0 -79.24 80.44 5.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.297 -1.119 . . . . 0.0 109.563 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -64.49 168.65 26.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -105.36 76.48 1.22 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -1.048 . . . . 0.0 110.346 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 48' ' ' ASN . . . 37.64 -162.02 0.01 OUTLIER Glycine 0 N--CA 1.495 2.578 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER 67.73 48.62 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.579 -0.953 . . . . 0.0 109.657 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 44.81 64.05 1.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.162 -0.961 . . . . 0.0 108.79 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -129.82 -47.18 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.238 -0.914 . . . . 0.0 110.023 -179.161 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.557 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 28.6 p -14.75 -56.15 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.303 0.573 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 52' ' ' VAL . 14.5 mmtp -63.55 -59.64 4.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.364 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.587 ' CG ' ' CG ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -56.29 -62.61 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.526 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -42.05 -44.88 3.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 110.029 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 34' ' ' THR . . . -59.48 -58.94 6.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.938 -1.102 . . . . 0.0 108.631 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . . . -48.43 -66.55 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.948 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.516 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.2 mm-40 -44.43 -40.1 5.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.333 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -56.07 -49.4 73.9 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 108.999 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.546 ' HE1' ' CG2' ' A' ' 38' ' ' VAL . 18.5 ttm -68.65 -62.57 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.723 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.616 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -47.75 -64.3 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.825 -1.172 . . . . 0.0 108.274 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 48.6 t -50.61 -34.92 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -52.2 -66.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 109.05 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.548 HD12 ' CE ' ' A' ' 14' ' ' MET . 1.3 mm? -53.83 -44.18 70.06 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.9 -1.125 . . . . 0.0 110.15 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.453 ' OE1' ' HA ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -53.55 -31.69 47.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.352 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.37 -41.7 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.617 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 64' ' ' GLU . 13.3 mt . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.522 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.9 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 N-CA-C 109.674 -0.933 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.889 HG22 ' CE1' ' A' ' 6' ' ' HIS . 5.7 mm -76.63 -51.17 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 t -52.05 -37.5 53.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.635 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 30.6 mt-30 -63.17 -53.65 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.021 HG22 ' CD2' ' A' ' 62' ' ' LEU . 24.2 t -54.9 -67.92 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.889 ' CE1' HG22 ' A' ' 2' ' ' ILE . 51.8 m80 -36.87 -38.89 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.331 -0.855 . . . . 0.0 109.448 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 2.7 mt-10 -60.08 -62.26 2.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.717 -0.615 . . . . 0.0 110.171 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.936 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -74.1 -51.46 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.936 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -44.3 -52.38 7.22 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -78.0 -37.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.08 -1.247 . . . . 0.0 110.17 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.537 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 8.6 mmtm -60.65 -16.84 43.12 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.468 -0.77 . . . . 0.0 111.171 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.585 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.7 tpt180 -116.32 -44.1 2.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.79 -1.194 . . . . 0.0 109.578 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.585 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER 155.46 -15.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.017 -0.427 . . . . 0.0 109.928 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.696 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -71.91 111.8 7.47 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.834 -1.166 . . . . 0.0 110.054 -179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.598 HG22 ' NE2' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -64.93 121.85 15.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.029 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.721 ' CG2' HG12 ' A' ' 5' ' ' VAL . 60.7 t -98.19 110.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.653 ' CD2' ' CG2' ' A' ' 37' ' ' ILE . 4.2 m-70 -136.49 95.5 3.17 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.588 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.871 ' CD1' HG23 ' A' ' 2' ' ' ILE . 60.2 m-85 -78.71 135.14 37.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 110.997 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.821 ' O ' HD23 ' A' ' 21' ' ' LEU . 4.7 mtmt -150.36 110.49 4.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.932 HG22 ' OG1' ' A' ' 34' ' ' THR . 95.2 t -78.62 118.39 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 108.818 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.923 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -118.76 10.26 12.34 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -178.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.125 . . . . 0.0 110.267 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 4.6 m-85 -99.87 127.09 46.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.029 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.815 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.6 mp -88.81 97.31 6.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.01 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 5.1 m -86.16 118.04 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.923 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -82.01 114.49 20.61 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.873 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.785 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.22 113.19 25.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.024 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -78.77 138.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.196 -0.94 . . . . 0.0 109.336 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.024 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -131.4 146.42 33.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 42.38 -112.88 0.5 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 2.77 11.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -1.204 . . . . 0.0 109.94 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.76 154.15 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 108.477 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.92 160.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.855 -1.153 . . . . 0.0 110.229 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.488 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 23.3 m -150.34 90.6 1.67 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.561 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 3.8 mt-10 -81.12 -172.84 3.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.865 -1.147 . . . . 0.0 110.686 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.31 119.57 0.83 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -80.37 92.01 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.072 -1.252 . . . . 0.0 111.107 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.516 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -35.57 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.701 -0.624 . . . . 0.0 110.935 -179.219 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 52' ' ' VAL . 13.4 mttp -76.29 -49.68 16.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.593 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.73 -35.72 81.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.145 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 2.1 tpp180 -76.87 -40.32 48.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 109.885 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -61.81 -51.67 67.33 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 108.356 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' N ' ' HE2' ' A' ' 18' ' ' PHE . . . -63.0 -56.38 17.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 110.051 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mt-10 -46.78 -43.6 18.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.731 -1.231 . . . . 0.0 108.112 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.97 -43.2 95.25 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.917 ' SD ' HG23 ' A' ' 38' ' ' VAL . 5.9 ttm -65.15 -70.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 110.484 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.021 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -47.71 -62.58 1.38 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 78.8 t -44.32 -38.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.37 -0.831 . . . . 0.0 108.991 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -58.03 -57.34 13.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.588 -0.695 . . . . 0.0 111.059 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.716 ' H ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -110.04 24.04 13.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.846 -1.159 . . . . 0.0 111.608 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.492 ' HG3' ' HB3' ' A' ' 62' ' ' LEU . 21.1 mm-40 -112.16 -20.41 11.92 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.483 ' HE2' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -98.6 -33.41 10.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.578 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.305 -1.352 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.681 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.675 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 3.0 Cg_exo . . . . . 0 N--CA 1.496 1.668 0 N-CA-C 109.597 -0.963 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.586 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.7 mm -80.32 -62.29 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.236 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -42.02 69.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.6 mm100 -57.1 -52.0 67.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.107 -0.995 . . . . 0.0 108.936 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.871 HG22 ' CD2' ' A' ' 62' ' ' LEU . 74.7 t -55.61 -68.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.645 ' HA ' HG21 ' A' ' 16' ' ' VAL . 44.6 m80 -35.15 -34.58 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.656 0.741 . . . . 0.0 109.578 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.2 mt-10 -68.61 -52.56 30.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.73 -0.606 . . . . 0.0 110.585 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.057 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -73.23 -45.89 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.676 -179.032 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 1.057 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -50.73 -52.97 27.66 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.4 -47.4 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.057 -1.26 . . . . 0.0 109.451 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -63.99 -10.05 19.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -125.22 8.06 7.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.833 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 80.19 -10.78 1.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.686 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.634 ' HE2' HG13 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -72.94 89.53 1.42 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.067 -1.021 . . . . 0.0 109.081 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -43.48 149.36 0.27 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 109.509 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 6' ' ' HIS . 39.9 t -125.93 102.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.167 -0.958 . . . . 0.0 109.033 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.689 ' N ' HG22 ' A' ' 37' ' ' ILE . 32.6 m170 -121.77 95.09 4.53 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.524 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.824 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 3.1 m-85 -81.21 129.82 34.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.955 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.695 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.66 111.41 4.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.922 HG22 ' OG1' ' A' ' 34' ' ' THR . 70.7 t -78.06 103.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 0.0 109.035 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.019 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -89.68 -21.85 22.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.072 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.647 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 2.8 m120 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.392 0.615 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.556 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 20.6 m-85 -103.98 119.3 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.785 HD12 ' HB3' ' A' ' 46' ' ' GLU . 2.1 mm -89.48 92.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.021 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.042 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 19.5 m -89.59 113.46 24.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.493 -0.754 . . . . 0.0 109.131 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.019 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.01 116.61 20.24 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.44 -0.788 . . . . 0.0 110.236 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.854 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -113.27 115.24 27.87 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.794 HG12 HG13 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -76.69 134.78 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.961 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.969 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -130.17 135.11 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 49.23 -127.29 21.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -104.51 5.05 33.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -1.13 . . . . 0.0 109.774 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -122.15 151.61 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 108.894 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.85 160.96 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.968 -1.083 . . . . 0.0 109.746 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.479 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 21.2 m -150.45 92.01 1.81 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -81.42 -173.74 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.878 -1.138 . . . . 0.0 110.446 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.37 110.95 0.46 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.785 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.2 pt-20 -79.25 75.61 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 110.681 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.55 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.738 HG13 ' N ' ' A' ' 53' ' ' SER . 1.2 p . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.738 ' N ' HG13 ' A' ' 52' ' ' VAL . 3.4 p 84.38 -57.93 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.915 -0.49 . . . . 0.0 109.693 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' N ' ' OG ' ' A' ' 53' ' ' SER . 4.6 pttp -80.06 -48.83 12.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 108.966 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.533 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 98.4 mttt -68.62 -30.03 68.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' HG3' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -79.49 -38.82 33.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.478 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.042 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.022 -1.049 . . . . 0.0 108.394 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.824 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -65.1 -54.69 26.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.474 -0.766 . . . . 0.0 110.214 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.4 mt-10 -48.51 -42.71 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.61 -1.306 . . . . 0.0 107.76 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 1.7 tptp -62.76 -39.46 94.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.969 ' SD ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -65.78 -71.46 0.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.613 . . . . 0.0 110.072 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.871 ' CD2' HG22 ' A' ' 5' ' ' VAL . 1.3 mt -51.76 -56.98 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.127 -0.983 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 79.0 t -47.19 -39.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 108.506 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -61.15 -68.39 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.748 . . . . 0.0 110.386 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.35 -27.96 1.84 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.185 . . . . 0.0 109.964 -178.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 24.2 mm-40 -54.03 -49.49 68.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.931 -1.106 . . . . 0.0 109.536 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -51.22 36.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.985 . . . . 0.0 109.338 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.48 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.496 1.651 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.714 HD11 ' HB3' ' A' ' 54' ' ' LYS . 3.4 mm -68.24 -54.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.152 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -53.09 -30.67 37.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 109.216 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.6 mm100 -65.04 -55.81 16.71 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.066 HG12 HG22 ' A' ' 16' ' ' VAL . 21.8 t -53.64 -67.67 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.691 ' CE1' HG22 ' A' ' 2' ' ' ILE . 54.5 m80 -36.46 -39.12 0.18 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 7.5 mt-10 -63.56 -59.02 5.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.845 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.977 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.8 pp -70.92 -50.4 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.897 -1.127 . . . . 0.0 110.31 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.977 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.53 -49.65 20.4 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.54 -45.6 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.664 -1.492 . . . . 0.0 109.823 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -64.0 -11.74 31.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.68 15.32 8.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.98 -1.075 . . . . 0.0 109.717 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 1.2 m-20 72.68 -4.82 2.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.545 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 3.0 mtp -79.75 91.2 5.28 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.809 -1.182 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -44.59 158.46 0.05 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.083 -1.011 . . . . 0.0 109.869 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.066 HG22 HG12 ' A' ' 5' ' ' VAL . 54.9 t -128.04 91.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.677 ' ND1' HG21 ' A' ' 37' ' ' ILE . 31.6 m170 -109.42 92.88 4.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.581 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.921 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 39.7 m-85 -81.47 115.1 20.63 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.809 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -149.71 117.71 6.32 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.07 -1.018 . . . . 0.0 109.481 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.759 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.0 t -79.13 116.86 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.981 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.52 5.06 13.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.503 -0.748 . . . . 0.0 110.957 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 O-C-N 120.761 -1.212 . . . . 0.0 110.398 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' HB3' HG13 ' A' ' 20' ' ' VAL . 5.2 m-85 -106.08 151.41 24.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.067 -1.021 . . . . 0.0 108.647 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 5.8 mm -87.55 102.05 12.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.128 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 91.6 m -88.78 111.1 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.807 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.981 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.27 117.06 20.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 110.3 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.944 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -111.69 112.7 24.58 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.677 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.62 137.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.047 -1.033 . . . . 0.0 110.159 -177.268 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.946 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.6 OUTLIER -131.29 126.19 58.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 56.05 -121.83 25.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.35 4.72 19.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.15 . . . . 0.0 109.418 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.49 161.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 0.0 108.923 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.86 142.05 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.868 -1.145 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.564 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 20.3 m -132.49 92.1 3.03 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.547 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.1 mp0 -85.36 -168.71 2.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.012 -1.055 . . . . 0.0 111.171 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -155.75 -179.25 30.69 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.5 -2.64 . . . . 0.0 106.5 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 2.5 mt-10 -133.92 71.33 1.46 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 119.453 1.626 . . . . 0.0 110.874 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . . . . . . 0 N--CA 1.494 2.549 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.867 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.475 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -33.81 -63.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.268 0.556 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.714 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -47.02 -51.04 18.25 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.111 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 56' ' ' ARG . 1.4 mttt -57.39 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.458 -0.776 . . . . 0.0 109.035 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -29.26 -66.48 0.09 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.889 -0.507 . . . . 0.0 111.226 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.128 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -46.36 -55.03 7.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 110.704 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.702 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -61.2 -53.96 50.3 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.19 -0.944 . . . . 0.0 111.529 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.582 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.8 mm-40 -49.47 -38.02 28.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.382 -1.449 . . . . 0.0 107.545 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 18.5 tptt -63.52 -41.16 98.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.946 ' SD ' HG23 ' A' ' 38' ' ' VAL . 3.3 ttm -68.48 -73.1 0.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.756 -0.59 . . . . 0.0 110.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.943 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -48.5 -47.58 38.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.326 -0.859 . . . . 0.0 109.857 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.603 ' HA ' ' NE2' ' A' ' 66' ' ' GLN . 72.2 t -60.71 -37.92 77.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 108.254 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -58.13 -58.01 10.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.634 -0.666 . . . . 0.0 110.341 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.581 HD13 HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.853 -1.155 . . . . 0.0 110.13 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.603 ' NE2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -50.75 -26.4 5.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -58.5 -53.42 58.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 68' ' ' LEU . 6.9 mt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.487 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.832 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.652 0 N-CA-C 109.646 -0.944 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.987 HG23 ' CD2' ' A' ' 18' ' ' PHE . 2.5 mp 81.43 -55.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 2' ' ' ILE . 92.9 p -46.38 -50.26 16.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.723 -1.235 . . . . 0.0 108.451 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.8 mt-30 -58.04 -51.78 68.25 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.877 HG22 ' CD2' ' A' ' 62' ' ' LEU . 47.0 t -49.51 -77.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.878 ' ND1' HG22 ' A' ' 2' ' ' ILE . 59.6 m80 -28.92 -41.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.419 0.628 . . . . 0.0 110.126 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 5' ' ' VAL . 4.0 mm-40 -60.34 -64.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.953 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -70.32 -49.43 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -0.957 . . . . 0.0 110.651 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.953 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.96 -56.32 7.74 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -32.56 51.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.259 . . . . 0.0 109.321 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.3 mmtp -76.7 -4.55 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 110.422 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -133.91 16.07 3.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.381 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 80.22 -10.98 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.656 -0.652 . . . . 0.0 109.98 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.829 ' SD ' HD22 ' A' ' 65' ' ' LEU . 5.2 mtt -75.74 100.37 4.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.81 -1.182 . . . . 0.0 109.674 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -50.5 174.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.827 -1.17 . . . . 0.0 109.55 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.869 ' CG2' HG12 ' A' ' 5' ' ' VAL . 95.8 t -149.09 88.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.656 ' ND1' HG21 ' A' ' 37' ' ' ILE . 33.0 m170 -112.18 95.76 5.64 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.708 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.987 ' CD2' HG23 ' A' ' 2' ' ' ILE . 33.0 m-85 -80.21 118.65 22.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.507 -0.745 . . . . 0.0 111.441 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 123.3 8.69 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.702 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.4 t -79.78 130.07 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.943 -1.098 . . . . 0.0 108.925 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.042 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -89.0 -22.37 23.03 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.773 -0.579 . . . . 0.0 109.721 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.528 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 33.8 m-80 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.706 0.765 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.616 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 7.2 m-85 -117.86 117.96 30.7 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.58 HD13 ' N ' ' A' ' 33' ' ' ILE . 1.6 mm -86.55 91.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.051 -1.031 . . . . 0.0 108.581 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.039 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 34.7 m -88.8 111.16 21.69 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.042 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -79.84 113.88 18.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.438 -0.789 . . . . 0.0 110.485 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.873 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.93 119.43 39.04 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.656 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -78.75 134.01 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.727 -1.233 . . . . 0.0 111.104 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.952 HG13 ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -129.97 140.5 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 50.61 -91.67 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.9 m -143.51 2.39 1.25 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -1.175 . . . . 0.0 110.35 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 40' ' ' SER . 17.2 mm -117.05 160.8 16.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.991 -1.068 . . . . 0.0 108.603 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.69 125.38 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.862 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.82 HG21 ' HA ' ' A' ' 61' ' ' MET . 73.4 m -115.29 88.67 2.93 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -80.88 -172.82 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.985 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.497 ' HA3' ' HG3' ' A' ' 60' ' ' LYS . . . -160.89 115.96 0.69 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.059 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.47 78.59 4.93 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.131 -1.217 . . . . 0.0 109.816 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.496 2.674 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.987 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.482 ' CG1' ' C ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.849 0.357 . . . . 0.0 110.322 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.511 ' OG ' ' CG ' ' A' ' 32' ' ' PHE . 3.9 m -33.49 -74.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.705 -0.622 . . . . 0.0 111.739 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 33.1 pttt -43.1 -51.73 5.74 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.145 -0.972 . . . . 0.0 111.1 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -54.51 -39.27 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.94 -1.1 . . . . 0.0 110.464 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.589 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -72.66 -35.85 67.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.039 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -63.82 -53.0 57.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.91 -1.119 . . . . 0.0 108.405 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.531 ' HB2' HG13 ' A' ' 2' ' ' ILE . . . -62.3 -64.05 1.05 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.429 -0.794 . . . . 0.0 109.403 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 30.9 mt-10 -50.91 -25.5 4.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.754 -1.216 . . . . 0.0 108.502 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -65.89 -53.15 43.36 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.952 ' CE ' HG13 ' A' ' 38' ' ' VAL . 3.6 ptp -73.62 -51.46 16.7 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.865 -1.534 . . . . 0.0 110.448 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.877 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -48.66 -55.95 9.87 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 62.5 t -54.52 -37.77 39.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -53.88 -72.81 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.843 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -44.87 -37.44 3.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.843 ' NE2' HD12 ' A' ' 65' ' ' LEU . 21.5 mm-40 -58.33 -45.94 87.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.02 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -36.37 83.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.024 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.574 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.553 ' HD2' ' CG ' ' A' ' 55' ' ' LYS . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.628 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.567 HD11 ' HB3' ' A' ' 54' ' ' LYS . 10.0 mm -95.12 -56.76 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.145 -0.972 . . . . 0.0 108.863 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -57.56 -33.84 68.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.556 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 3.2 pt20 -62.66 -48.88 77.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 108.479 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.05 HG22 HD21 ' A' ' 62' ' ' LEU . 99.1 t -59.98 -68.16 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.661 ' HA ' HG21 ' A' ' 16' ' ' VAL . 41.7 m80 -34.7 -34.28 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.579 0.704 . . . . 0.0 109.514 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' VAL . 6.3 mt-10 -67.76 -69.37 0.32 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.171 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.01 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -57.89 -52.94 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.16 -0.962 . . . . 0.0 109.492 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 1.01 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -46.82 -49.65 16.56 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.687 HG22 ' N ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -80.16 -65.34 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.338 . . . . 0.0 109.955 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.687 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -39.68 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.473 -0.767 . . . . 0.0 111.428 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -104.67 -49.67 3.47 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.78 -1.2 . . . . 0.0 109.272 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.6 m-20 150.34 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.585 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 4.5 mmt -56.19 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.154 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -46.41 158.37 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.725 -1.234 . . . . 0.0 109.361 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.746 ' CG2' HG12 ' A' ' 5' ' ' VAL . 96.9 t -130.35 82.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.619 ' ND1' HG21 ' A' ' 37' ' ' ILE . 33.8 m170 -110.22 89.2 2.96 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.003 -1.479 . . . . 0.0 111.117 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.794 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 52.9 m-85 -75.87 120.78 21.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.781 ' O ' HD23 ' A' ' 21' ' ' LEU . 31.4 tttp -145.65 116.78 7.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.046 HG22 ' OG1' ' A' ' 34' ' ' THR . 47.2 t -78.31 113.38 17.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.967 -1.083 . . . . 0.0 109.062 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.967 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -111.05 16.71 21.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.84 -178.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.565 ' CD ' HG13 ' A' ' 33' ' ' ILE . 2.0 mtt180 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 120.779 -1.201 . . . . 0.0 110.407 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 17.3 m-85 -121.36 139.35 53.54 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.657 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.569 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 5.1 mm -89.39 96.57 6.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.046 ' OG1' HG22 ' A' ' 20' ' ' VAL . 4.3 m -88.33 119.88 29.17 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.548 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.967 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -95.14 114.16 25.92 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.523 -0.735 . . . . 0.0 111.085 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.852 ' HB3' ' HE3' ' A' ' 61' ' ' MET . 5.5 t -101.91 126.05 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.676 ' O ' ' HE1' ' A' ' 61' ' ' MET . 0.1 OUTLIER -75.11 133.37 31.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.616 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -125.11 130.88 73.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.127 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.516 ' N ' ' SD ' ' A' ' 14' ' ' MET . . . 42.34 -107.53 0.11 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 t -116.53 -7.51 11.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.604 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 38' ' ' VAL . 11.2 mt -112.87 148.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 108.661 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -91.31 128.01 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.913 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.754 HG23 ' HB ' ' A' ' 38' ' ' VAL . 20.5 p -103.89 93.05 4.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 2.5 pt-20 -94.93 179.47 5.22 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.753 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -164.13 166.97 37.9 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -114.76 92.81 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.885 -1.362 . . . . 0.0 110.079 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.303 0.573 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.481 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 26.6 p -38.06 -33.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -72.9 -47.19 47.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.032 -1.042 . . . . 0.0 109.448 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.553 ' CG ' ' HD2' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -59.73 -51.79 68.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -60.29 -63.67 1.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.947 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.991 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -42.06 -48.61 4.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.397 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.23 -55.14 34.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.805 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.0 mm-40 -48.51 -33.54 9.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -66.1 -44.47 84.3 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.852 ' HE3' ' HB3' ' A' ' 36' ' ' CYS . 22.7 ttm -64.73 -60.73 2.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.389 -0.819 . . . . 0.0 110.081 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.05 HD21 HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -56.45 -61.24 2.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 53.8 t -49.71 -34.56 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.913 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' MET . 2.4 mm-40 -59.93 -63.75 1.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -59.57 -22.28 61.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.1 -1.0 . . . . 0.0 109.993 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 1.8 mp0 -82.22 -23.35 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 0.0 109.954 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -79.93 -35.1 38.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.011 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.59 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.543 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 3.3 Cg_exo . . . . . 0 N--CA 1.496 1.664 0 N-CA-C 109.634 -0.949 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' A' ' 54' ' ' LYS . 4.5 mm -72.5 -54.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.266 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.8 p -54.08 -37.31 64.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.432 -0.792 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.7 -60.87 3.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.918 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.05 ' HA ' HD21 ' A' ' 62' ' ' LEU . 39.4 t -51.32 -66.91 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.614 ' CE1' HG22 ' A' ' 2' ' ' ILE . 31.7 m80 -35.38 -35.96 0.06 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.578 -0.701 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -69.47 -50.63 43.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.472 -0.768 . . . . 0.0 110.261 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.065 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -74.57 -48.51 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.999 -1.063 . . . . 0.0 109.337 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 1.065 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -50.44 -50.79 34.36 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.11 -46.46 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.816 -1.402 . . . . 0.0 109.784 -179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.87 -10.97 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.997 . . . . 0.0 110.089 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -121.03 8.19 10.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 110.001 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER 80.35 -11.53 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.444 -0.785 . . . . 0.0 109.579 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.58 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 4.2 mtt -73.57 106.92 5.56 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.015 -1.053 . . . . 0.0 109.071 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.53 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -61.32 136.36 58.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.431 -0.793 . . . . 0.0 109.931 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.963 ' CG2' HG12 ' A' ' 5' ' ' VAL . 69.0 t -110.73 112.13 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.496 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.78 ' HB2' HG22 ' A' ' 37' ' ' ILE . 15.0 m-70 -131.15 103.76 6.68 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.644 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.801 ' CD2' HD12 ' A' ' 2' ' ' ILE . 2.9 m-85 -90.67 136.27 33.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.606 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.52 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -150.33 110.07 4.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.872 HG22 ' OG1' ' A' ' 34' ' ' THR . 68.9 t -77.51 123.13 33.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.963 -1.086 . . . . 0.0 108.389 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -107.19 -14.58 14.87 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.348 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.557 ' CB ' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.0 -1.063 . . . . 0.0 110.715 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.616 HD21 ' N ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.533 0.683 . . . . 0.0 109.278 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 58.6 m-85 -152.69 121.88 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.547 -0.721 . . . . 0.0 109.317 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.557 HG12 ' CB ' ' A' ' 22' ' ' ARG . 3.1 mm -89.4 92.15 3.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.1 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 31.1 m -87.76 109.83 20.01 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.969 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.855 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -77.55 122.07 24.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.984 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -126.18 111.67 14.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.464 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.08 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -78.49 136.63 23.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.223 -0.923 . . . . 0.0 110.844 -178.137 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.08 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.2 t -127.45 127.73 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 52.61 -118.05 7.3 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -111.1 0.47 16.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -1.161 . . . . 0.0 109.864 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mt -116.11 134.02 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 108.971 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.78 HG22 HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -97.55 142.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.893 -1.129 . . . . 0.0 110.714 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.468 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -135.97 112.91 10.31 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.59 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -84.23 -170.24 3.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.841 -1.162 . . . . 0.0 109.098 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -160.81 108.61 0.36 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.45 -1.357 . . . . 0.0 109.785 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.553 ' CB ' HD13 ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.04 79.1 4.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.258 -1.142 . . . . 0.0 109.871 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.518 ' CA ' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 65.3 m -57.68 -80.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.206 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.892 ' HB2' HD11 ' A' ' 2' ' ' ILE . 1.8 pttt -51.29 -53.39 36.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.259 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 24.3 ttpp -53.22 -29.55 33.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 109.628 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -74.35 -45.16 48.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.468 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.1 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -60.71 -57.36 13.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.246 -0.909 . . . . 0.0 108.553 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.793 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -54.55 -48.44 72.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.368 -0.833 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.7 mm-40 -53.56 -39.29 64.66 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.32 -37.66 84.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.588 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 64.0 mmm -70.18 -71.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.0 110.95 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.05 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -49.5 -48.79 47.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.066 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 75.1 t -60.04 -37.81 74.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -55.48 -61.09 2.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.595 -0.69 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.574 HD12 ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -60.79 -34.28 74.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 110.521 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.626 ' NE2' ' HA ' ' A' ' 66' ' ' GLN . 5.9 mm100 -65.56 -28.57 69.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.709 -1.244 . . . . 0.0 109.666 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -70.83 -30.16 66.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 C--N 1.304 -1.386 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.461 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.862 ' O ' HG23 ' A' ' 5' ' ' VAL . 5.4 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 N-CA-C 109.745 -0.906 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.558 HD12 ' CD2' ' A' ' 18' ' ' PHE . 5.1 mm -69.85 -58.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 p -55.6 -37.89 68.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.6 mm100 -60.96 -55.71 29.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 0.0 108.644 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.987 ' HA ' HD21 ' A' ' 62' ' ' LEU . 23.5 t -51.77 -70.11 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 42.0 m80 -34.68 -38.68 0.08 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.619 -0.675 . . . . 0.0 109.779 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.8 mt-10 -62.51 -63.8 1.12 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.433 -0.792 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.965 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.11 -49.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.191 -0.943 . . . . 0.0 110.58 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.965 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.59 -56.22 8.62 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -30.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.118 -1.225 . . . . 0.0 109.504 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 6.5 mttm -79.84 -3.76 49.24 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 110.267 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.73 14.32 4.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 109.384 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 80.69 -10.33 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.635 -0.666 . . . . 0.0 109.764 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.587 ' SD ' HD22 ' A' ' 65' ' ' LEU . 1.8 mtt -76.48 99.56 4.96 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.935 -1.103 . . . . 0.0 109.342 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -53.78 142.18 24.57 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.812 HG22 HG12 ' A' ' 5' ' ' VAL . 98.5 t -114.45 94.33 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.782 ' HB2' HG22 ' A' ' 37' ' ' ILE . 96.6 m-70 -119.26 102.74 8.91 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.161 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.809 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -86.84 125.3 33.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -138.99 114.67 9.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.015 HG22 ' OG1' ' A' ' 34' ' ' THR . 61.3 t -78.55 128.77 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.046 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.596 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -111.26 -11.16 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.706 -0.621 . . . . 0.0 110.097 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 12.3 mmt180 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.031 -1.043 . . . . 0.0 109.993 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.676 0.75 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 3.2 m-85 -108.62 126.44 52.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.548 ' CG1' ' HB2' ' A' ' 22' ' ' ARG . 1.3 mm -96.01 123.88 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.094 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 6.1 m -119.85 116.47 25.91 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.596 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -79.54 112.7 17.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.541 -0.725 . . . . 0.0 109.179 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.815 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -109.82 111.82 23.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.587 -1.321 . . . . 0.0 107.6 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.087 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -79.36 138.09 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 111.133 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.087 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -125.29 136.0 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 42.24 -88.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' VAL . 12.8 t -136.82 -7.13 1.88 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.087 -1.243 . . . . 0.0 110.609 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.634 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.9 mt -108.05 136.85 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.908 -1.12 . . . . 0.0 108.414 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -92.03 129.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.851 -1.156 . . . . 0.0 110.729 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -115.76 98.37 6.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.574 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -82.94 -174.15 5.11 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.599 -1.313 . . . . 0.0 109.639 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -149.73 172.95 29.61 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.76 76.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.285 -1.127 . . . . 0.0 108.693 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.088 HG22 ' CD ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.388 0.614 . . . . 0.0 109.414 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 35.2 p -48.93 -54.93 13.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.888 -1.132 . . . . 0.0 109.559 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -55.94 -70.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 109.926 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' CA ' ' HD2' ' A' ' 1' ' ' PRO . 48.5 mttp -41.35 -68.9 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.742 . . . . 0.0 109.559 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 1.088 ' CD ' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -36.67 -63.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.895 -0.503 . . . . 0.0 110.494 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.094 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -44.17 -49.31 9.14 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.925 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.791 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -55.67 -57.91 10.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.344 -0.847 . . . . 0.0 110.637 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 20.8 mt-10 -46.28 -45.24 17.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.762 -1.211 . . . . 0.0 108.136 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -56.23 -43.55 78.71 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . 1.013 ' SD ' HG13 ' A' ' 38' ' ' VAL . 4.8 ttm -66.41 -72.34 0.16 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.375 0.607 . . . . 0.0 110.602 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -46.89 -60.63 2.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.931 -1.106 . . . . 0.0 108.589 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 70.2 t -47.11 -39.13 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.749 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -58.07 -66.61 0.45 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.634 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -53.4 -28.2 28.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.979 -1.075 . . . . 0.0 110.547 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.634 ' NE2' HD12 ' A' ' 65' ' ' LEU . 31.5 mm-40 -65.11 -37.17 86.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.832 -1.168 . . . . 0.0 109.605 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -34.36 70.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.639 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.885 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.5 Cg_exo . . . . . 0 N--CA 1.496 1.625 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.584 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.0 mm -71.04 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -51.32 -37.64 48.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.349 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.5 mm-40 -62.45 -51.49 67.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.039 HG12 ' CG2' ' A' ' 16' ' ' VAL . 38.8 t -54.98 -66.83 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.37 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.527 ' CE1' HG22 ' A' ' 2' ' ' ILE . 62.2 m80 -38.38 -38.61 0.38 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.494 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -61.03 -63.18 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.733 -0.604 . . . . 0.0 110.69 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.964 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.14 -49.06 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.029 -1.044 . . . . 0.0 110.791 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.964 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -49.36 -54.25 16.8 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -67.49 -39.24 82.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.885 -1.362 . . . . 0.0 109.476 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 11.3 mttm -69.64 -9.36 53.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 109.892 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.67 10.09 7.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.237 -0.915 . . . . 0.0 109.09 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 79.32 -10.28 1.35 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.75 . . . . 0.0 109.42 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.588 ' HE3' ' HG ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -75.54 101.76 5.01 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.943 -1.098 . . . . 0.0 109.302 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -53.06 163.58 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.039 ' CG2' HG12 ' A' ' 5' ' ' VAL . 48.9 t -133.45 92.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.67 ' ND1' HG21 ' A' ' 37' ' ' ILE . 31.0 m170 -113.68 95.64 5.44 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.621 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.891 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 54.7 m-85 -81.65 119.32 23.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.623 -0.673 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.766 ' O ' HD23 ' A' ' 21' ' ' LEU . 8.3 ttmm -151.01 115.96 5.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.846 HG22 ' OG1' ' A' ' 34' ' ' THR . 93.4 t -79.01 119.29 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 0.0 108.668 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.987 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.21 1.39 13.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 110.984 -178.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 120.676 -1.265 . . . . 0.0 110.819 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.827 HD21 ' N ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 35.2 m-85 -144.55 141.55 29.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.6 mm -89.47 99.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.065 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 35.8 m -89.22 113.31 24.51 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.459 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.987 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -80.85 119.51 23.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -0.909 . . . . 0.0 110.036 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.818 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -114.37 116.01 28.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.67 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.32 134.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.816 -1.177 . . . . 0.0 109.983 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.944 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -129.19 131.22 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -10.0 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.504 3.226 0 CA-C-O 121.142 0.301 . . . . 0.0 112.579 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -36.29 -59.19 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.691 -0.888 . . . . 0.0 111.328 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.704 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -162.07 -168.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.935 -1.103 . . . . 0.0 108.854 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -89.1 133.47 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.095 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.451 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 2.4 m -121.63 103.57 9.0 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 15.2 pt-20 -84.46 -169.8 2.79 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 110.441 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -156.96 178.99 33.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -127.94 82.73 2.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.892 -1.358 . . . . 0.0 110.533 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.827 HG13 ' N ' ' A' ' 53' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.827 ' N ' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 83.18 -55.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 109.571 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -44.15 44.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.022 . . . . 0.0 108.89 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.536 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -66.01 -44.81 83.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.275 -0.89 . . . . 0.0 108.636 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.466 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -61.78 -64.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.065 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -41.35 -46.25 3.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.504 -0.747 . . . . 0.0 109.244 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 18' ' ' PHE . . . -57.91 -61.57 2.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.42 -0.8 . . . . 0.0 110.31 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -45.53 -50.26 13.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.795 -1.19 . . . . 0.0 108.59 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 12.9 tptt -51.22 -45.53 61.96 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.944 ' SD ' HG23 ' A' ' 38' ' ' VAL . 2.2 ttm -63.3 -70.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.59 -0.694 . . . . 0.0 110.353 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.921 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -46.25 -64.16 0.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 10.6 t -51.51 -29.48 9.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.448 -0.783 . . . . 0.0 109.561 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 3.8 mm-40 -67.89 -55.81 11.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.085 -1.01 . . . . 0.0 111.391 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -95.32 8.38 43.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.432 -1.418 . . . . 0.0 110.404 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 88.5 mt-30 -101.12 -13.33 18.22 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.381 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 -36.95 5.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 109.274 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.563 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.921 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.0 Cg_endo . . . . . 0 N--CA 1.495 1.608 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 2' ' ' ILE . 5.1 mm -71.73 -64.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.5 p -51.36 -42.11 61.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.42 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.1 mt-30 -57.66 -54.0 51.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 108.837 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.951 HG22 ' CG ' ' A' ' 62' ' ' LEU . 56.5 t -53.15 -68.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.553 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 54.6 m80 -34.97 -38.87 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.683 -0.636 . . . . 0.0 109.701 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.7 mt-10 -63.98 -56.53 14.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 110.06 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.068 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -72.41 -53.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.192 -0.943 . . . . 0.0 109.723 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 1.068 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -45.36 -48.34 11.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -73.84 -44.82 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.587 -1.537 . . . . 0.0 110.358 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.9 mtmt -64.61 -11.06 31.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.074 -1.016 . . . . 0.0 110.321 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -120.36 8.1 10.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.938 . . . . 0.0 109.856 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.0 t-20 78.86 -6.44 1.9 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.846 ' CE ' HD22 ' A' ' 65' ' ' LEU . 32.6 mtp -79.45 89.93 5.04 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -42.0 161.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.467 -0.771 . . . . 0.0 109.844 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.94 ' CG2' HG12 ' A' ' 5' ' ' VAL . 60.7 t -132.65 93.38 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.671 ' N ' HG22 ' A' ' 37' ' ' ILE . 28.7 m170 -110.31 97.7 7.11 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 118.306 -1.358 . . . . 0.0 110.439 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.753 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 39.0 m-85 -84.69 119.39 25.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 110.972 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.739 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.52 116.58 5.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.011 HG22 ' OG1' ' A' ' 34' ' ' THR . 86.4 t -78.66 126.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 109.327 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.927 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -126.78 9.49 6.99 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.624 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.553 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.192 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.471 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 3.0 m-85 -88.02 129.72 35.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.3 mp -89.45 96.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.04 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 26.4 m -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.888 0.852 . . . . 0.0 108.91 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.927 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -90.09 120.2 31.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.938 -0.476 . . . . 0.0 109.912 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.804 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -117.94 117.74 30.07 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.699 HG12 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -77.26 132.56 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.952 -1.092 . . . . 0.0 110.536 -177.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.668 HG22 ' HE2' ' A' ' 14' ' ' MET . 0.8 OUTLIER -125.0 108.24 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 14' ' ' MET . . . 18.6 -105.82 0.01 OUTLIER Glycine 0 N--CA 1.504 3.216 0 CA-C-O 121.44 0.467 . . . . 0.0 112.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.1 m -24.18 -56.14 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.449 HG13 ' C ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -156.4 -161.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.09 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.59 163.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.47 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.653 HG23 ' OE2' ' A' ' 64' ' ' GLU . 53.8 m -150.5 90.51 1.65 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.555 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 6.7 pt-20 -86.64 -169.97 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.918 -1.114 . . . . 0.0 109.903 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -172.87 156.01 24.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 1.2 pt-20 -110.79 98.23 7.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.833 -1.392 . . . . 0.0 110.623 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.582 ' HA3' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.493 2.478 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.867 0.365 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 54' ' ' LYS . 49.6 m -60.91 -93.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.89 -1.131 . . . . 0.0 110.217 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.0 OUTLIER -32.15 -61.41 0.25 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.522 -0.736 . . . . 0.0 111.424 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.509 ' HB3' ' CG ' ' A' ' 1' ' ' PRO . 1.1 mttt -49.35 -50.75 38.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.054 . . . . 0.0 109.808 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.582 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 7.6 tpt180 -55.53 -57.52 11.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 109.787 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.04 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -44.59 -47.14 10.31 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.047 0.927 . . . . 0.0 108.658 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -54.31 -64.72 0.74 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 74.2 mt-10 -49.02 -23.97 1.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.201 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -64.36 -53.95 40.54 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.236 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.614 ' HA ' HG21 ' A' ' 43' ' ' THR . 3.4 ptp -77.72 -51.36 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.419 -1.312 . . . . 0.0 110.196 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.951 ' CG ' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -46.74 -47.73 20.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.393 -1.442 . . . . 0.0 107.732 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 79.3 t -65.21 -38.66 83.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.653 ' OE2' HG23 ' A' ' 43' ' ' THR . 1.8 mm-40 -51.33 -68.79 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.846 HD22 ' CE ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -48.51 -44.32 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.602 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.683 ' NE2' HD12 ' A' ' 65' ' ' LEU . 5.1 mm-40 -45.51 -65.01 0.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.962 -1.086 . . . . 0.0 109.489 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -46.02 -52.46 11.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.629 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 68' ' ' LEU . 5.0 mt . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.566 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.537 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 N-CA-C 109.556 -0.978 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 1.012 HG22 ' CD2' ' A' ' 6' ' ' HIS . 7.9 mm -78.66 -47.88 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -46.81 -51.12 17.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -50.73 -57.65 7.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.931 -1.106 . . . . 0.0 110.271 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.044 HG22 ' CD2' ' A' ' 62' ' ' LEU . 24.9 t -54.08 -58.17 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.803 -1.186 . . . . 0.0 108.969 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 1.012 ' CD2' HG22 ' A' ' 2' ' ' ILE . 79.0 m-70 -42.56 -34.69 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.837 -1.164 . . . . 0.0 108.839 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 9.7 mt-10 -71.23 -71.73 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.485 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.052 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -54.48 -48.47 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 120.669 -1.269 . . . . 0.0 109.745 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 1.052 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -52.98 -59.2 9.71 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.9 -52.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.699 -1.471 . . . . 0.0 110.212 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -55.4 -19.47 9.24 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.046 -179.051 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -121.75 23.07 10.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.6 -1.313 . . . . 0.0 111.168 -179.063 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 7.9 t-20 77.53 -11.82 1.15 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.084 -1.01 . . . . 0.0 111.141 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.845 ' HB3' HG22 ' A' ' 38' ' ' VAL . 4.6 mtt -78.3 93.93 4.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.124 . . . . 0.0 109.603 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -42.63 166.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.893 -1.129 . . . . 0.0 110.194 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 6' ' ' HIS . 24.2 t -139.67 77.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.643 ' ND1' HG21 ' A' ' 37' ' ' ILE . 32.6 m170 -102.15 91.57 4.37 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.348 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD2' HG23 ' A' ' 2' ' ' ILE . 29.1 m-85 -80.1 110.14 15.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.548 0.689 . . . . 0.0 110.767 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -131.53 119.0 20.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 67.6 t -79.89 136.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.033 -1.042 . . . . 0.0 110.175 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 3.4 mt -96.04 -15.08 22.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.562 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.691 0.758 . . . . 0.0 110.665 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 1.1 m120 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.669 0.747 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 3.0 m-85 -90.33 128.54 36.47 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 2.9 mm -88.51 95.94 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.097 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.073 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 53.5 m -90.03 114.6 26.51 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -82.44 129.53 34.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.095 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.653 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -123.26 116.39 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.5 -1.375 . . . . 0.0 107.612 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.909 HG12 HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -80.41 136.34 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.01 -1.056 . . . . 0.0 111.961 -177.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.845 HG22 ' HB3' ' A' ' 14' ' ' MET . 0.9 OUTLIER -135.35 136.35 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 50.66 -124.44 19.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.34 5.54 23.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.16 148.27 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 108.898 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.909 HG22 HG12 ' A' ' 37' ' ' ILE . 1.5 t -108.07 143.2 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.946 -1.097 . . . . 0.0 110.293 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.552 ' OG1' ' CE ' ' A' ' 61' ' ' MET . 50.9 p -132.1 113.96 13.96 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -87.69 -168.02 2.08 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 110.008 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA2' ' HG2' ' A' ' 60' ' ' LYS . . . -161.11 114.47 0.61 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -77.99 83.65 4.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.959 -1.318 . . . . 0.0 109.88 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.588 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' C ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.933 0.397 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -24.35 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -69.16 -59.65 2.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.937 -1.102 . . . . 0.0 109.648 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 3.6 ttpm? -50.06 -42.89 50.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.847 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.588 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -69.99 -34.4 73.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.396 -0.815 . . . . 0.0 110.471 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.073 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -64.66 -51.13 64.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.891 -1.131 . . . . 0.0 108.645 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.53 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -60.97 -51.71 68.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 63' ' ' VAL . 4.8 mt-10 -51.18 -44.33 61.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.475 ' HG2' ' HA2' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -61.58 -36.23 80.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.671 ' HG3' HD23 ' A' ' 62' ' ' LEU . 34.8 tpp -70.25 -71.37 0.24 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.49 -0.756 . . . . 0.0 110.617 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.044 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -49.34 -52.69 26.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 108.33 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 59' ' ' GLU . 78.1 t -52.02 -39.7 26.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 108.653 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 61' ' ' MET . 1.8 mm-40 -59.36 -64.26 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.574 HD22 ' SD ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -53.58 -28.41 31.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.978 -1.076 . . . . 0.0 110.257 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 18.1 mm-40 -54.04 -62.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.842 -1.161 . . . . 0.0 109.615 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -54.92 -39.98 69.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.521 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 68' ' ' LEU . 5.2 mt . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.447 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.576 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 4.6 Cg_exo . . . . . 0 N--CA 1.493 1.497 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.948 HG22 ' CD2' ' A' ' 6' ' ' HIS . 8.1 mm -97.58 -50.91 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 109.111 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.49 -45.76 18.62 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 0.0 109.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -55.6 -60.18 3.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.975 . . . . 0.0 108.979 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.017 HG12 ' CG2' ' A' ' 16' ' ' VAL . 48.5 t -46.59 -68.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 108.355 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.948 ' CD2' HG22 ' A' ' 2' ' ' ILE . 92.9 m-70 -36.8 -38.93 0.19 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.457 -0.777 . . . . 0.0 110.242 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -67.0 -48.12 69.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.074 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -75.82 -52.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.176 -0.953 . . . . 0.0 109.449 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 1.074 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -48.5 -53.44 16.47 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.69 -41.46 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.669 -1.489 . . . . 0.0 109.06 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -63.27 -13.37 37.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.411 -0.806 . . . . 0.0 110.178 -179.008 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.31 10.5 8.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 12.5 t30 79.66 -9.21 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.603 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -75.98 91.22 3.04 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.119 -0.988 . . . . 0.0 109.642 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -42.86 160.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.017 ' CG2' HG12 ' A' ' 5' ' ' VAL . 41.4 t -128.2 96.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.709 ' ND1' HG21 ' A' ' 37' ' ' ILE . 31.0 m170 -114.12 94.57 4.88 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.126 -1.43 . . . . 0.0 110.957 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.821 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 52.5 m-85 -80.5 118.68 22.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.633 -0.667 . . . . 0.0 109.659 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.749 ' O ' HD23 ' A' ' 21' ' ' LEU . 27.7 tttt -149.39 116.02 5.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.105 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.918 HG22 ' OG1' ' A' ' 34' ' ' THR . 55.2 t -78.51 118.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.959 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -114.0 9.44 17.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.692 -0.63 . . . . 0.0 110.5 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 120.85 -1.156 . . . . 0.0 110.171 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 43.7 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.276 0.56 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 52.5 m-85 -150.42 125.65 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 109.195 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 46' ' ' GLU . 3.2 mm -89.29 92.12 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.064 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 99.7 m -88.89 115.08 26.18 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.94 0.876 . . . . 0.0 109.606 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.959 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -80.67 118.17 22.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.762 -0.586 . . . . 0.0 109.665 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.759 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -111.95 115.75 29.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.925 HG12 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -78.19 134.79 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.712 -1.243 . . . . 0.0 110.735 -177.289 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -136.55 120.67 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.585 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 8.75 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.506 3.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.916 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.487 ' C ' ' O ' ' A' ' 39' ' ' GLY . 18.4 m -29.3 -60.66 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.088 -0.654 . . . . 0.0 111.265 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -160.56 -167.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.552 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.925 HG22 HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -99.13 138.86 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.224 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.61 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.6 m -126.09 108.38 11.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -82.18 -168.86 2.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.997 -1.064 . . . . 0.0 109.891 -178.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 112.65 0.52 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.682 ' HB3' HD12 ' A' ' 33' ' ' ILE . 3.2 pt-20 -78.02 80.59 4.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.16 -1.2 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.529 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.533 ' CB ' ' OG1' ' A' ' 34' ' ' THR . 0.1 OUTLIER -36.36 -47.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.985 -0.447 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -47.45 76.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 1' ' ' PRO . 3.5 mttp -58.65 -65.17 0.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.967 . . . . 0.0 109.269 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.529 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -45.77 -60.96 1.93 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.579 -0.701 . . . . 0.0 109.552 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.064 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -43.28 -46.01 6.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.988 . . . . 0.0 109.797 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 1' ' ' PRO . . . -62.9 -65.15 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 58' ' ' ALA . 4.9 mt-10 -44.14 -59.63 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.946 -1.097 . . . . 0.0 108.504 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -43.67 -47.04 7.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.753 ' O ' HD13 ' A' ' 65' ' ' LEU . 39.0 tpp -60.09 -72.31 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.595 -0.69 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.798 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.2 mt -45.38 -67.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 62' ' ' LEU . 6.4 t -41.98 -33.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -67.8 -63.83 0.98 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.247 -0.908 . . . . 0.0 111.004 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.915 ' H ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -86.29 10.61 14.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.985 -178.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.481 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.3 mm-40 -96.77 -15.65 21.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.461 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.23 -32.6 22.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 67' ' ' LYS . 16.0 mt . . . . . 0 C--N 1.304 -1.392 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.678 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.6 Cg_exo . . . . . 0 N--CA 1.496 1.666 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 2' ' ' ILE . 8.0 mm -69.62 -65.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -55.59 -30.73 61.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.64 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 26.3 mt-30 -63.84 -55.24 24.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.198 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.069 HG22 ' CD2' ' A' ' 62' ' ' LEU . 36.1 t -57.94 -55.76 19.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.707 ' HA ' HG21 ' A' ' 16' ' ' VAL . 42.0 m80 -44.53 -38.83 4.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.694 -1.254 . . . . 0.0 108.684 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -62.46 -67.83 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.691 -0.631 . . . . 0.0 110.868 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.935 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.11 -50.48 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 0.0 110.274 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.935 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -44.37 -57.05 5.2 Favored Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.8 -29.65 41.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -1.18 . . . . 0.0 109.451 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -80.25 -3.29 48.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.414 -0.804 . . . . 0.0 110.58 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -134.84 16.19 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 109.842 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.4 t-20 78.53 -6.88 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.577 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 5.8 mmm -81.82 90.69 6.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.049 . . . . 0.0 108.79 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.769 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -41.79 157.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.115 -0.991 . . . . 0.0 110.391 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' A' ' 6' ' ' HIS . 24.3 t -131.72 80.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 108.657 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.636 ' NE2' HG22 ' A' ' 15' ' ' THR . 84.5 m-70 -117.7 96.86 5.56 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.695 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.8 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 3.2 m-30 -79.7 137.7 37.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 110.372 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.507 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 6.9 ptpt -150.71 118.48 6.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.756 HG22 ' OG1' ' A' ' 34' ' ' THR . 66.3 t -78.97 129.25 37.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 108.984 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -88.61 -25.55 22.38 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.554 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 33.3 m-20 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.328 0.585 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 35.8 m-85 -131.86 125.83 32.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.342 -0.848 . . . . 0.0 109.429 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.702 HD12 ' HB3' ' A' ' 46' ' ' GLU . 2.0 mm -88.94 94.1 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.397 -0.814 . . . . 0.0 108.896 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.999 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 23.6 m -89.54 111.73 22.72 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 109.575 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -78.06 116.54 18.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.46 -0.775 . . . . 0.0 109.724 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.661 ' O ' ' HE1' ' A' ' 61' ' ' MET . 0.0 OUTLIER -109.63 118.42 36.51 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.996 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -87.41 134.17 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.776 -1.202 . . . . 0.0 112.808 -176.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.996 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.5 m -144.11 142.97 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.017 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 54.52 19.11 11.91 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.64 ' CA ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER 87.43 -23.25 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.926 -0.749 . . . . 0.0 109.576 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 41' ' ' ILE . 1.3 mp -89.43 130.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -90.67 133.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 120.877 -1.139 . . . . 0.0 110.897 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.602 HG21 ' HG2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -128.71 105.7 8.44 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.539 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.613 ' CG ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -81.42 -172.92 4.07 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.112 -0.993 . . . . 0.0 111.455 -177.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' ' 60' ' ' LYS . . . -155.83 112.33 0.52 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.702 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -78.0 78.24 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.064 -1.256 . . . . 0.0 111.02 -178.418 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.495 2.587 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 52' ' ' VAL . 22.7 p -42.11 -46.27 4.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.285 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -44.66 96.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.499 ' HD2' ' HG3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -62.2 -73.63 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.827 . . . . 0.0 109.181 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.534 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -39.0 -38.24 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -0.759 . . . . 0.0 110.072 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.999 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -62.6 -51.33 67.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.95 -1.094 . . . . 0.0 108.539 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.8 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -65.2 -57.94 7.25 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.293 -0.879 . . . . 0.0 110.842 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.537 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 17.5 mt-10 -46.79 -43.85 18.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.568 -1.333 . . . . 0.0 107.762 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.5 tttp -60.0 -43.54 95.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.715 ' HE1' HG22 ' A' ' 38' ' ' VAL . 2.3 mmt -57.0 -72.09 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.019 0.914 . . . . 0.0 111.368 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.069 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -54.18 -56.98 13.04 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 49.1 t -47.91 -32.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.146 -0.971 . . . . 0.0 108.693 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.602 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -67.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.813 . . . . 0.0 110.027 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.876 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -53.36 -24.4 12.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.114 -0.992 . . . . 0.0 110.073 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.876 ' NE2' HD12 ' A' ' 65' ' ' LEU . 32.1 mm-40 -80.31 -33.09 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.881 -1.137 . . . . 0.0 109.011 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -68.29 -41.24 81.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.89 . . . . 0.0 109.379 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--N 1.305 -1.363 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.554 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.798 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.4 Cg_endo . . . . . 0 N--CA 1.497 1.695 0 N-CA-C 109.792 -0.888 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.514 HG22 ' CE1' ' A' ' 6' ' ' HIS . 4.8 mm -68.5 -59.21 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -53.15 -33.48 52.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.9 mt-30 -64.32 -49.88 69.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.702 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.996 ' HA ' HD21 ' A' ' 62' ' ' LEU . 19.6 t -57.73 -64.9 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.414 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.543 ' HA ' HG21 ' A' ' 16' ' ' VAL . 63.5 m80 -40.17 -39.0 0.84 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.624 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.0 mm-40 -62.2 -63.93 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.689 . . . . 0.0 110.676 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.938 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -67.75 -49.91 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.032 -1.043 . . . . 0.0 110.514 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.938 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.13 -54.3 9.94 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.83 -35.14 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.048 -1.266 . . . . 0.0 109.625 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.8 mmtm -76.16 -5.19 45.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -130.79 12.63 5.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.607 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 79.44 -8.7 1.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.785 ' SD ' HD22 ' A' ' 65' ' ' LEU . 4.3 mtt -76.21 96.18 3.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.995 -1.066 . . . . 0.0 109.376 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -49.75 153.75 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.017 -1.052 . . . . 0.0 109.438 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 5' ' ' VAL . 98.1 t -127.41 95.63 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.594 ' N ' HG22 ' A' ' 37' ' ' ILE . 31.2 m170 -116.47 92.69 3.95 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.425 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.888 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 43.6 m-85 -79.63 123.81 27.97 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.54 0.686 . . . . 0.0 110.43 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -150.19 117.18 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.85 HG22 ' OG1' ' A' ' 34' ' ' THR . 88.1 t -78.13 130.93 35.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 108.903 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.722 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -88.68 -26.38 21.87 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.956 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.889 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.478 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 2.6 m120 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 23.0 m-85 -144.54 137.72 27.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 109.653 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.0 mm -91.62 96.95 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.054 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m -89.53 118.79 29.42 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 110.374 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.722 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.0 122.61 26.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.776 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.831 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -120.35 115.92 24.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.383 -1.448 . . . . 0.0 107.292 178.719 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -77.54 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.102 -0.998 . . . . 0.0 111.214 -177.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.96 HG13 ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -121.56 141.31 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -52.77 83.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER 160.37 -45.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.453 -1.027 . . . . 0.0 108.55 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.805 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -168.44 -175.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.31 129.22 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.93 -1.106 . . . . 0.0 109.03 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.5 ' HB ' ' HE2' ' A' ' 61' ' ' MET . 31.8 m -119.52 90.34 3.31 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 5.6 pm0 -80.76 -171.17 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.925 -1.109 . . . . 0.0 109.604 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -162.77 165.63 36.41 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -122.35 93.04 3.85 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.965 -1.315 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.511 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 53' ' ' SER . 2.6 p . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -36.53 -41.45 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.835 -0.54 . . . . 0.0 110.464 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.1 OUTLIER -63.91 -61.97 1.94 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.981 -1.075 . . . . 0.0 109.416 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 7.7 mtpt -48.75 -62.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -44.52 -68.48 0.19 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.311 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.054 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -34.0 -47.63 0.28 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.352 0.596 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -58.33 -53.74 54.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 0.0 109.221 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -49.69 -40.91 41.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.023 -1.048 . . . . 0.0 108.388 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.5 -40.41 94.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.96 ' SD ' HG13 ' A' ' 38' ' ' VAL . 5.6 ttm -69.73 -70.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 110.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.996 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -48.49 -56.19 8.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 108.757 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 59' ' ' GLU . 99.0 t -50.66 -41.89 21.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.549 -0.72 . . . . 0.0 110.142 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.785 HD22 ' SD ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -48.83 -31.39 7.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.027 -1.046 . . . . 0.0 110.088 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.764 ' NE2' HD12 ' A' ' 65' ' ' LEU . 22.1 mm-40 -66.27 -41.65 89.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 0.0 109.738 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -66.46 -35.14 79.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.474 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.545 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.512 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 2.5 Cg_endo . . . . . 0 N--CA 1.496 1.626 0 N-CA-C 109.785 -0.891 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.822 HG22 ' ND1' ' A' ' 6' ' ' HIS . 5.6 mm -71.74 -46.51 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.79 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 p -59.61 -32.86 70.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 110.079 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 39.7 mt-30 -64.89 -55.59 18.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.012 . . . . 0.0 109.183 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.102 ' HA ' HD21 ' A' ' 62' ' ' LEU . 7.0 t -57.34 -63.61 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.822 ' ND1' HG22 ' A' ' 2' ' ' ILE . 33.1 m80 -39.41 -37.59 0.47 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.083 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 1.5 mt-10 -62.0 -67.59 0.4 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.521 -0.737 . . . . 0.0 110.427 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.947 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.62 -49.78 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.058 -1.026 . . . . 0.0 110.556 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.947 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.17 -55.28 7.73 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.34 -46.38 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.264 . . . . 0.0 109.919 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -62.83 -11.7 19.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.79 10.12 7.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.007 . . . . 0.0 109.781 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 39.3 t30 79.38 -10.58 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.946 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.538 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -72.51 86.09 1.16 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.956 -1.09 . . . . 0.0 108.8 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -39.72 163.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.613 0.72 . . . . 0.0 110.731 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.03 HG22 HG12 ' A' ' 5' ' ' VAL . 61.1 t -137.38 88.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.684 ' H ' HG22 ' A' ' 37' ' ' ILE . 30.7 m170 -105.87 93.51 4.68 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.13 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.86 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -86.76 131.14 34.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.613 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.89 114.09 4.82 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.895 HG22 ' OG1' ' A' ' 34' ' ' THR . 56.0 t -78.19 111.69 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.87 -1.144 . . . . 0.0 108.909 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -91.32 -25.36 19.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.812 -0.555 . . . . 0.0 109.791 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.544 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.631 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 m120 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.941 0.877 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' HB3' ' CB ' ' A' ' 53' ' ' SER . 9.6 m-85 -140.26 117.26 11.12 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 22' ' ' ARG . 3.3 mm -90.74 122.24 41.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 120.943 -1.098 . . . . 0.0 108.764 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.024 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 10.0 m -123.59 109.71 14.11 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -76.31 118.77 19.36 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.602 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.999 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -123.05 114.41 20.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.059 -1.026 . . . . 0.0 108.335 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.935 HG12 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -78.95 135.07 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -0.839 . . . . 0.0 111.548 -177.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.696 HG23 ' HE2' ' A' ' 61' ' ' MET . 0.9 OUTLIER -133.12 148.65 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 45.14 -124.11 6.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t -111.96 8.11 20.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.574 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.595 ' H ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -125.69 149.65 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 108.794 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.935 HG22 HG12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -103.87 141.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.453 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -132.96 114.16 13.68 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.7 mt-10 -82.72 -167.51 1.66 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.859 -1.15 . . . . 0.0 109.773 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -152.14 110.79 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.641 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -84.25 64.66 8.41 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.33 -1.1 . . . . 0.0 110.041 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.57 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.496 2.689 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.822 HG13 ' N ' ' A' ' 53' ' ' SER . 1.7 p . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.822 ' N ' HG13 ' A' ' 52' ' ' VAL . 3.0 p 84.3 -58.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.79 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 2' ' ' ILE . 7.9 ptmt -77.84 -47.26 19.25 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.228 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 18.4 tttm -66.21 -39.57 89.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.385 -0.822 . . . . 0.0 108.997 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.57 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -68.14 -46.14 71.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.371 -0.831 . . . . 0.0 109.425 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.024 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -56.56 -57.84 10.62 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.113 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.721 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . . . -53.34 -48.67 68.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.164 -0.96 . . . . 0.0 110.294 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.548 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 3.3 mt-10 -54.83 -35.77 64.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 11.8 tptp -64.52 -36.3 83.77 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.696 ' HE2' HG23 ' A' ' 38' ' ' VAL . 54.1 mmm -73.32 -71.12 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.649 -0.657 . . . . 0.0 110.704 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.102 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -49.57 -41.03 40.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 0.0 109.004 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 70.5 t -65.6 -39.72 85.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.64 -59.83 3.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.681 -0.637 . . . . 0.0 109.455 179.105 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -59.95 -40.87 90.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.272 -0.892 . . . . 0.0 110.292 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 8.8 mm-40 -46.41 -25.77 0.72 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.778 -1.201 . . . . 0.0 109.1 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.7 -66.04 0.64 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 109.283 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 68' ' ' LEU . 5.3 mt . . . . . 0 C--N 1.3 -1.562 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 5' ' ' VAL . 5.4 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.727 -0.913 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.583 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.9 mm -72.74 -64.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.392 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 p -53.16 -28.06 24.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.268 -0.895 . . . . 0.0 109.233 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.4 mt-30 -67.08 -51.83 49.5 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 108.589 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.014 ' HA ' HD21 ' A' ' 62' ' ' LEU . 19.1 t -58.37 -60.38 2.36 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.651 ' HA ' HG21 ' A' ' 16' ' ' VAL . 63.5 m80 -43.56 -39.98 3.74 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.953 -1.092 . . . . 0.0 109.093 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.1 mm-40 -60.53 -64.12 1.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 110.971 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.958 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.16 -49.95 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.891 -1.131 . . . . 0.0 110.727 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.958 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -48.0 -51.04 20.12 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -70.48 -46.35 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.662 -1.493 . . . . 0.0 109.889 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.92 -9.61 22.57 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.97 15.39 8.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 109.687 -179.35 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 72.64 -7.38 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.434 -0.791 . . . . 0.0 110.125 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 5.4 mtt -79.65 92.64 5.39 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.604 -1.31 . . . . 0.0 108.881 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -42.41 168.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.78 HG22 HG12 ' A' ' 5' ' ' VAL . 84.6 t -137.73 83.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 108.4 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.648 ' ND1' HG21 ' A' ' 37' ' ' ILE . 30.8 m170 -106.42 92.53 4.16 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.563 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.914 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 37.4 m-85 -78.36 122.04 25.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.651 -0.656 . . . . 0.0 110.394 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.34 122.02 8.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.977 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.2 t -77.42 130.01 36.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 108.526 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.805 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.67 -22.46 23.4 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.414 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.521 HD21 ' N ' ' A' ' 31' ' ' ASN . 1.2 m-80 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 6.2 m-85 -116.51 143.01 46.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.379 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 5.1 mm -90.62 111.8 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.12 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 7.4 m -103.86 118.63 37.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.144 -0.972 . . . . 0.0 110.737 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.805 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -84.68 122.96 29.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 0.0 111.141 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.653 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 4.1 t -114.63 121.07 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.648 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.86 130.57 36.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.662 -1.274 . . . . 0.0 109.929 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.704 HG21 ' SD ' ' A' ' 61' ' ' MET . 1.0 OUTLIER -135.5 119.35 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.387 0.613 . . . . 0.0 109.479 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 15.5 -101.44 0.01 OUTLIER Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.478 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -27.62 -60.79 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.223 -0.575 . . . . 0.0 111.247 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -164.79 -167.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.048 -1.032 . . . . 0.0 108.603 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.604 HG22 HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -89.67 134.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.996 -1.065 . . . . 0.0 110.168 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.8 m -123.25 107.96 12.26 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -90.05 -173.65 3.94 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.21 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -154.92 175.97 32.78 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -128.88 93.69 3.66 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.287 . . . . 0.0 109.683 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 53' ' ' SER . 2.9 p . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.535 0.684 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.483 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -39.59 -45.92 1.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.624 -0.672 . . . . 0.0 110.545 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' HG21 ' A' ' 34' ' ' THR . 1.9 tttt -62.31 -56.73 15.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.197 -0.939 . . . . 0.0 110.088 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -55.58 -65.64 0.56 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.651 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.514 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -43.8 -42.15 5.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.855 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.12 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -59.06 -46.07 89.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.075 -1.015 . . . . 0.0 108.779 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -61.18 -58.05 9.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 110.243 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.521 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -48.67 -40.61 28.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.909 -1.119 . . . . 0.0 107.996 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.62 -43.48 93.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.704 ' SD ' HG21 ' A' ' 38' ' ' VAL . 54.9 tpp -67.51 -70.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.612 -0.68 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.014 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -45.93 -60.17 2.41 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 84.9 t -48.77 -39.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 108.622 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -57.96 -69.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.929 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.854 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -45.72 -34.38 3.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.887 -1.133 . . . . 0.0 109.741 -179.061 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.854 ' NE2' HD12 ' A' ' 65' ' ' LEU . 28.9 mm-40 -63.82 -45.11 91.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.82 -1.175 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.06 -48.12 83.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--N 1.301 -1.525 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.542 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.523 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.7 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.642 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.5 mm -68.3 -66.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.2 -30.57 7.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 83.1 mm-40 -63.94 -61.62 2.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.025 ' HA ' HD21 ' A' ' 62' ' ' LEU . 26.2 t -51.52 -57.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.935 . . . . 0.0 108.61 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.637 ' HA ' HG21 ' A' ' 16' ' ' VAL . 51.2 m80 -44.41 -41.1 5.94 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.793 -1.192 . . . . 0.0 109.351 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.6 mm-40 -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.772 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.055 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -64.65 -54.08 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.184 -0.948 . . . . 0.0 110.355 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 1.055 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -48.97 -52.72 20.86 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.06 -45.53 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.352 . . . . 0.0 109.92 -178.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -65.12 -13.42 58.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -118.21 9.34 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 0.0 109.893 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 18.0 t-20 80.4 -12.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.62 ' CG ' HG13 ' A' ' 38' ' ' VAL . 5.6 mtt -76.52 98.89 4.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.998 -1.064 . . . . 0.0 108.662 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -46.6 172.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.695 -1.253 . . . . 0.0 109.85 -179.378 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.637 HG21 ' HA ' ' A' ' 6' ' ' HIS . 59.6 t -143.57 83.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.526 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.809 ' HB2' HG22 ' A' ' 37' ' ' ILE . 90.0 m-70 -116.81 97.35 5.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.399 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.853 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 58.7 m-85 -78.09 130.65 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.573 -0.704 . . . . 0.0 110.917 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.783 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -151.05 115.08 5.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.91 HG22 ' OG1' ' A' ' 34' ' ' THR . 78.9 t -78.37 118.95 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.965 -1.084 . . . . 0.0 108.461 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.985 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -114.03 -11.97 12.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.669 -0.645 . . . . 0.0 111.154 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 120.813 -1.179 . . . . 0.0 110.631 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 17.0 m-80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.606 0.717 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 45.6 m-85 -150.44 127.11 10.91 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 3.1 mm -89.6 96.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.135 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 19.9 m -88.73 114.06 24.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.44 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.985 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -87.76 115.28 25.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.551 -0.718 . . . . 0.0 111.098 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.652 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 12.4 t -105.59 114.5 28.71 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.001 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -77.59 130.47 36.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.739 -1.225 . . . . 0.0 109.906 -178.337 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.001 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.1 t -132.71 135.84 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.444 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 59.23 -116.16 8.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.402 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -120.56 12.43 11.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -1.091 . . . . 0.0 109.377 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' C ' ' A' ' 40' ' ' SER . 2.0 mp -135.0 151.21 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 108.984 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -95.9 135.46 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.015 -1.053 . . . . 0.0 110.424 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.608 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.2 m -121.93 101.8 7.78 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 5.2 mt-10 -88.16 -173.9 4.43 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 110.664 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -161.32 116.07 0.69 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.96 89.38 4.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.196 -1.179 . . . . 0.0 110.644 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.297 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 20' ' ' VAL . 1.7 p -39.31 -46.75 1.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 110.098 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -62.27 -75.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 1' ' ' PRO . 3.4 tttt -41.7 -66.53 0.33 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' NH1' ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -38.75 -56.6 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.744 . . . . 0.0 110.286 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.135 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -50.72 -50.42 55.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.171 -0.956 . . . . 0.0 110.036 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.664 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -58.08 -57.09 14.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.428 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 63' ' ' VAL . 39.0 mt-10 -48.21 -38.6 18.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.745 -1.222 . . . . 0.0 107.999 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.9 -43.46 98.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.688 ' SD ' HG21 ' A' ' 38' ' ' VAL . 41.0 tpp -67.83 -69.42 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.688 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.025 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -47.24 -60.14 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.307 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 59' ' ' GLU . 94.1 t -46.93 -41.01 5.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.085 -1.009 . . . . 0.0 108.395 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -54.51 -66.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.526 -0.734 . . . . 0.0 110.022 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -56.53 -21.42 26.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 110.164 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 20.2 mm-40 -67.06 -46.56 73.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.915 -1.116 . . . . 0.0 109.329 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' C ' HD23 ' A' ' 68' ' ' LEU . 26.7 mtmt -61.52 -53.51 55.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.312 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 68' ' ' LEU . 4.2 mt . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.599 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.921 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.3 Cg_endo . . . . . 0 N--CA 1.497 1.701 0 N-CA-C 109.739 -0.908 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 2' ' ' ILE . 4.8 mm -71.15 -59.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.392 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p -56.24 -33.3 65.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.28 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -64.09 -52.14 60.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 108.56 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.047 HG12 ' CG2' ' A' ' 16' ' ' VAL . 16.4 t -55.41 -66.23 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 54.1 m80 -39.68 -38.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.471 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -60.72 -62.67 1.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 110.46 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.948 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -69.6 -50.11 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.067 -1.021 . . . . 0.0 110.809 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.948 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.64 -52.23 15.55 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.9 -45.47 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.356 . . . . 0.0 109.62 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.44 -10.3 24.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 -179.111 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.45 10.03 7.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.637 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.7 OUTLIER 79.7 -11.46 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.147 179.78 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.556 ' HA ' ' CA ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -74.72 95.16 2.82 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -47.34 158.83 0.15 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.372 -0.83 . . . . 0.0 109.486 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.047 ' CG2' HG12 ' A' ' 5' ' ' VAL . 42.3 t -133.03 94.63 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.681 ' ND1' HG21 ' A' ' 37' ' ' ILE . 29.6 m170 -111.92 96.2 5.92 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.454 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.924 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 45.7 m-85 -83.51 120.03 25.42 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.8 ' O ' HD23 ' A' ' 21' ' ' LEU . 10.7 mttm -151.15 113.81 4.67 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.338 -0.851 . . . . 0.0 108.86 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.927 HG22 ' OG1' ' A' ' 34' ' ' THR . 72.3 t -78.57 118.87 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 108.672 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.973 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -117.24 -8.57 11.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 110.955 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.612 HH22 HD12 ' A' ' 21' ' ' LEU . 1.2 ttm-85 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 0.0 110.538 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 18.5 m-20 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.724 0.773 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 43.4 m-85 -150.86 132.56 14.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.4 mp -89.99 99.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.015 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 26.8 m -87.01 117.65 25.88 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.607 0.718 . . . . 0.0 109.229 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.973 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -81.01 117.07 21.3 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.499 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.983 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -117.41 114.36 23.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.71 HG12 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -76.93 132.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.067 -1.021 . . . . 0.0 110.77 -177.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -124.31 133.41 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -9.18 -84.1 0.01 OUTLIER Glycine 0 N--CA 1.507 3.383 0 CA-C-O 121.332 0.406 . . . . 0.0 112.781 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.476 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -35.11 -59.82 0.49 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.681 -0.894 . . . . 0.0 111.773 -178.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.646 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -161.31 -159.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.871 -1.143 . . . . 0.0 108.428 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.71 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -88.39 157.95 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.752 -1.218 . . . . 0.0 109.356 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.575 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 5.6 m -150.97 93.96 2.0 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.611 ' HG2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -79.56 -169.83 2.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 110.213 -179.105 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.561 ' HA2' ' CD ' ' A' ' 60' ' ' LYS . . . -170.78 118.86 0.77 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 4.3 pm0 -77.79 91.0 4.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -1.206 . . . . 0.0 110.585 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.496 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.665 ' OG ' HG21 ' A' ' 20' ' ' VAL . 9.2 p -33.51 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.24 0.543 . . . . 0.0 110.542 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -62.46 -50.1 72.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.326 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HG2' ' HG2' ' A' ' 1' ' ' PRO . 50.7 mtpt -57.41 -69.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -39.3 -61.83 0.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.999 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.015 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -43.06 -53.4 4.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -54.71 -53.56 53.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.317 -0.865 . . . . 0.0 110.923 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -49.43 -43.52 44.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.561 ' CD ' ' HA2' ' A' ' 45' ' ' GLY . 0.5 OUTLIER -55.02 -43.82 74.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.575 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 67.2 mmm -64.5 -67.67 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.872 0.844 . . . . 0.0 111.363 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.002 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -50.88 -57.19 9.1 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.028 -1.045 . . . . 0.0 108.959 -177.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 2.5 t -59.06 -25.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.202 -0.937 . . . . 0.0 109.007 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.609 ' HB3' HD13 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -64.5 -54.18 36.35 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.222 -0.924 . . . . 0.0 111.001 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.883 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -110.57 12.29 22.8 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.731 -1.231 . . . . 0.0 111.595 -178.695 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 76.3 mm-40 -94.94 -16.97 22.4 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.959 -1.088 . . . . 0.0 109.412 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -98.85 -49.07 4.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.598 HD23 ' N ' ' A' ' 68' ' ' LEU . 2.2 mt . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.8 Cg_exo . . . . . 0 N--CA 1.496 1.653 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.544 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.5 mm -79.59 -69.61 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.14 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -52.67 -23.86 7.43 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.7 mt-30 -66.85 -54.09 25.88 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.069 HG22 ' CD2' ' A' ' 62' ' ' LEU . 61.5 t -60.0 -55.93 20.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.664 ' HA ' HG21 ' A' ' 16' ' ' VAL . 89.7 m-70 -46.2 -37.16 6.75 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.875 -1.14 . . . . 0.0 108.599 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.5 mt-10 -62.18 -65.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 110.832 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.948 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.89 -49.7 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.58 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.948 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.22 -52.16 13.52 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.71 -45.73 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.809 -1.407 . . . . 0.0 109.852 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -66.2 -8.16 22.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 110.333 -179.122 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.52 10.01 8.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.625 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.9 t-20 79.86 -11.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.829 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.596 ' HE1' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -76.66 96.68 4.24 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.86 -1.15 . . . . 0.0 109.573 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -46.65 154.95 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.69 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 6' ' ' HIS . 46.8 t -129.92 90.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.606 ' ND1' HG21 ' A' ' 37' ' ' ILE . 34.0 m170 -114.34 91.85 3.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.56 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.807 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 57.3 m-85 -79.82 123.01 27.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.691 -0.631 . . . . 0.0 110.137 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.758 ' O ' HD23 ' A' ' 21' ' ' LEU . 13.8 mttt -150.92 112.25 4.39 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.924 HG22 ' OG1' ' A' ' 34' ' ' THR . 69.2 t -78.48 121.32 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.063 -1.023 . . . . 0.0 109.124 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.987 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -115.59 8.92 15.21 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.808 -178.313 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 3.6 mpp_? . . . . . 0 N--CA 1.493 1.714 0 O-C-N 120.88 -1.138 . . . . 0.0 110.058 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.389 0.614 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 52.1 m-85 -150.88 125.74 9.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.445 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 2.4 mm -89.8 93.42 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.039 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 18.0 m -88.05 112.71 22.93 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.823 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.987 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -79.57 115.45 19.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.997 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -113.67 113.99 25.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.606 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.58 132.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.152 -0.968 . . . . 0.0 110.515 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.783 HG21 HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -119.74 147.25 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -47.99 88.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 155.51 -50.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.812 -0.817 . . . . 0.0 109.118 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -170.68 -166.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.312 -0.868 . . . . 0.0 108.718 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.54 133.79 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.382 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.561 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.8 m -127.01 93.67 3.82 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 2.7 pm0 -80.49 -173.52 4.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.737 -1.227 . . . . 0.0 110.604 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.89 113.42 0.56 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.553 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -78.2 81.95 4.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.208 -1.172 . . . . 0.0 110.232 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.516 ' O ' ' C ' ' A' ' 53' ' ' SER . 1.2 p . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.516 ' C ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -29.84 -68.02 0.08 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 23.9 mmtt -45.83 -50.61 14.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 1' ' ' PRO . 6.7 tttt -58.66 -73.14 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.526 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -37.62 -67.23 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.201 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.039 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -40.56 -55.14 2.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -51.55 -57.46 9.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.813 . . . . 0.0 110.633 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.506 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 25.5 mt-10 -47.94 -44.87 30.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 108.253 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.2 -44.03 71.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 108.976 179.33 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.639 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 70.7 mmm -65.95 -66.27 0.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.806 0.812 . . . . 0.0 111.311 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.069 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -50.82 -60.4 3.11 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 8.7 t -56.28 -26.95 23.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.184 -0.947 . . . . 0.0 109.13 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.56 ' HB3' HD13 ' A' ' 65' ' ' LEU . 2.0 mm-40 -62.89 -55.56 24.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.873 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -112.57 16.05 19.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.744 -1.223 . . . . 0.0 111.49 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.536 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 9.5 mm-40 -98.86 -33.8 10.73 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.064 -1.022 . . . . 0.0 109.261 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -66.86 -26.06 66.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.509 179.811 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.5 Cg_exo . . . . . 0 N--CA 1.497 1.709 0 N-CA-C 109.613 -0.957 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.556 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.6 mm -72.23 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.937 . . . . 0.0 109.276 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -54.55 -31.6 56.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.0 mm100 -63.41 -53.5 51.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.251 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.066 HG22 ' CD2' ' A' ' 62' ' ' LEU . 61.1 t -58.53 -54.82 27.92 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 108.534 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.566 ' HA ' HG21 ' A' ' 16' ' ' VAL . 52.3 m80 -47.16 -37.59 10.32 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 120.618 -1.301 . . . . 0.0 108.755 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 13.0 mt-10 -63.24 -66.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.974 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.937 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -65.4 -49.33 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.012 . . . . 0.0 110.276 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.937 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.49 -56.6 7.12 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.2 OUTLIER -69.37 -30.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.076 -1.25 . . . . 0.0 109.73 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.1 mtmp? -79.92 -4.3 51.77 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.22 13.22 4.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.65 -179.556 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.8 t30 78.84 -7.6 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.777 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.575 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 3.5 mmt -78.84 95.2 5.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.958 -1.089 . . . . 0.0 109.01 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -47.38 155.35 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.786 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.704 ' CG2' HG12 ' A' ' 5' ' ' VAL . 45.8 t -131.72 93.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 108.724 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.604 ' ND1' HG21 ' A' ' 37' ' ' ILE . 32.8 m170 -118.85 91.3 3.52 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.664 -1.215 . . . . 0.0 110.316 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.724 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 57.1 m-85 -78.49 129.42 34.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 110.441 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.803 ' O ' HD23 ' A' ' 21' ' ' LEU . 28.3 mttt -151.47 110.78 3.94 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.807 HG22 ' OG1' ' A' ' 34' ' ' THR . 72.0 t -78.6 118.84 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 109.033 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.954 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -119.22 10.69 12.1 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.703 . . . . 0.0 110.677 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' CD ' HG13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.96 -1.087 . . . . 0.0 110.32 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.417 0.627 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 15.6 m-85 -136.67 133.95 36.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.548 HG13 ' CD ' ' A' ' 22' ' ' ARG . 4.9 mm -89.21 97.5 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.133 -0.979 . . . . 0.0 108.472 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.079 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 18.8 m -88.47 113.21 23.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.954 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -78.81 117.7 20.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.589 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.958 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -116.04 116.11 27.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.604 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -79.14 130.41 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 111.248 -177.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.906 HG13 ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -112.78 146.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.039 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -53.18 84.94 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 159.91 -46.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.585 -0.95 . . . . 0.0 108.451 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -169.79 -176.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.8 153.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.86 -1.15 . . . . 0.0 108.884 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 17.1 m -149.04 94.71 2.28 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -79.68 -172.74 3.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.894 -1.128 . . . . 0.0 110.237 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.04 117.78 0.79 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -77.86 88.83 4.06 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.999 -1.295 . . . . 0.0 110.105 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.502 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.511 ' HB3' ' CB ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -32.07 -38.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.263 0.554 . . . . 0.0 110.478 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.4 OUTLIER -69.45 -53.25 20.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.146 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG3' ' CG ' ' A' ' 1' ' ' PRO . 0.4 OUTLIER -56.35 -59.21 5.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.525 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -52.53 -43.03 64.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.118 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.079 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -55.3 -51.99 64.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.907 -1.12 . . . . 0.0 108.513 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.522 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -55.13 -50.02 70.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.571 -0.705 . . . . 0.0 110.168 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 8.3 mt-10 -54.37 -36.83 64.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.91 -36.44 83.96 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.343 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.906 ' CE ' HG13 ' A' ' 38' ' ' VAL . 80.0 mmm -71.49 -69.33 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.569 0.699 . . . . 0.0 111.141 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.066 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -51.8 -38.14 54.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 72.8 t -69.64 -36.37 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -58.07 -55.51 33.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.82 -38.35 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.026 -1.047 . . . . 0.0 109.527 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.422 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -66.01 -14.72 62.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 109.71 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -54.98 3.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.302 -1.496 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.57 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PRO . . . . . 0.587 ' CG ' ' CG ' ' A' ' 55' ' ' LYS . 5.0 Cg_exo . . . . . 0 N--CA 1.495 1.603 0 N-CA-C 109.557 -0.978 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.556 HD12 ' CE2' ' A' ' 18' ' ' PHE . 4.3 mm -66.42 -60.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 108.975 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -27.69 43.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.395 -0.815 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 11.4 mt-30 -64.76 -57.35 9.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.071 HG12 ' CG2' ' A' ' 16' ' ' VAL . 13.8 t -53.42 -63.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.545 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 53.1 m80 -39.86 -39.04 0.75 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.19 -0.944 . . . . 0.0 109.685 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 3.3 mt-10 -61.7 -62.06 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.95 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -70.02 -51.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.005 -1.059 . . . . 0.0 110.698 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.95 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.89 -49.29 17.59 Favored Glycine 0 N--CA 1.48 1.613 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.86 -46.29 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.529 -1.571 . . . . 0.0 109.851 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.73 -10.14 25.28 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 110.162 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -122.74 8.34 9.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.828 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 8.3 t-20 78.3 -8.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.416 -0.803 . . . . 0.0 109.627 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.83 ' HB3' HG12 ' A' ' 38' ' ' VAL . 8.6 mtp -78.66 87.67 4.58 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.899 -1.126 . . . . 0.0 109.404 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -40.28 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.579 -0.701 . . . . 0.0 109.896 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.071 ' CG2' HG12 ' A' ' 5' ' ' VAL . 42.0 t -137.43 78.85 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.638 ' ND1' HG21 ' A' ' 37' ' ' ILE . 31.7 m170 -100.73 95.59 6.76 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.951 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.721 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -76.28 127.77 33.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 109.672 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -147.97 110.97 4.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.983 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.0 t -76.39 117.23 20.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.981 -1.074 . . . . 0.0 108.873 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.887 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -93.0 -23.1 18.79 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.933 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.551 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 110.277 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 78.2 m-20 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.519 ' CB ' ' CB ' ' A' ' 53' ' ' SER . 4.4 m-85 -118.63 121.13 39.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.029 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 46' ' ' GLU . 1.8 mm -89.08 91.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.1 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 15.4 m -88.95 108.64 19.67 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.874 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.887 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -79.85 115.73 19.61 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 18' ' ' PHE . 5.0 t -108.21 121.23 44.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 176.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.638 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -76.28 128.78 37.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.925 -1.109 . . . . 0.0 110.428 -177.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.975 HG13 ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -116.69 102.94 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.169 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . 6.65 -73.4 0.0 OUTLIER Glycine 0 N--CA 1.504 3.169 0 C-N-CA 122.979 0.323 . . . . 0.0 112.547 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 38' ' ' VAL . 30.6 m -41.93 -65.8 0.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -1.053 . . . . 0.0 109.908 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -147.64 -139.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -113.37 161.89 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.19 . . . . 0.0 109.502 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.77 HG21 ' HA ' ' A' ' 61' ' ' MET . 19.8 m -150.37 91.92 1.81 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.616 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.5 pt-20 -86.17 -176.5 5.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.156 -0.965 . . . . 0.0 110.686 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -154.9 109.08 0.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.837 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.7 pm0 -79.24 80.44 5.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.297 -1.119 . . . . 0.0 109.563 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 53' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.557 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 28.6 p -14.75 -56.15 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.303 0.573 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 52' ' ' VAL . 14.5 mmtp -63.55 -59.64 4.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.364 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.587 ' CG ' ' CG ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -56.29 -62.61 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.554 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -42.05 -44.88 3.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 110.029 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.1 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -59.48 -58.94 6.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.938 -1.102 . . . . 0.0 108.631 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -48.43 -66.55 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.948 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.2 mm-40 -44.43 -40.1 5.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.333 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -56.07 -49.4 73.9 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 108.999 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.975 ' SD ' HG13 ' A' ' 38' ' ' VAL . 18.5 ttm -68.65 -62.57 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.723 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.015 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -47.75 -64.3 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.825 -1.172 . . . . 0.0 108.274 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 48.6 t -50.61 -34.92 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -52.2 -66.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 109.05 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.733 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.3 mm? -53.83 -44.18 70.06 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.9 -1.125 . . . . 0.0 110.15 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -53.55 -31.69 47.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.352 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.37 -41.7 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.617 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 64' ' ' GLU . 13.3 mt . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.522 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.9 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 N-CA-C 109.674 -0.933 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.889 HG22 ' CE1' ' A' ' 6' ' ' HIS . 5.7 mm -76.63 -51.17 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 t -52.05 -37.5 53.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.635 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 30.6 mt-30 -63.17 -53.65 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.021 HG22 ' CD2' ' A' ' 62' ' ' LEU . 24.2 t -54.9 -67.92 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.889 ' CE1' HG22 ' A' ' 2' ' ' ILE . 51.8 m80 -36.87 -38.89 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.331 -0.855 . . . . 0.0 109.448 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 2.7 mt-10 -60.08 -62.26 2.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.717 -0.615 . . . . 0.0 110.171 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.936 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -74.1 -51.46 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.936 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -44.3 -52.38 7.22 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -78.0 -37.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.08 -1.247 . . . . 0.0 110.17 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.537 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 8.6 mmtm -60.65 -16.84 43.12 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.468 -0.77 . . . . 0.0 111.171 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.585 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.7 tpt180 -116.32 -44.1 2.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.79 -1.194 . . . . 0.0 109.578 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.585 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER 155.46 -15.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.017 -0.427 . . . . 0.0 109.928 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.696 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -71.91 111.8 7.47 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.834 -1.166 . . . . 0.0 110.054 -179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.598 HG22 ' NE2' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -64.93 121.85 15.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.029 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.721 ' CG2' HG12 ' A' ' 5' ' ' VAL . 60.7 t -98.19 110.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.653 ' CD2' ' CG2' ' A' ' 37' ' ' ILE . 4.2 m-70 -136.49 95.5 3.17 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.588 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.871 ' CD1' HG23 ' A' ' 2' ' ' ILE . 60.2 m-85 -78.71 135.14 37.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 110.997 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.821 ' O ' HD23 ' A' ' 21' ' ' LEU . 4.7 mtmt -150.36 110.49 4.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.932 HG22 ' OG1' ' A' ' 34' ' ' THR . 95.2 t -78.62 118.39 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 108.818 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.923 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -118.76 10.26 12.34 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -178.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.488 ' C ' ' CG ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.16 166.88 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.125 . . . . 0.0 110.267 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 7.9 mt-10 -156.93 42.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.766 . . . . 0.0 109.429 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 31' ' ' ASN . 7.6 pt-20 -176.3 -169.12 0.29 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.989 -1.069 . . . . 0.0 110.032 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.48 -148.66 5.35 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.75 -62.1 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.189 1.926 . . . . 0.0 110.12 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' CB ' ' A' ' 28' ' ' HIS . . . -174.73 40.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 109.303 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.526 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.0 OUTLIER 164.4 73.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.347 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 28' ' ' HIS . 3.6 mtt 163.26 106.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.3 84.41 0.26 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.391 -0.818 . . . . 0.0 109.601 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 24' ' ' GLU . 6.5 m-20 -120.09 128.15 53.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.135 -0.978 . . . . 0.0 109.413 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 4.6 m-85 -99.87 127.09 46.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.029 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.815 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.6 mp -88.81 97.31 6.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.01 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 5.1 m -86.16 118.04 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.923 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -82.01 114.49 20.61 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.873 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.785 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.22 113.19 25.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.024 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -78.77 138.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.196 -0.94 . . . . 0.0 109.336 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.024 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -131.4 146.42 33.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 42.38 -112.88 0.5 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 2.77 11.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -1.204 . . . . 0.0 109.94 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.76 154.15 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 108.477 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.92 160.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.855 -1.153 . . . . 0.0 110.229 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.488 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 23.3 m -150.34 90.6 1.67 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.561 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 3.8 mt-10 -81.12 -172.84 3.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.865 -1.147 . . . . 0.0 110.686 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.31 119.57 0.83 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -80.37 92.01 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.072 -1.252 . . . . 0.0 111.107 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . -81.19 120.29 5.09 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.617 ' O ' HG11 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -61.4 101.44 0.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.152 -1.204 . . . . 0.0 110.207 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 133.69 177.11 14.72 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 51' ' ' LYS . 3.4 pttm -94.34 -46.49 7.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -1.126 . . . . 0.0 109.56 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 50' ' ' LYS . 12.4 tttt -84.14 -9.69 58.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -84.81 -39.34 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.516 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -35.57 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.701 -0.624 . . . . 0.0 110.935 -179.219 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 52' ' ' VAL . 13.4 mttp -76.29 -49.68 16.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.593 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.73 -35.72 81.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.145 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 2.1 tpp180 -76.87 -40.32 48.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 109.885 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -61.81 -51.67 67.33 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 108.356 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' N ' ' HE2' ' A' ' 18' ' ' PHE . . . -63.0 -56.38 17.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 110.051 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mt-10 -46.78 -43.6 18.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.731 -1.231 . . . . 0.0 108.112 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.97 -43.2 95.25 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.917 ' SD ' HG23 ' A' ' 38' ' ' VAL . 5.9 ttm -65.15 -70.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 110.484 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.021 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -47.71 -62.58 1.38 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 78.8 t -44.32 -38.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.37 -0.831 . . . . 0.0 108.991 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -58.03 -57.34 13.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.588 -0.695 . . . . 0.0 111.059 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.716 ' H ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -110.04 24.04 13.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.846 -1.159 . . . . 0.0 111.608 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.492 ' HG3' ' HB3' ' A' ' 62' ' ' LEU . 21.1 mm-40 -112.16 -20.41 11.92 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.483 ' HE2' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -98.6 -33.41 10.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.578 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.305 -1.352 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.681 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.675 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 3.0 Cg_exo . . . . . 0 N--CA 1.496 1.668 0 N-CA-C 109.597 -0.963 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.586 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.7 mm -80.32 -62.29 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.236 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -42.02 69.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.6 mm100 -57.1 -52.0 67.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.107 -0.995 . . . . 0.0 108.936 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.871 HG22 ' CD2' ' A' ' 62' ' ' LEU . 74.7 t -55.61 -68.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.645 ' HA ' HG21 ' A' ' 16' ' ' VAL . 44.6 m80 -35.15 -34.58 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.656 0.741 . . . . 0.0 109.578 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.2 mt-10 -68.61 -52.56 30.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.73 -0.606 . . . . 0.0 110.585 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.057 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -73.23 -45.89 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.676 -179.032 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 1.057 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -50.73 -52.97 27.66 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.4 -47.4 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.057 -1.26 . . . . 0.0 109.451 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -63.99 -10.05 19.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -125.22 8.06 7.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.833 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 80.19 -10.78 1.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.686 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.634 ' HE2' HG13 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -72.94 89.53 1.42 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.067 -1.021 . . . . 0.0 109.081 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -43.48 149.36 0.27 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 109.509 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 6' ' ' HIS . 39.9 t -125.93 102.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.167 -0.958 . . . . 0.0 109.033 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.689 ' N ' HG22 ' A' ' 37' ' ' ILE . 32.6 m170 -121.77 95.09 4.53 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.524 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.824 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 3.1 m-85 -81.21 129.82 34.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.955 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.695 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.66 111.41 4.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.922 HG22 ' OG1' ' A' ' 34' ' ' THR . 70.7 t -78.06 103.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 0.0 109.035 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.019 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -89.68 -21.85 22.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.072 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -131.81 144.21 50.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.647 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.561 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 39.2 mt-10 -133.04 113.61 12.99 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 109.643 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.588 ' HG3' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 34.91 63.2 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.716 -0.615 . . . . 0.0 110.482 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 24' ' ' GLU . . . 42.9 -141.61 1.96 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.81 -67.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.989 1.793 . . . . 0.0 110.119 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -167.57 81.17 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.342 -0.849 . . . . 0.0 109.565 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.526 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 45.8 m-70 -156.53 34.98 0.32 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 109.737 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 8.7 ptt? 39.85 30.49 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.461 -0.775 . . . . 0.0 110.268 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' N ' ' HB3' ' A' ' 24' ' ' GLU . 13.2 mttm -68.03 -98.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.109 -0.994 . . . . 0.0 109.768 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 6.4 m-20 -131.23 147.08 52.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.898 -1.126 . . . . 0.0 110.66 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 24' ' ' GLU . 20.6 m-85 -103.98 119.3 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.785 HD12 ' HB3' ' A' ' 46' ' ' GLU . 2.1 mm -89.48 92.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.021 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.042 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 19.5 m -89.59 113.46 24.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.493 -0.754 . . . . 0.0 109.131 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.019 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.01 116.61 20.24 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.44 -0.788 . . . . 0.0 110.236 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.854 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -113.27 115.24 27.87 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.794 HG12 HG13 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -76.69 134.78 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.961 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.969 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -130.17 135.11 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 49.23 -127.29 21.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -104.51 5.05 33.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -1.13 . . . . 0.0 109.774 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -122.15 151.61 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 108.894 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.85 160.96 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.968 -1.083 . . . . 0.0 109.746 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.479 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 21.2 m -150.45 92.01 1.81 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -81.42 -173.74 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.878 -1.138 . . . . 0.0 110.446 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.37 110.95 0.46 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.785 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.2 pt-20 -79.25 75.61 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 110.681 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.55 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -49.6 169.94 0.16 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.514 ' N ' HG11 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -113.45 98.24 6.96 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.962 -1.317 . . . . 0.0 110.959 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' ' HG2' ' A' ' 50' ' ' LYS . . . 33.99 -156.21 0.01 OUTLIER Glycine 0 N--CA 1.496 2.698 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 2.2 ptmt 45.9 -174.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.916 . . . . 0.0 109.465 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 89.02 0.05 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.738 HG13 ' N ' ' A' ' 53' ' ' SER . 1.2 p -146.64 -158.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.738 ' N ' HG13 ' A' ' 52' ' ' VAL . 3.4 p 84.38 -57.93 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.915 -0.49 . . . . 0.0 109.693 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' N ' ' OG ' ' A' ' 53' ' ' SER . 4.6 pttp -80.06 -48.83 12.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 108.966 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.533 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 98.4 mttt -68.62 -30.03 68.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' HG3' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -79.49 -38.82 33.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.478 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.042 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.022 -1.049 . . . . 0.0 108.394 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.824 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -65.1 -54.69 26.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.474 -0.766 . . . . 0.0 110.214 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.4 mt-10 -48.51 -42.71 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.61 -1.306 . . . . 0.0 107.76 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 1.7 tptp -62.76 -39.46 94.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.969 ' SD ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -65.78 -71.46 0.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.613 . . . . 0.0 110.072 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.871 ' CD2' HG22 ' A' ' 5' ' ' VAL . 1.3 mt -51.76 -56.98 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.127 -0.983 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 79.0 t -47.19 -39.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 108.506 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -61.15 -68.39 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.748 . . . . 0.0 110.386 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.35 -27.96 1.84 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.185 . . . . 0.0 109.964 -178.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 24.2 mm-40 -54.03 -49.49 68.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.931 -1.106 . . . . 0.0 109.536 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -51.22 36.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.985 . . . . 0.0 109.338 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.48 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.496 1.651 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.714 HD11 ' HB3' ' A' ' 54' ' ' LYS . 3.4 mm -68.24 -54.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.152 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -53.09 -30.67 37.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 109.216 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.6 mm100 -65.04 -55.81 16.71 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.066 HG12 HG22 ' A' ' 16' ' ' VAL . 21.8 t -53.64 -67.67 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.691 ' CE1' HG22 ' A' ' 2' ' ' ILE . 54.5 m80 -36.46 -39.12 0.18 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 7.5 mt-10 -63.56 -59.02 5.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.845 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.977 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.8 pp -70.92 -50.4 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.897 -1.127 . . . . 0.0 110.31 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.977 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.53 -49.65 20.4 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.54 -45.6 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.664 -1.492 . . . . 0.0 109.823 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -64.0 -11.74 31.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.68 15.32 8.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.98 -1.075 . . . . 0.0 109.717 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 1.2 m-20 72.68 -4.82 2.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.545 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 3.0 mtp -79.75 91.2 5.28 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.809 -1.182 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -44.59 158.46 0.05 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.083 -1.011 . . . . 0.0 109.869 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.066 HG22 HG12 ' A' ' 5' ' ' VAL . 54.9 t -128.04 91.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.677 ' ND1' HG21 ' A' ' 37' ' ' ILE . 31.6 m170 -109.42 92.88 4.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.581 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.921 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 39.7 m-85 -81.47 115.1 20.63 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.809 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -149.71 117.71 6.32 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.07 -1.018 . . . . 0.0 109.481 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.759 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.0 t -79.13 116.86 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.981 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.52 5.06 13.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.503 -0.748 . . . . 0.0 110.957 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -138.14 150.3 46.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.761 -1.212 . . . . 0.0 110.398 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 1.2 mp0 -131.24 121.88 25.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.527 -0.733 . . . . 0.0 109.208 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.49 166.96 21.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.42 103.89 1.65 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -59.52 -73.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.049 1.833 . . . . 0.0 110.327 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.476 ' H ' ' CD2' ' A' ' 28' ' ' HIS . . . -165.78 36.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.545 ' CD2' ' N ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -163.24 22.68 0.08 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.043 -1.035 . . . . 0.0 109.668 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 170.82 85.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.261 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.569 ' CB ' ' HA2' ' A' ' 49' ' ' GLY . 4.1 mttt -76.98 122.23 24.6 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 109.696 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -137.67 123.49 20.02 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.089 -1.007 . . . . 0.0 108.448 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.585 ' HB2' ' CB ' ' A' ' 48' ' ' ASN . 5.2 m-85 -106.08 151.41 24.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.067 -1.021 . . . . 0.0 108.647 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 5.8 mm -87.55 102.05 12.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.128 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 91.6 m -88.78 111.1 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.807 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.981 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.27 117.06 20.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 110.3 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.944 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -111.69 112.7 24.58 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.677 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.62 137.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.047 -1.033 . . . . 0.0 110.159 -177.268 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.946 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.6 OUTLIER -131.29 126.19 58.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 56.05 -121.83 25.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.35 4.72 19.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.15 . . . . 0.0 109.418 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.49 161.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 0.0 108.923 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.86 142.05 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.868 -1.145 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.564 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 20.3 m -132.49 92.1 3.03 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.547 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.1 mp0 -85.36 -168.71 2.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.012 -1.055 . . . . 0.0 111.171 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -155.75 -179.25 30.69 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.5 -2.64 . . . . 0.0 106.5 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 2.5 mt-10 -133.92 71.33 1.46 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 119.453 1.626 . . . . 0.0 110.874 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.612 ' O ' ' CB ' ' A' ' 48' ' ' ASN . . . -134.96 170.46 22.84 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.867 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.794 ' H ' HG12 ' A' ' 52' ' ' VAL . 4.7 t-20 148.0 -17.71 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 122.075 -0.662 . . . . 0.0 109.871 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.569 ' HA2' ' CB ' ' A' ' 30' ' ' LYS . . . -43.28 -48.39 6.77 Favored Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.11 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.15 72.06 1.45 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.1 -1.235 . . . . 0.0 109.978 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 50.13 49.0 21.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.31 -0.869 . . . . 0.0 109.783 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.794 HG12 ' H ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -117.19 -27.35 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.173 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.486 ' H ' ' HA ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -33.81 -63.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.268 0.556 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.714 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -47.02 -51.04 18.25 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.111 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 56' ' ' ARG . 1.4 mttt -57.39 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.458 -0.776 . . . . 0.0 109.035 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -29.26 -66.48 0.09 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.889 -0.507 . . . . 0.0 111.226 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.128 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -46.36 -55.03 7.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 110.704 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.702 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -61.2 -53.96 50.3 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.19 -0.944 . . . . 0.0 111.529 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.582 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.8 mm-40 -49.47 -38.02 28.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.382 -1.449 . . . . 0.0 107.545 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 18.5 tptt -63.52 -41.16 98.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.946 ' SD ' HG23 ' A' ' 38' ' ' VAL . 3.3 ttm -68.48 -73.1 0.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.756 -0.59 . . . . 0.0 110.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.943 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -48.5 -47.58 38.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.326 -0.859 . . . . 0.0 109.857 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.603 ' HA ' ' NE2' ' A' ' 66' ' ' GLN . 72.2 t -60.71 -37.92 77.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 108.254 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -58.13 -58.01 10.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.634 -0.666 . . . . 0.0 110.341 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.581 HD13 HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.853 -1.155 . . . . 0.0 110.13 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.603 ' NE2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -50.75 -26.4 5.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -58.5 -53.42 58.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 68' ' ' LEU . 6.9 mt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.487 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.832 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.652 0 N-CA-C 109.646 -0.944 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.987 HG23 ' CD2' ' A' ' 18' ' ' PHE . 2.5 mp 81.43 -55.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 2' ' ' ILE . 92.9 p -46.38 -50.26 16.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.723 -1.235 . . . . 0.0 108.451 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.8 mt-30 -58.04 -51.78 68.25 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.877 HG22 ' CD2' ' A' ' 62' ' ' LEU . 47.0 t -49.51 -77.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.878 ' ND1' HG22 ' A' ' 2' ' ' ILE . 59.6 m80 -28.92 -41.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.419 0.628 . . . . 0.0 110.126 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 5' ' ' VAL . 4.0 mm-40 -60.34 -64.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.953 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -70.32 -49.43 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -0.957 . . . . 0.0 110.651 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.953 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.96 -56.32 7.74 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -32.56 51.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.259 . . . . 0.0 109.321 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.3 mmtp -76.7 -4.55 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 110.422 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -133.91 16.07 3.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.381 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 80.22 -10.98 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.656 -0.652 . . . . 0.0 109.98 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.829 ' SD ' HD22 ' A' ' 65' ' ' LEU . 5.2 mtt -75.74 100.37 4.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.81 -1.182 . . . . 0.0 109.674 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -50.5 174.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.827 -1.17 . . . . 0.0 109.55 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.869 ' CG2' HG12 ' A' ' 5' ' ' VAL . 95.8 t -149.09 88.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.656 ' ND1' HG21 ' A' ' 37' ' ' ILE . 33.0 m170 -112.18 95.76 5.64 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.708 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.987 ' CD2' HG23 ' A' ' 2' ' ' ILE . 33.0 m-85 -80.21 118.65 22.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.507 -0.745 . . . . 0.0 111.441 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 123.3 8.69 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.702 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.4 t -79.78 130.07 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.943 -1.098 . . . . 0.0 108.925 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.042 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -89.0 -22.37 23.03 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.773 -0.579 . . . . 0.0 109.721 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.541 ' HG3' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 162.82 154.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.528 -179.326 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -103.19 87.59 2.93 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 3.3 mm-40 -41.0 143.22 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 110.104 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.479 ' HA3' ' HG3' ' A' ' 30' ' ' LYS . . . 100.7 148.82 22.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.92 -81.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.252 1.968 . . . . 0.0 110.431 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.474 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -156.5 77.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 0.0 109.289 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.534 ' O ' ' CG ' ' A' ' 29' ' ' MET . 17.3 m80 -153.98 58.86 0.73 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.89 . . . . 0.0 109.5 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.534 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 5.0 ptp 41.39 31.45 0.17 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.414 -0.804 . . . . 0.0 109.672 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -58.35 -161.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 110.131 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 33.8 m-80 -89.13 152.25 21.74 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.07 -1.019 . . . . 0.0 110.284 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.63 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 7.2 m-85 -117.86 117.96 30.7 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.58 HD13 ' N ' ' A' ' 33' ' ' ILE . 1.6 mm -86.55 91.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.051 -1.031 . . . . 0.0 108.581 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.039 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 34.7 m -88.8 111.16 21.69 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.042 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -79.84 113.88 18.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.438 -0.789 . . . . 0.0 110.485 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.873 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.93 119.43 39.04 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.656 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -78.75 134.01 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.727 -1.233 . . . . 0.0 111.104 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.952 HG13 ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -129.97 140.5 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 50.61 -91.67 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.9 m -143.51 2.39 1.25 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -1.175 . . . . 0.0 110.35 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 40' ' ' SER . 17.2 mm -117.05 160.8 16.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.991 -1.068 . . . . 0.0 108.603 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.69 125.38 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.862 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.82 HG21 ' HA ' ' A' ' 61' ' ' MET . 73.4 m -115.29 88.67 2.93 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -80.88 -172.82 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.985 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.497 ' HA3' ' HG3' ' A' ' 60' ' ' LYS . . . -160.89 115.96 0.69 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.059 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.47 78.59 4.93 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.131 -1.217 . . . . 0.0 109.816 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . -74.33 129.1 11.1 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.987 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.6 ' N ' HG11 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -48.97 88.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.389 -1.065 . . . . 0.0 109.961 179.171 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.615 ' O ' ' CB ' ' A' ' 50' ' ' LYS . . . -29.6 157.93 0.0 OUTLIER Glycine 0 N--CA 1.498 2.817 0 CA-C-O 121.597 0.554 . . . . 0.0 112.131 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.615 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER 97.94 57.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 4.0 tttp 72.57 59.91 0.12 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.6 HG11 ' N ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -164.64 -41.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.916 . . . . 0.0 110.322 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.511 ' OG ' ' CG ' ' A' ' 32' ' ' PHE . 3.9 m -33.49 -74.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.705 -0.622 . . . . 0.0 111.739 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 33.1 pttt -43.1 -51.73 5.74 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.145 -0.972 . . . . 0.0 111.1 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -54.51 -39.27 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.94 -1.1 . . . . 0.0 110.464 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.589 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -72.66 -35.85 67.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.039 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -63.82 -53.0 57.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.91 -1.119 . . . . 0.0 108.405 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.531 ' HB2' HG13 ' A' ' 2' ' ' ILE . . . -62.3 -64.05 1.05 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.429 -0.794 . . . . 0.0 109.403 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 30.9 mt-10 -50.91 -25.5 4.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.754 -1.216 . . . . 0.0 108.502 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -65.89 -53.15 43.36 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.952 ' CE ' HG13 ' A' ' 38' ' ' VAL . 3.6 ptp -73.62 -51.46 16.7 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.865 -1.534 . . . . 0.0 110.448 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.877 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -48.66 -55.95 9.87 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 62.5 t -54.52 -37.77 39.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -53.88 -72.81 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.843 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -44.87 -37.44 3.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.843 ' NE2' HD12 ' A' ' 65' ' ' LEU . 21.5 mm-40 -58.33 -45.94 87.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.02 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -36.37 83.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.024 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.574 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.553 ' HD2' ' CG ' ' A' ' 55' ' ' LYS . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.628 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.567 HD11 ' HB3' ' A' ' 54' ' ' LYS . 10.0 mm -95.12 -56.76 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.145 -0.972 . . . . 0.0 108.863 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -57.56 -33.84 68.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.556 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 3.2 pt20 -62.66 -48.88 77.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 108.479 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.05 HG22 HD21 ' A' ' 62' ' ' LEU . 99.1 t -59.98 -68.16 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.661 ' HA ' HG21 ' A' ' 16' ' ' VAL . 41.7 m80 -34.7 -34.28 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.579 0.704 . . . . 0.0 109.514 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' VAL . 6.3 mt-10 -67.76 -69.37 0.32 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.171 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.01 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -57.89 -52.94 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.16 -0.962 . . . . 0.0 109.492 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 1.01 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -46.82 -49.65 16.56 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.687 HG22 ' N ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -80.16 -65.34 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.338 . . . . 0.0 109.955 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.687 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -39.68 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.473 -0.767 . . . . 0.0 111.428 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -104.67 -49.67 3.47 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.78 -1.2 . . . . 0.0 109.272 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.6 m-20 150.34 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.585 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 4.5 mmt -56.19 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.154 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -46.41 158.37 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.725 -1.234 . . . . 0.0 109.361 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.746 ' CG2' HG12 ' A' ' 5' ' ' VAL . 96.9 t -130.35 82.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.619 ' ND1' HG21 ' A' ' 37' ' ' ILE . 33.8 m170 -110.22 89.2 2.96 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.003 -1.479 . . . . 0.0 111.117 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.794 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 52.9 m-85 -75.87 120.78 21.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.781 ' O ' HD23 ' A' ' 21' ' ' LEU . 31.4 tttp -145.65 116.78 7.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.046 HG22 ' OG1' ' A' ' 34' ' ' THR . 47.2 t -78.31 113.38 17.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.967 -1.083 . . . . 0.0 109.062 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.967 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -111.05 16.71 21.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.84 -178.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.565 ' CD ' HG13 ' A' ' 33' ' ' ILE . 2.0 mtt180 -147.45 155.81 42.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.779 -1.201 . . . . 0.0 110.407 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 10.2 mt-10 -156.18 119.07 4.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 6.9 pt-20 -140.06 172.13 13.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.085 -1.009 . . . . 0.0 110.084 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . 122.34 145.37 6.99 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.519 ' HG2' ' NE2' ' A' ' 28' ' ' HIS . 2.2 Cg_endo -62.05 -69.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.149 1.9 . . . . 0.0 110.178 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' H ' ' CD2' ' A' ' 28' ' ' HIS . . . -170.38 33.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 109.759 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' CD2' ' N ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -159.43 -70.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 51.6 mtm -86.35 58.27 4.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.21 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 48.7 mttt -74.77 115.49 14.41 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.314 -0.866 . . . . 0.0 110.04 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 36.2 m-20 -94.99 144.27 25.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.197 -0.94 . . . . 0.0 108.509 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' A' ' 49' ' ' GLY . 17.3 m-85 -121.36 139.35 53.54 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.657 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.569 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 5.1 mm -89.39 96.57 6.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.046 ' OG1' HG22 ' A' ' 20' ' ' VAL . 4.3 m -88.33 119.88 29.17 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.548 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.967 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -95.14 114.16 25.92 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.523 -0.735 . . . . 0.0 111.085 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.852 ' HB3' ' HE3' ' A' ' 61' ' ' MET . 5.5 t -101.91 126.05 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.676 ' O ' ' HE1' ' A' ' 61' ' ' MET . 0.1 OUTLIER -75.11 133.37 31.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.616 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -125.11 130.88 73.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.127 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' N ' ' SD ' ' A' ' 14' ' ' MET . . . 42.34 -107.53 0.11 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 t -116.53 -7.51 11.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.604 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 38' ' ' VAL . 11.2 mt -112.87 148.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 108.661 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -91.31 128.01 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.913 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.754 HG23 ' HB ' ' A' ' 38' ' ' VAL . 20.5 p -103.89 93.05 4.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 2.5 pt-20 -94.93 179.47 5.22 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.753 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -164.13 166.97 37.9 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -114.76 92.81 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.885 -1.362 . . . . 0.0 110.079 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . -73.86 167.82 54.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.505 ' C ' HG11 ' A' ' 52' ' ' VAL . 10.5 p-10 -110.69 92.51 4.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -1.172 . . . . 0.0 109.621 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 32' ' ' PHE . . . 140.2 -154.98 24.3 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 tttm -112.81 -45.95 3.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -1.217 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -88.73 -14.75 36.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.382 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -76.27 -39.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 0.0 109.463 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.481 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 26.6 p -38.06 -33.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -72.9 -47.19 47.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.032 -1.042 . . . . 0.0 109.448 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.553 ' CG ' ' HD2' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -59.73 -51.79 68.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -60.29 -63.67 1.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.947 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.991 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -42.06 -48.61 4.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.397 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.23 -55.14 34.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.805 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.0 mm-40 -48.51 -33.54 9.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -66.1 -44.47 84.3 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.852 ' HE3' ' HB3' ' A' ' 36' ' ' CYS . 22.7 ttm -64.73 -60.73 2.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.389 -0.819 . . . . 0.0 110.081 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.05 HD21 HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -56.45 -61.24 2.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 53.8 t -49.71 -34.56 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.913 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' MET . 2.4 mm-40 -59.93 -63.75 1.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -59.57 -22.28 61.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.1 -1.0 . . . . 0.0 109.993 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 1.8 mp0 -82.22 -23.35 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 0.0 109.954 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -79.93 -35.1 38.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.011 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.59 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.543 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 3.3 Cg_exo . . . . . 0 N--CA 1.496 1.664 0 N-CA-C 109.634 -0.949 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' A' ' 54' ' ' LYS . 4.5 mm -72.5 -54.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.266 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.8 p -54.08 -37.31 64.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.432 -0.792 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.7 -60.87 3.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.918 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.05 ' HA ' HD21 ' A' ' 62' ' ' LEU . 39.4 t -51.32 -66.91 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.614 ' CE1' HG22 ' A' ' 2' ' ' ILE . 31.7 m80 -35.38 -35.96 0.06 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.578 -0.701 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -69.47 -50.63 43.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.472 -0.768 . . . . 0.0 110.261 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.065 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -74.57 -48.51 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.999 -1.063 . . . . 0.0 109.337 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 1.065 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -50.44 -50.79 34.36 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.11 -46.46 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.816 -1.402 . . . . 0.0 109.784 -179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.87 -10.97 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.997 . . . . 0.0 110.089 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -121.03 8.19 10.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 110.001 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER 80.35 -11.53 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.444 -0.785 . . . . 0.0 109.579 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.58 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 4.2 mtt -73.57 106.92 5.56 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.015 -1.053 . . . . 0.0 109.071 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.53 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -61.32 136.36 58.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.431 -0.793 . . . . 0.0 109.931 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.963 ' CG2' HG12 ' A' ' 5' ' ' VAL . 69.0 t -110.73 112.13 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.496 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.78 ' HB2' HG22 ' A' ' 37' ' ' ILE . 15.0 m-70 -131.15 103.76 6.68 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.644 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.801 ' CD2' HD12 ' A' ' 2' ' ' ILE . 2.9 m-85 -90.67 136.27 33.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.606 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -150.33 110.07 4.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.872 HG22 ' OG1' ' A' ' 34' ' ' THR . 68.9 t -77.51 123.13 33.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.963 -1.086 . . . . 0.0 108.389 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -107.19 -14.58 14.87 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.348 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.557 ' CB ' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -122.27 149.57 43.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.0 -1.063 . . . . 0.0 110.715 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' CG ' ' C ' ' A' ' 22' ' ' ARG . 9.8 mt-10 -157.99 92.07 1.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -54.96 -166.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 109.725 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.97 -147.08 15.69 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 3.2 Cg_exo -59.97 -79.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.294 1.996 . . . . 0.0 110.571 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.549 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -118.62 79.41 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.549 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 2.4 m-70 -157.79 88.1 0.96 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 108.926 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.53 ' O ' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER 51.5 35.07 13.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.138 -0.976 . . . . 0.0 108.586 -179.301 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -41.83 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.658 -0.651 . . . . 0.0 110.094 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.578 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 2.3 m120 -139.9 -178.89 5.65 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.503 -0.748 . . . . 0.0 109.278 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 58.6 m-85 -152.69 121.88 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.547 -0.721 . . . . 0.0 109.317 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.557 HG12 ' CB ' ' A' ' 22' ' ' ARG . 3.1 mm -89.4 92.15 3.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.1 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 31.1 m -87.76 109.83 20.01 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.969 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.855 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -77.55 122.07 24.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.984 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -126.18 111.67 14.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.464 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.08 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -78.49 136.63 23.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.223 -0.923 . . . . 0.0 110.844 -178.137 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.08 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.2 t -127.45 127.73 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 52.61 -118.05 7.3 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -111.1 0.47 16.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -1.161 . . . . 0.0 109.864 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mt -116.11 134.02 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 108.971 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.78 HG22 HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -97.55 142.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.893 -1.129 . . . . 0.0 110.714 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.468 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -135.97 112.91 10.31 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.59 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -84.23 -170.24 3.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.841 -1.162 . . . . 0.0 109.098 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -160.81 108.61 0.36 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.45 -1.357 . . . . 0.0 109.785 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.553 ' CB ' HD13 ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.04 79.1 4.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.258 -1.142 . . . . 0.0 109.871 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 48' ' ' ASN . . . -85.25 136.75 14.72 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.598 ' HB2' HG11 ' A' ' 52' ' ' VAL . 16.1 m-20 -51.63 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -1.159 . . . . 0.0 111.164 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.776 ' O ' HG12 ' A' ' 52' ' ' VAL . . . -46.36 178.52 0.01 OUTLIER Glycine 0 N--CA 1.497 2.721 0 O-C-N 121.332 -0.855 . . . . 0.0 111.204 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -46.67 175.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.552 -0.97 . . . . 0.0 109.528 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? 59.82 33.22 21.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 49' ' ' GLY . 0.4 OUTLIER -179.66 -31.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.62 -0.675 . . . . 0.0 109.347 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 65.3 m -57.68 -80.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.206 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.892 ' HB2' HD11 ' A' ' 2' ' ' ILE . 1.8 pttt -51.29 -53.39 36.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.259 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 24.3 ttpp -53.22 -29.55 33.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 109.628 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -74.35 -45.16 48.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.468 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.1 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -60.71 -57.36 13.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.246 -0.909 . . . . 0.0 108.553 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.793 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -54.55 -48.44 72.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.368 -0.833 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.7 mm-40 -53.56 -39.29 64.66 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.32 -37.66 84.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.588 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 64.0 mmm -70.18 -71.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.0 110.95 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.05 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -49.5 -48.79 47.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.066 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 75.1 t -60.04 -37.81 74.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -55.48 -61.09 2.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.595 -0.69 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.574 HD12 ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -60.79 -34.28 74.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 110.521 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.626 ' NE2' ' HA ' ' A' ' 66' ' ' GLN . 5.9 mm100 -65.56 -28.57 69.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.709 -1.244 . . . . 0.0 109.666 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -70.83 -30.16 66.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 C--N 1.304 -1.386 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.461 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.862 ' O ' HG23 ' A' ' 5' ' ' VAL . 5.4 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 N-CA-C 109.745 -0.906 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.558 HD12 ' CD2' ' A' ' 18' ' ' PHE . 5.1 mm -69.85 -58.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 p -55.6 -37.89 68.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.6 mm100 -60.96 -55.71 29.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 0.0 108.644 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.987 ' HA ' HD21 ' A' ' 62' ' ' LEU . 23.5 t -51.77 -70.11 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 42.0 m80 -34.68 -38.68 0.08 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.619 -0.675 . . . . 0.0 109.779 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.8 mt-10 -62.51 -63.8 1.12 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.433 -0.792 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.965 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.11 -49.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.191 -0.943 . . . . 0.0 110.58 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.965 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.59 -56.22 8.62 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -30.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.118 -1.225 . . . . 0.0 109.504 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 6.5 mttm -79.84 -3.76 49.24 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 110.267 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.73 14.32 4.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 109.384 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 80.69 -10.33 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.635 -0.666 . . . . 0.0 109.764 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.587 ' SD ' HD22 ' A' ' 65' ' ' LEU . 1.8 mtt -76.48 99.56 4.96 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.935 -1.103 . . . . 0.0 109.342 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -53.78 142.18 24.57 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.812 HG22 HG12 ' A' ' 5' ' ' VAL . 98.5 t -114.45 94.33 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.782 ' HB2' HG22 ' A' ' 37' ' ' ILE . 96.6 m-70 -119.26 102.74 8.91 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.161 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.809 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -86.84 125.3 33.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -138.99 114.67 9.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.015 HG22 ' OG1' ' A' ' 34' ' ' THR . 61.3 t -78.55 128.77 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.046 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.596 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -111.26 -11.16 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.706 -0.621 . . . . 0.0 110.097 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 12.3 mmt180 -140.23 170.33 16.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.031 -1.043 . . . . 0.0 109.993 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 32' ' ' PHE . 24.1 mp0 -144.08 20.38 1.76 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 49.3 tt0 161.75 141.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.881 . . . . 0.0 109.749 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.43 -138.02 1.97 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 5.8 Cg_exo -59.42 -42.59 47.22 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.732 1.621 . . . . 0.0 109.578 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 26' ' ' PRO . . . 173.81 -77.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.456 -0.778 . . . . 0.0 109.589 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.52 ' NE2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -37.03 123.6 0.88 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.702 -0.624 . . . . 0.0 110.412 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.29 97.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.428 -0.795 . . . . 0.0 110.134 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -67.58 105.64 1.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 108.682 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 26.9 m-20 -108.6 141.43 40.54 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.676 0.75 . . . . 0.0 110.986 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 3.2 m-85 -108.62 126.44 52.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.548 ' CG1' ' HB2' ' A' ' 22' ' ' ARG . 1.3 mm -96.01 123.88 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.094 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 6.1 m -119.85 116.47 25.91 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.596 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -79.54 112.7 17.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.541 -0.725 . . . . 0.0 109.179 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.815 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -109.82 111.82 23.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.587 -1.321 . . . . 0.0 107.6 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.087 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -79.36 138.09 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 111.133 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.087 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -125.29 136.0 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 42.24 -88.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' VAL . 12.8 t -136.82 -7.13 1.88 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.087 -1.243 . . . . 0.0 110.609 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.634 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.9 mt -108.05 136.85 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.908 -1.12 . . . . 0.0 108.414 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -92.03 129.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.851 -1.156 . . . . 0.0 110.729 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -115.76 98.37 6.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.574 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -82.94 -174.15 5.11 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.599 -1.313 . . . . 0.0 109.639 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -149.73 172.95 29.61 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.76 76.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.285 -1.127 . . . . 0.0 108.693 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -85.01 -160.8 33.1 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 61.5 m-20 -89.73 -160.04 0.65 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.274 -1.133 . . . . 0.0 108.251 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.594 ' HA2' ' CD1' ' A' ' 32' ' ' PHE . . . -107.36 139.14 14.86 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 80.6 127.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.556 -0.967 . . . . 0.0 110.292 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 30.31 69.52 0.09 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.261 0.553 . . . . 0.0 110.859 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.088 HG22 ' CD ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -178.26 -42.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 0.0 109.414 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 35.2 p -48.93 -54.93 13.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.888 -1.132 . . . . 0.0 109.559 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -55.94 -70.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 109.926 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' CA ' ' HD2' ' A' ' 1' ' ' PRO . 48.5 mttp -41.35 -68.9 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.742 . . . . 0.0 109.559 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 1.088 ' CD ' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -36.67 -63.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.895 -0.503 . . . . 0.0 110.494 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.094 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -44.17 -49.31 9.14 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.925 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.791 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -55.67 -57.91 10.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.344 -0.847 . . . . 0.0 110.637 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 20.8 mt-10 -46.28 -45.24 17.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.762 -1.211 . . . . 0.0 108.136 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -56.23 -43.55 78.71 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 1.013 ' SD ' HG13 ' A' ' 38' ' ' VAL . 4.8 ttm -66.41 -72.34 0.16 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.375 0.607 . . . . 0.0 110.602 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -46.89 -60.63 2.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.931 -1.106 . . . . 0.0 108.589 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 70.2 t -47.11 -39.13 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.749 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -58.07 -66.61 0.45 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.634 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -53.4 -28.2 28.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.979 -1.075 . . . . 0.0 110.547 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.634 ' NE2' HD12 ' A' ' 65' ' ' LEU . 31.5 mm-40 -65.11 -37.17 86.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.832 -1.168 . . . . 0.0 109.605 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -34.36 70.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.639 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.885 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.5 Cg_exo . . . . . 0 N--CA 1.496 1.625 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.584 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.0 mm -71.04 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -51.32 -37.64 48.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.349 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.5 mm-40 -62.45 -51.49 67.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.039 HG12 ' CG2' ' A' ' 16' ' ' VAL . 38.8 t -54.98 -66.83 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.37 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.527 ' CE1' HG22 ' A' ' 2' ' ' ILE . 62.2 m80 -38.38 -38.61 0.38 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.494 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -61.03 -63.18 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.733 -0.604 . . . . 0.0 110.69 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.964 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.14 -49.06 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.029 -1.044 . . . . 0.0 110.791 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.964 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -49.36 -54.25 16.8 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -67.49 -39.24 82.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.885 -1.362 . . . . 0.0 109.476 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 11.3 mttm -69.64 -9.36 53.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 109.892 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.67 10.09 7.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.237 -0.915 . . . . 0.0 109.09 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 79.32 -10.28 1.35 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.75 . . . . 0.0 109.42 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.588 ' HE3' ' HG ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -75.54 101.76 5.01 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.943 -1.098 . . . . 0.0 109.302 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -53.06 163.58 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.039 ' CG2' HG12 ' A' ' 5' ' ' VAL . 48.9 t -133.45 92.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.67 ' ND1' HG21 ' A' ' 37' ' ' ILE . 31.0 m170 -113.68 95.64 5.44 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.621 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.891 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 54.7 m-85 -81.65 119.32 23.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.623 -0.673 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.766 ' O ' HD23 ' A' ' 21' ' ' LEU . 8.3 ttmm -151.01 115.96 5.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.846 HG22 ' OG1' ' A' ' 34' ' ' THR . 93.4 t -79.01 119.29 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 0.0 108.668 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.987 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.21 1.39 13.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 110.984 -178.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -152.95 163.08 40.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.676 -1.265 . . . . 0.0 110.819 -179.347 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -122.08 -162.62 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -143.09 104.03 4.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.002 -1.061 . . . . 0.0 109.687 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . 57.9 160.56 0.03 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.506 ' HD2' ' NE2' ' A' ' 28' ' ' HIS . 4.1 Cg_exo -60.67 -69.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.406 2.07 . . . . 0.0 110.347 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 30' ' ' LYS . . . -120.16 -63.77 1.33 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.402 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' NE2' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -38.89 106.01 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.651 -0.655 . . . . 0.0 109.625 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 69.01 81.77 0.18 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.258 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -84.96 64.8 8.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.7 m-20 -89.71 171.91 9.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.874 -1.141 . . . . 0.0 109.236 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 35.2 m-85 -144.55 141.55 29.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.6 mm -89.47 99.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.065 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 35.8 m -89.22 113.31 24.51 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.459 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.987 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -80.85 119.51 23.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -0.909 . . . . 0.0 110.036 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.818 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -114.37 116.01 28.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.67 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.32 134.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.816 -1.177 . . . . 0.0 109.983 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.944 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -129.19 131.22 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -10.0 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.504 3.226 0 CA-C-O 121.142 0.301 . . . . 0.0 112.579 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -36.29 -59.19 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.691 -0.888 . . . . 0.0 111.328 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.704 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -162.07 -168.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.935 -1.103 . . . . 0.0 108.854 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -89.1 133.47 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.095 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.451 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 2.4 m -121.63 103.57 9.0 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 15.2 pt-20 -84.46 -169.8 2.79 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 110.441 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -156.96 178.99 33.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -127.94 82.73 2.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.892 -1.358 . . . . 0.0 110.533 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . -52.83 167.62 1.04 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.583 ' N ' HG11 ' A' ' 52' ' ' VAL . 6.9 t-20 -130.67 81.5 2.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.257 . . . . 0.0 110.726 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.958 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 108.11 -172.07 16.73 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.31 -177.31 5.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.384 -1.068 . . . . 0.0 109.167 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt 48.96 23.78 0.76 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 108.831 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.958 HG12 ' O ' ' A' ' 49' ' ' GLY . 0.8 OUTLIER -144.93 -156.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.452 -0.78 . . . . 0.0 109.124 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.827 ' N ' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 83.18 -55.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 109.571 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -44.15 44.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.022 . . . . 0.0 108.89 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.536 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -66.01 -44.81 83.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.275 -0.89 . . . . 0.0 108.636 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -61.78 -64.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.065 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -41.35 -46.25 3.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.504 -0.747 . . . . 0.0 109.244 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 18' ' ' PHE . . . -57.91 -61.57 2.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.42 -0.8 . . . . 0.0 110.31 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -45.53 -50.26 13.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.795 -1.19 . . . . 0.0 108.59 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 12.9 tptt -51.22 -45.53 61.96 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.944 ' SD ' HG23 ' A' ' 38' ' ' VAL . 2.2 ttm -63.3 -70.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.59 -0.694 . . . . 0.0 110.353 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.921 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -46.25 -64.16 0.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 10.6 t -51.51 -29.48 9.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.448 -0.783 . . . . 0.0 109.561 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 3.8 mm-40 -67.89 -55.81 11.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.085 -1.01 . . . . 0.0 111.391 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -95.32 8.38 43.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.432 -1.418 . . . . 0.0 110.404 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 88.5 mt-30 -101.12 -13.33 18.22 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.381 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 -36.95 5.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 109.274 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.563 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.921 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.0 Cg_endo . . . . . 0 N--CA 1.495 1.608 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 2' ' ' ILE . 5.1 mm -71.73 -64.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.5 p -51.36 -42.11 61.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.42 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.1 mt-30 -57.66 -54.0 51.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 108.837 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.951 HG22 ' CG ' ' A' ' 62' ' ' LEU . 56.5 t -53.15 -68.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.553 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 54.6 m80 -34.97 -38.87 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.683 -0.636 . . . . 0.0 109.701 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.7 mt-10 -63.98 -56.53 14.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 110.06 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.068 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -72.41 -53.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.192 -0.943 . . . . 0.0 109.723 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 1.068 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -45.36 -48.34 11.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -73.84 -44.82 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.587 -1.537 . . . . 0.0 110.358 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.9 mtmt -64.61 -11.06 31.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.074 -1.016 . . . . 0.0 110.321 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -120.36 8.1 10.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.938 . . . . 0.0 109.856 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.0 t-20 78.86 -6.44 1.9 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.846 ' CE ' HD22 ' A' ' 65' ' ' LEU . 32.6 mtp -79.45 89.93 5.04 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -42.0 161.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.467 -0.771 . . . . 0.0 109.844 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.94 ' CG2' HG12 ' A' ' 5' ' ' VAL . 60.7 t -132.65 93.38 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.671 ' N ' HG22 ' A' ' 37' ' ' ILE . 28.7 m170 -110.31 97.7 7.11 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 118.306 -1.358 . . . . 0.0 110.439 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.753 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 39.0 m-85 -84.69 119.39 25.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 110.972 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.739 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.52 116.58 5.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.011 HG22 ' OG1' ' A' ' 34' ' ' THR . 86.4 t -78.66 126.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 109.327 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.927 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -126.78 9.49 6.99 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.624 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.553 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -145.05 156.43 43.92 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.192 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 32' ' ' PHE . 5.3 mt-10 -157.32 141.21 16.03 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 25' ' ' GLY . 37.9 tp10 -46.08 160.02 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -0.97 . . . . 0.0 109.763 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' HG3' ' A' ' 24' ' ' GLU . . . -64.31 -126.75 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.71 -81.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.017 1.812 . . . . 0.0 110.541 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.535 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -143.79 92.47 2.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 109.805 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.535 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 34.8 m-70 -157.69 91.34 1.14 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.281 -0.887 . . . . 0.0 108.915 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.471 ' O ' ' N ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER 50.92 78.72 0.1 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.073 -1.017 . . . . 0.0 108.4 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -55.4 86.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.557 -0.715 . . . . 0.0 110.45 -179.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 6.6 m120 -104.5 108.31 19.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.939 -1.101 . . . . 0.0 108.286 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 3.0 m-85 -88.02 129.72 35.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.3 mp -89.45 96.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.04 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 26.4 m -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.888 0.852 . . . . 0.0 108.91 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.927 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -90.09 120.2 31.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.938 -0.476 . . . . 0.0 109.912 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.804 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -117.94 117.74 30.07 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.699 HG12 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -77.26 132.56 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.952 -1.092 . . . . 0.0 110.536 -177.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.668 HG22 ' HE2' ' A' ' 14' ' ' MET . 0.8 OUTLIER -125.0 108.24 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 14' ' ' MET . . . 18.6 -105.82 0.01 OUTLIER Glycine 0 N--CA 1.504 3.216 0 CA-C-O 121.44 0.467 . . . . 0.0 112.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.1 m -24.18 -56.14 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.449 HG13 ' C ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -156.4 -161.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.09 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.59 163.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.47 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.653 HG23 ' OE2' ' A' ' 64' ' ' GLU . 53.8 m -150.5 90.51 1.65 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.555 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 6.7 pt-20 -86.64 -169.97 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.918 -1.114 . . . . 0.0 109.903 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -172.87 156.01 24.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 1.2 pt-20 -110.79 98.23 7.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.833 -1.392 . . . . 0.0 110.623 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.582 ' HA3' ' CB ' ' A' ' 56' ' ' ARG . . . -101.47 131.83 10.73 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.579 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -49.47 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.331 -1.099 . . . . 0.0 110.031 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 50' ' ' LYS . . . -30.46 155.66 0.0 OUTLIER Glycine 0 N--CA 1.497 2.748 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.652 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.6 OUTLIER 104.87 60.03 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 78.81 20.24 0.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.579 ' CG1' ' N ' ' A' ' 48' ' ' ASN . 0.8 OUTLIER -134.11 -17.52 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 54' ' ' LYS . 49.6 m -60.91 -93.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.89 -1.131 . . . . 0.0 110.217 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.0 OUTLIER -32.15 -61.41 0.25 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.522 -0.736 . . . . 0.0 111.424 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.509 ' HB3' ' CG ' ' A' ' 1' ' ' PRO . 1.1 mttt -49.35 -50.75 38.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.054 . . . . 0.0 109.808 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.582 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 7.6 tpt180 -55.53 -57.52 11.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 109.787 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.04 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -44.59 -47.14 10.31 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.047 0.927 . . . . 0.0 108.658 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -54.31 -64.72 0.74 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 74.2 mt-10 -49.02 -23.97 1.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.201 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -64.36 -53.95 40.54 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.236 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.614 ' HA ' HG21 ' A' ' 43' ' ' THR . 3.4 ptp -77.72 -51.36 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.419 -1.312 . . . . 0.0 110.196 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.951 ' CG ' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -46.74 -47.73 20.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.393 -1.442 . . . . 0.0 107.732 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 79.3 t -65.21 -38.66 83.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.653 ' OE2' HG23 ' A' ' 43' ' ' THR . 1.8 mm-40 -51.33 -68.79 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.846 HD22 ' CE ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -48.51 -44.32 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.602 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.683 ' NE2' HD12 ' A' ' 65' ' ' LEU . 5.1 mm-40 -45.51 -65.01 0.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.962 -1.086 . . . . 0.0 109.489 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -46.02 -52.46 11.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.629 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 68' ' ' LEU . 5.0 mt . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.566 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.537 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 N-CA-C 109.556 -0.978 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.012 HG22 ' CD2' ' A' ' 6' ' ' HIS . 7.9 mm -78.66 -47.88 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -46.81 -51.12 17.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -50.73 -57.65 7.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.931 -1.106 . . . . 0.0 110.271 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.044 HG22 ' CD2' ' A' ' 62' ' ' LEU . 24.9 t -54.08 -58.17 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.803 -1.186 . . . . 0.0 108.969 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 1.012 ' CD2' HG22 ' A' ' 2' ' ' ILE . 79.0 m-70 -42.56 -34.69 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.837 -1.164 . . . . 0.0 108.839 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 9.7 mt-10 -71.23 -71.73 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.485 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.052 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -54.48 -48.47 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 120.669 -1.269 . . . . 0.0 109.745 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 1.052 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -52.98 -59.2 9.71 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.9 -52.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.699 -1.471 . . . . 0.0 110.212 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -55.4 -19.47 9.24 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.046 -179.051 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -121.75 23.07 10.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.6 -1.313 . . . . 0.0 111.168 -179.063 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 7.9 t-20 77.53 -11.82 1.15 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.084 -1.01 . . . . 0.0 111.141 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.845 ' HB3' HG22 ' A' ' 38' ' ' VAL . 4.6 mtt -78.3 93.93 4.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.124 . . . . 0.0 109.603 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -42.63 166.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.893 -1.129 . . . . 0.0 110.194 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 6' ' ' HIS . 24.2 t -139.67 77.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.643 ' ND1' HG21 ' A' ' 37' ' ' ILE . 32.6 m170 -102.15 91.57 4.37 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.348 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD2' HG23 ' A' ' 2' ' ' ILE . 29.1 m-85 -80.1 110.14 15.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.548 0.689 . . . . 0.0 110.767 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -131.53 119.0 20.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 67.6 t -79.89 136.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.033 -1.042 . . . . 0.0 110.175 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 3.4 mt -96.04 -15.08 22.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.562 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 91.08 171.09 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.691 0.758 . . . . 0.0 110.665 179.1 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.793 ' OE1' ' HB3' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -44.47 175.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.72 0.772 . . . . 0.0 111.128 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.46 96.81 10.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.692 -0.63 . . . . 0.0 110.451 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.68 -122.27 27.44 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.75 ' HA ' ' NE2' ' A' ' 28' ' ' HIS . 9.7 Cg_endo -64.96 -140.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.66 1.573 . . . . 0.0 108.716 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.793 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . . . 57.81 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.473 -0.767 . . . . 0.0 111.388 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.75 ' NE2' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER 57.0 32.21 21.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.237 -0.914 . . . . 0.0 109.79 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.478 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.2 mmt -162.78 22.51 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.503 -0.748 . . . . 0.0 109.142 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 72.2 mttt -129.09 -111.88 0.27 Allowed 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.114 -0.991 . . . . 0.0 110.762 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' N ' ' OE2' ' A' ' 23' ' ' GLU . 1.1 m120 -91.38 118.5 30.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.75 -1.219 . . . . 0.0 111.041 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.611 ' CD1' ' HG2' ' A' ' 23' ' ' GLU . 3.0 m-85 -90.33 128.54 36.47 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 2.9 mm -88.51 95.94 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.097 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.073 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 53.5 m -90.03 114.6 26.51 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -82.44 129.53 34.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.095 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.653 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -123.26 116.39 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.5 -1.375 . . . . 0.0 107.612 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.909 HG12 HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -80.41 136.34 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.01 -1.056 . . . . 0.0 111.961 -177.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.845 HG22 ' HB3' ' A' ' 14' ' ' MET . 0.9 OUTLIER -135.35 136.35 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 50.66 -124.44 19.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.34 5.54 23.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.16 148.27 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 108.898 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.909 HG22 HG12 ' A' ' 37' ' ' ILE . 1.5 t -108.07 143.2 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.946 -1.097 . . . . 0.0 110.293 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.552 ' OG1' ' CE ' ' A' ' 61' ' ' MET . 50.9 p -132.1 113.96 13.96 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -87.69 -168.02 2.08 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 110.008 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA2' ' HG2' ' A' ' 60' ' ' LYS . . . -161.11 114.47 0.61 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -77.99 83.65 4.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.959 -1.318 . . . . 0.0 109.88 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.588 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . -86.68 122.28 6.06 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.54 ' O ' ' O ' ' A' ' 49' ' ' GLY . 11.3 m-20 -47.49 93.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -1.181 . . . . 0.0 109.508 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' ASN . . . -13.06 -114.58 0.0 OUTLIER Glycine 0 N--CA 1.506 3.361 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.772 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER 36.33 38.18 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.659 -0.906 . . . . 0.0 109.56 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 50' ' ' LYS . 2.1 ttmt 71.26 62.81 0.16 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' C ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -149.37 -44.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 110.252 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -24.35 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -69.16 -59.65 2.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.937 -1.102 . . . . 0.0 109.648 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 3.6 ttpm? -50.06 -42.89 50.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.847 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.588 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -69.99 -34.4 73.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.396 -0.815 . . . . 0.0 110.471 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.073 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -64.66 -51.13 64.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.891 -1.131 . . . . 0.0 108.645 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.53 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -60.97 -51.71 68.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 63' ' ' VAL . 4.8 mt-10 -51.18 -44.33 61.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.475 ' HG2' ' HA2' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -61.58 -36.23 80.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.671 ' HG3' HD23 ' A' ' 62' ' ' LEU . 34.8 tpp -70.25 -71.37 0.24 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.49 -0.756 . . . . 0.0 110.617 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.044 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -49.34 -52.69 26.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 108.33 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 59' ' ' GLU . 78.1 t -52.02 -39.7 26.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 108.653 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 61' ' ' MET . 1.8 mm-40 -59.36 -64.26 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.574 HD22 ' SD ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -53.58 -28.41 31.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.978 -1.076 . . . . 0.0 110.257 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 18.1 mm-40 -54.04 -62.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.842 -1.161 . . . . 0.0 109.615 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -54.92 -39.98 69.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.521 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 68' ' ' LEU . 5.2 mt . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.447 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.576 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 4.6 Cg_exo . . . . . 0 N--CA 1.493 1.497 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.948 HG22 ' CD2' ' A' ' 6' ' ' HIS . 8.1 mm -97.58 -50.91 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 109.111 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.49 -45.76 18.62 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 0.0 109.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -55.6 -60.18 3.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.975 . . . . 0.0 108.979 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.017 HG12 ' CG2' ' A' ' 16' ' ' VAL . 48.5 t -46.59 -68.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 108.355 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.948 ' CD2' HG22 ' A' ' 2' ' ' ILE . 92.9 m-70 -36.8 -38.93 0.19 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.457 -0.777 . . . . 0.0 110.242 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -67.0 -48.12 69.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.074 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -75.82 -52.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.176 -0.953 . . . . 0.0 109.449 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 1.074 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -48.5 -53.44 16.47 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.69 -41.46 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.669 -1.489 . . . . 0.0 109.06 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -63.27 -13.37 37.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.411 -0.806 . . . . 0.0 110.178 -179.008 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.31 10.5 8.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 12.5 t30 79.66 -9.21 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.603 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -75.98 91.22 3.04 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.119 -0.988 . . . . 0.0 109.642 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -42.86 160.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.017 ' CG2' HG12 ' A' ' 5' ' ' VAL . 41.4 t -128.2 96.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.709 ' ND1' HG21 ' A' ' 37' ' ' ILE . 31.0 m170 -114.12 94.57 4.88 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.126 -1.43 . . . . 0.0 110.957 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.821 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 52.5 m-85 -80.5 118.68 22.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.633 -0.667 . . . . 0.0 109.659 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.749 ' O ' HD23 ' A' ' 21' ' ' LEU . 27.7 tttt -149.39 116.02 5.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.105 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.918 HG22 ' OG1' ' A' ' 34' ' ' THR . 55.2 t -78.51 118.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.959 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -114.0 9.44 17.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.692 -0.63 . . . . 0.0 110.5 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -156.95 157.61 35.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.85 -1.156 . . . . 0.0 110.171 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.592 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -148.13 46.67 1.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.446 -0.784 . . . . 0.0 108.9 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -46.06 117.94 1.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.65 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' CD ' ' A' ' 30' ' ' LYS . . . 153.03 71.94 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.82 -74.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.129 1.886 . . . . 0.0 109.88 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.75 20.81 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.452 -0.78 . . . . 0.0 109.058 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.1 146.3 7.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.234 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 53.51 74.86 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.33 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 25' ' ' GLY . 1.1 mmmm -84.3 89.55 7.38 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.221 -0.924 . . . . 0.0 109.814 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 43.7 m-20 -107.31 -178.77 3.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.576 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 52.5 m-85 -150.42 125.65 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 109.195 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 46' ' ' GLU . 3.2 mm -89.29 92.12 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.064 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 99.7 m -88.89 115.08 26.18 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.94 0.876 . . . . 0.0 109.606 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.959 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -80.67 118.17 22.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.762 -0.586 . . . . 0.0 109.665 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.759 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -111.95 115.75 29.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.925 HG12 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -78.19 134.79 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.712 -1.243 . . . . 0.0 110.735 -177.289 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -136.55 120.67 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.585 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 8.75 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.506 3.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.916 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.487 ' C ' ' O ' ' A' ' 39' ' ' GLY . 18.4 m -29.3 -60.66 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.088 -0.654 . . . . 0.0 111.265 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -160.56 -167.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.552 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.925 HG22 HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -99.13 138.86 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.224 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.61 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.6 m -126.09 108.38 11.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -82.18 -168.86 2.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.997 -1.064 . . . . 0.0 109.891 -178.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 112.65 0.52 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.682 ' HB3' HD12 ' A' ' 33' ' ' ILE . 3.2 pt-20 -78.02 80.59 4.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.16 -1.2 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . -61.4 178.67 3.93 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -129.96 101.45 5.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -1.139 . . . . 0.0 109.834 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.731 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 119.89 162.94 12.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.78 164.79 22.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -1.125 . . . . 0.0 109.333 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER 56.22 18.44 3.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.221 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 49' ' ' GLY . 0.4 OUTLIER -123.47 -37.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.377 -0.827 . . . . 0.0 109.12 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.533 ' CB ' ' OG1' ' A' ' 34' ' ' THR . 0.1 OUTLIER -36.36 -47.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.985 -0.447 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -47.45 76.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 1' ' ' PRO . 3.5 mttp -58.65 -65.17 0.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.967 . . . . 0.0 109.269 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.529 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -45.77 -60.96 1.93 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.579 -0.701 . . . . 0.0 109.552 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.064 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -43.28 -46.01 6.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.988 . . . . 0.0 109.797 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 1' ' ' PRO . . . -62.9 -65.15 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 58' ' ' ALA . 4.9 mt-10 -44.14 -59.63 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.946 -1.097 . . . . 0.0 108.504 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -43.67 -47.04 7.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.753 ' O ' HD13 ' A' ' 65' ' ' LEU . 39.0 tpp -60.09 -72.31 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.595 -0.69 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.798 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.2 mt -45.38 -67.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 62' ' ' LEU . 6.4 t -41.98 -33.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -67.8 -63.83 0.98 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.247 -0.908 . . . . 0.0 111.004 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.915 ' H ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -86.29 10.61 14.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.985 -178.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.481 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.3 mm-40 -96.77 -15.65 21.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.461 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.23 -32.6 22.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 67' ' ' LYS . 16.0 mt . . . . . 0 C--N 1.304 -1.392 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.678 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.6 Cg_exo . . . . . 0 N--CA 1.496 1.666 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 2' ' ' ILE . 8.0 mm -69.62 -65.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -55.59 -30.73 61.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.64 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 26.3 mt-30 -63.84 -55.24 24.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.198 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.069 HG22 ' CD2' ' A' ' 62' ' ' LEU . 36.1 t -57.94 -55.76 19.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.707 ' HA ' HG21 ' A' ' 16' ' ' VAL . 42.0 m80 -44.53 -38.83 4.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.694 -1.254 . . . . 0.0 108.684 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -62.46 -67.83 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.691 -0.631 . . . . 0.0 110.868 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.935 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.11 -50.48 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 0.0 110.274 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.935 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -44.37 -57.05 5.2 Favored Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.8 -29.65 41.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -1.18 . . . . 0.0 109.451 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -80.25 -3.29 48.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.414 -0.804 . . . . 0.0 110.58 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -134.84 16.19 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 109.842 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.4 t-20 78.53 -6.88 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.577 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 5.8 mmm -81.82 90.69 6.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.049 . . . . 0.0 108.79 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.769 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -41.79 157.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.115 -0.991 . . . . 0.0 110.391 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' A' ' 6' ' ' HIS . 24.3 t -131.72 80.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 108.657 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.636 ' NE2' HG22 ' A' ' 15' ' ' THR . 84.5 m-70 -117.7 96.86 5.56 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.695 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.8 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 3.2 m-30 -79.7 137.7 37.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 110.372 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.507 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 6.9 ptpt -150.71 118.48 6.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.756 HG22 ' OG1' ' A' ' 34' ' ' THR . 66.3 t -78.97 129.25 37.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 108.984 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -88.61 -25.55 22.38 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.554 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER 161.96 -163.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.234 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.592 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -121.58 82.65 1.97 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.525 -0.735 . . . . 0.0 109.161 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 73.68 -161.59 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 109.522 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.51 -99.28 2.12 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.59 -77.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.074 1.849 . . . . 0.0 110.008 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -118.04 -146.3 0.39 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.48 -0.763 . . . . 0.0 109.063 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.513 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 44.52 36.83 1.83 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.089 -1.007 . . . . 0.0 109.109 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.493 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -67.42 -8.05 30.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.12 -34.6 22.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.838 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 33.3 m-20 -89.47 161.53 16.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.065 -1.022 . . . . 0.0 109.693 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 35.8 m-85 -131.86 125.83 32.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.342 -0.848 . . . . 0.0 109.429 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.702 HD12 ' HB3' ' A' ' 46' ' ' GLU . 2.0 mm -88.94 94.1 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.397 -0.814 . . . . 0.0 108.896 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.999 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 23.6 m -89.54 111.73 22.72 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 109.575 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -78.06 116.54 18.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.46 -0.775 . . . . 0.0 109.724 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.661 ' O ' ' HE1' ' A' ' 61' ' ' MET . 0.0 OUTLIER -109.63 118.42 36.51 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.996 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -87.41 134.17 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.776 -1.202 . . . . 0.0 112.808 -176.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.996 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.5 m -144.11 142.97 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.017 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 54.52 19.11 11.91 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.64 ' CA ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER 87.43 -23.25 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.926 -0.749 . . . . 0.0 109.576 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 41' ' ' ILE . 1.3 mp -89.43 130.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -90.67 133.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 120.877 -1.139 . . . . 0.0 110.897 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.602 HG21 ' HG2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -128.71 105.7 8.44 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.539 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.613 ' CG ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -81.42 -172.92 4.07 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.112 -0.993 . . . . 0.0 111.455 -177.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' ' 60' ' ' LYS . . . -155.83 112.33 0.52 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.702 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -78.0 78.24 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.064 -1.256 . . . . 0.0 111.02 -178.418 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 56' ' ' ARG . . . -53.85 177.61 0.23 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.455 ' H ' HG11 ' A' ' 52' ' ' VAL . 97.0 m-20 -128.82 86.72 2.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.959 -1.318 . . . . 0.0 110.703 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . 146.12 158.8 7.9 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 49' ' ' GLY . 2.4 mttm -42.97 -63.57 0.78 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.306 -1.114 . . . . 0.0 108.093 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.678 ' O ' HG12 ' A' ' 52' ' ' VAL . 29.2 mttt -83.86 -162.09 0.6 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER 81.82 -37.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.271 -0.893 . . . . 0.0 110.037 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 52' ' ' VAL . 22.7 p -42.11 -46.27 4.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.285 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -44.66 96.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.499 ' HD2' ' HG3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -62.2 -73.63 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.827 . . . . 0.0 109.181 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.534 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -39.0 -38.24 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -0.759 . . . . 0.0 110.072 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.999 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -62.6 -51.33 67.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.95 -1.094 . . . . 0.0 108.539 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.8 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -65.2 -57.94 7.25 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.293 -0.879 . . . . 0.0 110.842 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.537 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 17.5 mt-10 -46.79 -43.85 18.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.568 -1.333 . . . . 0.0 107.762 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.5 tttp -60.0 -43.54 95.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.715 ' HE1' HG22 ' A' ' 38' ' ' VAL . 2.3 mmt -57.0 -72.09 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.019 0.914 . . . . 0.0 111.368 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.069 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -54.18 -56.98 13.04 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 49.1 t -47.91 -32.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.146 -0.971 . . . . 0.0 108.693 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.602 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -67.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.813 . . . . 0.0 110.027 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.876 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -53.36 -24.4 12.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.114 -0.992 . . . . 0.0 110.073 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.876 ' NE2' HD12 ' A' ' 65' ' ' LEU . 32.1 mm-40 -80.31 -33.09 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.881 -1.137 . . . . 0.0 109.011 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -68.29 -41.24 81.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.89 . . . . 0.0 109.379 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--N 1.305 -1.363 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.554 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.798 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.4 Cg_endo . . . . . 0 N--CA 1.497 1.695 0 N-CA-C 109.792 -0.888 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.514 HG22 ' CE1' ' A' ' 6' ' ' HIS . 4.8 mm -68.5 -59.21 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -53.15 -33.48 52.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.9 mt-30 -64.32 -49.88 69.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.702 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.996 ' HA ' HD21 ' A' ' 62' ' ' LEU . 19.6 t -57.73 -64.9 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.414 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.543 ' HA ' HG21 ' A' ' 16' ' ' VAL . 63.5 m80 -40.17 -39.0 0.84 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.624 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.0 mm-40 -62.2 -63.93 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.689 . . . . 0.0 110.676 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.938 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -67.75 -49.91 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.032 -1.043 . . . . 0.0 110.514 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.938 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.13 -54.3 9.94 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.83 -35.14 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.048 -1.266 . . . . 0.0 109.625 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.8 mmtm -76.16 -5.19 45.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -130.79 12.63 5.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.607 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 79.44 -8.7 1.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.785 ' SD ' HD22 ' A' ' 65' ' ' LEU . 4.3 mtt -76.21 96.18 3.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.995 -1.066 . . . . 0.0 109.376 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -49.75 153.75 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.017 -1.052 . . . . 0.0 109.438 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 5' ' ' VAL . 98.1 t -127.41 95.63 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.594 ' N ' HG22 ' A' ' 37' ' ' ILE . 31.2 m170 -116.47 92.69 3.95 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.425 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.888 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 43.6 m-85 -79.63 123.81 27.97 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.54 0.686 . . . . 0.0 110.43 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -150.19 117.18 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.85 HG22 ' OG1' ' A' ' 34' ' ' THR . 88.1 t -78.13 130.93 35.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 108.903 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.722 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -88.68 -26.38 21.87 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 160.46 -165.08 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.889 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.601 ' HG3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -104.91 -158.34 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 13.8 tt0 178.3 133.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.646 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 139.55 141.38 4.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HG2' ' NE2' ' A' ' 28' ' ' HIS . 1.7 Cg_endo -63.04 -80.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.122 1.881 . . . . 0.0 110.3 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.11 14.02 1.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.523 ' NE2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -150.18 39.15 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.95 . . . . 0.0 109.406 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 30.7 mtt -152.85 79.02 1.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.187 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -76.23 92.72 3.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.478 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 6.0 m-20 -135.94 167.83 20.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.549 -0.72 . . . . 0.0 109.161 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.601 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 23.0 m-85 -144.54 137.72 27.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 109.653 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.0 mm -91.62 96.95 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.054 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m -89.53 118.79 29.42 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 110.374 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.722 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.0 122.61 26.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.776 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.831 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -120.35 115.92 24.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.383 -1.448 . . . . 0.0 107.292 178.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -77.54 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.102 -0.998 . . . . 0.0 111.214 -177.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.96 HG13 ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -121.56 141.31 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -52.77 83.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER 160.37 -45.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.453 -1.027 . . . . 0.0 108.55 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.805 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -168.44 -175.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.31 129.22 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.93 -1.106 . . . . 0.0 109.03 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.5 ' HB ' ' HE2' ' A' ' 61' ' ' MET . 31.8 m -119.52 90.34 3.31 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 5.6 pm0 -80.76 -171.17 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.925 -1.109 . . . . 0.0 109.604 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -162.77 165.63 36.41 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -122.35 93.04 3.85 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.965 -1.315 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.511 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . -88.56 -163.98 39.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.542 ' CA ' HG11 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -90.5 -161.44 0.8 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.266 -1.138 . . . . 0.0 108.638 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.578 ' HA2' ' CD1' ' A' ' 32' ' ' PHE . . . -89.18 -176.93 46.2 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 1.1 tttt 74.16 -156.5 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -1.161 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 54' ' ' LYS . 1.4 pttt -86.39 54.1 3.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.159 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.542 HG11 ' CA ' ' A' ' 48' ' ' ASN . 2.6 p -115.4 -43.56 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.523 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -36.53 -41.45 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.835 -0.54 . . . . 0.0 110.464 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.1 OUTLIER -63.91 -61.97 1.94 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.981 -1.075 . . . . 0.0 109.416 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 7.7 mtpt -48.75 -62.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -44.52 -68.48 0.19 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.311 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.054 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -34.0 -47.63 0.28 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.352 0.596 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -58.33 -53.74 54.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 0.0 109.221 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -49.69 -40.91 41.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.023 -1.048 . . . . 0.0 108.388 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.5 -40.41 94.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.96 ' SD ' HG13 ' A' ' 38' ' ' VAL . 5.6 ttm -69.73 -70.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 110.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.996 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -48.49 -56.19 8.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 108.757 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 59' ' ' GLU . 99.0 t -50.66 -41.89 21.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.549 -0.72 . . . . 0.0 110.142 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.785 HD22 ' SD ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -48.83 -31.39 7.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.027 -1.046 . . . . 0.0 110.088 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.764 ' NE2' HD12 ' A' ' 65' ' ' LEU . 22.1 mm-40 -66.27 -41.65 89.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 0.0 109.738 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -66.46 -35.14 79.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.474 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.545 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.512 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 2.5 Cg_endo . . . . . 0 N--CA 1.496 1.626 0 N-CA-C 109.785 -0.891 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.822 HG22 ' ND1' ' A' ' 6' ' ' HIS . 5.6 mm -71.74 -46.51 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.79 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 p -59.61 -32.86 70.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 110.079 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 39.7 mt-30 -64.89 -55.59 18.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.012 . . . . 0.0 109.183 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.102 ' HA ' HD21 ' A' ' 62' ' ' LEU . 7.0 t -57.34 -63.61 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.822 ' ND1' HG22 ' A' ' 2' ' ' ILE . 33.1 m80 -39.41 -37.59 0.47 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.083 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 1.5 mt-10 -62.0 -67.59 0.4 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.521 -0.737 . . . . 0.0 110.427 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.947 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.62 -49.78 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.058 -1.026 . . . . 0.0 110.556 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.947 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.17 -55.28 7.73 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.34 -46.38 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.264 . . . . 0.0 109.919 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -62.83 -11.7 19.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.79 10.12 7.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.007 . . . . 0.0 109.781 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 39.3 t30 79.38 -10.58 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.946 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.538 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -72.51 86.09 1.16 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.956 -1.09 . . . . 0.0 108.8 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -39.72 163.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.613 0.72 . . . . 0.0 110.731 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.03 HG22 HG12 ' A' ' 5' ' ' VAL . 61.1 t -137.38 88.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.684 ' H ' HG22 ' A' ' 37' ' ' ILE . 30.7 m170 -105.87 93.51 4.68 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.13 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.86 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -86.76 131.14 34.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.613 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.89 114.09 4.82 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.895 HG22 ' OG1' ' A' ' 34' ' ' THR . 56.0 t -78.19 111.69 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.87 -1.144 . . . . 0.0 108.909 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -91.32 -25.36 19.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.812 -0.555 . . . . 0.0 109.791 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.544 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -129.98 158.73 38.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.631 -179.359 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.585 ' HA ' ' CD2' ' A' ' 32' ' ' PHE . 55.2 mt-10 -153.53 68.69 0.79 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.348 -0.845 . . . . 0.0 109.389 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.602 ' HG3' ' CE1' ' A' ' 28' ' ' HIS . 0.1 OUTLIER 57.73 156.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.413 -0.805 . . . . 0.0 109.669 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . -61.76 -136.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' NE2' ' A' ' 28' ' ' HIS . 2.9 Cg_exo -55.66 -74.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.088 1.858 . . . . 0.0 110.913 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.691 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -153.37 124.72 7.55 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 109.629 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.691 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 168.08 -165.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.074 -1.016 . . . . 0.0 108.913 -178.225 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 mtm -107.7 50.02 0.79 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.098 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 2.3 mmmt -78.13 -144.35 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.306 -0.871 . . . . 0.0 110.215 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -109.2 178.37 4.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.96 -1.088 . . . . 0.0 111.243 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CD2' ' HA ' ' A' ' 23' ' ' GLU . 9.6 m-85 -140.26 117.26 11.12 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 22' ' ' ARG . 3.3 mm -90.74 122.24 41.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 120.943 -1.098 . . . . 0.0 108.764 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.024 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 10.0 m -123.59 109.71 14.11 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -76.31 118.77 19.36 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.602 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.999 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -123.05 114.41 20.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.059 -1.026 . . . . 0.0 108.335 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.935 HG12 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -78.95 135.07 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -0.839 . . . . 0.0 111.548 -177.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.696 HG23 ' HE2' ' A' ' 61' ' ' MET . 0.9 OUTLIER -133.12 148.65 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 45.14 -124.11 6.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t -111.96 8.11 20.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.574 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.595 ' H ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -125.69 149.65 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 108.794 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.935 HG22 HG12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -103.87 141.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.453 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -132.96 114.16 13.68 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.7 mt-10 -82.72 -167.51 1.66 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.859 -1.15 . . . . 0.0 109.773 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -152.14 110.79 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.641 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -84.25 64.66 8.41 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.33 -1.1 . . . . 0.0 110.041 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.57 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -47.86 -179.54 0.01 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.536 ' N ' HG11 ' A' ' 52' ' ' VAL . 11.6 p-10 -121.51 92.56 3.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.079 -1.248 . . . . 0.0 110.101 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 48' ' ' ASN . . . 24.22 -143.87 0.01 OUTLIER Glycine 0 N--CA 1.501 2.992 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 35.16 75.69 0.05 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.893 -0.769 . . . . 0.0 110.713 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER 41.61 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.822 HG13 ' N ' ' A' ' 53' ' ' SER . 1.7 p -162.32 -150.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.073 -1.017 . . . . 0.0 109.306 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.822 ' N ' HG13 ' A' ' 52' ' ' VAL . 3.0 p 84.3 -58.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.79 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 2' ' ' ILE . 7.9 ptmt -77.84 -47.26 19.25 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.228 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 18.4 tttm -66.21 -39.57 89.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.385 -0.822 . . . . 0.0 108.997 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.57 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -68.14 -46.14 71.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.371 -0.831 . . . . 0.0 109.425 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.024 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -56.56 -57.84 10.62 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.113 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.721 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . . . -53.34 -48.67 68.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.164 -0.96 . . . . 0.0 110.294 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.548 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 3.3 mt-10 -54.83 -35.77 64.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 11.8 tptp -64.52 -36.3 83.77 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.696 ' HE2' HG23 ' A' ' 38' ' ' VAL . 54.1 mmm -73.32 -71.12 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.649 -0.657 . . . . 0.0 110.704 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.102 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -49.57 -41.03 40.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 0.0 109.004 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 70.5 t -65.6 -39.72 85.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.64 -59.83 3.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.681 -0.637 . . . . 0.0 109.455 179.105 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -59.95 -40.87 90.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.272 -0.892 . . . . 0.0 110.292 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 8.8 mm-40 -46.41 -25.77 0.72 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.778 -1.201 . . . . 0.0 109.1 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.7 -66.04 0.64 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 109.283 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 68' ' ' LEU . 5.3 mt . . . . . 0 C--N 1.3 -1.562 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 5' ' ' VAL . 5.4 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.727 -0.913 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.583 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.9 mm -72.74 -64.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.392 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 p -53.16 -28.06 24.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.268 -0.895 . . . . 0.0 109.233 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.4 mt-30 -67.08 -51.83 49.5 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 108.589 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.014 ' HA ' HD21 ' A' ' 62' ' ' LEU . 19.1 t -58.37 -60.38 2.36 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.651 ' HA ' HG21 ' A' ' 16' ' ' VAL . 63.5 m80 -43.56 -39.98 3.74 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.953 -1.092 . . . . 0.0 109.093 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.1 mm-40 -60.53 -64.12 1.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 110.971 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.958 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.16 -49.95 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.891 -1.131 . . . . 0.0 110.727 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.958 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -48.0 -51.04 20.12 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -70.48 -46.35 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.662 -1.493 . . . . 0.0 109.889 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.92 -9.61 22.57 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.97 15.39 8.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 109.687 -179.35 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 72.64 -7.38 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.434 -0.791 . . . . 0.0 110.125 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 5.4 mtt -79.65 92.64 5.39 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.604 -1.31 . . . . 0.0 108.881 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -42.41 168.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.78 HG22 HG12 ' A' ' 5' ' ' VAL . 84.6 t -137.73 83.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 108.4 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.648 ' ND1' HG21 ' A' ' 37' ' ' ILE . 30.8 m170 -106.42 92.53 4.16 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.563 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.914 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 37.4 m-85 -78.36 122.04 25.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.651 -0.656 . . . . 0.0 110.394 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.34 122.02 8.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.977 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.2 t -77.42 130.01 36.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 108.526 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.805 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.67 -22.46 23.4 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 160.15 -165.35 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.414 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.584 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -112.07 -172.0 1.96 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' HG3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -142.92 134.24 26.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.975 . . . . 0.0 109.438 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.1 149.72 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.31 -62.27 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.092 1.862 . . . . 0.0 110.215 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -156.12 -146.44 0.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.443 -0.786 . . . . 0.0 109.215 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.539 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER 64.05 12.2 6.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.967 . . . . 0.0 109.165 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 164.07 72.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.141 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' C ' ' OD1' ' A' ' 31' ' ' ASN . 13.0 mtmt -57.28 109.4 0.67 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.176 -0.953 . . . . 0.0 109.79 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 3.9 m120 -143.35 133.18 23.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.469 -0.769 . . . . 0.0 109.363 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' A' ' 23' ' ' GLU . 6.2 m-85 -116.51 143.01 46.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.379 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' A' ' 24' ' ' GLU . 5.1 mm -90.62 111.8 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.12 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 7.4 m -103.86 118.63 37.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.144 -0.972 . . . . 0.0 110.737 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.805 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -84.68 122.96 29.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 0.0 111.141 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.653 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 4.1 t -114.63 121.07 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.648 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.86 130.57 36.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.662 -1.274 . . . . 0.0 109.929 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.704 HG21 ' SD ' ' A' ' 61' ' ' MET . 1.0 OUTLIER -135.5 119.35 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.387 0.613 . . . . 0.0 109.479 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 15.5 -101.44 0.01 OUTLIER Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.478 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -27.62 -60.79 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.223 -0.575 . . . . 0.0 111.247 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -164.79 -167.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.048 -1.032 . . . . 0.0 108.603 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.604 HG22 HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -89.67 134.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.996 -1.065 . . . . 0.0 110.168 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.8 m -123.25 107.96 12.26 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -90.05 -173.65 3.94 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.21 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -154.92 175.97 32.78 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -128.88 93.69 3.66 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.287 . . . . 0.0 109.683 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . -92.23 -170.89 41.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.601 ' CB ' HG11 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -80.33 -160.0 0.26 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.175 -1.191 . . . . 0.0 108.73 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' LYS . . . -121.24 80.62 0.34 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 0.3 OUTLIER 169.52 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.504 -0.998 . . . . 0.0 108.915 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 5.5 tttt 45.36 46.7 10.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 108.504 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.601 HG11 ' CB ' ' A' ' 48' ' ' ASN . 2.9 p -137.45 -41.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.399 -0.813 . . . . 0.0 109.751 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.483 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -39.59 -45.92 1.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.624 -0.672 . . . . 0.0 110.545 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' HG21 ' A' ' 34' ' ' THR . 1.9 tttt -62.31 -56.73 15.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.197 -0.939 . . . . 0.0 110.088 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -55.58 -65.64 0.56 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.651 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.514 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -43.8 -42.15 5.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.855 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.12 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -59.06 -46.07 89.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.075 -1.015 . . . . 0.0 108.779 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -61.18 -58.05 9.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 110.243 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.521 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -48.67 -40.61 28.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.909 -1.119 . . . . 0.0 107.996 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.62 -43.48 93.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.704 ' SD ' HG21 ' A' ' 38' ' ' VAL . 54.9 tpp -67.51 -70.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.612 -0.68 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.014 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -45.93 -60.17 2.41 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 84.9 t -48.77 -39.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 108.622 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -57.96 -69.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.929 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.854 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -45.72 -34.38 3.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.887 -1.133 . . . . 0.0 109.741 -179.061 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.854 ' NE2' HD12 ' A' ' 65' ' ' LEU . 28.9 mm-40 -63.82 -45.11 91.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.82 -1.175 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.06 -48.12 83.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--N 1.301 -1.525 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.542 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.523 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.7 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.642 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.5 mm -68.3 -66.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.2 -30.57 7.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 83.1 mm-40 -63.94 -61.62 2.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.025 ' HA ' HD21 ' A' ' 62' ' ' LEU . 26.2 t -51.52 -57.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.935 . . . . 0.0 108.61 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.637 ' HA ' HG21 ' A' ' 16' ' ' VAL . 51.2 m80 -44.41 -41.1 5.94 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.793 -1.192 . . . . 0.0 109.351 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.6 mm-40 -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.772 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.055 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -64.65 -54.08 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.184 -0.948 . . . . 0.0 110.355 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 1.055 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -48.97 -52.72 20.86 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.06 -45.53 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.352 . . . . 0.0 109.92 -178.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -65.12 -13.42 58.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -118.21 9.34 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 0.0 109.893 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 18.0 t-20 80.4 -12.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.62 ' CG ' HG13 ' A' ' 38' ' ' VAL . 5.6 mtt -76.52 98.89 4.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.998 -1.064 . . . . 0.0 108.662 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -46.6 172.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.695 -1.253 . . . . 0.0 109.85 -179.378 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.637 HG21 ' HA ' ' A' ' 6' ' ' HIS . 59.6 t -143.57 83.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.526 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.809 ' HB2' HG22 ' A' ' 37' ' ' ILE . 90.0 m-70 -116.81 97.35 5.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.399 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.853 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 58.7 m-85 -78.09 130.65 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.573 -0.704 . . . . 0.0 110.917 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.783 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -151.05 115.08 5.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.91 HG22 ' OG1' ' A' ' 34' ' ' THR . 78.9 t -78.37 118.95 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.965 -1.084 . . . . 0.0 108.461 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.985 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -114.03 -11.97 12.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.669 -0.645 . . . . 0.0 111.154 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -126.19 136.18 52.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.813 -1.179 . . . . 0.0 110.631 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 10.9 mt-10 -158.39 124.52 4.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 25' ' ' GLY . 5.5 mm-40 -39.23 137.26 0.76 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.44 -0.787 . . . . 0.0 109.926 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . -42.23 -90.74 0.01 OUTLIER Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.707 ' HA ' ' NE2' ' A' ' 28' ' ' HIS . 10.8 Cg_endo -68.94 -138.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 N-CA-C 107.216 -1.878 . . . . 0.0 107.216 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.611 ' O ' ' ND1' ' A' ' 28' ' ' HIS . . . 57.54 -77.24 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.18 -0.95 . . . . 0.0 111.477 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.707 ' NE2' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER 57.33 21.04 6.36 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.19 -0.944 . . . . 0.0 108.788 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.7 18.81 0.53 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.75 -86.09 0.42 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.287 -0.883 . . . . 0.0 109.821 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 17.0 m-80 -132.58 171.81 13.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.97 . . . . 0.0 110.031 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 45.6 m-85 -150.44 127.11 10.91 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 3.1 mm -89.6 96.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.135 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 19.9 m -88.73 114.06 24.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.44 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.985 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -87.76 115.28 25.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.551 -0.718 . . . . 0.0 111.098 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.652 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 12.4 t -105.59 114.5 28.71 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.001 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -77.59 130.47 36.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.739 -1.225 . . . . 0.0 109.906 -178.337 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.001 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.1 t -132.71 135.84 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.444 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 59.23 -116.16 8.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.402 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -120.56 12.43 11.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -1.091 . . . . 0.0 109.377 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' C ' ' A' ' 40' ' ' SER . 2.0 mp -135.0 151.21 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 108.984 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -95.9 135.46 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.015 -1.053 . . . . 0.0 110.424 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.608 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.2 m -121.93 101.8 7.78 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 5.2 mt-10 -88.16 -173.9 4.43 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 110.664 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -161.32 116.07 0.69 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.96 89.38 4.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.196 -1.179 . . . . 0.0 110.644 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.49 176.07 39.21 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 1.9 m120 -125.0 102.62 7.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -1.198 . . . . 0.0 110.277 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.762 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 106.85 149.03 15.74 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.03 171.34 1.77 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.124 -1.221 . . . . 0.0 109.146 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.2 16.28 4.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.163 -0.96 . . . . 0.0 109.244 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 49' ' ' GLY . 0.3 OUTLIER -131.46 -37.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 20' ' ' VAL . 1.7 p -39.31 -46.75 1.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 110.098 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -62.27 -75.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 1' ' ' PRO . 3.4 tttt -41.7 -66.53 0.33 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' NH1' ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -38.75 -56.6 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.744 . . . . 0.0 110.286 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.135 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -50.72 -50.42 55.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.171 -0.956 . . . . 0.0 110.036 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.664 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -58.08 -57.09 14.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.428 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 63' ' ' VAL . 39.0 mt-10 -48.21 -38.6 18.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.745 -1.222 . . . . 0.0 107.999 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.9 -43.46 98.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.688 ' SD ' HG21 ' A' ' 38' ' ' VAL . 41.0 tpp -67.83 -69.42 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.688 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.025 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -47.24 -60.14 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.307 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 59' ' ' GLU . 94.1 t -46.93 -41.01 5.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.085 -1.009 . . . . 0.0 108.395 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -54.51 -66.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.526 -0.734 . . . . 0.0 110.022 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -56.53 -21.42 26.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 110.164 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 20.2 mm-40 -67.06 -46.56 73.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.915 -1.116 . . . . 0.0 109.329 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' C ' HD23 ' A' ' 68' ' ' LEU . 26.7 mtmt -61.52 -53.51 55.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.312 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 68' ' ' LEU . 4.2 mt . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.599 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.921 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.3 Cg_endo . . . . . 0 N--CA 1.497 1.701 0 N-CA-C 109.739 -0.908 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 2' ' ' ILE . 4.8 mm -71.15 -59.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.392 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p -56.24 -33.3 65.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.28 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -64.09 -52.14 60.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 108.56 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.047 HG12 ' CG2' ' A' ' 16' ' ' VAL . 16.4 t -55.41 -66.23 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 54.1 m80 -39.68 -38.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.471 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -60.72 -62.67 1.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 110.46 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.948 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -69.6 -50.11 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.067 -1.021 . . . . 0.0 110.809 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.948 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.64 -52.23 15.55 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.9 -45.47 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.356 . . . . 0.0 109.62 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.44 -10.3 24.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 -179.111 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.45 10.03 7.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.637 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.7 OUTLIER 79.7 -11.46 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.147 179.78 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.556 ' HA ' ' CA ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -74.72 95.16 2.82 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -47.34 158.83 0.15 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.372 -0.83 . . . . 0.0 109.486 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.047 ' CG2' HG12 ' A' ' 5' ' ' VAL . 42.3 t -133.03 94.63 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.681 ' ND1' HG21 ' A' ' 37' ' ' ILE . 29.6 m170 -111.92 96.2 5.92 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.454 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.924 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 45.7 m-85 -83.51 120.03 25.42 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.8 ' O ' HD23 ' A' ' 21' ' ' LEU . 10.7 mttm -151.15 113.81 4.67 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.338 -0.851 . . . . 0.0 108.86 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.927 HG22 ' OG1' ' A' ' 34' ' ' THR . 72.3 t -78.57 118.87 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 108.672 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.973 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -117.24 -8.57 11.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 110.955 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.612 HH22 HD12 ' A' ' 21' ' ' LEU . 1.2 ttm-85 -124.84 158.72 32.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 0.0 110.538 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 3.0 mt-10 -154.75 156.59 36.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.598 -0.689 . . . . 0.0 109.23 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -59.4 -146.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.464 -0.773 . . . . 0.0 109.58 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . -55.24 -136.45 0.0 OUTLIER Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.566 ' CD ' ' NE2' ' A' ' 28' ' ' HIS . 9.9 Cg_exo -46.19 -76.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.895 1.73 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.582 ' O ' ' ND1' ' A' ' 28' ' ' HIS . . . -147.57 -71.32 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.0 -1.063 . . . . 0.0 109.761 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.582 ' ND1' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 37.92 -162.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.571 0.701 . . . . 0.0 110.346 178.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.5 mtt -126.78 33.89 4.88 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 76.5 mttt -64.37 -111.78 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.576 -0.702 . . . . 0.0 110.342 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 18.5 m-20 -118.57 171.25 8.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.646 -1.284 . . . . 0.0 110.462 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 43.4 m-85 -150.86 132.56 14.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.4 mp -89.99 99.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.015 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 26.8 m -87.01 117.65 25.88 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.607 0.718 . . . . 0.0 109.229 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.973 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -81.01 117.07 21.3 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.499 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.983 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -117.41 114.36 23.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.71 HG12 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -76.93 132.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.067 -1.021 . . . . 0.0 110.77 -177.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -124.31 133.41 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -9.18 -84.1 0.01 OUTLIER Glycine 0 N--CA 1.507 3.383 0 CA-C-O 121.332 0.406 . . . . 0.0 112.781 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.476 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -35.11 -59.82 0.49 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.681 -0.894 . . . . 0.0 111.773 -178.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.646 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -161.31 -159.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.871 -1.143 . . . . 0.0 108.428 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.71 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -88.39 157.95 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.752 -1.218 . . . . 0.0 109.356 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.575 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 5.6 m -150.97 93.96 2.0 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.611 ' HG2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -79.56 -169.83 2.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 110.213 -179.105 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.561 ' HA2' ' CD ' ' A' ' 60' ' ' LYS . . . -170.78 118.86 0.77 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 4.3 pm0 -77.79 91.0 4.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -1.206 . . . . 0.0 110.585 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . -82.23 154.9 33.83 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.615 ' O ' HG11 ' A' ' 52' ' ' VAL . 15.8 t-20 -93.77 101.74 13.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.893 -1.357 . . . . 0.0 109.886 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.6 170.21 11.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -81.74 -52.12 7.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.4 -1.059 . . . . 0.0 109.606 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.8 -36.74 28.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.689 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.615 HG11 ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -51.73 -37.86 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.941 . . . . 0.0 109.418 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.665 ' OG ' HG21 ' A' ' 20' ' ' VAL . 9.2 p -33.51 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.24 0.543 . . . . 0.0 110.542 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -62.46 -50.1 72.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.326 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HG2' ' HG2' ' A' ' 1' ' ' PRO . 50.7 mtpt -57.41 -69.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -39.3 -61.83 0.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.999 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.015 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -43.06 -53.4 4.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -54.71 -53.56 53.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.317 -0.865 . . . . 0.0 110.923 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -49.43 -43.52 44.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.561 ' CD ' ' HA2' ' A' ' 45' ' ' GLY . 0.5 OUTLIER -55.02 -43.82 74.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.575 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 67.2 mmm -64.5 -67.67 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.872 0.844 . . . . 0.0 111.363 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.002 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -50.88 -57.19 9.1 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.028 -1.045 . . . . 0.0 108.959 -177.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 2.5 t -59.06 -25.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.202 -0.937 . . . . 0.0 109.007 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.609 ' HB3' HD13 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -64.5 -54.18 36.35 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.222 -0.924 . . . . 0.0 111.001 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.883 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -110.57 12.29 22.8 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.731 -1.231 . . . . 0.0 111.595 -178.695 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 76.3 mm-40 -94.94 -16.97 22.4 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.959 -1.088 . . . . 0.0 109.412 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -98.85 -49.07 4.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.598 HD23 ' N ' ' A' ' 68' ' ' LEU . 2.2 mt . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.8 Cg_exo . . . . . 0 N--CA 1.496 1.653 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.544 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.5 mm -79.59 -69.61 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.14 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -52.67 -23.86 7.43 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.7 mt-30 -66.85 -54.09 25.88 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.069 HG22 ' CD2' ' A' ' 62' ' ' LEU . 61.5 t -60.0 -55.93 20.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.664 ' HA ' HG21 ' A' ' 16' ' ' VAL . 89.7 m-70 -46.2 -37.16 6.75 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.875 -1.14 . . . . 0.0 108.599 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.5 mt-10 -62.18 -65.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 110.832 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.948 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.89 -49.7 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.58 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.948 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.22 -52.16 13.52 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.71 -45.73 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.809 -1.407 . . . . 0.0 109.852 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -66.2 -8.16 22.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 110.333 -179.122 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.52 10.01 8.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.625 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.9 t-20 79.86 -11.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.829 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.596 ' HE1' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -76.66 96.68 4.24 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.86 -1.15 . . . . 0.0 109.573 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -46.65 154.95 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.69 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 6' ' ' HIS . 46.8 t -129.92 90.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.606 ' ND1' HG21 ' A' ' 37' ' ' ILE . 34.0 m170 -114.34 91.85 3.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.56 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.807 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 57.3 m-85 -79.82 123.01 27.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.691 -0.631 . . . . 0.0 110.137 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.758 ' O ' HD23 ' A' ' 21' ' ' LEU . 13.8 mttt -150.92 112.25 4.39 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.924 HG22 ' OG1' ' A' ' 34' ' ' THR . 69.2 t -78.48 121.32 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.063 -1.023 . . . . 0.0 109.124 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.987 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -115.59 8.92 15.21 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.808 -178.313 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 3.6 mpp_? -151.86 81.07 1.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.88 -1.138 . . . . 0.0 110.058 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.582 ' HA ' ' CD2' ' A' ' 32' ' ' PHE . 4.9 mp0 -75.2 93.42 2.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.123 -0.985 . . . . 0.0 109.735 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 3.4 tt0 77.47 -156.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.012 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.29 -150.25 10.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.545 ' HD2' ' NE2' ' A' ' 28' ' ' HIS . 2.8 Cg_exo -53.91 -69.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.13 1.887 . . . . 0.0 110.838 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.671 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -165.69 122.29 1.4 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.266 -0.896 . . . . 0.0 109.379 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.671 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 176.69 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.891 -1.131 . . . . 0.0 109.488 -178.015 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' ASN . 4.0 tpt 76.53 110.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.131 -0.981 . . . . 0.0 108.56 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 29' ' ' MET . 0.1 OUTLIER -30.56 92.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.423 0.63 . . . . 0.0 110.697 -179.328 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -114.0 -176.37 2.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.639 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 23' ' ' GLU . 52.1 m-85 -150.88 125.74 9.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.445 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 2.4 mm -89.8 93.42 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.039 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 18.0 m -88.05 112.71 22.93 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.823 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.987 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -79.57 115.45 19.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.997 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -113.67 113.99 25.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.606 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.58 132.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.152 -0.968 . . . . 0.0 110.515 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.783 HG21 HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -119.74 147.25 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -47.99 88.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 155.51 -50.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.812 -0.817 . . . . 0.0 109.118 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -170.68 -166.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.312 -0.868 . . . . 0.0 108.718 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.54 133.79 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.382 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.561 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.8 m -127.01 93.67 3.82 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 2.7 pm0 -80.49 -173.52 4.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.737 -1.227 . . . . 0.0 110.604 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.89 113.42 0.56 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.553 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -78.2 81.95 4.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.208 -1.172 . . . . 0.0 110.232 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -66.35 -178.92 9.4 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 6.6 t30 -129.16 106.1 8.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -1.211 . . . . 0.0 109.664 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.555 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 130.3 155.42 8.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HA ' ' CE1' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -65.97 -65.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.152 . . . . 0.0 109.219 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.78 74.71 7.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 109.095 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 49' ' ' GLY . 1.2 p -161.75 -40.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.232 -0.917 . . . . 0.0 109.23 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.516 ' C ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -29.84 -68.02 0.08 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 23.9 mmtt -45.83 -50.61 14.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 1' ' ' PRO . 6.7 tttt -58.66 -73.14 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.526 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -37.62 -67.23 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.201 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.039 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -40.56 -55.14 2.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -51.55 -57.46 9.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.813 . . . . 0.0 110.633 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.506 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 25.5 mt-10 -47.94 -44.87 30.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 108.253 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.2 -44.03 71.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 108.976 179.33 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.639 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 70.7 mmm -65.95 -66.27 0.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.806 0.812 . . . . 0.0 111.311 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.069 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -50.82 -60.4 3.11 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 8.7 t -56.28 -26.95 23.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.184 -0.947 . . . . 0.0 109.13 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' HB3' HD13 ' A' ' 65' ' ' LEU . 2.0 mm-40 -62.89 -55.56 24.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.873 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -112.57 16.05 19.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.744 -1.223 . . . . 0.0 111.49 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.536 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 9.5 mm-40 -98.86 -33.8 10.73 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.064 -1.022 . . . . 0.0 109.261 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -66.86 -26.06 66.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.509 179.811 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.5 Cg_exo . . . . . 0 N--CA 1.497 1.709 0 N-CA-C 109.613 -0.957 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.556 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.6 mm -72.23 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.937 . . . . 0.0 109.276 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -54.55 -31.6 56.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.0 mm100 -63.41 -53.5 51.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.251 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.066 HG22 ' CD2' ' A' ' 62' ' ' LEU . 61.1 t -58.53 -54.82 27.92 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 108.534 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.566 ' HA ' HG21 ' A' ' 16' ' ' VAL . 52.3 m80 -47.16 -37.59 10.32 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 120.618 -1.301 . . . . 0.0 108.755 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 13.0 mt-10 -63.24 -66.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.974 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.937 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -65.4 -49.33 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.012 . . . . 0.0 110.276 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.937 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.49 -56.6 7.12 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.2 OUTLIER -69.37 -30.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.076 -1.25 . . . . 0.0 109.73 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.1 mtmp? -79.92 -4.3 51.77 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.22 13.22 4.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.65 -179.556 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.8 t30 78.84 -7.6 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.777 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.575 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 3.5 mmt -78.84 95.2 5.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.958 -1.089 . . . . 0.0 109.01 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -47.38 155.35 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.786 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.704 ' CG2' HG12 ' A' ' 5' ' ' VAL . 45.8 t -131.72 93.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 108.724 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.604 ' ND1' HG21 ' A' ' 37' ' ' ILE . 32.8 m170 -118.85 91.3 3.52 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.664 -1.215 . . . . 0.0 110.316 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.724 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 57.1 m-85 -78.49 129.42 34.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 110.441 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.803 ' O ' HD23 ' A' ' 21' ' ' LEU . 28.3 mttt -151.47 110.78 3.94 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.807 HG22 ' OG1' ' A' ' 34' ' ' THR . 72.0 t -78.6 118.84 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 109.033 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.954 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -119.22 10.69 12.1 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.703 . . . . 0.0 110.677 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' CD ' HG13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -136.47 155.5 49.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.96 -1.087 . . . . 0.0 110.32 -179.601 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.588 ' HA ' ' CD2' ' A' ' 32' ' ' PHE . 12.3 mt-10 -144.94 52.09 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 109.025 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -45.12 116.53 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.883 . . . . 0.0 109.659 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.54 132.52 1.8 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 -61.98 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.934 1.756 . . . . 0.0 110.058 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.58 39.02 0.79 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.381 -0.824 . . . . 0.0 109.24 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -144.67 -149.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.33 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.6 ptp -125.34 71.79 1.22 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.459 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 5.5 mmtt -75.23 -97.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -0.912 . . . . 0.0 109.497 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -120.88 158.05 28.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.921 -1.112 . . . . 0.0 109.576 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' A' ' 23' ' ' GLU . 15.6 m-85 -136.67 133.95 36.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.548 HG13 ' CD ' ' A' ' 22' ' ' ARG . 4.9 mm -89.21 97.5 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.133 -0.979 . . . . 0.0 108.472 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.079 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 18.8 m -88.47 113.21 23.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.954 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -78.81 117.7 20.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.589 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.958 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -116.04 116.11 27.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.604 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -79.14 130.41 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 111.248 -177.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.906 HG13 ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -112.78 146.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.039 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -53.18 84.94 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 159.91 -46.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.585 -0.95 . . . . 0.0 108.451 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -169.79 -176.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.8 153.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.86 -1.15 . . . . 0.0 108.884 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 17.1 m -149.04 94.71 2.28 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -79.68 -172.74 3.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.894 -1.128 . . . . 0.0 110.237 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.04 117.78 0.79 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -77.86 88.83 4.06 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.999 -1.295 . . . . 0.0 110.105 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -74.84 178.19 46.46 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.583 ' O ' HG11 ' A' ' 52' ' ' VAL . 15.2 p-10 -115.24 98.54 6.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -1.144 . . . . 0.0 109.728 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.27 159.25 10.18 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -78.53 -33.76 47.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -1.119 . . . . 0.0 109.59 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.0 31.2 2.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.552 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.583 HG11 ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -136.22 -39.04 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.309 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.511 ' HB3' ' CB ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -32.07 -38.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.263 0.554 . . . . 0.0 110.478 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.4 OUTLIER -69.45 -53.25 20.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.146 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG3' ' CG ' ' A' ' 1' ' ' PRO . 0.4 OUTLIER -56.35 -59.21 5.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.525 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -52.53 -43.03 64.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.118 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.079 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -55.3 -51.99 64.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.907 -1.12 . . . . 0.0 108.513 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.522 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -55.13 -50.02 70.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.571 -0.705 . . . . 0.0 110.168 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 8.3 mt-10 -54.37 -36.83 64.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.91 -36.44 83.96 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.343 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.906 ' CE ' HG13 ' A' ' 38' ' ' VAL . 80.0 mmm -71.49 -69.33 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.569 0.699 . . . . 0.0 111.141 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.066 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -51.8 -38.14 54.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 72.8 t -69.64 -36.37 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -58.07 -55.51 33.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.82 -38.35 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.026 -1.047 . . . . 0.0 109.527 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.422 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -66.01 -14.72 62.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 109.71 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -54.98 3.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.302 -1.496 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.57 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.587 ' CG ' ' CG ' ' A' ' 55' ' ' LYS . 5.0 Cg_exo . . . . . 0 N--CA 1.495 1.603 0 N-CA-C 109.557 -0.978 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.556 HD12 ' CE2' ' A' ' 18' ' ' PHE . 4.3 mm -66.42 -60.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 108.975 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -27.69 43.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.395 -0.815 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 11.4 mt-30 -64.76 -57.35 9.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.071 HG12 ' CG2' ' A' ' 16' ' ' VAL . 13.8 t -53.42 -63.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.545 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 53.1 m80 -39.86 -39.04 0.75 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.19 -0.944 . . . . 0.0 109.685 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 3.3 mt-10 -61.7 -62.06 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.95 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -70.02 -51.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.005 -1.059 . . . . 0.0 110.698 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.95 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.89 -49.29 17.59 Favored Glycine 0 N--CA 1.48 1.613 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.86 -46.29 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.529 -1.571 . . . . 0.0 109.851 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.73 -10.14 25.28 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 110.162 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -122.74 8.34 9.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.828 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 8.3 t-20 78.3 -8.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.416 -0.803 . . . . 0.0 109.627 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.83 ' HB3' HG12 ' A' ' 38' ' ' VAL . 8.6 mtp -78.66 87.67 4.58 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.899 -1.126 . . . . 0.0 109.404 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -40.28 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.579 -0.701 . . . . 0.0 109.896 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.071 ' CG2' HG12 ' A' ' 5' ' ' VAL . 42.0 t -137.43 78.85 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.638 ' ND1' HG21 ' A' ' 37' ' ' ILE . 31.7 m170 -100.73 95.59 6.76 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.951 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.721 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -76.28 127.77 33.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 109.672 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -147.97 110.97 4.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.983 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.0 t -76.39 117.23 20.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.981 -1.074 . . . . 0.0 108.873 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.887 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -93.0 -23.1 18.79 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.933 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.551 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -138.39 151.2 47.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 110.277 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.563 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 24.0 mp0 -144.92 93.0 2.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.483 -0.761 . . . . 0.0 109.195 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 30' ' ' LYS . 3.0 tm-20 62.78 138.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -0.941 . . . . 0.0 109.425 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.466 ' O ' ' OE2' ' A' ' 24' ' ' GLU . . . -74.35 -139.1 0.52 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.472 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 3.8 Cg_exo -59.88 -76.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.094 1.863 . . . . 0.0 110.324 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.01 7.84 4.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -141.97 -172.98 3.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.919 . . . . 0.0 109.512 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.476 ' HG2' ' ND2' ' A' ' 31' ' ' ASN . 5.4 ttm 49.15 78.03 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -0.947 . . . . 0.0 109.297 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.513 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 8.2 mttt -84.37 46.82 1.26 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.476 ' ND2' ' HG2' ' A' ' 29' ' ' MET . 78.2 m-20 -89.7 145.29 25.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.829 -1.169 . . . . 0.0 109.352 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 4.4 m-85 -118.63 121.13 39.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.029 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 46' ' ' GLU . 1.8 mm -89.08 91.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.1 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 15.4 m -88.95 108.64 19.67 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.874 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.887 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -79.85 115.73 19.61 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 18' ' ' PHE . 5.0 t -108.21 121.23 44.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 176.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.638 HG21 ' ND1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -76.28 128.78 37.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.925 -1.109 . . . . 0.0 110.428 -177.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.975 HG13 ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -116.69 102.94 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.169 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . 6.65 -73.4 0.0 OUTLIER Glycine 0 N--CA 1.504 3.169 0 C-N-CA 122.979 0.323 . . . . 0.0 112.547 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 38' ' ' VAL . 30.6 m -41.93 -65.8 0.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -1.053 . . . . 0.0 109.908 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -147.64 -139.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -113.37 161.89 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.19 . . . . 0.0 109.502 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.77 HG21 ' HA ' ' A' ' 61' ' ' MET . 19.8 m -150.37 91.92 1.81 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.616 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.5 pt-20 -86.17 -176.5 5.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.156 -0.965 . . . . 0.0 110.686 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -154.9 109.08 0.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.837 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.7 pm0 -79.24 80.44 5.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.297 -1.119 . . . . 0.0 109.563 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -64.49 168.65 26.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 49' ' ' GLY . 2.0 t-20 -105.36 76.48 1.22 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -1.048 . . . . 0.0 110.346 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 48' ' ' ASN . . . 37.64 -162.02 0.01 OUTLIER Glycine 0 N--CA 1.495 2.578 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER 67.73 48.62 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.579 -0.953 . . . . 0.0 109.657 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 44.81 64.05 1.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.162 -0.961 . . . . 0.0 108.79 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -129.82 -47.18 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.238 -0.914 . . . . 0.0 110.023 -179.161 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.557 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 28.6 p -14.75 -56.15 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.303 0.573 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 52' ' ' VAL . 14.5 mmtp -63.55 -59.64 4.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.364 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.587 ' CG ' ' CG ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -56.29 -62.61 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -42.05 -44.88 3.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 110.029 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.1 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -59.48 -58.94 6.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.938 -1.102 . . . . 0.0 108.631 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -48.43 -66.55 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.948 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.2 mm-40 -44.43 -40.1 5.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.333 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -56.07 -49.4 73.9 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 108.999 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.975 ' SD ' HG13 ' A' ' 38' ' ' VAL . 18.5 ttm -68.65 -62.57 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.723 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.015 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -47.75 -64.3 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.825 -1.172 . . . . 0.0 108.274 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 48.6 t -50.61 -34.92 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -52.2 -66.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 109.05 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.733 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.3 mm? -53.83 -44.18 70.06 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.9 -1.125 . . . . 0.0 110.15 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -53.55 -31.69 47.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.352 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.37 -41.7 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.617 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 64' ' ' GLU . 13.3 mt . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.522 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.9 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 N-CA-C 109.674 -0.933 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.989 HG22 ' CD2' ' A' ' 6' ' ' HIS . 5.7 mm -76.63 -51.17 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 t -52.05 -37.5 53.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.635 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 30.6 mt-30 -63.17 -53.65 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.021 HG22 ' CD2' ' A' ' 62' ' ' LEU . 24.2 t -54.9 -67.92 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.989 ' CD2' HG22 ' A' ' 2' ' ' ILE . 92.4 m-70 -36.87 -38.89 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.331 -0.855 . . . . 0.0 109.448 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 2.7 mt-10 -60.08 -62.26 2.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.717 -0.615 . . . . 0.0 110.171 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.936 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -74.1 -51.46 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.936 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -44.3 -52.38 7.22 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -78.0 -37.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.08 -1.247 . . . . 0.0 110.17 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.537 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 8.6 mmtm -60.65 -16.84 43.12 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.468 -0.77 . . . . 0.0 111.171 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.585 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.7 tpt180 -116.32 -44.1 2.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.79 -1.194 . . . . 0.0 109.578 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.585 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER 155.46 -15.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.017 -0.427 . . . . 0.0 109.928 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.696 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -71.91 111.8 7.47 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.834 -1.166 . . . . 0.0 110.054 -179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.598 HG22 ' NE2' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -64.93 121.85 15.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.029 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.721 ' CG2' HG12 ' A' ' 5' ' ' VAL . 60.7 t -98.19 110.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.653 ' CD2' ' CG2' ' A' ' 37' ' ' ILE . 4.2 m-70 -136.49 95.5 3.17 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.588 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.871 ' CD1' HG23 ' A' ' 2' ' ' ILE . 60.2 m-85 -78.71 135.14 37.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 110.997 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.821 ' O ' HD23 ' A' ' 21' ' ' LEU . 4.7 mtmt -150.36 110.49 4.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.932 HG22 ' OG1' ' A' ' 34' ' ' THR . 95.2 t -78.62 118.39 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 108.818 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.923 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -118.76 10.26 12.34 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -178.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.125 . . . . 0.0 110.267 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 4.6 m-85 -99.87 127.09 46.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.029 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.815 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.6 mp -88.81 97.31 6.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.01 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 5.1 m -86.16 118.04 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.923 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -82.01 114.49 20.61 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.873 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.785 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.22 113.19 25.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.024 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -78.77 138.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.196 -0.94 . . . . 0.0 109.336 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.024 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -131.4 146.42 33.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 42.38 -112.88 0.5 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 2.77 11.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -1.204 . . . . 0.0 109.94 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.76 154.15 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 108.477 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.92 160.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.855 -1.153 . . . . 0.0 110.229 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.488 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 23.3 m -150.34 90.6 1.67 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.561 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 3.8 mt-10 -81.12 -172.84 3.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.865 -1.147 . . . . 0.0 110.686 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.31 119.57 0.83 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -80.37 92.01 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.072 -1.252 . . . . 0.0 111.107 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 54' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.516 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -35.57 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.701 -0.624 . . . . 0.0 110.935 -179.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 52' ' ' VAL . 13.4 mttp -76.29 -49.68 16.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.593 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.73 -35.72 81.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.145 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 2.1 tpp180 -76.87 -40.32 48.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 109.885 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -61.81 -51.67 67.33 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 108.356 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -63.0 -56.38 17.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 110.051 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mt-10 -46.78 -43.6 18.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.731 -1.231 . . . . 0.0 108.112 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.97 -43.2 95.25 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.917 ' SD ' HG23 ' A' ' 38' ' ' VAL . 5.9 ttm -65.15 -70.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 110.484 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.021 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -47.71 -62.58 1.38 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 78.8 t -44.32 -38.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.37 -0.831 . . . . 0.0 108.991 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -58.03 -57.34 13.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.588 -0.695 . . . . 0.0 111.059 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.716 ' H ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -110.04 24.04 13.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.846 -1.159 . . . . 0.0 111.608 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.492 ' HG3' ' HB3' ' A' ' 62' ' ' LEU . 21.1 mm-40 -112.16 -20.41 11.92 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.483 ' HE2' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -98.6 -33.41 10.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.578 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.305 -1.352 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.681 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.675 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 3.0 Cg_exo . . . . . 0 N--CA 1.496 1.668 0 N-CA-C 109.597 -0.963 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.586 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.7 mm -80.32 -62.29 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.236 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -42.02 69.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.6 mm100 -57.1 -52.0 67.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.107 -0.995 . . . . 0.0 108.936 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.871 HG22 ' CD2' ' A' ' 62' ' ' LEU . 74.7 t -55.61 -68.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.645 ' HA ' HG21 ' A' ' 16' ' ' VAL . 82.6 m-70 -35.15 -34.58 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.656 0.741 . . . . 0.0 109.578 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.2 mt-10 -68.61 -52.56 30.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.73 -0.606 . . . . 0.0 110.585 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.057 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -73.23 -45.89 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.676 -179.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 1.057 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -50.73 -52.97 27.66 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.4 -47.4 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.057 -1.26 . . . . 0.0 109.451 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -63.99 -10.05 19.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -125.22 8.06 7.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.833 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 80.19 -10.78 1.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.686 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.634 ' HE2' HG13 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -72.94 89.53 1.42 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.067 -1.021 . . . . 0.0 109.081 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -43.48 149.36 0.27 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 109.509 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 6' ' ' HIS . 39.9 t -125.93 102.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.167 -0.958 . . . . 0.0 109.033 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.881 ' CD2' HG21 ' A' ' 37' ' ' ILE . 39.0 m-70 -121.77 95.09 4.53 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.524 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.824 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 3.1 m-85 -81.21 129.82 34.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.955 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.695 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.66 111.41 4.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.922 HG22 ' OG1' ' A' ' 34' ' ' THR . 70.7 t -78.06 103.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 0.0 109.035 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.019 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -89.68 -21.85 22.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.072 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.647 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 2.8 m120 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.392 0.615 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.556 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 20.6 m-85 -103.98 119.3 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.785 HD12 ' HB3' ' A' ' 46' ' ' GLU . 2.1 mm -89.48 92.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.021 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.042 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 19.5 m -89.59 113.46 24.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.493 -0.754 . . . . 0.0 109.131 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.019 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.01 116.61 20.24 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.44 -0.788 . . . . 0.0 110.236 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.854 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -113.27 115.24 27.87 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.881 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -76.69 134.78 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.961 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.969 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -130.17 135.11 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 49.23 -127.29 21.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -104.51 5.05 33.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -1.13 . . . . 0.0 109.774 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -122.15 151.61 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 108.894 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.85 160.96 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.968 -1.083 . . . . 0.0 109.746 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.479 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 21.2 m -150.45 92.01 1.81 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -81.42 -173.74 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.878 -1.138 . . . . 0.0 110.446 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.37 110.95 0.46 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.785 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.2 pt-20 -79.25 75.61 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 110.681 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.55 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.738 HG13 ' N ' ' A' ' 53' ' ' SER . 1.2 p . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.738 ' N ' HG13 ' A' ' 52' ' ' VAL . 3.4 p 84.38 -57.93 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.915 -0.49 . . . . 0.0 109.693 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' N ' ' OG ' ' A' ' 53' ' ' SER . 4.6 pttp -80.06 -48.83 12.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 108.966 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.533 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 98.4 mttt -68.62 -30.03 68.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' HG3' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -79.49 -38.82 33.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.478 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.042 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.022 -1.049 . . . . 0.0 108.394 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.824 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -65.1 -54.69 26.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.474 -0.766 . . . . 0.0 110.214 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.4 mt-10 -48.51 -42.71 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.61 -1.306 . . . . 0.0 107.76 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 1.7 tptp -62.76 -39.46 94.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.969 ' SD ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -65.78 -71.46 0.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.613 . . . . 0.0 110.072 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.871 ' CD2' HG22 ' A' ' 5' ' ' VAL . 1.3 mt -51.76 -56.98 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.127 -0.983 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 79.0 t -47.19 -39.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 108.506 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -61.15 -68.39 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.748 . . . . 0.0 110.386 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.35 -27.96 1.84 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.185 . . . . 0.0 109.964 -178.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 24.2 mm-40 -54.03 -49.49 68.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.931 -1.106 . . . . 0.0 109.536 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -51.22 36.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.985 . . . . 0.0 109.338 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.48 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.496 1.651 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.822 HG22 ' CD2' ' A' ' 6' ' ' HIS . 3.4 mm -68.24 -54.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.152 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -53.09 -30.67 37.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 109.216 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.6 mm100 -65.04 -55.81 16.71 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.066 HG12 HG22 ' A' ' 16' ' ' VAL . 21.8 t -53.64 -67.67 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.822 ' CD2' HG22 ' A' ' 2' ' ' ILE . 90.7 m-70 -36.46 -39.12 0.18 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 7.5 mt-10 -63.56 -59.02 5.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.845 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.977 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.8 pp -70.92 -50.4 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.897 -1.127 . . . . 0.0 110.31 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.977 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.53 -49.65 20.4 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.54 -45.6 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.664 -1.492 . . . . 0.0 109.823 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -64.0 -11.74 31.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.68 15.32 8.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.98 -1.075 . . . . 0.0 109.717 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 1.2 m-20 72.68 -4.82 2.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.545 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 3.0 mtp -79.75 91.2 5.28 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.809 -1.182 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -44.59 158.46 0.05 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.083 -1.011 . . . . 0.0 109.869 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.066 HG22 HG12 ' A' ' 5' ' ' VAL . 54.9 t -128.04 91.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.877 ' CD2' HG21 ' A' ' 37' ' ' ILE . 27.7 m-70 -109.42 92.88 4.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.581 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.921 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 39.7 m-85 -81.47 115.1 20.63 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.809 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -149.71 117.71 6.32 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.07 -1.018 . . . . 0.0 109.481 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.759 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.0 t -79.13 116.86 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.981 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.52 5.06 13.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.503 -0.748 . . . . 0.0 110.957 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 O-C-N 120.761 -1.212 . . . . 0.0 110.398 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.559 ' HB3' HG13 ' A' ' 20' ' ' VAL . 5.2 m-85 -106.08 151.41 24.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.067 -1.021 . . . . 0.0 108.647 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 5.8 mm -87.55 102.05 12.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.128 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 91.6 m -88.78 111.1 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.807 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.981 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.27 117.06 20.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 110.3 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.944 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -111.69 112.7 24.58 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.877 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.62 137.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.047 -1.033 . . . . 0.0 110.159 -177.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.946 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.6 OUTLIER -131.29 126.19 58.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 56.05 -121.83 25.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.35 4.72 19.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.15 . . . . 0.0 109.418 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.49 161.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 0.0 108.923 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.86 142.05 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.868 -1.145 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.564 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 20.3 m -132.49 92.1 3.03 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.547 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.1 mp0 -85.36 -168.71 2.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.012 -1.055 . . . . 0.0 111.171 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -155.75 -179.25 30.69 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.5 -2.64 . . . . 0.0 106.5 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 2.5 mt-10 -133.92 71.33 1.46 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 119.453 1.626 . . . . 0.0 110.874 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . . . . . . 0 N--CA 1.494 2.549 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.867 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.475 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -33.81 -63.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.268 0.556 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.714 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -47.02 -51.04 18.25 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.111 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 56' ' ' ARG . 1.4 mttt -57.39 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.458 -0.776 . . . . 0.0 109.035 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -29.26 -66.48 0.09 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.889 -0.507 . . . . 0.0 111.226 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.128 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -46.36 -55.03 7.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 110.704 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.702 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -61.2 -53.96 50.3 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.19 -0.944 . . . . 0.0 111.529 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.582 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.8 mm-40 -49.47 -38.02 28.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.382 -1.449 . . . . 0.0 107.545 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 18.5 tptt -63.52 -41.16 98.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.946 ' SD ' HG23 ' A' ' 38' ' ' VAL . 3.3 ttm -68.48 -73.1 0.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.756 -0.59 . . . . 0.0 110.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.943 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -48.5 -47.58 38.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.326 -0.859 . . . . 0.0 109.857 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.582 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 72.2 t -60.71 -37.92 77.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 108.254 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -58.13 -58.01 10.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.634 -0.666 . . . . 0.0 110.341 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.581 HD13 HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.853 -1.155 . . . . 0.0 110.13 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -50.75 -26.4 5.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -58.5 -53.42 58.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 68' ' ' LEU . 6.9 mt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.487 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.832 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.652 0 N-CA-C 109.646 -0.944 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 1.078 HG22 ' CD2' ' A' ' 6' ' ' HIS . 2.5 mp 81.43 -55.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 2' ' ' ILE . 92.9 p -46.38 -50.26 16.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.723 -1.235 . . . . 0.0 108.451 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -58.04 -51.78 68.25 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.877 HG22 ' CD2' ' A' ' 62' ' ' LEU . 47.0 t -49.51 -77.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.078 ' CD2' HG22 ' A' ' 2' ' ' ILE . 93.4 m-70 -28.92 -41.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.419 0.628 . . . . 0.0 110.126 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 5' ' ' VAL . 4.0 mm-40 -60.34 -64.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.953 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -70.32 -49.43 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -0.957 . . . . 0.0 110.651 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.953 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.96 -56.32 7.74 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -32.56 51.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.259 . . . . 0.0 109.321 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.3 mmtp -76.7 -4.55 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 110.422 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -133.91 16.07 3.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.381 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 80.22 -10.98 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.656 -0.652 . . . . 0.0 109.98 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.829 ' SD ' HD22 ' A' ' 65' ' ' LEU . 5.2 mtt -75.74 100.37 4.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.81 -1.182 . . . . 0.0 109.674 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -50.5 174.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.827 -1.17 . . . . 0.0 109.55 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.869 ' CG2' HG12 ' A' ' 5' ' ' VAL . 95.8 t -149.09 88.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.856 ' CD2' HG21 ' A' ' 37' ' ' ILE . 45.7 m-70 -112.18 95.76 5.64 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.708 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.987 ' CD2' HG23 ' A' ' 2' ' ' ILE . 33.0 m-85 -80.21 118.65 22.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.507 -0.745 . . . . 0.0 111.441 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 123.3 8.69 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.702 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.4 t -79.78 130.07 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.943 -1.098 . . . . 0.0 108.925 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.042 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -89.0 -22.37 23.03 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.773 -0.579 . . . . 0.0 109.721 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.528 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 33.8 m-80 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.706 0.765 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.616 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 7.2 m-85 -117.86 117.96 30.7 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.58 ' N ' HD13 ' A' ' 33' ' ' ILE . 1.6 mm -86.55 91.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.051 -1.031 . . . . 0.0 108.581 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.039 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 34.7 m -88.8 111.16 21.69 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.042 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -79.84 113.88 18.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.438 -0.789 . . . . 0.0 110.485 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.873 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.93 119.43 39.04 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.856 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -78.75 134.01 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.727 -1.233 . . . . 0.0 111.104 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.952 HG13 ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -129.97 140.5 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' H ' ' CA ' ' A' ' 14' ' ' MET . . . 50.61 -91.67 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.9 m -143.51 2.39 1.25 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -1.175 . . . . 0.0 110.35 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 40' ' ' SER . 17.2 mm -117.05 160.8 16.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.991 -1.068 . . . . 0.0 108.603 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.69 125.38 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.862 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.82 HG21 ' HA ' ' A' ' 61' ' ' MET . 73.4 m -115.29 88.67 2.93 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -80.88 -172.82 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.985 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.497 ' HA3' ' HG3' ' A' ' 60' ' ' LYS . . . -160.89 115.96 0.69 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.059 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.47 78.59 4.93 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.131 -1.217 . . . . 0.0 109.816 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.496 2.674 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.987 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.482 ' CG1' ' C ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.849 0.357 . . . . 0.0 110.322 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.511 ' OG ' ' CG ' ' A' ' 32' ' ' PHE . 3.9 m -33.49 -74.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.705 -0.622 . . . . 0.0 111.739 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 33.1 pttt -43.1 -51.73 5.74 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.145 -0.972 . . . . 0.0 111.1 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -54.51 -39.27 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.94 -1.1 . . . . 0.0 110.464 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.589 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -72.66 -35.85 67.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.039 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -63.82 -53.0 57.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.91 -1.119 . . . . 0.0 108.405 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.531 ' HB2' HG13 ' A' ' 2' ' ' ILE . . . -62.3 -64.05 1.05 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.429 -0.794 . . . . 0.0 109.403 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.9 mt-10 -50.91 -25.5 4.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.754 -1.216 . . . . 0.0 108.502 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -65.89 -53.15 43.36 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.952 ' CE ' HG13 ' A' ' 38' ' ' VAL . 3.6 ptp -73.62 -51.46 16.7 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.865 -1.534 . . . . 0.0 110.448 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.877 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -48.66 -55.95 9.87 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 62.5 t -54.52 -37.77 39.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -53.88 -72.81 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.843 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -44.87 -37.44 3.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.843 ' NE2' HD12 ' A' ' 65' ' ' LEU . 21.5 mm-40 -58.33 -45.94 87.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.02 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -36.37 83.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.024 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.574 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.553 ' HD2' ' CG ' ' A' ' 55' ' ' LYS . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.628 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.655 HG22 ' CD2' ' A' ' 6' ' ' HIS . 10.0 mm -95.12 -56.76 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.145 -0.972 . . . . 0.0 108.863 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -57.56 -33.84 68.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.556 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 3.2 pt20 -62.66 -48.88 77.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 108.479 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.05 HG22 HD21 ' A' ' 62' ' ' LEU . 99.1 t -59.98 -68.16 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.661 ' HA ' HG21 ' A' ' 16' ' ' VAL . 81.5 m-70 -34.7 -34.28 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.579 0.704 . . . . 0.0 109.514 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' VAL . 6.3 mt-10 -67.76 -69.37 0.32 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.171 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.01 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -57.89 -52.94 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.16 -0.962 . . . . 0.0 109.492 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 1.01 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -46.82 -49.65 16.56 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.687 HG22 ' N ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -80.16 -65.34 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.338 . . . . 0.0 109.955 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.687 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -39.68 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.473 -0.767 . . . . 0.0 111.428 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -104.67 -49.67 3.47 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.78 -1.2 . . . . 0.0 109.272 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.6 m-20 150.34 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.585 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 4.5 mmt -56.19 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.154 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -46.41 158.37 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.725 -1.234 . . . . 0.0 109.361 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.746 ' CG2' HG12 ' A' ' 5' ' ' VAL . 96.9 t -130.35 82.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.819 ' CD2' HG21 ' A' ' 37' ' ' ILE . 23.9 m-70 -110.22 89.2 2.96 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.003 -1.479 . . . . 0.0 111.117 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.794 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 52.9 m-85 -75.87 120.78 21.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.781 ' O ' HD23 ' A' ' 21' ' ' LEU . 31.4 tttp -145.65 116.78 7.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.046 HG22 ' OG1' ' A' ' 34' ' ' THR . 47.2 t -78.31 113.38 17.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.967 -1.083 . . . . 0.0 109.062 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.967 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -111.05 16.71 21.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.84 -178.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.565 ' CD ' HG13 ' A' ' 33' ' ' ILE . 2.0 mtt180 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 120.779 -1.201 . . . . 0.0 110.407 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 17.3 m-85 -121.36 139.35 53.54 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.657 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.569 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 5.1 mm -89.39 96.57 6.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.046 ' OG1' HG22 ' A' ' 20' ' ' VAL . 4.3 m -88.33 119.88 29.17 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.548 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.967 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -95.14 114.16 25.92 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.523 -0.735 . . . . 0.0 111.085 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.852 ' HB3' ' HE3' ' A' ' 61' ' ' MET . 5.5 t -101.91 126.05 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.819 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -75.11 133.37 31.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.616 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -125.11 130.88 73.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.127 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.516 ' N ' ' SD ' ' A' ' 14' ' ' MET . . . 42.34 -107.53 0.11 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 t -116.53 -7.51 11.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.604 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 38' ' ' VAL . 11.2 mt -112.87 148.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 108.661 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -91.31 128.01 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.913 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.754 HG23 ' HB ' ' A' ' 38' ' ' VAL . 20.5 p -103.89 93.05 4.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 2.5 pt-20 -94.93 179.47 5.22 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.753 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -164.13 166.97 37.9 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -114.76 92.81 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.885 -1.362 . . . . 0.0 110.079 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.303 0.573 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.481 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 26.6 p -38.06 -33.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -72.9 -47.19 47.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.032 -1.042 . . . . 0.0 109.448 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.553 ' CG ' ' HD2' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -59.73 -51.79 68.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -60.29 -63.67 1.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.947 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.991 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -42.06 -48.61 4.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.397 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.23 -55.14 34.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.805 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.0 mm-40 -48.51 -33.54 9.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -66.1 -44.47 84.3 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.852 ' HE3' ' HB3' ' A' ' 36' ' ' CYS . 22.7 ttm -64.73 -60.73 2.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.389 -0.819 . . . . 0.0 110.081 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.05 HD21 HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -56.45 -61.24 2.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 53.8 t -49.71 -34.56 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.913 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' MET . 2.4 mm-40 -59.93 -63.75 1.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -59.57 -22.28 61.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.1 -1.0 . . . . 0.0 109.993 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 1.8 mp0 -82.22 -23.35 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 0.0 109.954 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -79.93 -35.1 38.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.011 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.59 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.543 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 3.3 Cg_exo . . . . . 0 N--CA 1.496 1.664 0 N-CA-C 109.634 -0.949 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' A' ' 54' ' ' LYS . 4.5 mm -72.5 -54.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.266 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.8 p -54.08 -37.31 64.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.432 -0.792 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.7 -60.87 3.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.918 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.05 ' HA ' HD21 ' A' ' 62' ' ' LEU . 39.4 t -51.32 -66.91 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.799 ' CD2' HG22 ' A' ' 2' ' ' ILE . 75.5 m-70 -35.38 -35.96 0.06 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.578 -0.701 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -69.47 -50.63 43.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.472 -0.768 . . . . 0.0 110.261 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.065 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -74.57 -48.51 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.999 -1.063 . . . . 0.0 109.337 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 1.065 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -50.44 -50.79 34.36 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.11 -46.46 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.816 -1.402 . . . . 0.0 109.784 -179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.87 -10.97 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.997 . . . . 0.0 110.089 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -121.03 8.19 10.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 110.001 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER 80.35 -11.53 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.444 -0.785 . . . . 0.0 109.579 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.58 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 4.2 mtt -73.57 106.92 5.56 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.015 -1.053 . . . . 0.0 109.071 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.53 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -61.32 136.36 58.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.431 -0.793 . . . . 0.0 109.931 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.963 ' CG2' HG12 ' A' ' 5' ' ' VAL . 69.0 t -110.73 112.13 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.496 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.78 ' HB2' HG22 ' A' ' 37' ' ' ILE . 15.0 m-70 -131.15 103.76 6.68 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.644 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.801 ' CD2' HD12 ' A' ' 2' ' ' ILE . 2.9 m-85 -90.67 136.27 33.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.606 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.52 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -150.33 110.07 4.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.872 HG22 ' OG1' ' A' ' 34' ' ' THR . 68.9 t -77.51 123.13 33.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.963 -1.086 . . . . 0.0 108.389 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -107.19 -14.58 14.87 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.348 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.557 ' CB ' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.0 -1.063 . . . . 0.0 110.715 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.578 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 2.3 m120 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.533 0.683 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 58.6 m-85 -152.69 121.88 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.547 -0.721 . . . . 0.0 109.317 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.557 HG12 ' CB ' ' A' ' 22' ' ' ARG . 3.1 mm -89.4 92.15 3.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.1 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 31.1 m -87.76 109.83 20.01 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.969 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.855 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -77.55 122.07 24.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.984 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -126.18 111.67 14.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.464 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.08 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -78.49 136.63 23.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.223 -0.923 . . . . 0.0 110.844 -178.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.08 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.2 t -127.45 127.73 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 52.61 -118.05 7.3 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -111.1 0.47 16.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -1.161 . . . . 0.0 109.864 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mt -116.11 134.02 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 108.971 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.78 HG22 HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -97.55 142.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.893 -1.129 . . . . 0.0 110.714 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.468 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -135.97 112.91 10.31 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.59 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -84.23 -170.24 3.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.841 -1.162 . . . . 0.0 109.098 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -160.81 108.61 0.36 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.45 -1.357 . . . . 0.0 109.785 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.553 ' CB ' HD13 ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.04 79.1 4.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.258 -1.142 . . . . 0.0 109.871 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.518 ' CA ' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 65.3 m -57.68 -80.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.206 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.892 ' HB2' HD11 ' A' ' 2' ' ' ILE . 1.8 pttt -51.29 -53.39 36.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.259 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 24.3 ttpp -53.22 -29.55 33.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 109.628 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -74.35 -45.16 48.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.468 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.1 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -60.71 -57.36 13.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.246 -0.909 . . . . 0.0 108.553 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.793 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -54.55 -48.44 72.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.368 -0.833 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.7 mm-40 -53.56 -39.29 64.66 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.32 -37.66 84.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.588 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 64.0 mmm -70.18 -71.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.0 110.95 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.05 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -49.5 -48.79 47.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.066 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 75.1 t -60.04 -37.81 74.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -55.48 -61.09 2.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.595 -0.69 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.718 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -60.79 -34.28 74.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 110.521 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.718 ' NE2' HD12 ' A' ' 65' ' ' LEU . 21.2 mm-40 -65.56 -28.57 69.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.709 -1.244 . . . . 0.0 109.666 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -70.83 -30.16 66.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 C--N 1.304 -1.386 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.461 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.862 ' O ' HG23 ' A' ' 5' ' ' VAL . 5.4 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 N-CA-C 109.745 -0.906 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.624 HG22 ' CD2' ' A' ' 6' ' ' HIS . 5.1 mm -69.85 -58.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 p -55.6 -37.89 68.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.6 mm100 -60.96 -55.71 29.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 0.0 108.644 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.987 ' HA ' HD21 ' A' ' 62' ' ' LEU . 23.5 t -51.77 -70.11 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.624 ' CD2' HG22 ' A' ' 2' ' ' ILE . 86.3 m-70 -34.68 -38.68 0.08 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.619 -0.675 . . . . 0.0 109.779 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.8 mt-10 -62.51 -63.8 1.12 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.433 -0.792 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.965 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.11 -49.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.191 -0.943 . . . . 0.0 110.58 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.965 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.59 -56.22 8.62 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -30.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.118 -1.225 . . . . 0.0 109.504 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 6.5 mttm -79.84 -3.76 49.24 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 110.267 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.73 14.32 4.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 109.384 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 80.69 -10.33 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.635 -0.666 . . . . 0.0 109.764 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.587 ' SD ' HD22 ' A' ' 65' ' ' LEU . 1.8 mtt -76.48 99.56 4.96 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.935 -1.103 . . . . 0.0 109.342 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -53.78 142.18 24.57 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.812 HG22 HG12 ' A' ' 5' ' ' VAL . 98.5 t -114.45 94.33 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.782 ' HB2' HG22 ' A' ' 37' ' ' ILE . 96.6 m-70 -119.26 102.74 8.91 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.161 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.809 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -86.84 125.3 33.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -138.99 114.67 9.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.015 HG22 ' OG1' ' A' ' 34' ' ' THR . 61.3 t -78.55 128.77 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.046 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.596 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -111.26 -11.16 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.706 -0.621 . . . . 0.0 110.097 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 12.3 mmt180 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.031 -1.043 . . . . 0.0 109.993 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.676 0.75 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 3.2 m-85 -108.62 126.44 52.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.548 ' CG1' ' HB2' ' A' ' 22' ' ' ARG . 1.3 mm -96.01 123.88 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.094 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 6.1 m -119.85 116.47 25.91 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.596 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -79.54 112.7 17.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.541 -0.725 . . . . 0.0 109.179 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.815 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -109.82 111.82 23.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.587 -1.321 . . . . 0.0 107.6 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.087 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -79.36 138.09 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 111.133 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.087 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -125.29 136.0 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 42.24 -88.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' VAL . 12.8 t -136.82 -7.13 1.88 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.087 -1.243 . . . . 0.0 110.609 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.634 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.9 mt -108.05 136.85 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.908 -1.12 . . . . 0.0 108.414 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -92.03 129.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.851 -1.156 . . . . 0.0 110.729 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -115.76 98.37 6.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.574 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -82.94 -174.15 5.11 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.599 -1.313 . . . . 0.0 109.639 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -149.73 172.95 29.61 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.76 76.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.285 -1.127 . . . . 0.0 108.693 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.088 HG22 ' CD ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.388 0.614 . . . . 0.0 109.414 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 35.2 p -48.93 -54.93 13.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.888 -1.132 . . . . 0.0 109.559 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -55.94 -70.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 109.926 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' CA ' ' HD2' ' A' ' 1' ' ' PRO . 48.5 mttp -41.35 -68.9 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.742 . . . . 0.0 109.559 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 1.088 ' CD ' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -36.67 -63.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.895 -0.503 . . . . 0.0 110.494 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.094 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -44.17 -49.31 9.14 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.925 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.791 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -55.67 -57.91 10.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.344 -0.847 . . . . 0.0 110.637 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 20.8 mt-10 -46.28 -45.24 17.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.762 -1.211 . . . . 0.0 108.136 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -56.23 -43.55 78.71 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 1.013 ' SD ' HG13 ' A' ' 38' ' ' VAL . 4.8 ttm -66.41 -72.34 0.16 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.375 0.607 . . . . 0.0 110.602 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -46.89 -60.63 2.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.931 -1.106 . . . . 0.0 108.589 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 70.2 t -47.11 -39.13 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.749 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -58.07 -66.61 0.45 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.634 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -53.4 -28.2 28.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.979 -1.075 . . . . 0.0 110.547 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.634 ' NE2' HD12 ' A' ' 65' ' ' LEU . 31.5 mm-40 -65.11 -37.17 86.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.832 -1.168 . . . . 0.0 109.605 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -34.36 70.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.639 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.885 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.5 Cg_exo . . . . . 0 N--CA 1.496 1.625 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.584 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.0 mm -71.04 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -51.32 -37.64 48.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.349 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.5 mm-40 -62.45 -51.49 67.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.039 HG12 ' CG2' ' A' ' 16' ' ' VAL . 38.8 t -54.98 -66.83 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.37 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.545 ' CD2' HG22 ' A' ' 2' ' ' ILE . 93.6 m-70 -38.38 -38.61 0.38 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.494 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -61.03 -63.18 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.733 -0.604 . . . . 0.0 110.69 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.964 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.14 -49.06 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.029 -1.044 . . . . 0.0 110.791 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.964 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -49.36 -54.25 16.8 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -67.49 -39.24 82.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.885 -1.362 . . . . 0.0 109.476 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 11.3 mttm -69.64 -9.36 53.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 109.892 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.67 10.09 7.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.237 -0.915 . . . . 0.0 109.09 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 79.32 -10.28 1.35 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.75 . . . . 0.0 109.42 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.588 ' HE3' ' HG ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -75.54 101.76 5.01 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.943 -1.098 . . . . 0.0 109.302 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -53.06 163.58 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.039 ' CG2' HG12 ' A' ' 5' ' ' VAL . 48.9 t -133.45 92.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.87 ' CD2' HG21 ' A' ' 37' ' ' ILE . 31.8 m-70 -113.68 95.64 5.44 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.621 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.891 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 54.7 m-85 -81.65 119.32 23.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.623 -0.673 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.766 ' O ' HD23 ' A' ' 21' ' ' LEU . 8.3 ttmm -151.01 115.96 5.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.846 HG22 ' OG1' ' A' ' 34' ' ' THR . 93.4 t -79.01 119.29 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 0.0 108.668 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.987 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.21 1.39 13.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 110.984 -178.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 120.676 -1.265 . . . . 0.0 110.819 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 1.7 m-20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 35.2 m-85 -144.55 141.55 29.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.6 mm -89.47 99.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.065 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 35.8 m -89.22 113.31 24.51 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.459 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.987 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -80.85 119.51 23.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -0.909 . . . . 0.0 110.036 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.818 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -114.37 116.01 28.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.87 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.32 134.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.816 -1.177 . . . . 0.0 109.983 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.944 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -129.19 131.22 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -10.0 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.504 3.226 0 CA-C-O 121.142 0.301 . . . . 0.0 112.579 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -36.29 -59.19 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.691 -0.888 . . . . 0.0 111.328 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.704 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -162.07 -168.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.935 -1.103 . . . . 0.0 108.854 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -89.1 133.47 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.095 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.451 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 2.4 m -121.63 103.57 9.0 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 15.2 pt-20 -84.46 -169.8 2.79 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 110.441 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -156.96 178.99 33.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -127.94 82.73 2.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.892 -1.358 . . . . 0.0 110.533 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.827 HG13 ' N ' ' A' ' 53' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.827 ' N ' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 83.18 -55.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 109.571 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -44.15 44.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.022 . . . . 0.0 108.89 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.536 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -66.01 -44.81 83.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.275 -0.89 . . . . 0.0 108.636 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.466 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -61.78 -64.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.065 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -41.35 -46.25 3.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.504 -0.747 . . . . 0.0 109.244 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 18' ' ' PHE . . . -57.91 -61.57 2.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.42 -0.8 . . . . 0.0 110.31 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -45.53 -50.26 13.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.795 -1.19 . . . . 0.0 108.59 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 12.9 tptt -51.22 -45.53 61.96 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.944 ' SD ' HG23 ' A' ' 38' ' ' VAL . 2.2 ttm -63.3 -70.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.59 -0.694 . . . . 0.0 110.353 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.921 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -46.25 -64.16 0.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 10.6 t -51.51 -29.48 9.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.448 -0.783 . . . . 0.0 109.561 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 3.8 mm-40 -67.89 -55.81 11.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.085 -1.01 . . . . 0.0 111.391 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -95.32 8.38 43.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.432 -1.418 . . . . 0.0 110.404 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 88.5 mt-30 -101.12 -13.33 18.22 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.381 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 -36.95 5.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 109.274 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.563 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.921 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.0 Cg_endo . . . . . 0 N--CA 1.495 1.608 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.485 HG22 ' CD2' ' A' ' 6' ' ' HIS . 5.1 mm -71.73 -64.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.5 p -51.36 -42.11 61.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.42 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.1 mt-30 -57.66 -54.0 51.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 108.837 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.951 HG22 ' CG ' ' A' ' 62' ' ' LEU . 56.5 t -53.15 -68.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.553 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 88.0 m-70 -34.97 -38.87 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.683 -0.636 . . . . 0.0 109.701 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.7 mt-10 -63.98 -56.53 14.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 110.06 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.068 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -72.41 -53.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.192 -0.943 . . . . 0.0 109.723 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 1.068 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -45.36 -48.34 11.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -73.84 -44.82 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.587 -1.537 . . . . 0.0 110.358 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.9 mtmt -64.61 -11.06 31.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.074 -1.016 . . . . 0.0 110.321 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -120.36 8.1 10.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.938 . . . . 0.0 109.856 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.0 t-20 78.86 -6.44 1.9 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.846 ' CE ' HD22 ' A' ' 65' ' ' LEU . 32.6 mtp -79.45 89.93 5.04 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -42.0 161.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.467 -0.771 . . . . 0.0 109.844 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.94 ' CG2' HG12 ' A' ' 5' ' ' VAL . 60.7 t -132.65 93.38 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.851 ' CD2' HG21 ' A' ' 37' ' ' ILE . 40.8 m-70 -110.31 97.7 7.11 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 118.306 -1.358 . . . . 0.0 110.439 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.753 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 39.0 m-85 -84.69 119.39 25.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 110.972 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.739 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.52 116.58 5.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.011 HG22 ' OG1' ' A' ' 34' ' ' THR . 86.4 t -78.66 126.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 109.327 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.927 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -126.78 9.49 6.99 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.624 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.553 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.192 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.471 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 3.0 m-85 -88.02 129.72 35.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.3 mp -89.45 96.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.04 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 26.4 m -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.888 0.852 . . . . 0.0 108.91 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.927 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -90.09 120.2 31.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.938 -0.476 . . . . 0.0 109.912 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.804 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -117.94 117.74 30.07 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.851 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -77.26 132.56 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.952 -1.092 . . . . 0.0 110.536 -177.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.668 HG22 ' HE2' ' A' ' 14' ' ' MET . 0.8 OUTLIER -125.0 108.24 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 14' ' ' MET . . . 18.6 -105.82 0.01 OUTLIER Glycine 0 N--CA 1.504 3.216 0 CA-C-O 121.44 0.467 . . . . 0.0 112.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.1 m -24.18 -56.14 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.449 HG13 ' C ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -156.4 -161.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.09 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.59 163.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.47 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.653 HG23 ' OE2' ' A' ' 64' ' ' GLU . 53.8 m -150.5 90.51 1.65 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.555 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 6.7 pt-20 -86.64 -169.97 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.918 -1.114 . . . . 0.0 109.903 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -172.87 156.01 24.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 1.2 pt-20 -110.79 98.23 7.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.833 -1.392 . . . . 0.0 110.623 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.582 ' HA3' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.493 2.478 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 56' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.867 0.365 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 54' ' ' LYS . 49.6 m -60.91 -93.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.89 -1.131 . . . . 0.0 110.217 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.0 OUTLIER -32.15 -61.41 0.25 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.522 -0.736 . . . . 0.0 111.424 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.509 ' HB3' ' CG ' ' A' ' 1' ' ' PRO . 1.1 mttt -49.35 -50.75 38.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.054 . . . . 0.0 109.808 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.582 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 7.6 tpt180 -55.53 -57.52 11.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 109.787 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.04 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -44.59 -47.14 10.31 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.047 0.927 . . . . 0.0 108.658 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -54.31 -64.72 0.74 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 74.2 mt-10 -49.02 -23.97 1.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.201 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -64.36 -53.95 40.54 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.236 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.614 ' HA ' HG21 ' A' ' 43' ' ' THR . 3.4 ptp -77.72 -51.36 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.419 -1.312 . . . . 0.0 110.196 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.951 ' CG ' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -46.74 -47.73 20.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.393 -1.442 . . . . 0.0 107.732 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 79.3 t -65.21 -38.66 83.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.653 ' OE2' HG23 ' A' ' 43' ' ' THR . 1.8 mm-40 -51.33 -68.79 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.846 HD22 ' CE ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -48.51 -44.32 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.602 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.683 ' NE2' HD12 ' A' ' 65' ' ' LEU . 5.1 mm-40 -45.51 -65.01 0.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.962 -1.086 . . . . 0.0 109.489 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -46.02 -52.46 11.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.629 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 68' ' ' LEU . 5.0 mt . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.566 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.537 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 N-CA-C 109.556 -0.978 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 1.012 HG22 ' CD2' ' A' ' 6' ' ' HIS . 7.9 mm -78.66 -47.88 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -46.81 -51.12 17.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -50.73 -57.65 7.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.931 -1.106 . . . . 0.0 110.271 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.044 HG22 ' CD2' ' A' ' 62' ' ' LEU . 24.9 t -54.08 -58.17 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.803 -1.186 . . . . 0.0 108.969 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.012 ' CD2' HG22 ' A' ' 2' ' ' ILE . 79.0 m-70 -42.56 -34.69 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.837 -1.164 . . . . 0.0 108.839 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 9.7 mt-10 -71.23 -71.73 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.485 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.052 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -54.48 -48.47 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 120.669 -1.269 . . . . 0.0 109.745 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 1.052 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -52.98 -59.2 9.71 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.9 -52.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.699 -1.471 . . . . 0.0 110.212 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -55.4 -19.47 9.24 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.046 -179.051 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -121.75 23.07 10.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.6 -1.313 . . . . 0.0 111.168 -179.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 77.53 -11.82 1.15 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.084 -1.01 . . . . 0.0 111.141 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.845 ' HB3' HG22 ' A' ' 38' ' ' VAL . 4.6 mtt -78.3 93.93 4.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.124 . . . . 0.0 109.603 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -42.63 166.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.893 -1.129 . . . . 0.0 110.194 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 6' ' ' HIS . 24.2 t -139.67 77.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.843 ' CD2' HG21 ' A' ' 37' ' ' ILE . 36.8 m-70 -102.15 91.57 4.37 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.348 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD2' HG23 ' A' ' 2' ' ' ILE . 29.1 m-85 -80.1 110.14 15.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.548 0.689 . . . . 0.0 110.767 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -131.53 119.0 20.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 67.6 t -79.89 136.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.033 -1.042 . . . . 0.0 110.175 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 3.4 mt -96.04 -15.08 22.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.562 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.691 0.758 . . . . 0.0 110.665 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 1.1 m120 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.669 0.747 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 3.0 m-85 -90.33 128.54 36.47 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 2.9 mm -88.51 95.94 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.097 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.073 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 53.5 m -90.03 114.6 26.51 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -82.44 129.53 34.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.095 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.653 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -123.26 116.39 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.5 -1.375 . . . . 0.0 107.612 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.909 HG12 HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -80.41 136.34 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.01 -1.056 . . . . 0.0 111.961 -177.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.845 HG22 ' HB3' ' A' ' 14' ' ' MET . 0.9 OUTLIER -135.35 136.35 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 50.66 -124.44 19.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.34 5.54 23.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.16 148.27 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 108.898 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.909 HG22 HG12 ' A' ' 37' ' ' ILE . 1.5 t -108.07 143.2 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.946 -1.097 . . . . 0.0 110.293 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.552 ' OG1' ' CE ' ' A' ' 61' ' ' MET . 50.9 p -132.1 113.96 13.96 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -87.69 -168.02 2.08 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 110.008 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA2' ' HG2' ' A' ' 60' ' ' LYS . . . -161.11 114.47 0.61 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -77.99 83.65 4.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.959 -1.318 . . . . 0.0 109.88 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.588 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' C ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.933 0.397 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -24.35 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -69.16 -59.65 2.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.937 -1.102 . . . . 0.0 109.648 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 3.6 ttpm? -50.06 -42.89 50.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.847 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.588 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -69.99 -34.4 73.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.396 -0.815 . . . . 0.0 110.471 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.073 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -64.66 -51.13 64.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.891 -1.131 . . . . 0.0 108.645 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.53 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -60.97 -51.71 68.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 63' ' ' VAL . 4.8 mt-10 -51.18 -44.33 61.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.475 ' HG2' ' HA2' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -61.58 -36.23 80.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.671 ' HG3' HD23 ' A' ' 62' ' ' LEU . 34.8 tpp -70.25 -71.37 0.24 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.49 -0.756 . . . . 0.0 110.617 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.044 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -49.34 -52.69 26.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 108.33 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 59' ' ' GLU . 78.1 t -52.02 -39.7 26.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 108.653 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 61' ' ' MET . 1.8 mm-40 -59.36 -64.26 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.574 HD22 ' SD ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -53.58 -28.41 31.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.978 -1.076 . . . . 0.0 110.257 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 18.1 mm-40 -54.04 -62.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.842 -1.161 . . . . 0.0 109.615 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -54.92 -39.98 69.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.521 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 68' ' ' LEU . 5.2 mt . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.447 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.576 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 4.6 Cg_exo . . . . . 0 N--CA 1.493 1.497 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.948 HG22 ' CD2' ' A' ' 6' ' ' HIS . 8.1 mm -97.58 -50.91 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 109.111 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.49 -45.76 18.62 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 0.0 109.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -55.6 -60.18 3.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.975 . . . . 0.0 108.979 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.017 HG12 ' CG2' ' A' ' 16' ' ' VAL . 48.5 t -46.59 -68.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 108.355 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.948 ' CD2' HG22 ' A' ' 2' ' ' ILE . 92.9 m-70 -36.8 -38.93 0.19 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.457 -0.777 . . . . 0.0 110.242 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -67.0 -48.12 69.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.074 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -75.82 -52.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.176 -0.953 . . . . 0.0 109.449 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 1.074 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -48.5 -53.44 16.47 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.69 -41.46 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.669 -1.489 . . . . 0.0 109.06 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -63.27 -13.37 37.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.411 -0.806 . . . . 0.0 110.178 -179.008 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.31 10.5 8.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 12.5 t30 79.66 -9.21 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.603 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -75.98 91.22 3.04 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.119 -0.988 . . . . 0.0 109.642 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -42.86 160.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.017 ' CG2' HG12 ' A' ' 5' ' ' VAL . 41.4 t -128.2 96.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.909 ' CD2' HG21 ' A' ' 37' ' ' ILE . 37.4 m-70 -114.12 94.57 4.88 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.126 -1.43 . . . . 0.0 110.957 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.821 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 52.5 m-85 -80.5 118.68 22.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.633 -0.667 . . . . 0.0 109.659 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.749 ' O ' HD23 ' A' ' 21' ' ' LEU . 27.7 tttt -149.39 116.02 5.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.105 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.918 HG22 ' OG1' ' A' ' 34' ' ' THR . 55.2 t -78.51 118.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.959 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -114.0 9.44 17.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.692 -0.63 . . . . 0.0 110.5 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 120.85 -1.156 . . . . 0.0 110.171 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 43.7 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.276 0.56 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 52.5 m-85 -150.42 125.65 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 109.195 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 46' ' ' GLU . 3.2 mm -89.29 92.12 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.064 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 99.7 m -88.89 115.08 26.18 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.94 0.876 . . . . 0.0 109.606 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.959 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -80.67 118.17 22.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.762 -0.586 . . . . 0.0 109.665 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.759 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -111.95 115.75 29.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.925 HG12 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -78.19 134.79 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.712 -1.243 . . . . 0.0 110.735 -177.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -136.55 120.67 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.585 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 8.75 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.506 3.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.916 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.487 ' C ' ' O ' ' A' ' 39' ' ' GLY . 18.4 m -29.3 -60.66 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.088 -0.654 . . . . 0.0 111.265 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -160.56 -167.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.552 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.925 HG22 HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -99.13 138.86 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.224 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.61 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.6 m -126.09 108.38 11.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -82.18 -168.86 2.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.997 -1.064 . . . . 0.0 109.891 -178.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 112.65 0.52 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.682 ' HB3' HD12 ' A' ' 33' ' ' ILE . 3.2 pt-20 -78.02 80.59 4.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.16 -1.2 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.529 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.533 ' CB ' ' OG1' ' A' ' 34' ' ' THR . 0.1 OUTLIER -36.36 -47.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.985 -0.447 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -47.45 76.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 1' ' ' PRO . 3.5 mttp -58.65 -65.17 0.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.967 . . . . 0.0 109.269 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.529 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -45.77 -60.96 1.93 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.579 -0.701 . . . . 0.0 109.552 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.064 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -43.28 -46.01 6.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.988 . . . . 0.0 109.797 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 1' ' ' PRO . . . -62.9 -65.15 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 58' ' ' ALA . 4.9 mt-10 -44.14 -59.63 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.946 -1.097 . . . . 0.0 108.504 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -43.67 -47.04 7.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.753 ' O ' HD13 ' A' ' 65' ' ' LEU . 39.0 tpp -60.09 -72.31 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.595 -0.69 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.798 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.2 mt -45.38 -67.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 62' ' ' LEU . 6.4 t -41.98 -33.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -67.8 -63.83 0.98 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.247 -0.908 . . . . 0.0 111.004 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.915 ' H ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -86.29 10.61 14.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.985 -178.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.481 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.3 mm-40 -96.77 -15.65 21.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.461 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.23 -32.6 22.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 67' ' ' LYS . 16.0 mt . . . . . 0 C--N 1.304 -1.392 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.678 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.6 Cg_exo . . . . . 0 N--CA 1.496 1.666 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 2' ' ' ILE . 8.0 mm -69.62 -65.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -55.59 -30.73 61.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.64 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 26.3 mt-30 -63.84 -55.24 24.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.198 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.069 HG22 ' CD2' ' A' ' 62' ' ' LEU . 36.1 t -57.94 -55.76 19.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.707 ' HA ' HG21 ' A' ' 16' ' ' VAL . 82.3 m-70 -44.53 -38.83 4.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.694 -1.254 . . . . 0.0 108.684 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -62.46 -67.83 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.691 -0.631 . . . . 0.0 110.868 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.935 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.11 -50.48 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 0.0 110.274 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.935 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -44.37 -57.05 5.2 Favored Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.8 -29.65 41.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -1.18 . . . . 0.0 109.451 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -80.25 -3.29 48.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.414 -0.804 . . . . 0.0 110.58 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -134.84 16.19 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 109.842 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.4 t-20 78.53 -6.88 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.577 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 5.8 mmm -81.82 90.69 6.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.049 . . . . 0.0 108.79 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.769 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -41.79 157.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.115 -0.991 . . . . 0.0 110.391 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' A' ' 6' ' ' HIS . 24.3 t -131.72 80.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 108.657 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.636 ' NE2' HG22 ' A' ' 15' ' ' THR . 84.5 m-70 -117.7 96.86 5.56 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.695 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.8 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 3.2 m-30 -79.7 137.7 37.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 110.372 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 6.9 ptpt -150.71 118.48 6.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.756 HG22 ' OG1' ' A' ' 34' ' ' THR . 66.3 t -78.97 129.25 37.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 108.984 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -88.61 -25.55 22.38 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.554 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 33.3 m-20 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.328 0.585 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 35.8 m-85 -131.86 125.83 32.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.342 -0.848 . . . . 0.0 109.429 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.702 HD12 ' HB3' ' A' ' 46' ' ' GLU . 2.0 mm -88.94 94.1 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.397 -0.814 . . . . 0.0 108.896 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.999 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 23.6 m -89.54 111.73 22.72 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 109.575 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -78.06 116.54 18.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.46 -0.775 . . . . 0.0 109.724 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.661 ' O ' ' HE1' ' A' ' 61' ' ' MET . 0.0 OUTLIER -109.63 118.42 36.51 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.996 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -87.41 134.17 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.776 -1.202 . . . . 0.0 112.808 -176.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.996 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.5 m -144.11 142.97 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.017 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 54.52 19.11 11.91 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.64 ' CA ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER 87.43 -23.25 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.926 -0.749 . . . . 0.0 109.576 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 41' ' ' ILE . 1.3 mp -89.43 130.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -90.67 133.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 120.877 -1.139 . . . . 0.0 110.897 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.602 HG21 ' HG2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -128.71 105.7 8.44 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.613 ' CG ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -81.42 -172.92 4.07 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.112 -0.993 . . . . 0.0 111.455 -177.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' ' 60' ' ' LYS . . . -155.83 112.33 0.52 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.702 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -78.0 78.24 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.064 -1.256 . . . . 0.0 111.02 -178.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.495 2.587 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 52' ' ' VAL . 22.7 p -42.11 -46.27 4.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.285 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -44.66 96.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.499 ' HD2' ' HG3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -62.2 -73.63 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.827 . . . . 0.0 109.181 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.534 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -39.0 -38.24 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -0.759 . . . . 0.0 110.072 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.999 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -62.6 -51.33 67.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.95 -1.094 . . . . 0.0 108.539 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.8 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -65.2 -57.94 7.25 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.293 -0.879 . . . . 0.0 110.842 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.537 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 17.5 mt-10 -46.79 -43.85 18.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.568 -1.333 . . . . 0.0 107.762 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.5 tttp -60.0 -43.54 95.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.715 ' HE1' HG22 ' A' ' 38' ' ' VAL . 2.3 mmt -57.0 -72.09 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.019 0.914 . . . . 0.0 111.368 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.069 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -54.18 -56.98 13.04 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 49.1 t -47.91 -32.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.146 -0.971 . . . . 0.0 108.693 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.602 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -67.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.813 . . . . 0.0 110.027 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.876 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -53.36 -24.4 12.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.114 -0.992 . . . . 0.0 110.073 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.876 ' NE2' HD12 ' A' ' 65' ' ' LEU . 32.1 mm-40 -80.31 -33.09 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.881 -1.137 . . . . 0.0 109.011 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -68.29 -41.24 81.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.89 . . . . 0.0 109.379 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--N 1.305 -1.363 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.554 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.798 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.4 Cg_endo . . . . . 0 N--CA 1.497 1.695 0 N-CA-C 109.792 -0.888 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.595 HG22 ' CD2' ' A' ' 6' ' ' HIS . 4.8 mm -68.5 -59.21 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -53.15 -33.48 52.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.9 mt-30 -64.32 -49.88 69.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.702 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.996 ' HA ' HD21 ' A' ' 62' ' ' LEU . 19.6 t -57.73 -64.9 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.414 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.595 ' CD2' HG22 ' A' ' 2' ' ' ILE . 93.7 m-70 -40.17 -39.0 0.84 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.624 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.0 mm-40 -62.2 -63.93 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.689 . . . . 0.0 110.676 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.938 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -67.75 -49.91 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.032 -1.043 . . . . 0.0 110.514 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.938 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.13 -54.3 9.94 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.83 -35.14 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.048 -1.266 . . . . 0.0 109.625 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.8 mmtm -76.16 -5.19 45.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -130.79 12.63 5.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.607 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 79.44 -8.7 1.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.785 ' SD ' HD22 ' A' ' 65' ' ' LEU . 4.3 mtt -76.21 96.18 3.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.995 -1.066 . . . . 0.0 109.376 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -49.75 153.75 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.017 -1.052 . . . . 0.0 109.438 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 5' ' ' VAL . 98.1 t -127.41 95.63 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.766 ' CD2' HG21 ' A' ' 37' ' ' ILE . 26.1 m-70 -116.47 92.69 3.95 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.425 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.888 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 43.6 m-85 -79.63 123.81 27.97 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.54 0.686 . . . . 0.0 110.43 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -150.19 117.18 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.85 HG22 ' OG1' ' A' ' 34' ' ' THR . 88.1 t -78.13 130.93 35.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 108.903 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.722 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -88.68 -26.38 21.87 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.956 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.889 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.478 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 2.6 m120 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.533 ' CB ' ' OG ' ' A' ' 53' ' ' SER . 23.0 m-85 -144.54 137.72 27.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 109.653 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.0 mm -91.62 96.95 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.054 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m -89.53 118.79 29.42 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 110.374 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.722 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.0 122.61 26.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.776 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.831 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -120.35 115.92 24.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.383 -1.448 . . . . 0.0 107.292 178.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.766 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -77.54 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.102 -0.998 . . . . 0.0 111.214 -177.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.96 HG13 ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -121.56 141.31 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -52.77 83.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER 160.37 -45.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.453 -1.027 . . . . 0.0 108.55 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.805 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -168.44 -175.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.31 129.22 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.93 -1.106 . . . . 0.0 109.03 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.5 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 31.8 m -119.52 90.34 3.31 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 5.6 pm0 -80.76 -171.17 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.925 -1.109 . . . . 0.0 109.604 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -162.77 165.63 36.41 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -122.35 93.04 3.85 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.965 -1.315 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.511 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 53' ' ' SER . 2.6 p . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -36.53 -41.45 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.835 -0.54 . . . . 0.0 110.464 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.1 OUTLIER -63.91 -61.97 1.94 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.981 -1.075 . . . . 0.0 109.416 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 7.7 mtpt -48.75 -62.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -44.52 -68.48 0.19 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.311 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.054 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -34.0 -47.63 0.28 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.352 0.596 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -58.33 -53.74 54.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 0.0 109.221 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -49.69 -40.91 41.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.023 -1.048 . . . . 0.0 108.388 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.5 -40.41 94.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.96 ' SD ' HG13 ' A' ' 38' ' ' VAL . 5.6 ttm -69.73 -70.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 110.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.996 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -48.49 -56.19 8.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 108.757 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 59' ' ' GLU . 99.0 t -50.66 -41.89 21.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.549 -0.72 . . . . 0.0 110.142 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.785 HD22 ' SD ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -48.83 -31.39 7.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.027 -1.046 . . . . 0.0 110.088 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.764 ' NE2' HD12 ' A' ' 65' ' ' LEU . 22.1 mm-40 -66.27 -41.65 89.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 0.0 109.738 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -66.46 -35.14 79.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.474 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.545 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.512 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 2.5 Cg_endo . . . . . 0 N--CA 1.496 1.626 0 N-CA-C 109.785 -0.891 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 1.022 HG22 ' CD2' ' A' ' 6' ' ' HIS . 5.6 mm -71.74 -46.51 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.79 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 p -59.61 -32.86 70.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 110.079 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 39.7 mt-30 -64.89 -55.59 18.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.012 . . . . 0.0 109.183 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.102 ' HA ' HD21 ' A' ' 62' ' ' LEU . 7.0 t -57.34 -63.61 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 1.022 ' CD2' HG22 ' A' ' 2' ' ' ILE . 81.7 m-70 -39.41 -37.59 0.47 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.083 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 1.5 mt-10 -62.0 -67.59 0.4 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.521 -0.737 . . . . 0.0 110.427 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.947 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.62 -49.78 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.058 -1.026 . . . . 0.0 110.556 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.947 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.17 -55.28 7.73 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.34 -46.38 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.264 . . . . 0.0 109.919 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -62.83 -11.7 19.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.79 10.12 7.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.007 . . . . 0.0 109.781 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 39.3 t30 79.38 -10.58 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.946 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.538 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -72.51 86.09 1.16 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.956 -1.09 . . . . 0.0 108.8 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -39.72 163.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.613 0.72 . . . . 0.0 110.731 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.03 HG22 HG12 ' A' ' 5' ' ' VAL . 61.1 t -137.38 88.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.866 ' CD2' HG21 ' A' ' 37' ' ' ILE . 51.6 m-70 -105.87 93.51 4.68 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.13 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.86 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -86.76 131.14 34.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.613 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.89 114.09 4.82 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.895 HG22 ' OG1' ' A' ' 34' ' ' THR . 56.0 t -78.19 111.69 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.87 -1.144 . . . . 0.0 108.909 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -91.32 -25.36 19.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.812 -0.555 . . . . 0.0 109.791 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.544 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.631 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 m120 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.941 0.877 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' HB3' ' CB ' ' A' ' 53' ' ' SER . 9.6 m-85 -140.26 117.26 11.12 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 22' ' ' ARG . 3.3 mm -90.74 122.24 41.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 120.943 -1.098 . . . . 0.0 108.764 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.024 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 10.0 m -123.59 109.71 14.11 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -76.31 118.77 19.36 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.602 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.999 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -123.05 114.41 20.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.059 -1.026 . . . . 0.0 108.335 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.935 HG12 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -78.95 135.07 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -0.839 . . . . 0.0 111.548 -177.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.696 HG23 ' HE2' ' A' ' 61' ' ' MET . 0.9 OUTLIER -133.12 148.65 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 45.14 -124.11 6.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t -111.96 8.11 20.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.574 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.595 ' H ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -125.69 149.65 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 108.794 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.935 HG22 HG12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -103.87 141.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.453 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -132.96 114.16 13.68 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.7 mt-10 -82.72 -167.51 1.66 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.859 -1.15 . . . . 0.0 109.773 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -152.14 110.79 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.641 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -84.25 64.66 8.41 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.33 -1.1 . . . . 0.0 110.041 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.57 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.496 2.689 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.822 HG13 ' N ' ' A' ' 53' ' ' SER . 1.7 p . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.822 ' N ' HG13 ' A' ' 52' ' ' VAL . 3.0 p 84.3 -58.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.79 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 2' ' ' ILE . 7.9 ptmt -77.84 -47.26 19.25 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.228 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 18.4 tttm -66.21 -39.57 89.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.385 -0.822 . . . . 0.0 108.997 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.57 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -68.14 -46.14 71.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.371 -0.831 . . . . 0.0 109.425 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.024 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -56.56 -57.84 10.62 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.113 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.721 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . . . -53.34 -48.67 68.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.164 -0.96 . . . . 0.0 110.294 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.548 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 3.3 mt-10 -54.83 -35.77 64.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 11.8 tptp -64.52 -36.3 83.77 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.696 ' HE2' HG23 ' A' ' 38' ' ' VAL . 54.1 mmm -73.32 -71.12 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.649 -0.657 . . . . 0.0 110.704 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.102 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -49.57 -41.03 40.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 0.0 109.004 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 70.5 t -65.6 -39.72 85.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.64 -59.83 3.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.681 -0.637 . . . . 0.0 109.455 179.105 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -59.95 -40.87 90.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.272 -0.892 . . . . 0.0 110.292 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 8.8 mm-40 -46.41 -25.77 0.72 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.778 -1.201 . . . . 0.0 109.1 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.7 -66.04 0.64 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 109.283 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.536 ' N ' HD23 ' A' ' 68' ' ' LEU . 5.3 mt . . . . . 0 C--N 1.3 -1.562 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 5' ' ' VAL . 5.4 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.727 -0.913 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.583 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.9 mm -72.74 -64.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.392 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 p -53.16 -28.06 24.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.268 -0.895 . . . . 0.0 109.233 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.4 mt-30 -67.08 -51.83 49.5 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 108.589 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.014 ' HA ' HD21 ' A' ' 62' ' ' LEU . 19.1 t -58.37 -60.38 2.36 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.651 ' HA ' HG21 ' A' ' 16' ' ' VAL . 92.6 m-70 -43.56 -39.98 3.74 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.953 -1.092 . . . . 0.0 109.093 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.1 mm-40 -60.53 -64.12 1.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 110.971 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.958 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.16 -49.95 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.891 -1.131 . . . . 0.0 110.727 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.958 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -48.0 -51.04 20.12 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -70.48 -46.35 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.662 -1.493 . . . . 0.0 109.889 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.92 -9.61 22.57 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.97 15.39 8.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 109.687 -179.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 72.64 -7.38 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.434 -0.791 . . . . 0.0 110.125 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 5.4 mtt -79.65 92.64 5.39 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.604 -1.31 . . . . 0.0 108.881 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -42.41 168.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.78 HG22 HG12 ' A' ' 5' ' ' VAL . 84.6 t -137.73 83.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 108.4 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.848 ' CD2' HG21 ' A' ' 37' ' ' ILE . 37.3 m-70 -106.42 92.53 4.16 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.563 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.914 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 37.4 m-85 -78.36 122.04 25.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.651 -0.656 . . . . 0.0 110.394 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.34 122.02 8.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.977 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.2 t -77.42 130.01 36.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 108.526 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.805 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.67 -22.46 23.4 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.414 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 6.2 m-85 -116.51 143.01 46.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.379 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 5.1 mm -90.62 111.8 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.12 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 7.4 m -103.86 118.63 37.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.144 -0.972 . . . . 0.0 110.737 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.805 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -84.68 122.96 29.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 0.0 111.141 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.653 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 4.1 t -114.63 121.07 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.848 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.86 130.57 36.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.662 -1.274 . . . . 0.0 109.929 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.704 HG21 ' SD ' ' A' ' 61' ' ' MET . 1.0 OUTLIER -135.5 119.35 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.387 0.613 . . . . 0.0 109.479 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 15.5 -101.44 0.01 OUTLIER Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.478 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -27.62 -60.79 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.223 -0.575 . . . . 0.0 111.247 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -164.79 -167.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.048 -1.032 . . . . 0.0 108.603 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.604 HG22 HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -89.67 134.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.996 -1.065 . . . . 0.0 110.168 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.8 m -123.25 107.96 12.26 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -90.05 -173.65 3.94 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.21 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -154.92 175.97 32.78 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -128.88 93.69 3.66 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.287 . . . . 0.0 109.683 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 53' ' ' SER . 2.9 p . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.535 0.684 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.483 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -39.59 -45.92 1.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.624 -0.672 . . . . 0.0 110.545 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' HG21 ' A' ' 34' ' ' THR . 1.9 tttt -62.31 -56.73 15.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.197 -0.939 . . . . 0.0 110.088 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -55.58 -65.64 0.56 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.651 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.514 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -43.8 -42.15 5.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.855 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.12 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -59.06 -46.07 89.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.075 -1.015 . . . . 0.0 108.779 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -61.18 -58.05 9.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 110.243 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.521 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -48.67 -40.61 28.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.909 -1.119 . . . . 0.0 107.996 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.62 -43.48 93.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.704 ' SD ' HG21 ' A' ' 38' ' ' VAL . 54.9 tpp -67.51 -70.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.612 -0.68 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.014 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -45.93 -60.17 2.41 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 84.9 t -48.77 -39.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 108.622 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -57.96 -69.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.929 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.854 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -45.72 -34.38 3.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.887 -1.133 . . . . 0.0 109.741 -179.061 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.854 ' NE2' HD12 ' A' ' 65' ' ' LEU . 28.9 mm-40 -63.82 -45.11 91.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.82 -1.175 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.06 -48.12 83.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--N 1.301 -1.525 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.542 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.523 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.7 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.642 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.5 mm -68.3 -66.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.2 -30.57 7.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 21.1 mm100 -63.94 -61.62 2.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.025 ' HA ' HD21 ' A' ' 62' ' ' LEU . 26.2 t -51.52 -57.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.935 . . . . 0.0 108.61 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.637 ' HA ' HG21 ' A' ' 16' ' ' VAL . 89.2 m-70 -44.41 -41.1 5.94 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.793 -1.192 . . . . 0.0 109.351 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.6 mm-40 -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.772 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.055 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -64.65 -54.08 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.184 -0.948 . . . . 0.0 110.355 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 1.055 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -48.97 -52.72 20.86 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.06 -45.53 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.352 . . . . 0.0 109.92 -178.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -65.12 -13.42 58.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -118.21 9.34 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 0.0 109.893 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 18.0 t-20 80.4 -12.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.62 ' CG ' HG13 ' A' ' 38' ' ' VAL . 5.6 mtt -76.52 98.89 4.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.998 -1.064 . . . . 0.0 108.662 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -46.6 172.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.695 -1.253 . . . . 0.0 109.85 -179.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.637 HG21 ' HA ' ' A' ' 6' ' ' HIS . 59.6 t -143.57 83.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.526 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.809 ' HB2' HG22 ' A' ' 37' ' ' ILE . 90.0 m-70 -116.81 97.35 5.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.399 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.853 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 58.7 m-85 -78.09 130.65 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.573 -0.704 . . . . 0.0 110.917 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.783 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -151.05 115.08 5.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.91 HG22 ' OG1' ' A' ' 34' ' ' THR . 78.9 t -78.37 118.95 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.965 -1.084 . . . . 0.0 108.461 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.985 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -114.03 -11.97 12.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.669 -0.645 . . . . 0.0 111.154 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 120.813 -1.179 . . . . 0.0 110.631 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 17.0 m-80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.606 0.717 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 45.6 m-85 -150.44 127.11 10.91 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 3.1 mm -89.6 96.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.135 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 19.9 m -88.73 114.06 24.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.44 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.985 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -87.76 115.28 25.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.551 -0.718 . . . . 0.0 111.098 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.652 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 12.4 t -105.59 114.5 28.71 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.001 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -77.59 130.47 36.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.739 -1.225 . . . . 0.0 109.906 -178.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.001 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.1 t -132.71 135.84 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.444 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 59.23 -116.16 8.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.402 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -120.56 12.43 11.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -1.091 . . . . 0.0 109.377 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' C ' ' A' ' 40' ' ' SER . 2.0 mp -135.0 151.21 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 108.984 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -95.9 135.46 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.015 -1.053 . . . . 0.0 110.424 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.608 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.2 m -121.93 101.8 7.78 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 5.2 mt-10 -88.16 -173.9 4.43 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 110.664 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -161.32 116.07 0.69 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.96 89.38 4.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.196 -1.179 . . . . 0.0 110.644 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.297 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 20' ' ' VAL . 1.7 p -39.31 -46.75 1.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 110.098 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -62.27 -75.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 1' ' ' PRO . 3.4 tttt -41.7 -66.53 0.33 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' NH1' ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -38.75 -56.6 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.744 . . . . 0.0 110.286 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.135 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -50.72 -50.42 55.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.171 -0.956 . . . . 0.0 110.036 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.664 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -58.08 -57.09 14.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.428 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 63' ' ' VAL . 39.0 mt-10 -48.21 -38.6 18.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.745 -1.222 . . . . 0.0 107.999 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.9 -43.46 98.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.688 ' SD ' HG21 ' A' ' 38' ' ' VAL . 41.0 tpp -67.83 -69.42 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.688 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.025 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -47.24 -60.14 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 59' ' ' GLU . 94.1 t -46.93 -41.01 5.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.085 -1.009 . . . . 0.0 108.395 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -54.51 -66.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.526 -0.734 . . . . 0.0 110.022 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -56.53 -21.42 26.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 110.164 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 20.2 mm-40 -67.06 -46.56 73.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.915 -1.116 . . . . 0.0 109.329 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' C ' HD23 ' A' ' 68' ' ' LEU . 26.7 mtmt -61.52 -53.51 55.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.312 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.574 ' N ' HD23 ' A' ' 68' ' ' LEU . 4.2 mt . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.599 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.921 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.3 Cg_endo . . . . . 0 N--CA 1.497 1.701 0 N-CA-C 109.739 -0.908 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 2' ' ' ILE . 4.8 mm -71.15 -59.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.392 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p -56.24 -33.3 65.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.28 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -64.09 -52.14 60.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 108.56 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.047 HG12 ' CG2' ' A' ' 16' ' ' VAL . 16.4 t -55.41 -66.23 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 91.4 m-70 -39.68 -38.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.471 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -60.72 -62.67 1.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 110.46 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.948 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -69.6 -50.11 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.067 -1.021 . . . . 0.0 110.809 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.948 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.64 -52.23 15.55 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.9 -45.47 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.356 . . . . 0.0 109.62 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.44 -10.3 24.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 -179.111 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.45 10.03 7.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.637 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.7 OUTLIER 79.7 -11.46 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.147 179.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.556 ' HA ' ' CA ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -74.72 95.16 2.82 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -47.34 158.83 0.15 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.372 -0.83 . . . . 0.0 109.486 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.047 ' CG2' HG12 ' A' ' 5' ' ' VAL . 42.3 t -133.03 94.63 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.878 ' CD2' HG21 ' A' ' 37' ' ' ILE . 35.8 m-70 -111.92 96.2 5.92 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.454 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.924 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 45.7 m-85 -83.51 120.03 25.42 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.8 ' O ' HD23 ' A' ' 21' ' ' LEU . 10.7 mttm -151.15 113.81 4.67 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.338 -0.851 . . . . 0.0 108.86 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.927 HG22 ' OG1' ' A' ' 34' ' ' THR . 72.3 t -78.57 118.87 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 108.672 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.973 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -117.24 -8.57 11.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 110.955 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.612 HH22 HD12 ' A' ' 21' ' ' LEU . 1.2 ttm-85 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 0.0 110.538 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 18.5 m-20 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.724 0.773 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 43.4 m-85 -150.86 132.56 14.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.4 mp -89.99 99.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.015 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 26.8 m -87.01 117.65 25.88 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.607 0.718 . . . . 0.0 109.229 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.973 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -81.01 117.07 21.3 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.499 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.983 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -117.41 114.36 23.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.878 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.93 132.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.067 -1.021 . . . . 0.0 110.77 -177.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -124.31 133.41 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -9.18 -84.1 0.01 OUTLIER Glycine 0 N--CA 1.507 3.383 0 CA-C-O 121.332 0.406 . . . . 0.0 112.781 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.476 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -35.11 -59.82 0.49 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.681 -0.894 . . . . 0.0 111.773 -178.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.646 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -161.31 -159.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.871 -1.143 . . . . 0.0 108.428 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.71 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -88.39 157.95 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.752 -1.218 . . . . 0.0 109.356 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.575 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 5.6 m -150.97 93.96 2.0 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.611 ' HG2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -79.56 -169.83 2.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 110.213 -179.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.561 ' HA2' ' CD ' ' A' ' 60' ' ' LYS . . . -170.78 118.86 0.77 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 4.3 pm0 -77.79 91.0 4.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -1.206 . . . . 0.0 110.585 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.496 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.665 ' OG ' HG21 ' A' ' 20' ' ' VAL . 9.2 p -33.51 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.24 0.543 . . . . 0.0 110.542 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -62.46 -50.1 72.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.326 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HG2' ' HG2' ' A' ' 1' ' ' PRO . 50.7 mtpt -57.41 -69.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -39.3 -61.83 0.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.999 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.015 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -43.06 -53.4 4.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -54.71 -53.56 53.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.317 -0.865 . . . . 0.0 110.923 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -49.43 -43.52 44.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.561 ' CD ' ' HA2' ' A' ' 45' ' ' GLY . 0.5 OUTLIER -55.02 -43.82 74.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.575 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 67.2 mmm -64.5 -67.67 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.872 0.844 . . . . 0.0 111.363 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.002 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -50.88 -57.19 9.1 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.028 -1.045 . . . . 0.0 108.959 -177.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 2.5 t -59.06 -25.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.202 -0.937 . . . . 0.0 109.007 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.609 ' HB3' HD13 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -64.5 -54.18 36.35 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.222 -0.924 . . . . 0.0 111.001 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.883 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -110.57 12.29 22.8 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.731 -1.231 . . . . 0.0 111.595 -178.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 76.3 mm-40 -94.94 -16.97 22.4 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.959 -1.088 . . . . 0.0 109.412 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -98.85 -49.07 4.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.598 ' N ' HD23 ' A' ' 68' ' ' LEU . 2.2 mt . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.8 Cg_exo . . . . . 0 N--CA 1.496 1.653 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.544 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.5 mm -79.59 -69.61 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.14 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -52.67 -23.86 7.43 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.7 mt-30 -66.85 -54.09 25.88 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.069 HG22 ' CD2' ' A' ' 62' ' ' LEU . 61.5 t -60.0 -55.93 20.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.664 ' HA ' HG21 ' A' ' 16' ' ' VAL . 89.7 m-70 -46.2 -37.16 6.75 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.875 -1.14 . . . . 0.0 108.599 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.5 mt-10 -62.18 -65.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 110.832 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.948 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.89 -49.7 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.58 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.948 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.22 -52.16 13.52 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.71 -45.73 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.809 -1.407 . . . . 0.0 109.852 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -66.2 -8.16 22.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 110.333 -179.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.52 10.01 8.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.625 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.9 t-20 79.86 -11.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.829 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.596 ' HE1' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -76.66 96.68 4.24 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.86 -1.15 . . . . 0.0 109.573 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -46.65 154.95 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.69 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 6' ' ' HIS . 46.8 t -129.92 90.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.806 ' CD2' HG21 ' A' ' 37' ' ' ILE . 24.5 m-70 -114.34 91.85 3.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.56 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.807 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 57.3 m-85 -79.82 123.01 27.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.691 -0.631 . . . . 0.0 110.137 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.758 ' O ' HD23 ' A' ' 21' ' ' LEU . 13.8 mttt -150.92 112.25 4.39 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.924 HG22 ' OG1' ' A' ' 34' ' ' THR . 69.2 t -78.48 121.32 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.063 -1.023 . . . . 0.0 109.124 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.987 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -115.59 8.92 15.21 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.808 -178.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 3.6 mpp_? . . . . . 0 N--CA 1.493 1.714 0 O-C-N 120.88 -1.138 . . . . 0.0 110.058 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.389 0.614 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 52.1 m-85 -150.88 125.74 9.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.445 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 2.4 mm -89.8 93.42 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.039 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 18.0 m -88.05 112.71 22.93 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.823 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.987 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -79.57 115.45 19.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.997 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -113.67 113.99 25.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.806 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.58 132.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.152 -0.968 . . . . 0.0 110.515 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.783 HG21 HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -119.74 147.25 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -47.99 88.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 155.51 -50.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.812 -0.817 . . . . 0.0 109.118 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -170.68 -166.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.312 -0.868 . . . . 0.0 108.718 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.54 133.79 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.382 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.561 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.8 m -127.01 93.67 3.82 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 2.7 pm0 -80.49 -173.52 4.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.737 -1.227 . . . . 0.0 110.604 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.89 113.42 0.56 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.553 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -78.2 81.95 4.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.208 -1.172 . . . . 0.0 110.232 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.516 ' O ' ' C ' ' A' ' 53' ' ' SER . 1.2 p . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.516 ' C ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -29.84 -68.02 0.08 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 23.9 mmtt -45.83 -50.61 14.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 1' ' ' PRO . 6.7 tttt -58.66 -73.14 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.526 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -37.62 -67.23 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.201 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.039 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -40.56 -55.14 2.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -51.55 -57.46 9.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.813 . . . . 0.0 110.633 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.506 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 25.5 mt-10 -47.94 -44.87 30.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 108.253 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.2 -44.03 71.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 108.976 179.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.639 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 70.7 mmm -65.95 -66.27 0.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.806 0.812 . . . . 0.0 111.311 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.069 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -50.82 -60.4 3.11 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 8.7 t -56.28 -26.95 23.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.184 -0.947 . . . . 0.0 109.13 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.56 ' HB3' HD13 ' A' ' 65' ' ' LEU . 2.0 mm-40 -62.89 -55.56 24.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.873 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -112.57 16.05 19.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.744 -1.223 . . . . 0.0 111.49 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.536 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 9.5 mm-40 -98.86 -33.8 10.73 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.064 -1.022 . . . . 0.0 109.261 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -66.86 -26.06 66.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.509 179.811 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.5 Cg_exo . . . . . 0 N--CA 1.497 1.709 0 N-CA-C 109.613 -0.957 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.556 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.6 mm -72.23 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.937 . . . . 0.0 109.276 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -54.55 -31.6 56.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.0 mm100 -63.41 -53.5 51.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.251 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.066 HG22 ' CD2' ' A' ' 62' ' ' LEU . 61.1 t -58.53 -54.82 27.92 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 108.534 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.566 ' HA ' HG21 ' A' ' 16' ' ' VAL . 87.4 m-70 -47.16 -37.59 10.32 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 120.618 -1.301 . . . . 0.0 108.755 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 13.0 mt-10 -63.24 -66.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.974 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.937 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -65.4 -49.33 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.012 . . . . 0.0 110.276 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.937 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.49 -56.6 7.12 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.2 OUTLIER -69.37 -30.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.076 -1.25 . . . . 0.0 109.73 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.1 mtmp? -79.92 -4.3 51.77 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.22 13.22 4.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.65 -179.556 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.8 t30 78.84 -7.6 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.777 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.575 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 3.5 mmt -78.84 95.2 5.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.958 -1.089 . . . . 0.0 109.01 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -47.38 155.35 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.786 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.704 ' CG2' HG12 ' A' ' 5' ' ' VAL . 45.8 t -131.72 93.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 108.724 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.804 ' CD2' HG21 ' A' ' 37' ' ' ILE . 29.1 m-70 -118.85 91.3 3.52 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.664 -1.215 . . . . 0.0 110.316 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.724 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 57.1 m-85 -78.49 129.42 34.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 110.441 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.803 ' O ' HD23 ' A' ' 21' ' ' LEU . 28.3 mttt -151.47 110.78 3.94 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.807 HG22 ' OG1' ' A' ' 34' ' ' THR . 72.0 t -78.6 118.84 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 109.033 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.954 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -119.22 10.69 12.1 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.703 . . . . 0.0 110.677 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' CD ' HG13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.96 -1.087 . . . . 0.0 110.32 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.417 0.627 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 15.6 m-85 -136.67 133.95 36.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.548 HG13 ' CD ' ' A' ' 22' ' ' ARG . 4.9 mm -89.21 97.5 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.133 -0.979 . . . . 0.0 108.472 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.079 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 18.8 m -88.47 113.21 23.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.954 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -78.81 117.7 20.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.589 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.958 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -116.04 116.11 27.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.804 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -79.14 130.41 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 111.248 -177.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.906 HG13 ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -112.78 146.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.039 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -53.18 84.94 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 159.91 -46.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.585 -0.95 . . . . 0.0 108.451 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -169.79 -176.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.8 153.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.86 -1.15 . . . . 0.0 108.884 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 17.1 m -149.04 94.71 2.28 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -79.68 -172.74 3.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.894 -1.128 . . . . 0.0 110.237 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.04 117.78 0.79 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -77.86 88.83 4.06 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.999 -1.295 . . . . 0.0 110.105 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.502 ' O ' ' C ' ' A' ' 53' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.511 ' HB3' ' CB ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -32.07 -38.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.263 0.554 . . . . 0.0 110.478 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.4 OUTLIER -69.45 -53.25 20.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.146 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG3' ' CG ' ' A' ' 1' ' ' PRO . 0.4 OUTLIER -56.35 -59.21 5.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.525 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -52.53 -43.03 64.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.118 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.079 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -55.3 -51.99 64.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.907 -1.12 . . . . 0.0 108.513 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.522 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -55.13 -50.02 70.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.571 -0.705 . . . . 0.0 110.168 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 8.3 mt-10 -54.37 -36.83 64.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.91 -36.44 83.96 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.906 ' CE ' HG13 ' A' ' 38' ' ' VAL . 80.0 mmm -71.49 -69.33 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.569 0.699 . . . . 0.0 111.141 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.066 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -51.8 -38.14 54.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 72.8 t -69.64 -36.37 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -58.07 -55.51 33.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.82 -38.35 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.026 -1.047 . . . . 0.0 109.527 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.422 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -66.01 -14.72 62.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 109.71 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -54.98 3.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.302 -1.496 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.57 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . 0.587 ' CG ' ' CG ' ' A' ' 55' ' ' LYS . 5.0 Cg_exo . . . . . 0 N--CA 1.495 1.603 0 N-CA-C 109.557 -0.978 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.571 HG22 ' CD2' ' A' ' 6' ' ' HIS . 4.3 mm -66.42 -60.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 108.975 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -27.69 43.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.395 -0.815 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 11.4 mt-30 -64.76 -57.35 9.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.071 HG12 ' CG2' ' A' ' 16' ' ' VAL . 13.8 t -53.42 -63.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.571 ' CD2' HG22 ' A' ' 2' ' ' ILE . 90.5 m-70 -39.86 -39.04 0.75 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.19 -0.944 . . . . 0.0 109.685 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 3.3 mt-10 -61.7 -62.06 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.95 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -70.02 -51.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.005 -1.059 . . . . 0.0 110.698 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.95 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.89 -49.29 17.59 Favored Glycine 0 N--CA 1.48 1.613 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.86 -46.29 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.529 -1.571 . . . . 0.0 109.851 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.73 -10.14 25.28 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 110.162 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -122.74 8.34 9.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.828 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 8.3 t-20 78.3 -8.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.416 -0.803 . . . . 0.0 109.627 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.83 ' HB3' HG12 ' A' ' 38' ' ' VAL . 8.6 mtp -78.66 87.67 4.58 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.899 -1.126 . . . . 0.0 109.404 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -40.28 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.579 -0.701 . . . . 0.0 109.896 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.071 ' CG2' HG12 ' A' ' 5' ' ' VAL . 42.0 t -137.43 78.85 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.837 ' CD2' HG21 ' A' ' 37' ' ' ILE . 37.3 m-70 -100.73 95.59 6.76 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.951 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.721 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -76.28 127.77 33.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 109.672 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -147.97 110.97 4.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.983 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.0 t -76.39 117.23 20.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.981 -1.074 . . . . 0.0 108.873 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.887 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -93.0 -23.1 18.79 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.933 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.551 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 110.277 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 78.2 m-20 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.519 ' CB ' ' CB ' ' A' ' 53' ' ' SER . 4.4 m-85 -118.63 121.13 39.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.029 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 46' ' ' GLU . 1.8 mm -89.08 91.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.1 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 15.4 m -88.95 108.64 19.67 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.874 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.887 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -79.85 115.73 19.61 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 18' ' ' PHE . 5.0 t -108.21 121.23 44.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 176.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.837 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -76.28 128.78 37.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.925 -1.109 . . . . 0.0 110.428 -177.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.975 HG13 ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -116.69 102.94 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . 6.65 -73.4 0.0 OUTLIER Glycine 0 N--CA 1.504 3.169 0 C-N-CA 122.979 0.323 . . . . 0.0 112.547 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 38' ' ' VAL . 30.6 m -41.93 -65.8 0.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -1.053 . . . . 0.0 109.908 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -147.64 -139.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -113.37 161.89 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.19 . . . . 0.0 109.502 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.77 HG21 ' HA ' ' A' ' 61' ' ' MET . 19.8 m -150.37 91.92 1.81 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.616 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.5 pt-20 -86.17 -176.5 5.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.156 -0.965 . . . . 0.0 110.686 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -154.9 109.08 0.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.837 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.7 pm0 -79.24 80.44 5.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.297 -1.119 . . . . 0.0 109.563 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 53' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.557 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 28.6 p -14.75 -56.15 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.303 0.573 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 52' ' ' VAL . 14.5 mmtp -63.55 -59.64 4.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.364 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.587 ' CG ' ' CG ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -56.29 -62.61 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.554 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -42.05 -44.88 3.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 110.029 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.1 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -59.48 -58.94 6.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.938 -1.102 . . . . 0.0 108.631 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -48.43 -66.55 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.948 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.2 mm-40 -44.43 -40.1 5.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.333 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -56.07 -49.4 73.9 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 108.999 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.975 ' SD ' HG13 ' A' ' 38' ' ' VAL . 18.5 ttm -68.65 -62.57 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.723 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.015 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -47.75 -64.3 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.825 -1.172 . . . . 0.0 108.274 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 48.6 t -50.61 -34.92 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -52.2 -66.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 109.05 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.733 HD22 ' H ' ' A' ' 65' ' ' LEU . 1.3 mm? -53.83 -44.18 70.06 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.9 -1.125 . . . . 0.0 110.15 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -53.55 -31.69 47.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.352 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.37 -41.7 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.617 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 64' ' ' GLU . 13.3 mt . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.522 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.9 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 N-CA-C 109.674 -0.933 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.989 HG22 ' CD2' ' A' ' 6' ' ' HIS . 5.7 mm -76.63 -51.17 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.324 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 t -52.05 -37.5 53.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.635 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 30.6 mt-30 -63.17 -53.65 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.021 HG22 ' CD2' ' A' ' 62' ' ' LEU . 24.2 t -54.9 -67.92 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.989 ' CD2' HG22 ' A' ' 2' ' ' ILE . 92.4 m-70 -36.87 -38.89 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.331 -0.855 . . . . 0.0 109.448 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 2.7 mt-10 -60.08 -62.26 2.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.717 -0.615 . . . . 0.0 110.171 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.936 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -74.1 -51.46 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.936 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -44.3 -52.38 7.22 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -78.0 -37.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.08 -1.247 . . . . 0.0 110.17 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.537 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 8.6 mmtm -60.65 -16.84 43.12 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.468 -0.77 . . . . 0.0 111.171 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.585 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.7 tpt180 -116.32 -44.1 2.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.79 -1.194 . . . . 0.0 109.578 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.585 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.8 OUTLIER 155.46 -15.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.017 -0.427 . . . . 0.0 109.928 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.696 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -71.91 111.8 7.47 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.834 -1.166 . . . . 0.0 110.054 -179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.598 HG22 ' NE2' ' A' ' 17' ' ' HIS . 0.0 OUTLIER -64.93 121.85 15.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 109.029 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.721 ' CG2' HG12 ' A' ' 5' ' ' VAL . 60.7 t -98.19 110.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.36 -0.838 . . . . 0.0 110.043 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.653 ' CD2' ' CG2' ' A' ' 37' ' ' ILE . 4.2 m-70 -136.49 95.5 3.17 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 118.869 -1.132 . . . . 0.0 109.588 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.871 ' CD1' HG23 ' A' ' 2' ' ' ILE . 60.2 m-85 -78.71 135.14 37.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 110.997 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.821 ' O ' HD23 ' A' ' 21' ' ' LEU . 4.7 mtmt -150.36 110.49 4.15 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.932 HG22 ' OG1' ' A' ' 34' ' ' THR . 95.2 t -78.62 118.39 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 108.818 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.923 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -118.76 10.26 12.34 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.659 -178.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.488 ' C ' ' CG ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -139.16 166.88 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.125 . . . . 0.0 110.267 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 7.9 mt-10 -156.93 42.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.766 . . . . 0.0 109.429 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 31' ' ' ASN . 7.6 pt-20 -176.3 -169.12 0.29 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.989 -1.069 . . . . 0.0 110.032 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.48 -148.66 5.35 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.75 -62.1 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.189 1.926 . . . . 0.0 110.12 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' CB ' ' A' ' 28' ' ' HIS . . . -174.73 40.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 109.303 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.606 ' N ' ' CD2' ' A' ' 28' ' ' HIS . 0.2 OUTLIER 164.4 73.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.347 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 28' ' ' HIS . 3.6 mtt 163.26 106.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.3 84.41 0.26 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.391 -0.818 . . . . 0.0 109.601 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 24' ' ' GLU . 6.5 m-20 -120.09 128.15 53.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.135 -0.978 . . . . 0.0 109.413 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 4.6 m-85 -99.87 127.09 46.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.029 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.815 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.6 mp -88.81 97.31 6.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.01 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 5.1 m -86.16 118.04 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.923 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -82.01 114.49 20.61 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.873 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.785 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.22 113.19 25.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.024 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -78.77 138.9 19.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.196 -0.94 . . . . 0.0 109.336 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.024 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.5 OUTLIER -131.4 146.42 33.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 42.38 -112.88 0.5 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -118.74 2.77 11.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -1.204 . . . . 0.0 109.94 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.76 154.15 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 108.477 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.92 160.25 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.855 -1.153 . . . . 0.0 110.229 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.488 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 23.3 m -150.34 90.6 1.67 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.561 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 3.8 mt-10 -81.12 -172.84 3.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.865 -1.147 . . . . 0.0 110.686 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.31 119.57 0.83 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -80.37 92.01 5.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.072 -1.252 . . . . 0.0 111.107 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . -81.19 120.29 5.09 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.617 ' O ' HG11 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -61.4 101.44 0.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.152 -1.204 . . . . 0.0 110.207 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 133.69 177.11 14.72 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 51' ' ' LYS . 3.4 pttm -94.34 -46.49 7.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -1.126 . . . . 0.0 109.56 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 50' ' ' LYS . 12.4 tttt -84.14 -9.69 58.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -84.81 -39.34 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.516 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -35.57 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.701 -0.624 . . . . 0.0 110.935 -179.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 52' ' ' VAL . 13.4 mttp -76.29 -49.68 16.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.593 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.73 -35.72 81.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 110.145 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 2.1 tpp180 -76.87 -40.32 48.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 109.885 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -61.81 -51.67 67.33 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.858 -1.151 . . . . 0.0 108.356 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -63.0 -56.38 17.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.541 -0.724 . . . . 0.0 110.051 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.1 mt-10 -46.78 -43.6 18.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.731 -1.231 . . . . 0.0 108.112 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.97 -43.2 95.25 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.917 ' SD ' HG23 ' A' ' 38' ' ' VAL . 5.9 ttm -65.15 -70.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.613 0.72 . . . . 0.0 110.484 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.021 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -47.71 -62.58 1.38 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 78.8 t -44.32 -38.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.37 -0.831 . . . . 0.0 108.991 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -58.03 -57.34 13.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.588 -0.695 . . . . 0.0 111.059 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.716 ' H ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -110.04 24.04 13.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.846 -1.159 . . . . 0.0 111.608 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.492 ' HG3' ' HB3' ' A' ' 62' ' ' LEU . 21.1 mm-40 -112.16 -20.41 11.92 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.483 ' HE2' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -98.6 -33.41 10.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.578 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.305 -1.352 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.681 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.675 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 3.0 Cg_exo . . . . . 0 N--CA 1.496 1.668 0 N-CA-C 109.597 -0.963 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.586 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.7 mm -80.32 -62.29 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.236 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -42.02 69.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.39 -0.819 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.6 mm100 -57.1 -52.0 67.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.107 -0.995 . . . . 0.0 108.936 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.871 HG22 ' CD2' ' A' ' 62' ' ' LEU . 74.7 t -55.61 -68.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.645 ' HA ' HG21 ' A' ' 16' ' ' VAL . 82.6 m-70 -35.15 -34.58 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.656 0.741 . . . . 0.0 109.578 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.2 mt-10 -68.61 -52.56 30.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.73 -0.606 . . . . 0.0 110.585 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.057 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -73.23 -45.89 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.729 -1.189 . . . . 0.0 108.676 -179.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 1.057 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -50.73 -52.97 27.66 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.4 -47.4 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.057 -1.26 . . . . 0.0 109.451 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -63.99 -10.05 19.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 110.342 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -125.22 8.06 7.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 109.833 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 80.19 -10.78 1.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.505 -0.747 . . . . 0.0 109.686 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.634 ' HE2' HG13 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -72.94 89.53 1.42 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.067 -1.021 . . . . 0.0 109.081 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -43.48 149.36 0.27 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 109.509 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 6' ' ' HIS . 39.9 t -125.93 102.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.167 -0.958 . . . . 0.0 109.033 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.881 ' CD2' HG21 ' A' ' 37' ' ' ILE . 39.0 m-70 -121.77 95.09 4.53 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.524 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.824 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 3.1 m-85 -81.21 129.82 34.76 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.955 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.695 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.66 111.41 4.27 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.922 HG22 ' OG1' ' A' ' 34' ' ' THR . 70.7 t -78.06 103.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 0.0 109.035 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.019 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -89.68 -21.85 22.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.072 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -131.81 144.21 50.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.647 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.561 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 39.2 mt-10 -133.04 113.61 12.99 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 109.643 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.588 ' HG3' ' CZ ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 34.91 63.2 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.716 -0.615 . . . . 0.0 110.482 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 24' ' ' GLU . . . 42.9 -141.61 1.96 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.81 -67.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.989 1.793 . . . . 0.0 110.119 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -167.57 81.17 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.342 -0.849 . . . . 0.0 109.565 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.526 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 45.8 m-70 -156.53 34.98 0.32 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 109.737 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 8.7 ptt? 39.85 30.49 0.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.461 -0.775 . . . . 0.0 110.268 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' N ' ' HB3' ' A' ' 24' ' ' GLU . 13.2 mttm -68.03 -98.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.109 -0.994 . . . . 0.0 109.768 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.47 ' N ' ' HA ' ' A' ' 24' ' ' GLU . 2.8 m120 -131.23 147.08 52.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.898 -1.126 . . . . 0.0 110.66 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 24' ' ' GLU . 20.6 m-85 -103.98 119.3 38.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.785 HD12 ' HB3' ' A' ' 46' ' ' GLU . 2.1 mm -89.48 92.01 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.91 -1.119 . . . . 0.0 109.021 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.042 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 19.5 m -89.59 113.46 24.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.493 -0.754 . . . . 0.0 109.131 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.019 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.01 116.61 20.24 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.44 -0.788 . . . . 0.0 110.236 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.854 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -113.27 115.24 27.87 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.881 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -76.69 134.78 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.961 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.969 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -130.17 135.11 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 49.23 -127.29 21.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -104.51 5.05 33.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -1.13 . . . . 0.0 109.774 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 38' ' ' VAL . 1.0 OUTLIER -122.15 151.61 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 108.894 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.85 160.96 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.968 -1.083 . . . . 0.0 109.746 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.479 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 21.2 m -150.45 92.01 1.81 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -81.42 -173.74 4.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.878 -1.138 . . . . 0.0 110.446 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.37 110.95 0.46 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.785 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.2 pt-20 -79.25 75.61 5.81 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 110.681 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.55 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -49.6 169.94 0.16 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.514 ' N ' HG11 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -113.45 98.24 6.96 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.962 -1.317 . . . . 0.0 110.959 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' ' HG2' ' A' ' 50' ' ' LYS . . . 33.99 -156.21 0.01 OUTLIER Glycine 0 N--CA 1.496 2.698 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 2.2 ptmt 45.9 -174.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.643 -0.916 . . . . 0.0 109.465 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 89.02 0.05 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.738 HG13 ' N ' ' A' ' 53' ' ' SER . 1.2 p -146.64 -158.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.738 ' N ' HG13 ' A' ' 52' ' ' VAL . 3.4 p 84.38 -57.93 0.11 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.915 -0.49 . . . . 0.0 109.693 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' N ' ' OG ' ' A' ' 53' ' ' SER . 4.6 pttp -80.06 -48.83 12.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 108.966 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.533 ' HG2' ' CG ' ' A' ' 1' ' ' PRO . 98.4 mttt -68.62 -30.03 68.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.309 -0.869 . . . . 0.0 109.183 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' HG3' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -79.49 -38.82 33.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.478 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.042 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.022 -1.049 . . . . 0.0 108.394 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.824 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -65.1 -54.69 26.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.474 -0.766 . . . . 0.0 110.214 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.4 mt-10 -48.51 -42.71 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.61 -1.306 . . . . 0.0 107.76 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 1.7 tptp -62.76 -39.46 94.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.969 ' SD ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -65.78 -71.46 0.19 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.613 . . . . 0.0 110.072 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.871 ' CD2' HG22 ' A' ' 5' ' ' VAL . 1.3 mt -51.76 -56.98 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.127 -0.983 . . . . 0.0 109.064 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 79.0 t -47.19 -39.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 108.506 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -61.15 -68.39 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.748 . . . . 0.0 110.386 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.35 -27.96 1.84 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.185 . . . . 0.0 109.964 -178.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 24.2 mm-40 -54.03 -49.49 68.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.931 -1.106 . . . . 0.0 109.536 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -51.22 36.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.985 . . . . 0.0 109.338 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--N 1.301 -1.511 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.48 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.496 1.651 0 N-CA-C 109.687 -0.928 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.822 HG22 ' CD2' ' A' ' 6' ' ' HIS . 3.4 mm -68.24 -54.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.152 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -53.09 -30.67 37.68 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 109.216 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.6 mm100 -65.04 -55.81 16.71 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.066 HG12 HG22 ' A' ' 16' ' ' VAL . 21.8 t -53.64 -67.67 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.373 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.822 ' CD2' HG22 ' A' ' 2' ' ' ILE . 90.7 m-70 -36.46 -39.12 0.18 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.42 -0.8 . . . . 0.0 110.047 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 7.5 mt-10 -63.56 -59.02 5.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.845 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.977 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.8 pp -70.92 -50.4 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.897 -1.127 . . . . 0.0 110.31 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.977 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.53 -49.65 20.4 Favored Glycine 0 N--CA 1.478 1.469 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.54 -45.6 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.664 -1.492 . . . . 0.0 109.823 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -64.0 -11.74 31.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.68 15.32 8.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.98 -1.075 . . . . 0.0 109.717 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 1.2 m-20 72.68 -4.82 2.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.545 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 3.0 mtp -79.75 91.2 5.28 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.809 -1.182 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -44.59 158.46 0.05 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.083 -1.011 . . . . 0.0 109.869 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.066 HG22 HG12 ' A' ' 5' ' ' VAL . 54.9 t -128.04 91.39 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.877 ' CD2' HG21 ' A' ' 37' ' ' ILE . 27.7 m-70 -109.42 92.88 4.23 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.087 -1.445 . . . . 0.0 110.581 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.921 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 39.7 m-85 -81.47 115.1 20.63 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.809 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -149.71 117.71 6.32 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.07 -1.018 . . . . 0.0 109.481 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.759 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.0 t -79.13 116.86 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.981 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.52 5.06 13.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.503 -0.748 . . . . 0.0 110.957 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -138.14 150.3 46.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.761 -1.212 . . . . 0.0 110.398 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 1.2 mp0 -131.24 121.88 25.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.527 -0.733 . . . . 0.0 109.208 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.49 166.96 21.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.42 103.89 1.65 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -59.52 -73.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.049 1.833 . . . . 0.0 110.327 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.476 ' H ' ' CD2' ' A' ' 28' ' ' HIS . . . -165.78 36.02 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 110.017 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.545 ' N ' ' CD2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -163.24 22.68 0.08 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.043 -1.035 . . . . 0.0 109.668 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 170.82 85.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.261 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.569 ' CB ' ' HA2' ' A' ' 49' ' ' GLY . 4.1 mttt -76.98 122.23 24.6 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 109.696 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -137.67 123.49 20.02 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.089 -1.007 . . . . 0.0 108.448 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.639 ' CE1' ' ND2' ' A' ' 48' ' ' ASN . 5.2 m-85 -106.08 151.41 24.72 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.067 -1.021 . . . . 0.0 108.647 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 5.8 mm -87.55 102.05 12.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.128 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 91.6 m -88.78 111.1 21.61 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.807 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.981 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.27 117.06 20.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.403 -0.811 . . . . 0.0 110.3 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.944 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -111.69 112.7 24.58 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.877 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.62 137.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.047 -1.033 . . . . 0.0 110.159 -177.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.946 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.6 OUTLIER -131.29 126.19 58.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.498 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 56.05 -121.83 25.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.35 4.72 19.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.15 . . . . 0.0 109.418 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.49 161.97 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 0.0 108.923 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.86 142.05 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.868 -1.145 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.564 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 20.3 m -132.49 92.1 3.03 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.547 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.1 mp0 -85.36 -168.71 2.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.012 -1.055 . . . . 0.0 111.171 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -155.75 -179.25 30.69 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.5 -2.64 . . . . 0.0 106.5 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 2.5 mt-10 -133.92 71.33 1.46 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 119.453 1.626 . . . . 0.0 110.874 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.612 ' O ' ' CB ' ' A' ' 48' ' ' ASN . . . -134.96 170.46 22.84 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.867 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.794 ' H ' HG12 ' A' ' 52' ' ' VAL . 0.6 OUTLIER 148.0 -17.71 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 122.075 -0.662 . . . . 0.0 109.871 179.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.569 ' HA2' ' CB ' ' A' ' 30' ' ' LYS . . . -43.28 -48.39 6.77 Favored Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.11 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.15 72.06 1.45 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.1 -1.235 . . . . 0.0 109.978 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 50.13 49.0 21.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.31 -0.869 . . . . 0.0 109.783 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.794 HG12 ' H ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -117.19 -27.35 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.173 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.486 ' H ' ' HA ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -33.81 -63.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.268 0.556 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.714 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -47.02 -51.04 18.25 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.111 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 56' ' ' ARG . 1.4 mttt -57.39 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.458 -0.776 . . . . 0.0 109.035 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -29.26 -66.48 0.09 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.889 -0.507 . . . . 0.0 111.226 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.128 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -46.36 -55.03 7.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 110.704 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.702 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -61.2 -53.96 50.3 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.19 -0.944 . . . . 0.0 111.529 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.582 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.8 mm-40 -49.47 -38.02 28.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.382 -1.449 . . . . 0.0 107.545 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 18.5 tptt -63.52 -41.16 98.5 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.946 ' SD ' HG23 ' A' ' 38' ' ' VAL . 3.3 ttm -68.48 -73.1 0.15 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.756 -0.59 . . . . 0.0 110.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.943 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -48.5 -47.58 38.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.326 -0.859 . . . . 0.0 109.857 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.582 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 72.2 t -60.71 -37.92 77.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.818 -1.176 . . . . 0.0 108.254 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -58.13 -58.01 10.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.634 -0.666 . . . . 0.0 110.341 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.581 HD13 HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -59.85 -35.88 75.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.853 -1.155 . . . . 0.0 110.13 -179.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -50.75 -26.4 5.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.002 -1.061 . . . . 0.0 109.719 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -58.5 -53.42 58.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 68' ' ' LEU . 6.9 mt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.487 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.832 ' O ' HD12 ' A' ' 2' ' ' ILE . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.652 0 N-CA-C 109.646 -0.944 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.078 HG22 ' CD2' ' A' ' 6' ' ' HIS . 2.5 mp 81.43 -55.58 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 2' ' ' ILE . 92.9 p -46.38 -50.26 16.8 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.723 -1.235 . . . . 0.0 108.451 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -58.04 -51.78 68.25 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.877 HG22 ' CD2' ' A' ' 62' ' ' LEU . 47.0 t -49.51 -77.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.078 ' CD2' HG22 ' A' ' 2' ' ' ILE . 93.4 m-70 -28.92 -41.96 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.419 0.628 . . . . 0.0 110.126 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 5' ' ' VAL . 4.0 mm-40 -60.34 -64.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.443 -0.785 . . . . 0.0 110.207 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.953 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -70.32 -49.43 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.168 -0.957 . . . . 0.0 110.651 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.953 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.96 -56.32 7.74 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -32.56 51.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.259 . . . . 0.0 109.321 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.3 mmtp -76.7 -4.55 43.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 110.422 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -133.91 16.07 3.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.381 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER 80.22 -10.98 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.656 -0.652 . . . . 0.0 109.98 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.829 ' SD ' HD22 ' A' ' 65' ' ' LEU . 5.2 mtt -75.74 100.37 4.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.81 -1.182 . . . . 0.0 109.674 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -50.5 174.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.827 -1.17 . . . . 0.0 109.55 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.869 ' CG2' HG12 ' A' ' 5' ' ' VAL . 95.8 t -149.09 88.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.856 ' CD2' HG21 ' A' ' 37' ' ' ILE . 45.7 m-70 -112.18 95.76 5.64 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.708 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.987 ' CD2' HG23 ' A' ' 2' ' ' ILE . 33.0 m-85 -80.21 118.65 22.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.507 -0.745 . . . . 0.0 111.441 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 123.3 8.69 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.702 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.4 t -79.78 130.07 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.943 -1.098 . . . . 0.0 108.925 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.042 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -89.0 -22.37 23.03 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.773 -0.579 . . . . 0.0 109.721 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.541 ' HG3' ' N ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER 162.82 154.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.528 -179.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -103.19 87.59 2.93 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 3.3 mm-40 -41.0 143.22 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 110.104 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.479 ' HA3' ' HG3' ' A' ' 30' ' ' LYS . . . 100.7 148.82 22.65 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.92 -81.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.252 1.968 . . . . 0.0 110.431 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.474 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -156.5 77.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 0.0 109.289 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.534 ' O ' ' CG ' ' A' ' 29' ' ' MET . 28.2 m-70 -153.98 58.86 0.73 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.89 . . . . 0.0 109.5 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.534 ' CG ' ' O ' ' A' ' 28' ' ' HIS . 5.0 ptp 41.39 31.45 0.17 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.414 -0.804 . . . . 0.0 109.672 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -58.35 -161.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 110.131 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 33.8 m-80 -89.13 152.25 21.74 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.07 -1.019 . . . . 0.0 110.284 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.63 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 7.2 m-85 -117.86 117.96 30.7 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.58 ' N ' HD13 ' A' ' 33' ' ' ILE . 1.6 mm -86.55 91.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.051 -1.031 . . . . 0.0 108.581 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.039 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 34.7 m -88.8 111.16 21.69 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.042 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -79.84 113.88 18.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.438 -0.789 . . . . 0.0 110.485 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.873 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.93 119.43 39.04 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 178.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.856 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -78.75 134.01 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.727 -1.233 . . . . 0.0 111.104 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.952 HG13 ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -129.97 140.5 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' H ' ' CA ' ' A' ' 14' ' ' MET . . . 50.61 -91.67 0.01 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.9 m -143.51 2.39 1.25 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.203 -1.175 . . . . 0.0 110.35 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 40' ' ' SER . 17.2 mm -117.05 160.8 16.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.991 -1.068 . . . . 0.0 108.603 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.69 125.38 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.862 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.82 HG21 ' HA ' ' A' ' 61' ' ' MET . 73.4 m -115.29 88.67 2.93 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -80.88 -172.82 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.985 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.497 ' HA3' ' HG3' ' A' ' 60' ' ' LYS . . . -160.89 115.96 0.69 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.059 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -78.47 78.59 4.93 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.131 -1.217 . . . . 0.0 109.816 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' CA ' ' CB ' ' A' ' 56' ' ' ARG . . . -74.33 129.1 11.1 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.987 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.6 ' N ' HG11 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -48.97 88.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.389 -1.065 . . . . 0.0 109.961 179.171 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.615 ' O ' ' CB ' ' A' ' 50' ' ' LYS . . . -29.6 157.93 0.0 OUTLIER Glycine 0 N--CA 1.498 2.817 0 CA-C-O 121.597 0.554 . . . . 0.0 112.131 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.615 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER 97.94 57.92 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 4.0 tttp 72.57 59.91 0.12 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.6 HG11 ' N ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -164.64 -41.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.916 . . . . 0.0 110.322 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.511 ' OG ' ' CG ' ' A' ' 32' ' ' PHE . 3.9 m -33.49 -74.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.705 -0.622 . . . . 0.0 111.739 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 55' ' ' LYS . 33.1 pttt -43.1 -51.73 5.74 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.145 -0.972 . . . . 0.0 111.1 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -54.51 -39.27 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.94 -1.1 . . . . 0.0 110.464 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.589 ' CB ' ' CA ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -72.66 -35.85 67.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.039 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -63.82 -53.0 57.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.91 -1.119 . . . . 0.0 108.405 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.531 ' HB2' HG13 ' A' ' 2' ' ' ILE . . . -62.3 -64.05 1.05 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.429 -0.794 . . . . 0.0 109.403 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.9 mt-10 -50.91 -25.5 4.67 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.754 -1.216 . . . . 0.0 108.502 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -65.89 -53.15 43.36 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.603 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.952 ' CE ' HG13 ' A' ' 38' ' ' VAL . 3.6 ptp -73.62 -51.46 16.7 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 117.865 -1.534 . . . . 0.0 110.448 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.877 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -48.66 -55.95 9.87 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 62.5 t -54.52 -37.77 39.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -53.88 -72.81 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.57 -0.706 . . . . 0.0 109.372 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.843 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -44.87 -37.44 3.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 109.884 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.843 ' NE2' HD12 ' A' ' 65' ' ' LEU . 21.5 mm-40 -58.33 -45.94 87.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.02 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.5 -36.37 83.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.061 -1.024 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 C--N 1.303 -1.415 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.574 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.553 ' HD2' ' CG ' ' A' ' 55' ' ' LYS . 2.0 Cg_endo . . . . . 0 N--CA 1.496 1.628 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.655 HG22 ' CD2' ' A' ' 6' ' ' HIS . 10.0 mm -95.12 -56.76 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.145 -0.972 . . . . 0.0 108.863 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -57.56 -33.84 68.57 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.342 -0.849 . . . . 0.0 109.053 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.556 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 3.2 pt20 -62.66 -48.88 77.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 108.479 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.05 HG22 HD21 ' A' ' 62' ' ' LEU . 99.1 t -59.98 -68.16 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.661 ' HA ' HG21 ' A' ' 16' ' ' VAL . 81.5 m-70 -34.7 -34.28 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.579 0.704 . . . . 0.0 109.514 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' VAL . 6.3 mt-10 -67.76 -69.37 0.32 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.171 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.01 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -57.89 -52.94 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.16 -0.962 . . . . 0.0 109.492 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 1.01 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -46.82 -49.65 16.56 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.687 HG22 ' N ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -80.16 -65.34 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.338 . . . . 0.0 109.955 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.687 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -39.68 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.473 -0.767 . . . . 0.0 111.428 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.594 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -104.67 -49.67 3.47 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.78 -1.2 . . . . 0.0 109.272 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.6 m-20 150.34 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.585 ' O ' ' CA ' ' A' ' 9' ' ' GLY . 4.5 mmt -56.19 97.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 110.154 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -46.41 158.37 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.725 -1.234 . . . . 0.0 109.361 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.746 ' CG2' HG12 ' A' ' 5' ' ' VAL . 96.9 t -130.35 82.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.819 ' CD2' HG21 ' A' ' 37' ' ' ILE . 23.9 m-70 -110.22 89.2 2.96 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.003 -1.479 . . . . 0.0 111.117 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.794 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 52.9 m-85 -75.87 120.78 21.69 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.781 ' O ' HD23 ' A' ' 21' ' ' LEU . 31.4 tttp -145.65 116.78 7.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.046 HG22 ' OG1' ' A' ' 34' ' ' THR . 47.2 t -78.31 113.38 17.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 120.967 -1.083 . . . . 0.0 109.062 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.967 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -111.05 16.71 21.0 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.84 -178.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.565 ' CD ' HG13 ' A' ' 33' ' ' ILE . 2.0 mtt180 -147.45 155.81 42.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.779 -1.201 . . . . 0.0 110.407 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 10.2 mt-10 -156.18 119.07 4.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 6.9 pt-20 -140.06 172.13 13.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.085 -1.009 . . . . 0.0 110.084 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 30' ' ' LYS . . . 122.34 145.37 6.99 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.519 ' HG2' ' NE2' ' A' ' 28' ' ' HIS . 2.2 Cg_endo -62.05 -69.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.149 1.9 . . . . 0.0 110.178 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' H ' ' CD2' ' A' ' 28' ' ' HIS . . . -170.38 33.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 109.759 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -159.43 -70.23 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 51.6 mtm -86.35 58.27 4.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 109.21 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 48.7 mttt -74.77 115.49 14.41 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.314 -0.866 . . . . 0.0 110.04 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 36.2 m-20 -94.99 144.27 25.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.197 -0.94 . . . . 0.0 108.509 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' A' ' 49' ' ' GLY . 17.3 m-85 -121.36 139.35 53.54 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 109.657 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.569 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 5.1 mm -89.39 96.57 6.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.046 ' OG1' HG22 ' A' ' 20' ' ' VAL . 4.3 m -88.33 119.88 29.17 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.548 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.967 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -95.14 114.16 25.92 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.523 -0.735 . . . . 0.0 111.085 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.852 ' HB3' ' HE3' ' A' ' 61' ' ' MET . 5.5 t -101.91 126.05 48.72 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.819 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.1 OUTLIER -75.11 133.37 31.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.616 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -125.11 130.88 73.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.127 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' N ' ' SD ' ' A' ' 14' ' ' MET . . . 42.34 -107.53 0.11 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 t -116.53 -7.51 11.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.604 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 38' ' ' VAL . 11.2 mt -112.87 148.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 108.661 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -91.31 128.01 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.869 -1.145 . . . . 0.0 110.913 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.754 HG23 ' HB ' ' A' ' 38' ' ' VAL . 20.5 p -103.89 93.05 4.67 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 2.5 pt-20 -94.93 179.47 5.22 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.748 -1.22 . . . . 0.0 109.753 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -164.13 166.97 37.9 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -114.76 92.81 4.07 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.885 -1.362 . . . . 0.0 110.079 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . -73.86 167.82 54.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.505 ' C ' HG11 ' A' ' 52' ' ' VAL . 10.5 p-10 -110.69 92.51 4.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -1.172 . . . . 0.0 109.621 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 32' ' ' PHE . . . 140.2 -154.98 24.3 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 tttm -112.81 -45.95 3.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -1.217 . . . . 0.0 109.564 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -88.73 -14.75 36.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.382 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' CD ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -76.27 -39.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 0.0 109.463 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.481 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 26.6 p -38.06 -33.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.671 -0.643 . . . . 0.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -72.9 -47.19 47.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.032 -1.042 . . . . 0.0 109.448 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.553 ' CG ' ' HD2' ' A' ' 1' ' ' PRO . 0.3 OUTLIER -59.73 -51.79 68.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -60.29 -63.67 1.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.947 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.991 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -42.06 -48.61 4.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.397 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.23 -55.14 34.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.805 . . . . 0.0 109.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 3.0 mm-40 -48.51 -33.54 9.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -66.1 -44.47 84.3 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.852 ' HE3' ' HB3' ' A' ' 36' ' ' CYS . 22.7 ttm -64.73 -60.73 2.76 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.389 -0.819 . . . . 0.0 110.081 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.05 HD21 HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -56.45 -61.24 2.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 53.8 t -49.71 -34.56 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.913 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' MET . 2.4 mm-40 -59.93 -63.75 1.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 0.0 109.885 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -59.57 -22.28 61.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.1 -1.0 . . . . 0.0 109.993 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 1.8 mp0 -82.22 -23.35 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.007 -1.058 . . . . 0.0 109.954 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -79.93 -35.1 38.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.082 -1.011 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--N 1.302 -1.46 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.59 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.543 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 3.3 Cg_exo . . . . . 0 N--CA 1.496 1.664 0 N-CA-C 109.634 -0.949 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' A' ' 54' ' ' LYS . 4.5 mm -72.5 -54.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.266 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.8 p -54.08 -37.31 64.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.432 -0.792 . . . . 0.0 109.505 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -58.7 -60.87 3.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.918 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.05 ' HA ' HD21 ' A' ' 62' ' ' LEU . 39.4 t -51.32 -66.91 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.323 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.799 ' CD2' HG22 ' A' ' 2' ' ' ILE . 75.5 m-70 -35.38 -35.96 0.06 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.578 -0.701 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.56 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -69.47 -50.63 43.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.472 -0.768 . . . . 0.0 110.261 -179.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.065 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -74.57 -48.51 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.999 -1.063 . . . . 0.0 109.337 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 1.065 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -50.44 -50.79 34.36 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.11 -46.46 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.816 -1.402 . . . . 0.0 109.784 -179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.87 -10.97 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.997 . . . . 0.0 110.089 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -121.03 8.19 10.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.231 -0.918 . . . . 0.0 110.001 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.0 OUTLIER 80.35 -11.53 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.444 -0.785 . . . . 0.0 109.579 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.58 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 4.2 mtt -73.57 106.92 5.56 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.015 -1.053 . . . . 0.0 109.071 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.53 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -61.32 136.36 58.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.431 -0.793 . . . . 0.0 109.931 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.963 ' CG2' HG12 ' A' ' 5' ' ' VAL . 69.0 t -110.73 112.13 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 109.496 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.78 ' HB2' HG22 ' A' ' 37' ' ' ILE . 15.0 m-70 -131.15 103.76 6.68 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.644 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.801 ' CD2' HD12 ' A' ' 2' ' ' ILE . 2.9 m-85 -90.67 136.27 33.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.606 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -150.33 110.07 4.06 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.872 HG22 ' OG1' ' A' ' 34' ' ' THR . 68.9 t -77.51 123.13 33.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 120.963 -1.086 . . . . 0.0 108.389 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -107.19 -14.58 14.87 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.348 -177.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.557 ' CB ' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -122.27 149.57 43.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.0 -1.063 . . . . 0.0 110.715 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' CG ' ' C ' ' A' ' 22' ' ' ARG . 9.8 mt-10 -157.99 92.07 1.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -54.96 -166.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 109.725 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -104.97 -147.08 15.69 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 3.2 Cg_exo -59.97 -79.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.294 1.996 . . . . 0.0 110.571 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.549 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -118.62 79.41 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.549 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 2.4 m-70 -157.79 88.1 0.96 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 108.926 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.53 ' O ' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER 51.5 35.07 13.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.138 -0.976 . . . . 0.0 108.586 -179.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -41.83 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.658 -0.651 . . . . 0.0 110.094 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.578 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 2.3 m120 -139.9 -178.89 5.65 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.503 -0.748 . . . . 0.0 109.278 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 58.6 m-85 -152.69 121.88 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.547 -0.721 . . . . 0.0 109.317 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.557 HG12 ' CB ' ' A' ' 22' ' ' ARG . 3.1 mm -89.4 92.15 3.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.1 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 31.1 m -87.76 109.83 20.01 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.969 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.855 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -77.55 122.07 24.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.984 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -126.18 111.67 14.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.759 -1.213 . . . . 0.0 108.464 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.08 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -78.49 136.63 23.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.223 -0.923 . . . . 0.0 110.844 -178.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.08 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.2 t -127.45 127.73 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 52.61 -118.05 7.3 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -111.1 0.47 16.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -1.161 . . . . 0.0 109.864 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 mt -116.11 134.02 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 108.971 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.78 HG22 HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -97.55 142.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.893 -1.129 . . . . 0.0 110.714 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.468 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -135.97 112.91 10.31 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.59 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -84.23 -170.24 3.0 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.841 -1.162 . . . . 0.0 109.098 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -160.81 108.61 0.36 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.45 -1.357 . . . . 0.0 109.785 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.553 ' CB ' HD13 ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.04 79.1 4.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.258 -1.142 . . . . 0.0 109.871 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 48' ' ' ASN . . . -85.25 136.75 14.72 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.598 ' HB2' HG11 ' A' ' 52' ' ' VAL . 16.1 m-20 -51.63 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -1.159 . . . . 0.0 111.164 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.776 ' O ' HG12 ' A' ' 52' ' ' VAL . . . -46.36 178.52 0.01 OUTLIER Glycine 0 N--CA 1.497 2.721 0 O-C-N 121.332 -0.855 . . . . 0.0 111.204 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -46.67 175.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.552 -0.97 . . . . 0.0 109.528 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? 59.82 33.22 21.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 49' ' ' GLY . 0.4 OUTLIER -179.66 -31.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.62 -0.675 . . . . 0.0 109.347 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 65.3 m -57.68 -80.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 0.0 110.206 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.892 ' HB2' HD11 ' A' ' 2' ' ' ILE . 1.8 pttt -51.29 -53.39 36.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.259 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 24.3 ttpp -53.22 -29.55 33.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 109.628 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -74.35 -45.16 48.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.409 -0.807 . . . . 0.0 109.468 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.1 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -60.71 -57.36 13.03 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.246 -0.909 . . . . 0.0 108.553 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.793 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -54.55 -48.44 72.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.368 -0.833 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 2.7 mm-40 -53.56 -39.29 64.66 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.32 -37.66 84.06 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.588 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 64.0 mmm -70.18 -71.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.0 110.95 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.05 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -49.5 -48.79 47.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.964 . . . . 0.0 109.066 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 75.1 t -60.04 -37.81 74.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -55.48 -61.09 2.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.595 -0.69 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.718 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -60.79 -34.28 74.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 110.521 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.718 ' NE2' HD12 ' A' ' 65' ' ' LEU . 21.2 mm-40 -65.56 -28.57 69.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.709 -1.244 . . . . 0.0 109.666 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -70.83 -30.16 66.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 109.4 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 C--N 1.304 -1.386 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.461 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.862 ' O ' HG23 ' A' ' 5' ' ' VAL . 5.4 Cg_exo . . . . . 0 N--CA 1.495 1.591 0 N-CA-C 109.745 -0.906 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.624 HG22 ' CD2' ' A' ' 6' ' ' HIS . 5.1 mm -69.85 -58.02 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.269 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 p -55.6 -37.89 68.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.6 mm100 -60.96 -55.71 29.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 0.0 108.644 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.987 ' HA ' HD21 ' A' ' 62' ' ' LEU . 23.5 t -51.77 -70.11 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.624 ' CD2' HG22 ' A' ' 2' ' ' ILE . 86.3 m-70 -34.68 -38.68 0.08 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.619 -0.675 . . . . 0.0 109.779 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.8 mt-10 -62.51 -63.8 1.12 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.433 -0.792 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.965 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.11 -49.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.191 -0.943 . . . . 0.0 110.58 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.965 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.59 -56.22 8.62 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.98 -30.73 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.118 -1.225 . . . . 0.0 109.504 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 6.5 mttm -79.84 -3.76 49.24 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 110.267 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.73 14.32 4.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 109.384 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER 80.69 -10.33 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.635 -0.666 . . . . 0.0 109.764 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.587 ' SD ' HD22 ' A' ' 65' ' ' LEU . 1.8 mtt -76.48 99.56 4.96 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.935 -1.103 . . . . 0.0 109.342 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -53.78 142.18 24.57 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.085 -1.009 . . . . 0.0 109.006 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.812 HG22 HG12 ' A' ' 5' ' ' VAL . 98.5 t -114.45 94.33 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.0 109.123 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.782 ' HB2' HG22 ' A' ' 37' ' ' ILE . 96.6 m-70 -119.26 102.74 8.91 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.161 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.809 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -86.84 125.3 33.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.353 -0.842 . . . . 0.0 110.115 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -138.99 114.67 9.92 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.015 HG22 ' OG1' ' A' ' 34' ' ' THR . 61.3 t -78.55 128.77 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.046 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.596 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -111.26 -11.16 14.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.706 -0.621 . . . . 0.0 110.097 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 12.3 mmt180 -140.23 170.33 16.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.031 -1.043 . . . . 0.0 109.993 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 32' ' ' PHE . 24.1 mp0 -144.08 20.38 1.76 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.544 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 49.3 tt0 161.75 141.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.881 . . . . 0.0 109.749 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.43 -138.02 1.97 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 5.8 Cg_exo -59.42 -42.59 47.22 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.732 1.621 . . . . 0.0 109.578 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 26' ' ' PRO . . . 173.81 -77.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.456 -0.778 . . . . 0.0 109.589 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.52 ' NE2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -37.03 123.6 0.88 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.702 -0.624 . . . . 0.0 110.412 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.29 97.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.428 -0.795 . . . . 0.0 110.134 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -67.58 105.64 1.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 108.682 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 26.9 m-20 -108.6 141.43 40.54 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.676 0.75 . . . . 0.0 110.986 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 3.2 m-85 -108.62 126.44 52.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.548 ' CG1' ' HB2' ' A' ' 22' ' ' ARG . 1.3 mm -96.01 123.88 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.094 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 6.1 m -119.85 116.47 25.91 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.041 -1.064 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.596 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -79.54 112.7 17.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.541 -0.725 . . . . 0.0 109.179 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.815 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -109.82 111.82 23.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.587 -1.321 . . . . 0.0 107.6 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.087 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -79.36 138.09 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 111.133 -177.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.087 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -125.29 136.0 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 42.24 -88.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 38' ' ' VAL . 12.8 t -136.82 -7.13 1.88 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.087 -1.243 . . . . 0.0 110.609 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.634 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.9 mt -108.05 136.85 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.908 -1.12 . . . . 0.0 108.414 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -92.03 129.12 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.851 -1.156 . . . . 0.0 110.729 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.2 p -115.76 98.37 6.64 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.574 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -82.94 -174.15 5.11 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.599 -1.313 . . . . 0.0 109.639 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -149.73 172.95 29.61 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.76 76.68 1.57 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.285 -1.127 . . . . 0.0 108.693 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -85.01 -160.8 33.1 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 61.5 m-20 -89.73 -160.04 0.65 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.274 -1.133 . . . . 0.0 108.251 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.594 ' HA2' ' CD1' ' A' ' 32' ' ' PHE . . . -107.36 139.14 14.86 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER 80.6 127.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.556 -0.967 . . . . 0.0 110.292 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 30.31 69.52 0.09 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.261 0.553 . . . . 0.0 110.859 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.088 HG22 ' CD ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -178.26 -42.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 0.0 109.414 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . 35.2 p -48.93 -54.93 13.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.888 -1.132 . . . . 0.0 109.559 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -55.94 -70.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.412 -0.805 . . . . 0.0 109.926 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' CA ' ' HD2' ' A' ' 1' ' ' PRO . 48.5 mttp -41.35 -68.9 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.742 . . . . 0.0 109.559 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 1.088 ' CD ' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -36.67 -63.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.895 -0.503 . . . . 0.0 110.494 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.094 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -44.17 -49.31 9.14 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.073 -1.017 . . . . 0.0 108.925 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.791 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -55.67 -57.91 10.0 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.344 -0.847 . . . . 0.0 110.637 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 20.8 mt-10 -46.28 -45.24 17.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.762 -1.211 . . . . 0.0 108.136 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -56.23 -43.55 78.71 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 1.013 ' SD ' HG13 ' A' ' 38' ' ' VAL . 4.8 ttm -66.41 -72.34 0.16 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.375 0.607 . . . . 0.0 110.602 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -46.89 -60.63 2.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.931 -1.106 . . . . 0.0 108.589 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 70.2 t -47.11 -39.13 4.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.749 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -58.07 -66.61 0.45 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.634 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -53.4 -28.2 28.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.979 -1.075 . . . . 0.0 110.547 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.634 ' NE2' HD12 ' A' ' 65' ' ' LEU . 31.5 mm-40 -65.11 -37.17 86.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.832 -1.168 . . . . 0.0 109.605 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -34.36 70.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.639 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.885 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.5 Cg_exo . . . . . 0 N--CA 1.496 1.625 0 N-CA-C 109.784 -0.891 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.584 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.0 mm -71.04 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -51.32 -37.64 48.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.349 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.5 mm-40 -62.45 -51.49 67.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.039 HG12 ' CG2' ' A' ' 16' ' ' VAL . 38.8 t -54.98 -66.83 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.37 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.545 ' CD2' HG22 ' A' ' 2' ' ' ILE . 93.6 m-70 -38.38 -38.61 0.38 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.494 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -61.03 -63.18 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.733 -0.604 . . . . 0.0 110.69 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.964 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.14 -49.06 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.029 -1.044 . . . . 0.0 110.791 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.964 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -49.36 -54.25 16.8 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -67.49 -39.24 82.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.885 -1.362 . . . . 0.0 109.476 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 11.3 mttm -69.64 -9.36 53.88 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.352 -0.843 . . . . 0.0 109.892 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.67 10.09 7.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.237 -0.915 . . . . 0.0 109.09 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 79.32 -10.28 1.35 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.75 . . . . 0.0 109.42 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.588 ' HE3' ' HG ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -75.54 101.76 5.01 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.943 -1.098 . . . . 0.0 109.302 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -53.06 163.58 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.054 -1.029 . . . . 0.0 109.473 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.039 ' CG2' HG12 ' A' ' 5' ' ' VAL . 48.9 t -133.45 92.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.87 ' CD2' HG21 ' A' ' 37' ' ' ILE . 31.8 m-70 -113.68 95.64 5.44 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.621 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.891 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 54.7 m-85 -81.65 119.32 23.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.623 -0.673 . . . . 0.0 110.278 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.766 ' O ' HD23 ' A' ' 21' ' ' LEU . 8.3 ttmm -151.01 115.96 5.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.317 -0.864 . . . . 0.0 109.066 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.846 HG22 ' OG1' ' A' ' 34' ' ' THR . 93.4 t -79.01 119.29 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.06 -1.025 . . . . 0.0 108.668 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.987 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -116.21 1.39 13.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 110.984 -178.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -152.95 163.08 40.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.676 -1.265 . . . . 0.0 110.819 -179.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -122.08 -162.62 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -143.09 104.03 4.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.002 -1.061 . . . . 0.0 109.687 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . 57.9 160.56 0.03 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.506 ' HD2' ' NE2' ' A' ' 28' ' ' HIS . 4.1 Cg_exo -60.67 -69.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.406 2.07 . . . . 0.0 110.347 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 30' ' ' LYS . . . -120.16 -63.77 1.33 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.595 -0.691 . . . . 0.0 109.402 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' NE2' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -38.89 106.01 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.651 -0.655 . . . . 0.0 109.625 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 69.01 81.77 0.18 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.258 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -84.96 64.8 8.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.7 m-20 -89.71 171.91 9.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.874 -1.141 . . . . 0.0 109.236 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 35.2 m-85 -144.55 141.55 29.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.6 mm -89.47 99.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.065 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 35.8 m -89.22 113.31 24.51 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.459 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.987 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -80.85 119.51 23.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -0.909 . . . . 0.0 110.036 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.818 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -114.37 116.01 28.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.87 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.32 134.36 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.816 -1.177 . . . . 0.0 109.983 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.944 HG23 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -129.19 131.22 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -10.0 -85.01 0.01 OUTLIER Glycine 0 N--CA 1.504 3.226 0 CA-C-O 121.142 0.301 . . . . 0.0 112.579 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -36.29 -59.19 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.691 -0.888 . . . . 0.0 111.328 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.704 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -162.07 -168.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.935 -1.103 . . . . 0.0 108.854 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -89.1 133.47 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.095 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.451 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 2.4 m -121.63 103.57 9.0 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 15.2 pt-20 -84.46 -169.8 2.79 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.808 -1.183 . . . . 0.0 110.441 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -156.96 178.99 33.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 107.967 -2.053 . . . . 0.0 107.967 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -127.94 82.73 2.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.892 -1.358 . . . . 0.0 110.533 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 53' ' ' SER . . . -52.83 167.62 1.04 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.583 ' N ' HG11 ' A' ' 52' ' ' VAL . 6.9 t-20 -130.67 81.5 2.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.257 . . . . 0.0 110.726 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.958 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 108.11 -172.07 16.73 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.31 -177.31 5.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.384 -1.068 . . . . 0.0 109.167 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt 48.96 23.78 0.76 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 108.831 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.958 HG12 ' O ' ' A' ' 49' ' ' GLY . 0.8 OUTLIER -144.93 -156.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.452 -0.78 . . . . 0.0 109.124 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.827 ' N ' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER 83.18 -55.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 109.571 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -44.15 44.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.022 . . . . 0.0 108.89 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.536 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -66.01 -44.81 83.68 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.275 -0.89 . . . . 0.0 108.636 179.173 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -61.78 -64.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.065 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -41.35 -46.25 3.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.504 -0.747 . . . . 0.0 109.244 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 18' ' ' PHE . . . -57.91 -61.57 2.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.42 -0.8 . . . . 0.0 110.31 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -45.53 -50.26 13.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.795 -1.19 . . . . 0.0 108.59 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 12.9 tptt -51.22 -45.53 61.96 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.944 ' SD ' HG23 ' A' ' 38' ' ' VAL . 2.2 ttm -63.3 -70.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.59 -0.694 . . . . 0.0 110.353 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.921 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -46.25 -64.16 0.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 10.6 t -51.51 -29.48 9.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.448 -0.783 . . . . 0.0 109.561 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 3.8 mm-40 -67.89 -55.81 11.44 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.085 -1.01 . . . . 0.0 111.391 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -95.32 8.38 43.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.432 -1.418 . . . . 0.0 110.404 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 88.5 mt-30 -101.12 -13.33 18.22 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.4 -0.813 . . . . 0.0 109.381 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 -36.95 5.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 109.274 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.563 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.921 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.0 Cg_endo . . . . . 0 N--CA 1.495 1.608 0 N-CA-C 109.567 -0.974 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.485 HG22 ' CD2' ' A' ' 6' ' ' HIS . 5.1 mm -71.73 -64.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.5 p -51.36 -42.11 61.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.42 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 6.1 mt-30 -57.66 -54.0 51.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 108.837 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.951 HG22 ' CG ' ' A' ' 62' ' ' LEU . 56.5 t -53.15 -68.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.553 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 88.0 m-70 -34.97 -38.87 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.683 -0.636 . . . . 0.0 109.701 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 4.7 mt-10 -63.98 -56.53 14.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 110.06 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.068 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -72.41 -53.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.192 -0.943 . . . . 0.0 109.723 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 1.068 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -45.36 -48.34 11.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -73.84 -44.82 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.587 -1.537 . . . . 0.0 110.358 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.9 mtmt -64.61 -11.06 31.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.074 -1.016 . . . . 0.0 110.321 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -120.36 8.1 10.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.938 . . . . 0.0 109.856 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.0 t-20 78.86 -6.44 1.9 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.846 ' CE ' HD22 ' A' ' 65' ' ' LEU . 32.6 mtp -79.45 89.93 5.04 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -42.0 161.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.467 -0.771 . . . . 0.0 109.844 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.94 ' CG2' HG12 ' A' ' 5' ' ' VAL . 60.7 t -132.65 93.38 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.851 ' CD2' HG21 ' A' ' 37' ' ' ILE . 40.8 m-70 -110.31 97.7 7.11 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 118.306 -1.358 . . . . 0.0 110.439 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.753 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 39.0 m-85 -84.69 119.39 25.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 110.972 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.739 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.52 116.58 5.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.011 HG22 ' OG1' ' A' ' 34' ' ' THR . 86.4 t -78.66 126.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 109.327 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.927 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -126.78 9.49 6.99 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.624 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.553 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -145.05 156.43 43.92 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.636 -1.225 . . . . 0.0 111.192 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 32' ' ' PHE . 5.3 mt-10 -157.32 141.21 16.03 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 25' ' ' GLY . 37.9 tp10 -46.08 160.02 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -0.97 . . . . 0.0 109.763 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' HG3' ' A' ' 24' ' ' GLU . . . -64.31 -126.75 0.01 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.71 -81.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.017 1.812 . . . . 0.0 110.541 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.535 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -143.79 92.47 2.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 109.805 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.535 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 34.8 m-70 -157.69 91.34 1.14 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.281 -0.887 . . . . 0.0 108.915 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.471 ' O ' ' N ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER 50.92 78.72 0.1 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.073 -1.017 . . . . 0.0 108.4 -179.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -55.4 86.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.557 -0.715 . . . . 0.0 110.45 -179.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 6.6 m120 -104.5 108.31 19.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.939 -1.101 . . . . 0.0 108.286 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 3.0 m-85 -88.02 129.72 35.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.3 mp -89.45 96.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.04 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 26.4 m -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.888 0.852 . . . . 0.0 108.91 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.927 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -90.09 120.2 31.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.938 -0.476 . . . . 0.0 109.912 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.804 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -117.94 117.74 30.07 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.851 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -77.26 132.56 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.952 -1.092 . . . . 0.0 110.536 -177.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.668 HG22 ' HE2' ' A' ' 14' ' ' MET . 0.8 OUTLIER -125.0 108.24 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 14' ' ' MET . . . 18.6 -105.82 0.01 OUTLIER Glycine 0 N--CA 1.504 3.216 0 CA-C-O 121.44 0.467 . . . . 0.0 112.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.1 m -24.18 -56.14 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.449 HG13 ' C ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -156.4 -161.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.954 -1.091 . . . . 0.0 109.09 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.59 163.95 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.47 179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.653 HG23 ' OE2' ' A' ' 64' ' ' GLU . 53.8 m -150.5 90.51 1.65 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.555 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 6.7 pt-20 -86.64 -169.97 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.918 -1.114 . . . . 0.0 109.903 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -172.87 156.01 24.03 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 1.2 pt-20 -110.79 98.23 7.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.833 -1.392 . . . . 0.0 110.623 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.582 ' HA3' ' CB ' ' A' ' 56' ' ' ARG . . . -101.47 131.83 10.73 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.579 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -49.47 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.331 -1.099 . . . . 0.0 110.031 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.652 ' O ' ' CB ' ' A' ' 50' ' ' LYS . . . -30.46 155.66 0.0 OUTLIER Glycine 0 N--CA 1.497 2.748 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.652 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 0.6 OUTLIER 104.87 60.03 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 78.81 20.24 0.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.579 ' CG1' ' N ' ' A' ' 48' ' ' ASN . 0.8 OUTLIER -134.11 -17.52 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.485 ' O ' ' C ' ' A' ' 54' ' ' LYS . 49.6 m -60.91 -93.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.89 -1.131 . . . . 0.0 110.217 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.541 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.0 OUTLIER -32.15 -61.41 0.25 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.522 -0.736 . . . . 0.0 111.424 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.509 ' HB3' ' CG ' ' A' ' 1' ' ' PRO . 1.1 mttt -49.35 -50.75 38.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.054 . . . . 0.0 109.808 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.582 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 7.6 tpt180 -55.53 -57.52 11.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.471 -0.768 . . . . 0.0 109.787 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.04 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -44.59 -47.14 10.31 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.047 0.927 . . . . 0.0 108.658 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -54.31 -64.72 0.74 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 74.2 mt-10 -49.02 -23.97 1.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.201 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -64.36 -53.95 40.54 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.463 -0.773 . . . . 0.0 109.236 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.614 ' HA ' HG21 ' A' ' 43' ' ' THR . 3.4 ptp -77.72 -51.36 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.419 -1.312 . . . . 0.0 110.196 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.951 ' CG ' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -46.74 -47.73 20.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.393 -1.442 . . . . 0.0 107.732 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 79.3 t -65.21 -38.66 83.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.653 ' OE2' HG23 ' A' ' 43' ' ' THR . 1.8 mm-40 -51.33 -68.79 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.846 HD22 ' CE ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -48.51 -44.32 35.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.937 . . . . 0.0 109.602 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.683 ' NE2' HD12 ' A' ' 65' ' ' LEU . 5.1 mm-40 -45.51 -65.01 0.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.962 -1.086 . . . . 0.0 109.489 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -46.02 -52.46 11.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.629 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 68' ' ' LEU . 5.0 mt . . . . . 0 C--N 1.302 -1.492 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.566 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.537 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 1.3 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 N-CA-C 109.556 -0.978 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.012 HG22 ' CD2' ' A' ' 6' ' ' HIS . 7.9 mm -78.66 -47.88 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 110.01 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 t -46.81 -51.12 17.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.128 -0.982 . . . . 0.0 110.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -50.73 -57.65 7.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.931 -1.106 . . . . 0.0 110.271 -179.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.044 HG22 ' CD2' ' A' ' 62' ' ' LEU . 24.9 t -54.08 -58.17 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.803 -1.186 . . . . 0.0 108.969 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.012 ' CD2' HG22 ' A' ' 2' ' ' ILE . 79.0 m-70 -42.56 -34.69 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.837 -1.164 . . . . 0.0 108.839 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 9.7 mt-10 -71.23 -71.73 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.764 -0.585 . . . . 0.0 110.485 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.052 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -54.48 -48.47 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 120.669 -1.269 . . . . 0.0 109.745 -179.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 1.052 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -52.98 -59.2 9.71 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.9 -52.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.699 -1.471 . . . . 0.0 110.212 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -55.4 -19.47 9.24 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.046 -179.051 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -121.75 23.07 10.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.6 -1.313 . . . . 0.0 111.168 -179.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 77.53 -11.82 1.15 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.084 -1.01 . . . . 0.0 111.141 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.845 ' HB3' HG22 ' A' ' 38' ' ' VAL . 4.6 mtt -78.3 93.93 4.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.124 . . . . 0.0 109.603 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -42.63 166.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.893 -1.129 . . . . 0.0 110.194 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.818 HG21 ' HA ' ' A' ' 6' ' ' HIS . 24.2 t -139.67 77.81 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.843 ' CD2' HG21 ' A' ' 37' ' ' ILE . 36.8 m-70 -102.15 91.57 4.37 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.77 -1.172 . . . . 0.0 110.348 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.66 ' CD2' HG23 ' A' ' 2' ' ' ILE . 29.1 m-85 -80.1 110.14 15.23 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.548 0.689 . . . . 0.0 110.767 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -131.53 119.0 20.91 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 67.6 t -79.89 136.05 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.033 -1.042 . . . . 0.0 110.175 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 3.4 mt -96.04 -15.08 22.46 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.562 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 91.08 171.09 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.691 0.758 . . . . 0.0 110.665 179.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.793 ' OE1' ' HB3' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -44.47 175.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.72 0.772 . . . . 0.0 111.128 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.46 96.81 10.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.692 -0.63 . . . . 0.0 110.451 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.68 -122.27 27.44 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.75 ' HA ' ' NE2' ' A' ' 28' ' ' HIS . 9.7 Cg_endo -64.96 -140.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.66 1.573 . . . . 0.0 108.716 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.793 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . . . 57.81 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.473 -0.767 . . . . 0.0 111.388 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.75 ' NE2' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER 57.0 32.21 21.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.237 -0.914 . . . . 0.0 109.79 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.478 ' N ' ' HG3' ' A' ' 23' ' ' GLU . 3.2 mmt -162.78 22.51 0.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.503 -0.748 . . . . 0.0 109.142 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 72.2 mttt -129.09 -111.88 0.27 Allowed 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.114 -0.991 . . . . 0.0 110.762 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' N ' ' OE2' ' A' ' 23' ' ' GLU . 1.1 m120 -91.38 118.5 30.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.75 -1.219 . . . . 0.0 111.041 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.611 ' CD1' ' HG2' ' A' ' 23' ' ' GLU . 3.0 m-85 -90.33 128.54 36.47 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 2.9 mm -88.51 95.94 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.097 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.073 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 53.5 m -90.03 114.6 26.51 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -82.44 129.53 34.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.095 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.653 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -123.26 116.39 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.5 -1.375 . . . . 0.0 107.612 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.909 HG12 HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -80.41 136.34 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.01 -1.056 . . . . 0.0 111.961 -177.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.845 HG22 ' HB3' ' A' ' 14' ' ' MET . 0.9 OUTLIER -135.35 136.35 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 50.66 -124.44 19.57 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.34 5.54 23.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.16 148.27 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 108.898 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.909 HG22 HG12 ' A' ' 37' ' ' ILE . 1.5 t -108.07 143.2 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.946 -1.097 . . . . 0.0 110.293 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.552 ' OG1' ' CE ' ' A' ' 61' ' ' MET . 50.9 p -132.1 113.96 13.96 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -87.69 -168.02 2.08 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 110.008 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA2' ' HG2' ' A' ' 60' ' ' LYS . . . -161.11 114.47 0.61 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.2 OUTLIER -77.99 83.65 4.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.959 -1.318 . . . . 0.0 109.88 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.588 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . -86.68 122.28 6.06 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.54 ' O ' ' O ' ' A' ' 49' ' ' GLY . 3.8 m120 -47.49 93.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -1.181 . . . . 0.0 109.508 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' ASN . . . -13.06 -114.58 0.0 OUTLIER Glycine 0 N--CA 1.506 3.361 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.772 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER 36.33 38.18 0.07 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.659 -0.906 . . . . 0.0 109.56 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 50' ' ' LYS . 2.1 ttmt 71.26 62.81 0.16 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' C ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -149.37 -44.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 110.252 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -24.35 -43.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -69.16 -59.65 2.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.937 -1.102 . . . . 0.0 109.648 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 3.6 ttpm? -50.06 -42.89 50.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.847 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.588 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -69.99 -34.4 73.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.396 -0.815 . . . . 0.0 110.471 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.073 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -64.66 -51.13 64.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.891 -1.131 . . . . 0.0 108.645 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.53 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -60.97 -51.71 68.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.532 -0.73 . . . . 0.0 109.772 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 63' ' ' VAL . 4.8 mt-10 -51.18 -44.33 61.51 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.475 ' HG2' ' HA2' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -61.58 -36.23 80.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.671 ' HG3' HD23 ' A' ' 62' ' ' LEU . 34.8 tpp -70.25 -71.37 0.24 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.49 -0.756 . . . . 0.0 110.617 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.044 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -49.34 -52.69 26.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 108.33 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 59' ' ' GLU . 78.1 t -52.02 -39.7 26.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 108.653 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 61' ' ' MET . 1.8 mm-40 -59.36 -64.26 1.01 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.574 HD22 ' SD ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -53.58 -28.41 31.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.978 -1.076 . . . . 0.0 110.257 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 18.1 mm-40 -54.04 -62.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.842 -1.161 . . . . 0.0 109.615 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -54.92 -39.98 69.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.521 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 68' ' ' LEU . 5.2 mt . . . . . 0 C--N 1.301 -1.517 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.447 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.576 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 4.6 Cg_exo . . . . . 0 N--CA 1.493 1.497 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.948 HG22 ' CD2' ' A' ' 6' ' ' HIS . 8.1 mm -97.58 -50.91 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 109.111 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.49 -45.76 18.62 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 0.0 109.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER -55.6 -60.18 3.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.975 . . . . 0.0 108.979 179.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.017 HG12 ' CG2' ' A' ' 16' ' ' VAL . 48.5 t -46.59 -68.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 108.355 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.948 ' CD2' HG22 ' A' ' 2' ' ' ILE . 92.9 m-70 -36.8 -38.93 0.19 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.457 -0.777 . . . . 0.0 110.242 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -67.0 -48.12 69.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.824 . . . . 0.0 110.48 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.074 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -75.82 -52.67 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.176 -0.953 . . . . 0.0 109.449 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 1.074 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -48.5 -53.44 16.47 Favored Glycine 0 C--N 1.298 -1.579 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -66.69 -41.46 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.669 -1.489 . . . . 0.0 109.06 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -63.27 -13.37 37.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.411 -0.806 . . . . 0.0 110.178 -179.008 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.31 10.5 8.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 12.5 t30 79.66 -9.21 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.603 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -75.98 91.22 3.04 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.119 -0.988 . . . . 0.0 109.642 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -42.86 160.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.017 ' CG2' HG12 ' A' ' 5' ' ' VAL . 41.4 t -128.2 96.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.909 ' CD2' HG21 ' A' ' 37' ' ' ILE . 37.4 m-70 -114.12 94.57 4.88 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 118.126 -1.43 . . . . 0.0 110.957 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.821 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 52.5 m-85 -80.5 118.68 22.32 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.633 -0.667 . . . . 0.0 109.659 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.749 ' O ' HD23 ' A' ' 21' ' ' LEU . 27.7 tttt -149.39 116.02 5.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.105 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.918 HG22 ' OG1' ' A' ' 34' ' ' THR . 55.2 t -78.51 118.69 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.378 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.959 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -114.0 9.44 17.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.692 -0.63 . . . . 0.0 110.5 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HB3' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -156.95 157.61 35.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.85 -1.156 . . . . 0.0 110.171 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.592 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -148.13 46.67 1.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.446 -0.784 . . . . 0.0 108.9 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -46.06 117.94 1.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.65 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' O ' ' CD ' ' A' ' 30' ' ' LYS . . . 153.03 71.94 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.82 -74.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.129 1.886 . . . . 0.0 109.88 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.75 20.81 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.452 -0.78 . . . . 0.0 109.058 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.1 146.3 7.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.234 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 53.51 74.86 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.33 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 25' ' ' GLY . 1.1 mmmm -84.3 89.55 7.38 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.221 -0.924 . . . . 0.0 109.814 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.533 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 43.7 m-20 -107.31 -178.77 3.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.576 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 52.5 m-85 -150.42 125.65 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 109.195 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 46' ' ' GLU . 3.2 mm -89.29 92.12 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.064 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 99.7 m -88.89 115.08 26.18 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.94 0.876 . . . . 0.0 109.606 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.959 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -80.67 118.17 22.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.762 -0.586 . . . . 0.0 109.665 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.759 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -111.95 115.75 29.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.925 HG12 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -78.19 134.79 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.712 -1.243 . . . . 0.0 110.735 -177.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' A' ' 61' ' ' MET . 0.5 OUTLIER -136.55 120.67 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.585 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 8.75 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.506 3.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.916 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.487 ' C ' ' O ' ' A' ' 39' ' ' GLY . 18.4 m -29.3 -60.66 0.14 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.088 -0.654 . . . . 0.0 111.265 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -160.56 -167.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.124 -0.985 . . . . 0.0 108.552 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.925 HG22 HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -99.13 138.86 22.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.224 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.61 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.6 m -126.09 108.38 11.29 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -82.18 -168.86 2.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.997 -1.064 . . . . 0.0 109.891 -178.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.69 112.65 0.52 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.682 ' HB3' HD12 ' A' ' 33' ' ' ILE . 3.2 pt-20 -78.02 80.59 4.45 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.16 -1.2 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . -61.4 178.67 3.93 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -129.96 101.45 5.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -1.139 . . . . 0.0 109.834 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.731 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 119.89 162.94 12.05 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.78 164.79 22.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -1.125 . . . . 0.0 109.333 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER 56.22 18.44 3.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.221 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 49' ' ' GLY . 0.4 OUTLIER -123.47 -37.61 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.377 -0.827 . . . . 0.0 109.12 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.533 ' CB ' ' OG1' ' A' ' 34' ' ' THR . 0.1 OUTLIER -36.36 -47.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.985 -0.447 . . . . 0.0 110.827 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -47.45 76.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 1' ' ' PRO . 3.5 mttp -58.65 -65.17 0.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.967 . . . . 0.0 109.269 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.529 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -45.77 -60.96 1.93 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.579 -0.701 . . . . 0.0 109.552 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.064 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -43.28 -46.01 6.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.988 . . . . 0.0 109.797 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 1' ' ' PRO . . . -62.9 -65.15 0.73 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.27 -0.894 . . . . 0.0 110.407 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 58' ' ' ALA . 4.9 mt-10 -44.14 -59.63 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.946 -1.097 . . . . 0.0 108.504 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -43.67 -47.04 7.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.753 ' O ' HD13 ' A' ' 65' ' ' LEU . 39.0 tpp -60.09 -72.31 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.595 -0.69 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.798 HD21 ' HA ' ' A' ' 5' ' ' VAL . 1.2 mt -45.38 -67.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 62' ' ' LEU . 6.4 t -41.98 -33.44 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -67.8 -63.83 0.98 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.247 -0.908 . . . . 0.0 111.004 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.915 ' H ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -86.29 10.61 14.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.065 -1.022 . . . . 0.0 110.985 -178.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.481 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.3 mm-40 -96.77 -15.65 21.24 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.366 -0.834 . . . . 0.0 109.461 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.23 -32.6 22.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 67' ' ' LYS . 16.0 mt . . . . . 0 C--N 1.304 -1.392 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.522 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.678 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.6 Cg_exo . . . . . 0 N--CA 1.496 1.666 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 2' ' ' ILE . 8.0 mm -69.62 -65.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -55.59 -30.73 61.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.64 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 26.3 mt-30 -63.84 -55.24 24.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.198 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.069 HG22 ' CD2' ' A' ' 62' ' ' LEU . 36.1 t -57.94 -55.76 19.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.707 ' HA ' HG21 ' A' ' 16' ' ' VAL . 82.3 m-70 -44.53 -38.83 4.43 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.694 -1.254 . . . . 0.0 108.684 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -62.46 -67.83 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.691 -0.631 . . . . 0.0 110.868 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.935 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.11 -50.48 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 0.0 110.274 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.935 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -44.37 -57.05 5.2 Favored Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.8 -29.65 41.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.194 -1.18 . . . . 0.0 109.451 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -80.25 -3.29 48.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.414 -0.804 . . . . 0.0 110.58 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -134.84 16.19 3.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 109.842 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 3.4 t-20 78.53 -6.88 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.927 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.577 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 5.8 mmm -81.82 90.69 6.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.049 . . . . 0.0 108.79 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.769 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -41.79 157.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.115 -0.991 . . . . 0.0 110.391 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' A' ' 6' ' ' HIS . 24.3 t -131.72 80.91 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 108.657 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.636 ' NE2' HG22 ' A' ' 15' ' ' THR . 84.5 m-70 -117.7 96.86 5.56 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.695 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.8 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 3.2 m-30 -79.7 137.7 37.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 110.372 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 6.9 ptpt -150.71 118.48 6.18 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.756 HG22 ' OG1' ' A' ' 34' ' ' THR . 66.3 t -78.97 129.25 37.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.077 -1.014 . . . . 0.0 108.984 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -88.61 -25.55 22.38 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.554 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER 161.96 -163.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.234 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.592 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -121.58 82.65 1.97 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.525 -0.735 . . . . 0.0 109.161 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 73.68 -161.59 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 109.522 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -116.51 -99.28 2.12 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.59 -77.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.074 1.849 . . . . 0.0 110.008 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 28' ' ' HIS . . . -118.04 -146.3 0.39 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.48 -0.763 . . . . 0.0 109.063 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 44.52 36.83 1.83 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.089 -1.007 . . . . 0.0 109.109 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.493 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -67.42 -8.05 30.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.12 -34.6 22.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.838 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 33.3 m-20 -89.47 161.53 16.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.065 -1.022 . . . . 0.0 109.693 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 35.8 m-85 -131.86 125.83 32.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.342 -0.848 . . . . 0.0 109.429 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.702 HD12 ' HB3' ' A' ' 46' ' ' GLU . 2.0 mm -88.94 94.1 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.397 -0.814 . . . . 0.0 108.896 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.999 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 23.6 m -89.54 111.73 22.72 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 109.575 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -78.06 116.54 18.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.46 -0.775 . . . . 0.0 109.724 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.661 ' O ' ' HE1' ' A' ' 61' ' ' MET . 0.0 OUTLIER -109.63 118.42 36.51 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.996 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -87.41 134.17 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.776 -1.202 . . . . 0.0 112.808 -176.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.996 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.5 m -144.11 142.97 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.017 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 54.52 19.11 11.91 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.64 ' CA ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER 87.43 -23.25 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.926 -0.749 . . . . 0.0 109.576 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 41' ' ' ILE . 1.3 mp -89.43 130.47 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -90.67 133.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 120.877 -1.139 . . . . 0.0 110.897 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.602 HG21 ' HG2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -128.71 105.7 8.44 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.613 ' CG ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -81.42 -172.92 4.07 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.112 -0.993 . . . . 0.0 111.455 -177.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' ' 60' ' ' LYS . . . -155.83 112.33 0.52 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.702 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -78.0 78.24 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.064 -1.256 . . . . 0.0 111.02 -178.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 56' ' ' ARG . . . -53.85 177.61 0.23 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.455 ' H ' HG11 ' A' ' 52' ' ' VAL . 97.0 m-20 -128.82 86.72 2.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.959 -1.318 . . . . 0.0 110.703 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 50' ' ' LYS . . . 146.12 158.8 7.9 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 49' ' ' GLY . 2.4 mttm -42.97 -63.57 0.78 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.306 -1.114 . . . . 0.0 108.093 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.678 ' O ' HG12 ' A' ' 52' ' ' VAL . 29.2 mttt -83.86 -162.09 0.6 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER 81.82 -37.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.271 -0.893 . . . . 0.0 110.037 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 52' ' ' VAL . 22.7 p -42.11 -46.27 4.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.285 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -44.66 96.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.499 ' HD2' ' HG3' ' A' ' 1' ' ' PRO . 0.8 OUTLIER -62.2 -73.63 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.376 -0.827 . . . . 0.0 109.181 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.534 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -39.0 -38.24 0.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -0.759 . . . . 0.0 110.072 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.999 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -62.6 -51.33 67.74 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.95 -1.094 . . . . 0.0 108.539 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.8 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . . . -65.2 -57.94 7.25 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.293 -0.879 . . . . 0.0 110.842 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.537 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 17.5 mt-10 -46.79 -43.85 18.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.568 -1.333 . . . . 0.0 107.762 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.5 tttp -60.0 -43.54 95.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.715 ' HE1' HG22 ' A' ' 38' ' ' VAL . 2.3 mmt -57.0 -72.09 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.019 0.914 . . . . 0.0 111.368 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.069 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -54.18 -56.98 13.04 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 49.1 t -47.91 -32.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.146 -0.971 . . . . 0.0 108.693 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.602 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -67.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.4 -0.813 . . . . 0.0 110.027 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.876 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -53.36 -24.4 12.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.114 -0.992 . . . . 0.0 110.073 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.876 ' NE2' HD12 ' A' ' 65' ' ' LEU . 32.1 mm-40 -80.31 -33.09 37.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.881 -1.137 . . . . 0.0 109.011 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -68.29 -41.24 81.26 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.89 . . . . 0.0 109.379 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--N 1.305 -1.363 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.554 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.798 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.4 Cg_endo . . . . . 0 N--CA 1.497 1.695 0 N-CA-C 109.792 -0.888 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.595 HG22 ' CD2' ' A' ' 6' ' ' HIS . 4.8 mm -68.5 -59.21 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 t -53.15 -33.48 52.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.9 mt-30 -64.32 -49.88 69.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.702 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.996 ' HA ' HD21 ' A' ' 62' ' ' LEU . 19.6 t -57.73 -64.9 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.414 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.595 ' CD2' HG22 ' A' ' 2' ' ' ILE . 93.7 m-70 -40.17 -39.0 0.84 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.624 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.0 mm-40 -62.2 -63.93 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.597 -0.689 . . . . 0.0 110.676 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.938 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -67.75 -49.91 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.032 -1.043 . . . . 0.0 110.514 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.938 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.13 -54.3 9.94 Favored Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -69.83 -35.14 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.048 -1.266 . . . . 0.0 109.625 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 8.8 mmtm -76.16 -5.19 45.6 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -130.79 12.63 5.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.607 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER 79.44 -8.7 1.56 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.527 -0.733 . . . . 0.0 109.659 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.785 ' SD ' HD22 ' A' ' 65' ' ' LEU . 4.3 mtt -76.21 96.18 3.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 120.995 -1.066 . . . . 0.0 109.376 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -49.75 153.75 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.017 -1.052 . . . . 0.0 109.438 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 5' ' ' VAL . 98.1 t -127.41 95.63 3.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.766 ' CD2' HG21 ' A' ' 37' ' ' ILE . 26.1 m-70 -116.47 92.69 3.95 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.425 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.888 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 43.6 m-85 -79.63 123.81 27.97 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.54 0.686 . . . . 0.0 110.43 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -150.19 117.18 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.85 HG22 ' OG1' ' A' ' 34' ' ' THR . 88.1 t -78.13 130.93 35.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 108.903 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.722 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -88.68 -26.38 21.87 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.538 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 160.46 -165.08 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.889 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.601 ' HG3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -104.91 -158.34 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 13.8 tt0 178.3 133.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.646 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 139.55 141.38 4.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HG2' ' NE2' ' A' ' 28' ' ' HIS . 1.7 Cg_endo -63.04 -80.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.122 1.881 . . . . 0.0 110.3 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.11 14.02 1.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.523 ' NE2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -150.18 39.15 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.95 . . . . 0.0 109.406 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 30.7 mtt -152.85 79.02 1.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.187 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -76.23 92.72 3.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.478 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 2.6 m120 -135.94 167.83 20.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.549 -0.72 . . . . 0.0 109.161 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.601 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 23.0 m-85 -144.54 137.72 27.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.129 -0.982 . . . . 0.0 109.653 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 4.0 mm -91.62 96.95 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.054 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m -89.53 118.79 29.42 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 110.374 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.722 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -80.0 122.61 26.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.776 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.831 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -120.35 115.92 24.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.383 -1.448 . . . . 0.0 107.292 178.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.766 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -77.54 138.13 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.102 -0.998 . . . . 0.0 111.214 -177.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.96 HG13 ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -121.56 141.31 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -52.77 83.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER 160.37 -45.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.453 -1.027 . . . . 0.0 108.55 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.805 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -168.44 -175.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.31 129.22 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.93 -1.106 . . . . 0.0 109.03 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.5 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 31.8 m -119.52 90.34 3.31 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.586 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 5.6 pm0 -80.76 -171.17 3.0 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.925 -1.109 . . . . 0.0 109.604 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -162.77 165.63 36.41 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HB3' HD13 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -122.35 93.04 3.85 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.965 -1.315 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.511 ' CA ' ' HG3' ' A' ' 56' ' ' ARG . . . -88.56 -163.98 39.85 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.542 ' CA ' HG11 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -90.5 -161.44 0.8 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.266 -1.138 . . . . 0.0 108.638 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.578 ' HA2' ' CD1' ' A' ' 32' ' ' PHE . . . -89.18 -176.93 46.2 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 49' ' ' GLY . 1.1 tttt 74.16 -156.5 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -1.161 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 54' ' ' LYS . 1.4 pttt -86.39 54.1 3.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.159 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.542 HG11 ' CA ' ' A' ' 48' ' ' ASN . 2.6 p -115.4 -43.56 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.335 -0.853 . . . . 0.0 109.523 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -36.53 -41.45 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.835 -0.54 . . . . 0.0 110.464 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.1 OUTLIER -63.91 -61.97 1.94 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.981 -1.075 . . . . 0.0 109.416 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' CG ' ' HG2' ' A' ' 1' ' ' PRO . 7.7 mtpt -48.75 -62.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.063 -1.023 . . . . 0.0 109.118 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HG3' ' CA ' ' A' ' 47' ' ' GLY . 0.9 OUTLIER -44.52 -68.48 0.19 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.311 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.054 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -34.0 -47.63 0.28 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.352 0.596 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -58.33 -53.74 54.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 0.0 109.221 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -49.69 -40.91 41.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.023 -1.048 . . . . 0.0 108.388 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.5 -40.41 94.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.96 ' SD ' HG13 ' A' ' 38' ' ' VAL . 5.6 ttm -69.73 -70.36 0.29 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 110.271 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.996 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -48.49 -56.19 8.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 108.757 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 59' ' ' GLU . 99.0 t -50.66 -41.89 21.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.549 -0.72 . . . . 0.0 110.142 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.785 HD22 ' SD ' ' A' ' 14' ' ' MET . 0.0 OUTLIER -48.83 -31.39 7.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.027 -1.046 . . . . 0.0 110.088 -178.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.764 ' NE2' HD12 ' A' ' 65' ' ' LEU . 22.1 mm-40 -66.27 -41.65 89.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.878 -1.139 . . . . 0.0 109.738 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -66.46 -35.14 79.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.474 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.545 -179.977 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.512 ' CB ' ' HA ' ' A' ' 55' ' ' LYS . 2.5 Cg_endo . . . . . 0 N--CA 1.496 1.626 0 N-CA-C 109.785 -0.891 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.022 HG22 ' CD2' ' A' ' 6' ' ' HIS . 5.6 mm -71.74 -46.51 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.79 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 p -59.61 -32.86 70.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 110.079 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 39.7 mt-30 -64.89 -55.59 18.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.012 . . . . 0.0 109.183 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.102 ' HA ' HD21 ' A' ' 62' ' ' LEU . 7.0 t -57.34 -63.61 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 1.022 ' CD2' HG22 ' A' ' 2' ' ' ILE . 81.7 m-70 -39.41 -37.59 0.47 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.083 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 1.5 mt-10 -62.0 -67.59 0.4 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.521 -0.737 . . . . 0.0 110.427 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.947 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.62 -49.78 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.058 -1.026 . . . . 0.0 110.556 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.947 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.17 -55.28 7.73 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.34 -46.38 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.264 . . . . 0.0 109.919 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -62.83 -11.7 19.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 110.501 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.79 10.12 7.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.007 . . . . 0.0 109.781 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 39.3 t30 79.38 -10.58 1.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.946 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.538 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -72.51 86.09 1.16 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.956 -1.09 . . . . 0.0 108.8 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -39.72 163.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.613 0.72 . . . . 0.0 110.731 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.03 HG22 HG12 ' A' ' 5' ' ' VAL . 61.1 t -137.38 88.72 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.866 ' CD2' HG21 ' A' ' 37' ' ' ILE . 51.6 m-70 -105.87 93.51 4.68 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.13 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.86 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -86.76 131.14 34.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.613 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -150.89 114.09 4.82 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.895 HG22 ' OG1' ' A' ' 34' ' ' THR . 56.0 t -78.19 111.69 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.87 -1.144 . . . . 0.0 108.909 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -91.32 -25.36 19.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.812 -0.555 . . . . 0.0 109.791 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.544 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -129.98 158.73 38.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.631 -179.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.585 ' HA ' ' CD2' ' A' ' 32' ' ' PHE . 55.2 mt-10 -153.53 68.69 0.79 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.348 -0.845 . . . . 0.0 109.389 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.602 ' HG3' ' CE1' ' A' ' 28' ' ' HIS . 0.1 OUTLIER 57.73 156.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.413 -0.805 . . . . 0.0 109.669 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . -61.76 -136.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' NE2' ' A' ' 28' ' ' HIS . 2.9 Cg_exo -55.66 -74.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.088 1.858 . . . . 0.0 110.913 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.691 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -153.37 124.72 7.55 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 109.629 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.691 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 168.08 -165.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.074 -1.016 . . . . 0.0 108.913 -178.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 mtm -107.7 50.02 0.79 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.098 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 2.3 mmmt -78.13 -144.35 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.306 -0.871 . . . . 0.0 110.215 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -109.2 178.37 4.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.96 -1.088 . . . . 0.0 111.243 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CD2' ' HA ' ' A' ' 23' ' ' GLU . 9.6 m-85 -140.26 117.26 11.12 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 22' ' ' ARG . 3.3 mm -90.74 122.24 41.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 120.943 -1.098 . . . . 0.0 108.764 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.024 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 10.0 m -123.59 109.71 14.11 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . . . -76.31 118.77 19.36 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.602 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.999 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -123.05 114.41 20.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.059 -1.026 . . . . 0.0 108.335 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.935 HG12 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -78.95 135.07 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.357 -0.839 . . . . 0.0 111.548 -177.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.696 HG23 ' HE2' ' A' ' 61' ' ' MET . 0.9 OUTLIER -133.12 148.65 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 14' ' ' MET . . . 45.14 -124.11 6.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t -111.96 8.11 20.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.574 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.595 ' H ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -125.69 149.65 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 108.794 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.935 HG22 HG12 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -103.87 141.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.453 ' O ' ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -132.96 114.16 13.68 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 1.7 mt-10 -82.72 -167.51 1.66 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.859 -1.15 . . . . 0.0 109.773 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -152.14 110.79 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.641 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -84.25 64.66 8.41 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.33 -1.1 . . . . 0.0 110.041 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.57 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -47.86 -179.54 0.01 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.536 ' N ' HG11 ' A' ' 52' ' ' VAL . 11.6 p-10 -121.51 92.56 3.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.079 -1.248 . . . . 0.0 110.101 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 48' ' ' ASN . . . 24.22 -143.87 0.01 OUTLIER Glycine 0 N--CA 1.501 2.992 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 35.16 75.69 0.05 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.893 -0.769 . . . . 0.0 110.713 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER 41.61 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.324 -0.86 . . . . 0.0 109.534 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.822 HG13 ' N ' ' A' ' 53' ' ' SER . 1.7 p -162.32 -150.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.073 -1.017 . . . . 0.0 109.306 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.822 ' N ' HG13 ' A' ' 52' ' ' VAL . 3.0 p 84.3 -58.21 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.636 -0.665 . . . . 0.0 109.79 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.54 ' HB2' HD11 ' A' ' 2' ' ' ILE . 7.9 ptmt -77.84 -47.26 19.25 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.228 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HA ' ' CB ' ' A' ' 1' ' ' PRO . 18.4 tttm -66.21 -39.57 89.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.385 -0.822 . . . . 0.0 108.997 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.57 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -68.14 -46.14 71.64 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.371 -0.831 . . . . 0.0 109.425 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.024 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -56.56 -57.84 10.62 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.113 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.721 ' HB2' ' HE2' ' A' ' 18' ' ' PHE . . . -53.34 -48.67 68.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.164 -0.96 . . . . 0.0 110.294 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.548 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 3.3 mt-10 -54.83 -35.77 64.31 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 11.8 tptp -64.52 -36.3 83.77 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.696 ' HE2' HG23 ' A' ' 38' ' ' VAL . 54.1 mmm -73.32 -71.12 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.649 -0.657 . . . . 0.0 110.704 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.102 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -49.57 -41.03 40.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 0.0 109.004 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 70.5 t -65.6 -39.72 85.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.64 -59.83 3.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.681 -0.637 . . . . 0.0 109.455 179.105 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -59.95 -40.87 90.47 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.272 -0.892 . . . . 0.0 110.292 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 8.8 mm-40 -46.41 -25.77 0.72 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.778 -1.201 . . . . 0.0 109.1 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.7 -66.04 0.64 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.413 -0.804 . . . . 0.0 109.283 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.536 ' N ' HD23 ' A' ' 68' ' ' LEU . 5.3 mt . . . . . 0 C--N 1.3 -1.562 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 5' ' ' VAL . 5.4 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.727 -0.913 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.583 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.9 mm -72.74 -64.77 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.392 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 p -53.16 -28.06 24.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.268 -0.895 . . . . 0.0 109.233 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 3.4 mt-30 -67.08 -51.83 49.5 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 108.589 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.014 ' HA ' HD21 ' A' ' 62' ' ' LEU . 19.1 t -58.37 -60.38 2.36 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.651 ' HA ' HG21 ' A' ' 16' ' ' VAL . 92.6 m-70 -43.56 -39.98 3.74 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.953 -1.092 . . . . 0.0 109.093 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 2.1 mm-40 -60.53 -64.12 1.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.746 . . . . 0.0 110.971 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.958 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -68.16 -49.95 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.891 -1.131 . . . . 0.0 110.727 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.958 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -48.0 -51.04 20.12 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -70.48 -46.35 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.662 -1.493 . . . . 0.0 109.889 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -64.92 -9.61 22.57 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.231 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.97 15.39 8.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 109.687 -179.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER 72.64 -7.38 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.434 -0.791 . . . . 0.0 110.125 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.585 ' CE ' ' CG1' ' A' ' 38' ' ' VAL . 5.4 mtt -79.65 92.64 5.39 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.604 -1.31 . . . . 0.0 108.881 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -42.41 168.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 -179.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.78 HG22 HG12 ' A' ' 5' ' ' VAL . 84.6 t -137.73 83.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 108.4 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.848 ' CD2' HG21 ' A' ' 37' ' ' ILE . 37.3 m-70 -106.42 92.53 4.16 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.563 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.914 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 37.4 m-85 -78.36 122.04 25.25 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.651 -0.656 . . . . 0.0 110.394 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.34 122.02 8.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.977 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.2 t -77.42 130.01 36.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 108.526 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.805 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -88.67 -22.46 23.4 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -177.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.557 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 160.15 -165.35 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.669 -0.813 . . . . 0.0 110.414 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.584 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -112.07 -172.0 1.96 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.579 ' HG3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -142.92 134.24 26.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.975 . . . . 0.0 109.438 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.1 149.72 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.31 -62.27 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.092 1.862 . . . . 0.0 110.215 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -156.12 -146.44 0.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.443 -0.786 . . . . 0.0 109.215 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.539 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 1.7 m-70 64.05 12.2 6.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.967 . . . . 0.0 109.165 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER 164.07 72.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.141 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' C ' ' OD1' ' A' ' 31' ' ' ASN . 13.0 mtmt -57.28 109.4 0.67 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.176 -0.953 . . . . 0.0 109.79 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 3.9 m120 -143.35 133.18 23.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.469 -0.769 . . . . 0.0 109.363 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' A' ' 23' ' ' GLU . 6.2 m-85 -116.51 143.01 46.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 110.379 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' A' ' 24' ' ' GLU . 5.1 mm -90.62 111.8 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.12 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 7.4 m -103.86 118.63 37.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.144 -0.972 . . . . 0.0 110.737 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.805 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -84.68 122.96 29.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.608 -0.682 . . . . 0.0 111.141 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.653 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 4.1 t -114.63 121.07 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.848 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.86 130.57 36.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.662 -1.274 . . . . 0.0 109.929 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.704 HG21 ' SD ' ' A' ' 61' ' ' MET . 1.0 OUTLIER -135.5 119.35 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.387 0.613 . . . . 0.0 109.479 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 14' ' ' MET . . . 15.5 -101.44 0.01 OUTLIER Glycine 0 N--CA 1.501 3.032 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.478 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -27.62 -60.79 0.1 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.223 -0.575 . . . . 0.0 111.247 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -164.79 -167.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.048 -1.032 . . . . 0.0 108.603 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.604 HG22 HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -89.67 134.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.996 -1.065 . . . . 0.0 110.168 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 1.8 m -123.25 107.96 12.26 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -90.05 -173.65 3.94 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.21 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ILE . . . -154.92 175.97 32.78 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -128.88 93.69 3.66 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.013 -1.287 . . . . 0.0 109.683 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . -92.23 -170.89 41.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.601 ' CB ' HG11 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -80.33 -160.0 0.26 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.175 -1.191 . . . . 0.0 108.73 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' LYS . . . -121.24 80.62 0.34 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 0.3 OUTLIER 169.52 87.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.504 -0.998 . . . . 0.0 108.915 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 5.5 tttt 45.36 46.7 10.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 108.504 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.601 HG11 ' CB ' ' A' ' 48' ' ' ASN . 2.9 p -137.45 -41.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.399 -0.813 . . . . 0.0 109.751 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.483 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -39.59 -45.92 1.7 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.624 -0.672 . . . . 0.0 110.545 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' HG21 ' A' ' 34' ' ' THR . 1.9 tttt -62.31 -56.73 15.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.197 -0.939 . . . . 0.0 110.088 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -55.58 -65.64 0.56 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 109.651 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.514 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -43.8 -42.15 5.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.855 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.12 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -59.06 -46.07 89.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.075 -1.015 . . . . 0.0 108.779 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -61.18 -58.05 9.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.61 -0.681 . . . . 0.0 110.243 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.521 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -48.67 -40.61 28.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.909 -1.119 . . . . 0.0 107.996 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -59.62 -43.48 93.76 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.704 ' SD ' HG21 ' A' ' 38' ' ' VAL . 54.9 tpp -67.51 -70.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.612 -0.68 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.014 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -45.93 -60.17 2.41 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 108.648 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 84.9 t -48.77 -39.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 108.622 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -57.96 -69.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.929 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.854 HD12 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -45.72 -34.38 3.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.887 -1.133 . . . . 0.0 109.741 -179.061 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.854 ' NE2' HD12 ' A' ' 65' ' ' LEU . 28.9 mm-40 -63.82 -45.11 91.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.82 -1.175 . . . . 0.0 109.566 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -61.06 -48.12 83.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -0.984 . . . . 0.0 109.457 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--N 1.301 -1.525 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.542 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.523 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.7 Cg_exo . . . . . 0 N--CA 1.496 1.636 0 N-CA-C 109.686 -0.928 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.642 ' N ' HD13 ' A' ' 2' ' ' ILE . 2.5 mm -68.3 -66.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.2 -30.57 7.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.189 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 21.1 mm100 -63.94 -61.62 2.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.037 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.025 ' HA ' HD21 ' A' ' 62' ' ' LEU . 26.2 t -51.52 -57.48 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.935 . . . . 0.0 108.61 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.637 ' HA ' HG21 ' A' ' 16' ' ' VAL . 89.2 m-70 -44.41 -41.1 5.94 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.793 -1.192 . . . . 0.0 109.351 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.6 mm-40 -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.772 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.055 HD13 ' N ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -64.65 -54.08 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.184 -0.948 . . . . 0.0 110.355 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 1.055 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -48.97 -52.72 20.86 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -67.06 -45.53 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.352 . . . . 0.0 109.92 -178.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -65.12 -13.42 58.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -118.21 9.34 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 0.0 109.893 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 18.0 t-20 80.4 -12.23 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.483 -0.761 . . . . 0.0 109.658 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.62 ' CG ' HG13 ' A' ' 38' ' ' VAL . 5.6 mtt -76.52 98.89 4.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.998 -1.064 . . . . 0.0 108.662 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -46.6 172.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.695 -1.253 . . . . 0.0 109.85 -179.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.637 HG21 ' HA ' ' A' ' 6' ' ' HIS . 59.6 t -143.57 83.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 108.526 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.809 ' HB2' HG22 ' A' ' 37' ' ' ILE . 90.0 m-70 -116.81 97.35 5.92 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.399 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.853 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 58.7 m-85 -78.09 130.65 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.573 -0.704 . . . . 0.0 110.917 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.783 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -151.05 115.08 5.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.91 HG22 ' OG1' ' A' ' 34' ' ' THR . 78.9 t -78.37 118.95 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.965 -1.084 . . . . 0.0 108.461 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.985 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -114.03 -11.97 12.66 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.669 -0.645 . . . . 0.0 111.154 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -126.19 136.18 52.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.813 -1.179 . . . . 0.0 110.631 -179.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 10.9 mt-10 -158.39 124.52 4.62 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 25' ' ' GLY . 5.5 mm-40 -39.23 137.26 0.76 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.44 -0.787 . . . . 0.0 109.926 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . -42.23 -90.74 0.01 OUTLIER Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.707 ' HA ' ' NE2' ' A' ' 28' ' ' HIS . 10.8 Cg_endo -68.94 -138.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 N-CA-C 107.216 -1.878 . . . . 0.0 107.216 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.611 ' O ' ' ND1' ' A' ' 28' ' ' HIS . . . 57.54 -77.24 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.18 -0.95 . . . . 0.0 111.477 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.707 ' NE2' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER 57.33 21.04 6.36 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.19 -0.944 . . . . 0.0 108.788 -179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.7 18.81 0.53 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.75 -86.09 0.42 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.287 -0.883 . . . . 0.0 109.821 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 17.0 m-80 -132.58 171.81 13.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.97 . . . . 0.0 110.031 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 31' ' ' ASN . 45.6 m-85 -150.44 127.11 10.91 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 3.1 mm -89.6 96.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.135 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 19.9 m -88.73 114.06 24.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.44 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.985 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -87.76 115.28 25.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.551 -0.718 . . . . 0.0 111.098 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.652 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 12.4 t -105.59 114.5 28.71 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.001 HD13 ' N ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -77.59 130.47 36.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.739 -1.225 . . . . 0.0 109.906 -178.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.001 ' N ' HD13 ' A' ' 37' ' ' ILE . 1.1 t -132.71 135.84 56.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.444 ' H ' ' N ' ' A' ' 15' ' ' THR . . . 59.23 -116.16 8.43 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.402 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -120.56 12.43 11.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -1.091 . . . . 0.0 109.377 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' C ' ' A' ' 40' ' ' SER . 2.0 mp -135.0 151.21 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 108.984 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -95.9 135.46 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.015 -1.053 . . . . 0.0 110.424 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.608 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.2 m -121.93 101.8 7.78 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 5.2 mt-10 -88.16 -173.9 4.43 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 110.664 -178.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -161.32 116.07 0.69 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.574 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 pt-20 -78.96 89.38 4.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.196 -1.179 . . . . 0.0 110.644 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.49 176.07 39.21 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 3.4 m-20 -125.0 102.62 7.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -1.198 . . . . 0.0 110.277 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.762 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 106.85 149.03 15.74 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.03 171.34 1.77 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.124 -1.221 . . . . 0.0 109.146 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.2 16.28 4.79 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.163 -0.96 . . . . 0.0 109.244 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 49' ' ' GLY . 0.3 OUTLIER -131.46 -37.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 20' ' ' VAL . 1.7 p -39.31 -46.75 1.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.575 -0.703 . . . . 0.0 110.098 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -62.27 -75.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 109.92 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 1' ' ' PRO . 3.4 tttt -41.7 -66.53 0.33 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' NH1' ' CG ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -38.75 -56.6 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.51 -0.744 . . . . 0.0 110.286 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.135 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -50.72 -50.42 55.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.171 -0.956 . . . . 0.0 110.036 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.664 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -58.08 -57.09 14.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 110.428 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' HG23 ' A' ' 63' ' ' VAL . 39.0 mt-10 -48.21 -38.6 18.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.745 -1.222 . . . . 0.0 107.999 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -61.9 -43.46 98.8 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.688 ' SD ' HG21 ' A' ' 38' ' ' VAL . 41.0 tpp -67.83 -69.42 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.6 -0.688 . . . . 0.0 110.06 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.025 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -47.24 -60.14 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -179.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 59' ' ' GLU . 94.1 t -46.93 -41.01 5.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.085 -1.009 . . . . 0.0 108.395 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -54.51 -66.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.526 -0.734 . . . . 0.0 110.022 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -56.53 -21.42 26.15 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.997 -1.064 . . . . 0.0 110.164 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 20.2 mm-40 -67.06 -46.56 73.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.915 -1.116 . . . . 0.0 109.329 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' C ' HD23 ' A' ' 68' ' ' LEU . 26.7 mtmt -61.52 -53.51 55.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.312 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.574 ' N ' HD23 ' A' ' 68' ' ' LEU . 4.2 mt . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.599 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.921 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.3 Cg_endo . . . . . 0 N--CA 1.497 1.701 0 N-CA-C 109.739 -0.908 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 2' ' ' ILE . 4.8 mm -71.15 -59.03 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.392 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.0 p -56.24 -33.3 65.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.28 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -64.09 -52.14 60.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 108.56 179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.047 HG12 ' CG2' ' A' ' 16' ' ' VAL . 16.4 t -55.41 -66.23 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 91.4 m-70 -39.68 -38.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.471 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -60.72 -62.67 1.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 110.46 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.948 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -69.6 -50.11 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.067 -1.021 . . . . 0.0 110.809 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.948 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.64 -52.23 15.55 Favored Glycine 0 N--CA 1.481 1.65 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -68.9 -45.47 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.356 . . . . 0.0 109.62 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.44 -10.3 24.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 -179.111 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -125.45 10.03 7.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.637 -179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 0.7 OUTLIER 79.7 -11.46 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 110.147 179.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.556 ' HA ' ' CA ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -74.72 95.16 2.82 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.793 -1.192 . . . . 0.0 109.564 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -47.34 158.83 0.15 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.372 -0.83 . . . . 0.0 109.486 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.047 ' CG2' HG12 ' A' ' 5' ' ' VAL . 42.3 t -133.03 94.63 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.878 ' CD2' HG21 ' A' ' 37' ' ' ILE . 35.8 m-70 -111.92 96.2 5.92 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.454 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.924 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 45.7 m-85 -83.51 120.03 25.42 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.366 0.603 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.8 ' O ' HD23 ' A' ' 21' ' ' LEU . 10.7 mttm -151.15 113.81 4.67 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.338 -0.851 . . . . 0.0 108.86 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.927 HG22 ' OG1' ' A' ' 34' ' ' THR . 72.3 t -78.57 118.87 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 108.672 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.973 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -117.24 -8.57 11.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.54 -0.725 . . . . 0.0 110.955 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.612 HH22 HD12 ' A' ' 21' ' ' LEU . 1.2 ttm-85 -124.84 158.72 32.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 0.0 110.538 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 3.0 mt-10 -154.75 156.59 36.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.598 -0.689 . . . . 0.0 109.23 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' O ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -59.4 -146.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.464 -0.773 . . . . 0.0 109.58 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 24' ' ' GLU . . . -55.24 -136.45 0.0 OUTLIER Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.566 ' CD ' ' NE2' ' A' ' 28' ' ' HIS . 9.9 Cg_exo -46.19 -76.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.895 1.73 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.582 ' O ' ' ND1' ' A' ' 28' ' ' HIS . . . -147.57 -71.32 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.0 -1.063 . . . . 0.0 109.761 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.582 ' ND1' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 37.92 -162.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.571 0.701 . . . . 0.0 110.346 178.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 22.5 mtt -126.78 33.89 4.88 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 76.5 mttt -64.37 -111.78 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.576 -0.702 . . . . 0.0 110.342 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.549 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 18.5 m-20 -118.57 171.25 8.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.646 -1.284 . . . . 0.0 110.462 -179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 43.4 m-85 -150.86 132.56 14.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.4 mp -89.99 99.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.015 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 26.8 m -87.01 117.65 25.88 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.607 0.718 . . . . 0.0 109.229 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.973 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -81.01 117.07 21.3 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.499 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.983 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -117.41 114.36 23.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.878 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.93 132.73 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.067 -1.021 . . . . 0.0 110.77 -177.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.805 HG21 HD11 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -124.31 133.41 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.451 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . -9.18 -84.1 0.01 OUTLIER Glycine 0 N--CA 1.507 3.383 0 CA-C-O 121.332 0.406 . . . . 0.0 112.781 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.476 ' C ' HG13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -35.11 -59.82 0.49 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.681 -0.894 . . . . 0.0 111.773 -178.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.646 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -161.31 -159.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.871 -1.143 . . . . 0.0 108.428 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.71 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -88.39 157.95 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.752 -1.218 . . . . 0.0 109.356 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.575 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 5.6 m -150.97 93.96 2.0 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.611 ' HG2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -79.56 -169.83 2.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 110.213 -179.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.561 ' HA2' ' CD ' ' A' ' 60' ' ' LYS . . . -170.78 118.86 0.77 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 4.3 pm0 -77.79 91.0 4.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -1.206 . . . . 0.0 110.585 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 56' ' ' ARG . . . -82.23 154.9 33.83 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.615 ' O ' HG11 ' A' ' 52' ' ' VAL . 49.6 t30 -93.77 101.74 13.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.893 -1.357 . . . . 0.0 109.886 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 137.6 170.21 11.83 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -81.74 -52.12 7.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.4 -1.059 . . . . 0.0 109.606 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.8 -36.74 28.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.689 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.615 HG11 ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -51.73 -37.86 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.941 . . . . 0.0 109.418 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.665 ' OG ' HG21 ' A' ' 20' ' ' VAL . 9.2 p -33.51 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.24 0.543 . . . . 0.0 110.542 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -62.46 -50.1 72.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.326 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HG2' ' HG2' ' A' ' 1' ' ' PRO . 50.7 mtpt -57.41 -69.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.089 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -39.3 -61.83 0.73 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.999 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.015 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -43.06 -53.4 4.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -54.71 -53.56 53.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.317 -0.865 . . . . 0.0 110.923 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.1 mm-40 -49.43 -43.52 44.74 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.561 ' CD ' ' HA2' ' A' ' 45' ' ' GLY . 0.5 OUTLIER -55.02 -43.82 74.05 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.575 ' CE ' ' HB ' ' A' ' 43' ' ' THR . 67.2 mmm -64.5 -67.67 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.872 0.844 . . . . 0.0 111.363 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.002 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -50.88 -57.19 9.1 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.028 -1.045 . . . . 0.0 108.959 -177.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 2.5 t -59.06 -25.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.202 -0.937 . . . . 0.0 109.007 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.609 ' HB3' HD13 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -64.5 -54.18 36.35 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.222 -0.924 . . . . 0.0 111.001 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.883 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -110.57 12.29 22.8 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.731 -1.231 . . . . 0.0 111.595 -178.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 76.3 mm-40 -94.94 -16.97 22.4 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 120.959 -1.088 . . . . 0.0 109.412 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -98.85 -49.07 4.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.357 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.598 ' N ' HD23 ' A' ' 68' ' ' LEU . 2.2 mt . . . . . 0 C--N 1.303 -1.452 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.8 Cg_exo . . . . . 0 N--CA 1.496 1.653 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.544 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.5 mm -79.59 -69.61 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.94 . . . . 0.0 109.14 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -52.67 -23.86 7.43 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 1.7 mt-30 -66.85 -54.09 25.88 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.069 HG22 ' CD2' ' A' ' 62' ' ' LEU . 61.5 t -60.0 -55.93 20.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.393 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.664 ' HA ' HG21 ' A' ' 16' ' ' VAL . 89.7 m-70 -46.2 -37.16 6.75 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.875 -1.14 . . . . 0.0 108.599 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 3.5 mt-10 -62.18 -65.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 110.832 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.948 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -66.89 -49.7 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.974 -1.079 . . . . 0.0 110.58 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.948 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -47.22 -52.16 13.52 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.71 -45.73 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.809 -1.407 . . . . 0.0 109.852 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -66.2 -8.16 22.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -0.814 . . . . 0.0 110.333 -179.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.554 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -124.52 10.01 8.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.625 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 1.9 t-20 79.86 -11.03 1.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.829 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.596 ' HE1' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -76.66 96.68 4.24 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 120.86 -1.15 . . . . 0.0 109.573 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -46.65 154.95 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.69 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 6' ' ' HIS . 46.8 t -129.92 90.23 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.806 ' CD2' HG21 ' A' ' 37' ' ' ILE . 24.5 m-70 -114.34 91.85 3.76 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.56 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.807 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 57.3 m-85 -79.82 123.01 27.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.691 -0.631 . . . . 0.0 110.137 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.758 ' O ' HD23 ' A' ' 21' ' ' LEU . 13.8 mttt -150.92 112.25 4.39 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.924 HG22 ' OG1' ' A' ' 34' ' ' THR . 69.2 t -78.48 121.32 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.063 -1.023 . . . . 0.0 109.124 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.987 HD21 ' HB2' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -115.59 8.92 15.21 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.808 -178.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.529 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 3.6 mpp_? -151.86 81.07 1.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.88 -1.138 . . . . 0.0 110.058 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.582 ' HA ' ' CD2' ' A' ' 32' ' ' PHE . 4.9 mp0 -75.2 93.42 2.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.123 -0.985 . . . . 0.0 109.735 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 3.4 tt0 77.47 -156.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.012 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.29 -150.25 10.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.545 ' HD2' ' NE2' ' A' ' 28' ' ' HIS . 2.8 Cg_exo -53.91 -69.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.13 1.887 . . . . 0.0 110.838 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.671 ' C ' ' CG ' ' A' ' 28' ' ' HIS . . . -165.69 122.29 1.4 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.266 -0.896 . . . . 0.0 109.379 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.671 ' CG ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 176.69 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.891 -1.131 . . . . 0.0 109.488 -178.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 31' ' ' ASN . 4.0 tpt 76.53 110.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.131 -0.981 . . . . 0.0 108.56 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 29' ' ' MET . 0.1 OUTLIER -30.56 92.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.423 0.63 . . . . 0.0 110.697 -179.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -114.0 -176.37 2.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.639 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 23' ' ' GLU . 52.1 m-85 -150.88 125.74 9.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.488 -0.757 . . . . 0.0 109.445 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 46' ' ' GLU . 2.4 mm -89.8 93.42 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.039 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 18.0 m -88.05 112.71 22.93 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.823 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.987 ' HB2' HD21 ' A' ' 21' ' ' LEU . . . -79.57 115.45 19.2 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.997 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -113.67 113.99 25.79 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.806 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -76.58 132.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.152 -0.968 . . . . 0.0 110.515 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.783 HG21 HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -119.74 147.25 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -47.99 88.86 0.01 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 155.51 -50.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.812 -0.817 . . . . 0.0 109.118 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -170.68 -166.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.312 -0.868 . . . . 0.0 108.718 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.54 133.79 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.995 -1.065 . . . . 0.0 109.382 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.561 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 4.8 m -127.01 93.67 3.82 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 2.7 pm0 -80.49 -173.52 4.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.737 -1.227 . . . . 0.0 110.604 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.89 113.42 0.56 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.553 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -78.2 81.95 4.55 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.208 -1.172 . . . . 0.0 110.232 -179.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -66.35 -178.92 9.4 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 31' ' ' ASN . 6.6 t30 -129.16 106.1 8.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -1.211 . . . . 0.0 109.664 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.555 ' O ' HG12 ' A' ' 52' ' ' VAL . . . 130.3 155.42 8.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HA ' ' CE1' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -65.97 -65.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.152 . . . . 0.0 109.219 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.78 74.71 7.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 109.095 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 49' ' ' GLY . 1.2 p -161.75 -40.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.232 -0.917 . . . . 0.0 109.23 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.516 ' C ' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -29.84 -68.02 0.08 Allowed 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 23.9 mmtt -45.83 -50.61 14.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 1' ' ' PRO . 6.7 tttt -58.66 -73.14 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.526 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -37.62 -67.23 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.201 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.039 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -40.56 -55.14 2.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -51.55 -57.46 9.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.813 . . . . 0.0 110.633 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.506 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 25.5 mt-10 -47.94 -44.87 30.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.242 . . . . 0.0 108.253 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -54.2 -44.03 71.26 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.496 -0.753 . . . . 0.0 108.976 179.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.639 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 70.7 mmm -65.95 -66.27 0.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.806 0.812 . . . . 0.0 111.311 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.069 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -50.82 -60.4 3.11 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 8.7 t -56.28 -26.95 23.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 121.184 -0.947 . . . . 0.0 109.13 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' HB3' HD13 ' A' ' 65' ' ' LEU . 2.0 mm-40 -62.89 -55.56 24.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.873 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -112.57 16.05 19.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.744 -1.223 . . . . 0.0 111.49 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.536 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 9.5 mm-40 -98.86 -33.8 10.73 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.064 -1.022 . . . . 0.0 109.261 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -66.86 -26.06 66.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.306 -1.324 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.509 179.811 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.621 ' O ' HG23 ' A' ' 5' ' ' VAL . 4.5 Cg_exo . . . . . 0 N--CA 1.497 1.709 0 N-CA-C 109.613 -0.957 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.556 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.6 mm -72.23 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.937 . . . . 0.0 109.276 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -54.55 -31.6 56.78 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.228 -0.92 . . . . 0.0 109.17 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 2.0 mm100 -63.41 -53.5 51.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.251 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.066 HG22 ' CD2' ' A' ' 62' ' ' LEU . 61.1 t -58.53 -54.82 27.92 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.477 0 O-C-N 121.054 -1.029 . . . . 0.0 108.534 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.566 ' HA ' HG21 ' A' ' 16' ' ' VAL . 87.4 m-70 -47.16 -37.59 10.32 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 120.618 -1.301 . . . . 0.0 108.755 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 13.0 mt-10 -63.24 -66.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.724 -0.61 . . . . 0.0 110.974 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.937 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.6 pp -65.4 -49.33 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.08 -1.012 . . . . 0.0 110.276 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.937 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.49 -56.6 7.12 Favored Glycine 0 C--N 1.295 -1.7 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.2 OUTLIER -69.37 -30.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.076 -1.25 . . . . 0.0 109.73 -179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.1 mtmp? -79.92 -4.3 51.77 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.16 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -132.22 13.22 4.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.65 -179.556 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 2.8 t30 78.84 -7.6 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.777 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.575 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 3.5 mmt -78.84 95.2 5.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.958 -1.089 . . . . 0.0 109.01 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -47.38 155.35 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.786 -179.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.704 ' CG2' HG12 ' A' ' 5' ' ' VAL . 45.8 t -131.72 93.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 108.724 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.804 ' CD2' HG21 ' A' ' 37' ' ' ILE . 29.1 m-70 -118.85 91.3 3.52 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.664 -1.215 . . . . 0.0 110.316 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.724 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 57.1 m-85 -78.49 129.42 34.86 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.555 -0.716 . . . . 0.0 110.441 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.803 ' O ' HD23 ' A' ' 21' ' ' LEU . 28.3 mttt -151.47 110.78 3.94 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.807 HG22 ' OG1' ' A' ' 34' ' ' THR . 72.0 t -78.6 118.84 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 109.033 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.954 HD21 ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -119.22 10.69 12.1 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.703 . . . . 0.0 110.677 -178.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' CD ' HG13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -136.47 155.5 49.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.96 -1.087 . . . . 0.0 110.32 -179.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.588 ' HA ' ' CD2' ' A' ' 32' ' ' PHE . 12.3 mt-10 -144.94 52.09 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 109.025 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -45.12 116.53 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.883 . . . . 0.0 109.659 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 152.54 132.52 1.8 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 -61.98 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.934 1.756 . . . . 0.0 110.058 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -149.58 39.02 0.79 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.381 -0.824 . . . . 0.0 109.24 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -144.67 -149.69 0.29 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.33 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.6 ptp -125.34 71.79 1.22 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.459 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 5.5 mmtt -75.23 -97.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -0.912 . . . . 0.0 109.497 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -120.88 158.05 28.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.921 -1.112 . . . . 0.0 109.576 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' A' ' 23' ' ' GLU . 15.6 m-85 -136.67 133.95 36.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.548 HG13 ' CD ' ' A' ' 22' ' ' ARG . 4.9 mm -89.21 97.5 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.133 -0.979 . . . . 0.0 108.472 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.079 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 18.8 m -88.47 113.21 23.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.954 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -78.81 117.7 20.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.589 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.958 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -116.04 116.11 27.31 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.804 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -79.14 130.41 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 111.248 -177.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.906 HG13 ' CE ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -112.78 146.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.039 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -53.18 84.94 0.01 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 159.91 -46.65 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.585 -0.95 . . . . 0.0 108.451 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -169.79 -176.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.8 153.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.86 -1.15 . . . . 0.0 108.884 178.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.591 ' HB ' ' CE ' ' A' ' 61' ' ' MET . 17.1 m -149.04 94.71 2.28 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -79.68 -172.74 3.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.894 -1.128 . . . . 0.0 110.237 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.04 117.78 0.79 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -77.86 88.83 4.06 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.999 -1.295 . . . . 0.0 110.105 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -74.84 178.19 46.46 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.583 ' O ' HG11 ' A' ' 52' ' ' VAL . 15.2 p-10 -115.24 98.54 6.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -1.144 . . . . 0.0 109.728 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.27 159.25 10.18 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -78.53 -33.76 47.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -1.119 . . . . 0.0 109.59 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.0 31.2 2.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.552 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.583 HG11 ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -136.22 -39.04 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.309 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.511 ' HB3' ' CB ' ' A' ' 32' ' ' PHE . 0.4 OUTLIER -32.07 -38.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.263 0.554 . . . . 0.0 110.478 -179.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HA ' HG21 ' A' ' 34' ' ' THR . 0.4 OUTLIER -69.45 -53.25 20.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.146 179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG3' ' CG ' ' A' ' 1' ' ' PRO . 0.4 OUTLIER -56.35 -59.21 5.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.525 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -52.53 -43.03 64.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.118 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.079 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -55.3 -51.99 64.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.907 -1.12 . . . . 0.0 108.513 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.522 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -55.13 -50.02 70.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.571 -0.705 . . . . 0.0 110.168 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 8.3 mt-10 -54.37 -36.83 64.3 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.91 -36.44 83.96 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.906 ' CE ' HG13 ' A' ' 38' ' ' VAL . 80.0 mmm -71.49 -69.33 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.569 0.699 . . . . 0.0 111.141 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.066 ' CD2' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -51.8 -38.14 54.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 59' ' ' GLU . 72.8 t -69.64 -36.37 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -58.07 -55.51 33.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.647 -0.658 . . . . 0.0 109.288 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.82 -38.35 90.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.026 -1.047 . . . . 0.0 109.527 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.422 ' CD ' ' O ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -66.01 -14.72 62.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 109.71 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -54.98 3.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.302 -1.496 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.57 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.587 ' CG ' ' CG ' ' A' ' 55' ' ' LYS . 5.0 Cg_exo . . . . . 0 N--CA 1.495 1.603 0 N-CA-C 109.557 -0.978 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.571 HG22 ' CD2' ' A' ' 6' ' ' HIS . 4.3 mm -66.42 -60.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 108.975 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -27.69 43.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.395 -0.815 . . . . 0.0 109.45 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 11.4 mt-30 -64.76 -57.35 9.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.071 HG12 ' CG2' ' A' ' 16' ' ' VAL . 13.8 t -53.42 -63.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.571 ' CD2' HG22 ' A' ' 2' ' ' ILE . 90.5 m-70 -39.86 -39.04 0.75 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.19 -0.944 . . . . 0.0 109.685 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 3.3 mt-10 -61.7 -62.06 2.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.481 -0.762 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.95 HD12 ' N ' ' A' ' 9' ' ' GLY . 2.7 pp -70.02 -51.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.005 -1.059 . . . . 0.0 110.698 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.95 ' N ' HD12 ' A' ' 8' ' ' ILE . . . -46.89 -49.29 17.59 Favored Glycine 0 N--CA 1.48 1.613 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 6' ' ' HIS . 0.3 OUTLIER -70.86 -46.29 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.529 -1.571 . . . . 0.0 109.851 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -64.73 -10.14 25.28 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 110.162 -179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -122.74 8.34 9.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 109.828 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 12' ' ' ARG . 8.3 t-20 78.3 -8.02 1.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.416 -0.803 . . . . 0.0 109.627 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.83 ' HB3' HG12 ' A' ' 38' ' ' VAL . 8.6 mtp -78.66 87.67 4.58 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.899 -1.126 . . . . 0.0 109.404 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -40.28 164.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.579 -0.701 . . . . 0.0 109.896 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.071 ' CG2' HG12 ' A' ' 5' ' ' VAL . 42.0 t -137.43 78.85 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.837 ' CD2' HG21 ' A' ' 37' ' ' ILE . 37.3 m-70 -100.73 95.59 6.76 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.404 -1.318 . . . . 0.0 109.951 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.721 ' HZ ' HG21 ' A' ' 5' ' ' VAL . 3.2 m-85 -76.28 127.77 33.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 109.672 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -147.97 110.97 4.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.983 HG22 ' OG1' ' A' ' 34' ' ' THR . 53.0 t -76.39 117.23 20.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 120.981 -1.074 . . . . 0.0 108.873 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.887 HD11 ' HB2' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -93.0 -23.1 18.79 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.933 -177.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.551 ' HB2' HG12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -138.39 151.2 47.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 110.277 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.563 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 24.0 mp0 -144.92 93.0 2.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.483 -0.761 . . . . 0.0 109.195 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 30' ' ' LYS . 3.0 tm-20 62.78 138.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -0.941 . . . . 0.0 109.425 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.466 ' O ' ' OE2' ' A' ' 24' ' ' GLU . . . -74.35 -139.1 0.52 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.472 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 3.8 Cg_exo -59.88 -76.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.094 1.863 . . . . 0.0 110.324 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.01 7.84 4.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.467 ' N ' ' CD2' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -141.97 -172.98 3.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.919 . . . . 0.0 109.512 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.476 ' HG2' ' ND2' ' A' ' 31' ' ' ASN . 5.4 ttm 49.15 78.03 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -0.947 . . . . 0.0 109.297 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.513 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 8.2 mttt -84.37 46.82 1.26 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.476 ' ND2' ' HG2' ' A' ' 29' ' ' MET . 78.2 m-20 -89.7 145.29 25.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.829 -1.169 . . . . 0.0 109.352 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 4.4 m-85 -118.63 121.13 39.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.029 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 46' ' ' GLU . 1.8 mm -89.08 91.21 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.1 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 15.4 m -88.95 108.64 19.67 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.874 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.887 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -79.85 115.73 19.61 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 18' ' ' PHE . 5.0 t -108.21 121.23 44.45 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 176.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.837 HG21 ' CD2' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -76.28 128.78 37.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 120.925 -1.109 . . . . 0.0 110.428 -177.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.975 HG13 ' SD ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -116.69 102.94 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 38' ' ' VAL . . . 6.65 -73.4 0.0 OUTLIER Glycine 0 N--CA 1.504 3.169 0 C-N-CA 122.979 0.323 . . . . 0.0 112.547 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 38' ' ' VAL . 30.6 m -41.93 -65.8 0.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -1.053 . . . . 0.0 109.908 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -147.64 -139.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -113.37 161.89 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.19 . . . . 0.0 109.502 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.77 HG21 ' HA ' ' A' ' 61' ' ' MET . 19.8 m -150.37 91.92 1.81 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.616 ' CB ' ' HA ' ' A' ' 35' ' ' ALA . 1.5 pt-20 -86.17 -176.5 5.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.156 -0.965 . . . . 0.0 110.686 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 57' ' ' ALA . . . -154.9 109.08 0.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.837 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.7 pm0 -79.24 80.44 5.6 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.297 -1.119 . . . . 0.0 109.563 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' CG ' ' A' ' 56' ' ' ARG . . . -64.49 168.65 26.13 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.478 ' O ' ' O ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -105.36 76.48 1.22 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -1.048 . . . . 0.0 110.346 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 48' ' ' ASN . . . 37.64 -162.02 0.01 OUTLIER Glycine 0 N--CA 1.495 2.578 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER 67.73 48.62 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.579 -0.953 . . . . 0.0 109.657 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 44.81 64.05 1.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.162 -0.961 . . . . 0.0 108.79 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -129.82 -47.18 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.238 -0.914 . . . . 0.0 110.023 -179.161 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.557 ' N ' ' CG1' ' A' ' 52' ' ' VAL . 28.6 p -14.75 -56.15 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.303 0.573 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 52' ' ' VAL . 14.5 mmtp -63.55 -59.64 4.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.364 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.587 ' CG ' ' CG ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER -56.29 -62.61 1.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' CG ' ' HA2' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -42.05 -44.88 3.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 110.029 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.1 ' HB2' ' HB ' ' A' ' 34' ' ' THR . . . -59.48 -58.94 6.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.938 -1.102 . . . . 0.0 108.631 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -48.43 -66.55 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.948 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 1.2 mm-40 -44.43 -40.1 5.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.333 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -56.07 -49.4 73.9 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.249 -0.907 . . . . 0.0 108.999 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.975 ' SD ' HG13 ' A' ' 38' ' ' VAL . 18.5 ttm -68.65 -62.57 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.723 . . . . 0.0 110.466 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.015 HD21 ' HA ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -47.75 -64.3 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.825 -1.172 . . . . 0.0 108.274 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 59' ' ' GLU . 48.6 t -50.61 -34.92 12.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' MET . 0.0 OUTLIER -52.2 -66.2 0.43 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 109.05 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.733 HD22 ' H ' ' A' ' 65' ' ' LEU . 1.3 mm? -53.83 -44.18 70.06 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.9 -1.125 . . . . 0.0 110.15 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -53.55 -31.69 47.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.352 -179.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.37 -41.7 19.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.617 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 64' ' ' GLU . 13.3 mt . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 stop_ save_